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Abstract 
Mosquito-borne arboviruses are a considerable threat to human and animal health across 
the world. Many of them are classed as emerging or re-emerging pathogens and the 
incidence of disease for a number of serious viral infections has increased as they expand 
their geographical and host ranges. As with other invertebrates, mosquitoes lack the 
adaptive immune response present in vertebrates and instead rely on their innate immune 
defences to modulate viral infections. Nevertheless, in contrast to vertebrates, arboviral 
infections in their arthropod vector are non-pathogenic and have no cytopathic effect or 
detrimental impact on their survival. The response considered to be the most important for 
antiviral defence in mosquitoes is RNA interference (RNAi) which is a sequence-specific 
RNA silencing mechanism. Most of what is known about antiviral RNAi in arthropods has 
been established in Drosophila as the model insect organism. These studies have benefited 
from an extensive range of genetic mutants, molecular tools, reporter assays and genetic 
profiling. The absence of these tools for use in mosquito research is a substantial deficit for 
arboviral studies in their natural vector system and must be rectified in order to fully 
understand the influence vector immunity has on virus transmission. This thesis discusses 
the development of a ‘molecular tool-box’ for advancing the acquisition of knowledge in 
this area.  
Efficient RNAi gene silencing and its effect on the antiviral RNAi response was 
established in vitro using Semliki Forest virus (SFV) as a model arbovirus. This assay 
determined that knockdown of Argonaute-2 had the most substantial impact on virus 
replication compared to the knockdown of other RNAi proteins. In addition, the limited 
detection of virus-derived small RNAs, key molecules of the antiviral RNAi response by 
Northern blot analysis provides further support to previous evidence that SFV may 
circumvent the antiviral response. It is believed to sequester its genomic RNA, resulting in 
restricted access by the RNAi machinery and preventing the generation of large quantities 
of virus-derived small RNAs. However, some SFV-derived small RNAs are known to be 
produced and these have been shown to generate a pattern of ‘hot’ and ‘cold’ spots along 
the full-length coding sequences. This thesis has determined that this pattern is not 
exclusive to viral-derived double stranded RNA (dsRNA) trigger molecules, but is also 
exhibited following the treatment of mosquito cells in culture with non-viral dsRNA. This 
implies that all exogenous dsRNA is processed by RNAi in a similar manner. 
ii 
 
This study has also characterised the presence of an RNA-dependent RNA polymerase 
(RdRP) encoded by Aedes aegypti mosquitoes. RdRPs are important for the amplification 
and spread of the RNAi signal in other organisms such as plants and worms; however, only 
one study suggested the existence of an RdRP in Drosophila. Although, this project 
proposed the presence and transcription of a homologue of the Drosophila RdRP in the 
Aedes aegypti-derived Aag2 cell line, protein knockdown assays revealed that it had no 
effect on virus replication in vitro; suggesting that it does not function as an RdRP in the 
antiviral RNAi process.  
Due to the lack of antibodies against the major RNAi proteins (Dicer-1, Dicer-2, 
Argonaute-1 and Argonaute-2) in mosquitoes, these antibodies were designed and screened 
which allowed the identification of several candidates for the detection of the proteins in 
mosquito cells in culture. Further to this, recombinant forms of the RNAi initiator protein 
Dicer-2 and the slicer protein Argonaute-2 were successfully generated and tested in vitro 
using different promoters to establish their use for future temporal and spatial kinetic 
studies. It was concluded that of the promoters tested the most successful for the 
expression of these reporter constructs was the subgenomic promoter of SFV. However, a 
second promoter, the Aedes aegypti polyubiquitin promoter, may prove more suitable in 
the future.   
Finally, this project studied the antiviral capabilities of a non-haematophagous mosquito 
cell line which would not come across an arboviral infection by traditional blood- feeding 
routes. Instead the mosquito larvae sustain their adult life stages by feeding on the larvae of 
other species which may be vertically infected. A cell line derived from Toxorhynchites 
amboinensis was characterised and was shown to carry out RNAi if induced by dsRNA 
suggesting that they are able to mount an antiviral response to acquired infections. This 
study also determined that the cell line contains an endogenous insect specific virus and, 
although the source of this is unknown, it adds an interesting new dimension to mosquito 
antiviral immunity.          
This thesis enhances RNAi research in Aedes mosquitoes by presenting novel molecular 
tools and reporter assays which will be highly valuable for facilitating future 
investigations. The studies performed also add to what is already understood regarding the 
interaction between SFV and mosquito antiviral immunity through the RNAi response and 
pinpoint the central role of Argonaute-2 in this pathway.    
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1.1 Arboviruses  
 
1.1.1 Overview  
Arboviruses are arthropod-borne viruses which are transmitted by haematophagous (blood 
feeding) arthropod vectors including mosquitoes, ticks, midges and sandflies and can be 
transmitted to susceptible vertebrates when the vector takes a blood meal. A unique feature 
of arboviruses is that in order to complete their transmission cycle they are required to 
replicate in both vertebrate and invertebrate organisms and successfully bypass the 
immune barriers exhibited by both vector and host. Infections are a major medical, 
veterinary and ecological burden worldwide. The predominant diseases resulting from 
infection are encephalitis, haemorrhagic fever and febrile illnesses (Meltzer, 2012). 
Although some human and animal vaccines against certain arboviral infections exist, for 
many this form of treatment has yet to be developed (Metz and Pijlman, 2011). Moreover, 
arboviruses are an increasing global threat. A rise in human travel and trade combined with 
climate change, greater urbanisation and population densities, as well as insect habitat 
adaptation, has allowed the incidence of arboviral diseases to become more widespread. 
The capacity for these viruses to cause disease and reach epidemic status is controlled by 
several key factors and it is widely accepted that both genetic and environmental 
influences will affect vector competency. These aspects will be discussed fully in Chapter 
1.2.3 and Chapter 1.2.4.        
Taxonomically, arboviruses are classed on morphology, antigenic properties, replicative 
mechanisms and genetic strategies. The majority fall into the families of Togaviridae, 
Flaviviridae, Bunyaviridae, Reoviridae and Rhabdoviridae (Table 1.1). Only one example 
of a DNA arbovirus is known, the African swine fever virus (ASFV, Asfarviridae) which is 
spread by ticks (Tulman et al., 2009). The natural enzootic transmission cycle, illustrated 
in Figure 1.1, begins when a vector takes a blood meal from an infected vertebrate host. 
Animal hosts are often rodents, birds and sub-human primates. The pathogen is then 
delivered to the midgut where it must cross the epithelium, escape the midgut and cross 
into the haemocoel (Chapter 1.2.3). It must then replicate within a number of tissues and 
disseminate to the salivary glands. High viral tires are released into the saliva and can be 
transmitted to a suitable new naive host when the arthropod takes a subsequent meal. 
Transmission to humans can take place; although, in most cases they are considered to be 
dead-end hosts as the resulting viraemia is usually too low to allow further transmission to 
occur. However, efficient transmission of chikungunya (CHIKV), yellow fever virus 
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(YFV) and dengue (DENV) viruses has been observed where the enzootic cycle has been 
lost and these viruses are capable of being past between mosquito vectors and human hosts 
without the need for an animal intermediate (Weaver, 2006, Weaver and Reisen, 2010, 
Durbin et al., 2013, Weaver, 2014). In this way, extensive epidemics can be efficiently 
maintained in urban areas. In addition to classical horizontal transmission, other routes of 
transmission such as vertical (from an infected adult to its offspring) and venereal 
transmission (from a vertically infected male to a female) are documented. These are less 
common and are discussed in more detail in Chapter 6.   
 
 
 
Figure 1.1: Enzootic cycle of arbovirus transmission. Arboviruses cycle between arthropod 
vectors, such as mosquitoes, midges and ticks, to susceptible vertebrate hosts. Hosts include birds, 
mammals and sub-human primates. Human infections occur but viraemia is often too low to permit 
onward transmission and they are therefore considered to be dead end hosts.     
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Table 1.1: Arbovirus families. Example family members, their genetic structure and vector species.    
Genome Family Genus Virus (Abbr.) Segments Vector Main Species Reference 
(+)ssRNA 
Togaviridae Alphavirus 
Sindbis virus (SINV) 
One Mosquito 
Aedes spp. 
(Griffin, 2013, Kuhn, 
2013)  
Chikungunya virus (CHIKV) Aedes spp. 
Venezuelan equine encepalitis virus (VEEV) Aedes spp. 
Semliki Forest virus (SFV) Aedes spp. 
O'nyong nyong virus (ONNV) Anopheles spp. 
Eastern equine encepalitis virus (EEEV) Culiseta spp. 
Western equine encepalitis virus (WEEV) Culex spp. 
Ross River virus (RRV) Culex spp. 
Flaviviridae Flavivirus 
West Nile virus (WNV) 
One 
Mosquito Culex spp. 
(Gubler et al., 2007, 
Lindenbach et al., 
2007) 
Dengue virus (DENV) Mosquito Ae. aegypti 
Yellow Fever virus (YFV) Mosquito Aedes spp. 
Japanese encephalitis virus (JEV) Mosquito Aedes spp. 
Tick-borne encephalitis virus (TBEV) Tick Ixodes spp 
Powassan virus (POWV) Tick Ixodes spp 
(-)ssRNA 
Bunyaviridae 
Phlebovirus Rift Valley fever virus (RVFV) 
Three 
Mosquito Aedes spp. 
(Schmaljohn and 
Nichol, 2007, Beer et 
al., 2013) 
Orthobunyavirus 
La Crosse virus (LACV) Mosquito Ae. triseriatus 
Schmallenberg virus (SBV) Midge Culicoides spp. 
Nairovirus 
Crimean-Congo haemorrhagic fever virus 
(CCHFV) 
Tick Hyalomma spp. 
Rhabdoviridae Vesiculovirus 
Vesticular stomatitis virus (VSV) 
One Sand fly Phlebotominae (Lyles et al., 2013) 
Chandipura virus (CHPV) 
dsRNA Reoviridae Orbivirus 
Bluetongue virus (BTV) 
Ten 
Midge Culicoides spp. 
(Roy, 2013) African horse sickness virus (AHSV) Midge Culicoides spp. 
Colorado tick fever virus (CTFV) Tick Dermacentor andersoni 
dsDNA Asfaviridae Asfivirus African swine fever virus (ASFV) One Tick Ornithodoros spp. (Dixon et al., 2013) 
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1.1.2 Medically and Veterinary Important Arboviral Families  
 
1.1.2.1 Bunyaviridae  
The Bunyaviridae family is the largest group of RNA viruses and contains >350 viral 
species, most of which are arthropod-borne and some which are classed as containment 
level 3/4 pathogens. Given the number of prominent malignant human and animal 
pathogens this family contains, such as Rift Valley fever virus (RVFV), La Crosse virus 
(LACV), Crimean-Congo haemorrhagic fever virus (CCFHV) the recently emerged 
Schmallenberg virus (SBV) and severe fever with thrombocytopenia syndrome virus 
(SFTSV), bunyaviruses are a significant threat to human health and animal welfare across 
a number of continents.    
Bunyaviruses are divided into five genera: Orthobunyavirus, Phlebovirus, Hantavirus, 
Nairovirus and Tospovirus (Elliott, 1990, Schmaljohn and Nichol, 2007, Walter and Barr, 
2011). Orthobunyaviruses, phleboviruses and nairoviruses are spread by midges, 
mosquitoes, ticks and sandflies (Tesh, 1988, Labuda, 1991), whereas tospoviruses, the only 
pathogenic plant genus in the Bunyaviridae family, are transmitted by thrip vectors 
(Whitfield et al., 2005). Hantaviruses are the exception as they are not classed as 
arboviruses due to the absence of a known vector and are spread by rodents (Schmaljohn 
and Hjelle, 1997, Zhang, 2014). All member viruses share certain features. They are 
enveloped and contain a negative sense single stranded RNA (ss(-)RNA) genome which is 
divided into three segments, named according to their size (Elliott, 1990, Schmaljohn and 
Nichol, 2007). The L (Large) segment encodes the L protein which acts as the viral RNA-
dependent RNA polymerase (RdRp) (Endres et al., 1989). The M (Medium) segment 
encodes the precursor for the viral glycoproteins which are produced following post-
translational processing (Lees et al., 1986). The S (Small) segment encodes the 
multifunctional nucleocapsid (N) protein (Eifan and Elliott, 2009). Some phleboviruses 
have an ambisense S segment which allows bi-directional coding during replication 
(Shope, 1996). As with other multi-segmented genome viruses, bunyaviruses are known to 
undergo genomic re-assortment during mixed infections (Beaty et al., 1985, Borucki et al., 
1999, Reese et al., 2008).  
The spherical virions are approximately 100 nm in diameter and are composed of four 
structural proteins; the two external glycoproteins (Gn and Gc), the N and the L protein. It 
is understood that the N protein binds and coats the viral RNA and interacts with the L 
protein to form ribonucleoprotein (RNP) complexes with a specific ‘panhandle’ structure, 
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linking them to the envelope proteins (Kaukinen et al., 2005). Certain viruses have also 
been shown to encode non-structural protein(s) on their M (NSm) and/or S (NSs) segments 
which are hypothesised to interact with the immune system and be involved in viral 
pathogenesis; although, their functions are still largely unknown (Eifan et al., 2013).   
Many bunyaviruses are classed as emerging or re-emerging agents due to the expansion of 
their host and geographical ranges. In particular, there has been a great increase in the 
geographic distribution of RVFV over the past 17 years and outbreaks have been reported 
in East Africa (1997/98 and 2006/07) (Anyamba et al., 2010), Kenya (1997/98 and 
2006/07) (Woods et al., 2002, Nguku et al., 2010), Sudan (2007) (Hassan et al., 2011), 
Southern Africa (2008-2010) (Anyamba et al., 2010) and Saudi Arabia and Yemen (2000, 
2010) (Balkhy and Memish, 2003, Aradaib et al., 2013). SFTSV is a newly identified 
member of the phlebovirus genus and has so far been recognised as a human pathogen in 
China, Japan and South Korea (Feldmann, 2011, Zhang et al., 2013b). It emerged in 2007 
from the Huaiyangshan mountain range in China and is believed to be carried by a tick 
vector, specifically Haemaphysalis longicornis (Xu et al., 2011, Yu et al., 2011, Zhang et 
al., 2011, Zhang et al., 2012). However, direct human-human transmission has also been 
documented (Gai et al., 2012, Liu et al., 2012). As the name suggests, symptoms include 
fever, leukopenia, thrombocytopenia and it has a high case fatality rate of between 12 - 30 
%. More recently, the emergence of SBV in 2011 had a devastating agricultural and 
economic impact following its spread across Germany, the Netherlands, Belgium, France, 
Italy, Luxembourg, Spain and the United Kingdom (Steukers et al., 2012, Beer et al., 2013, 
Doceul et al., 2013, Balenghien et al., 2014). The virus, classed as an orthobunyavirus, is 
transmitted by a midge vector and causes fever, diarrhoea, milk drop, loss of appetite and 
abortion in sheep, cattle and goat herds. Offspring of infected individuals can be still born 
and live births were often found to have congenital malformations and physical 
abnormalities.  
 
1.1.2.2 Flaviviridae  
There are >70 members of the Flaviviridae family which belong to one of three genera, 
Flavivirus, Hepacivirus and Pestivirus. The Flavivirus genus is the largest and is the only 
one to contain arboviruses transmitted by either mosquitoes; such as YFV, DENV, West 
Nile virus (WNV) and Japanese encephalitis virus (JEV), or ticks; such as tick-borne 
encephalitis virus (TBEV) (Gubler et al., 2007, Schweitzer et al., 2009, Rust, 2012). In 
addition to arthropod-borne viruses, the flaviviruses also contain a group with no known 
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vector (Kuno et al., 1998, Cook and Holmes, 2006), as well as insect specific flaviviruses 
(ISF) which have been shown to be incapable of infecting vertebrates (Cammisa-Parks et 
al., 1992) (discussed in detail in Chapter 6). As a result, flaviviruses are of particular 
interest to evolutionary virologists as a model for understanding the evolution of vector-
borne diseases and may provide some insight into important features of emerging and re-
emerging viruses (Holmes, 1998).  
Flaviviruses are enveloped and contain a single stranded, un-segmented positive sense 
(ss(+)RNA) genome which is approximately 10.7 kb long (Rice et al., 1985, Lindenbach 
and Rice, 2003, Harris et al., 2006, Lindenbach et al., 2007). The genomic RNA has a 5’ 
cap but unlike cellular mRNAs they lack a polyadenylated (poly(A)) tail at the 3’ end. It is 
translated as a single polyprotein flanked by 5’ and 3’ untranslated regions (UTRs). These 
regions form complex secondary structures and play important roles in the regulation of 
translation, RNA synthesis and virus replication (Charlier et al., 2002, Markoff, 2003, 
Gritsun et al., 2006). The polyprotein is co- and post- translationally cleaved by a 
combination of viral and host proteases into three structural proteins (the capsid protein 
[C], the membrane glycoprotein precursor [prM] and the envelope glycoprotein [E]) and 
seven non-structural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). 
NS5 is the most highly conserved protein within the flaviviruses and codes for the RdRP 
(Mandl et al., 1989). The NS proteins, including NS5, and additional host factors form the 
replication complex to facilitate the synthesis of new viral RNA (Lindenbach et al., 2007). 
The C protein is important for the formation of the icosahedral nucleocapsid which 
encapsidates the genome (Mukhopadhyay et al., 2005). The nucleocapsid is surrounded by 
a host-derived lipid bilayer in which is embedded the E protein, the chief structural protein 
documented to be the principle target for neutralising antibodies (Sanchez et al., 2005, 
VanBlargan et al., 2013). In immature virions, the prM protein protects the E protein from 
degradation. During the exit of the virus from the cell, the prM protein is cleaved into the 
mature M protein and the ‘pr’ segment so only mature virons present the M protein 
embedded in the bilayer. The resulting mature virons are spherical and are about 50 nm in 
diameter (Lindenbach et al., 2007).  
Mosquito-borne flaviviruses represent some of the most serious emerging and re-emerging 
global pathogens (Mackenzie et al., 2004). They can be divided into those transmitted 
primarily by Culex spp. vectors (WNV, JEV) and those from Aedes spp. vectors (DENV, 
YFV). Interestingly, this is also split into those resulting in encephalitic disease being 
associated with Culex transmission and those viruses resulting in haemorrhagic diseases 
associating with Aedes spp. (Gaunt et al., 2001). DENV is responsible for the greatest 
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incidence of disease and mortality within the genus and there is currently no effective 
vaccine or specific treatment available. It is the pathogen behind dengue fever as well as 
the life threatening dengue haemorrhagic fever and dengue toxic shock syndrome. Over 2.5 
billion people (> 40 % of the population) are said to live in dengue-endemic areas in more 
than 100 countries worldwide (Guzman and Kouri, 2002, Bhatt et al., 2013). It results in 
between 50 - 100 million cases with approximately 22,000 deaths worldwide annually 
(Gubler, 2012) compared to an estimated 200,000 cases/40,000 deaths from YFV (Monath, 
2001) and 50,000 cases/15,000 deaths from JEV worldwide (Solomon and Vaughn, 2002, 
Fischer et al., 2008). The emergence and recurrence of epidemic dengue has become more 
frequent with larger epidemics and more severe symptoms (Halstead, 1992, Gubler and 
Clark, 1995, Gubler, 1998b, Gubler, 2002, Gubler, 2011, Gubler, 2012, Messina et al., 
2014, Schaffner and Mathis, 2014). The most recent outbreak occurring in Japan in 
September 2014, the first since 1945 (Torres, 2014). It should also be noted that recently a 
fifth dengue virus serotype was identified from an outbreak in Malaysia in 2007 (Normile, 
2013), in addition to the four (DENV-1, DENV-2, DENV-3, DENV-4) previously 
characterised serotypes (Zanotto et al., 1996). This discovery remains controversial, but if 
confirmed it will further complicate future vaccine developments and has implications for 
disease control.     
 
1.1.2.3 Togaviridae  
Viruses belonging to the Togaviridae family are divided between two genera: Alphaviruses 
and Rubiviruses (Kuhn, 2013). The Rubivirus genus contains a single virus, rubella virus 
which is a common disease in children but with no arthropod vector. This is unlike the 
Alphavirus genus which contains a number of arboviruses. There are approximately 30 
acknowledged arthropod-borne alphaviruses consisting of both human and animal 
pathogens (Weaver et al., 2000). They are subdivided into those which infect terrestrial 
hosts, usually mammals or birds, and those infecting fish. Salmonid fish, like trout and 
salmon, are hosts to aquatic alphaviruses such as salmon pancreatic disease virus and 
sleeping disease virus. Although sea lice are known to be infected, they have not been 
conclusively verified as a vector for these viruses (McLoughlin and Graham, 2007, 
Forrester et al., 2012b, Kuhn, 2013). In addition, a novel ‘mosquito-specific’ alphavirus 
named Eilat virus, was recently described which is speculated to be incapable of 
replicating in vertebrate cells (Nasar et al., 2012). The alphavirus transmission cycle 
generally involves mosquito vectors; although ticks and lice are able to transmit some 
alphaviruses. Most infections are known to cause a range of symptoms including: fever, 
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rashes, arthritis, arthralgia and, most prominently, encephalitis (Zacks and Paessler, 2010). 
Although rubella virus shares several properties with alphaviruses, such as genomic 
organisation and virion structure, as it is not classed as an arbovirus only the alphavirus 
genus shall be described in detail.     
 
1.1.2.4 Genus Alphavirus 
1.1.2.4.1 Spread and Geographical Distribution  
As most alphaviruses are transmitted by arthropod vectors this is likely to impact their 
geographic dispersal; however, they have been shown to have a worldwide distribution. 
They can be defined as either Old World or New World viruses depending on the 
geographical origin of isolation. Old World alphaviruses, including CHIKV, Semliki 
Forest virus (SFV), Sindbis virus (SINV) and o’nyong-nyong virus (ONNV) originating in 
Africa and Asia, in addition to Ross River virus (RRV) identified in Australia, are 
responsible for causing rashes, myalgia and arthralgia. New World alphaviruses consist of 
those identified in the Americas which generally cause encephalitis (Zacks and Paessler, 
2010). These include Eastern equine encephalitis virus (EEEV), Western equine 
encephalitis virus (WEEV) and Venezuelan equine encephalitis virus (VEEV).  
Although historically classed as a virus of Africa, CHIKV has spread extensively 
throughout the Old World and the New. It was first isolated in 1952 in Tanzania 
(Robinson, 1955) and was named chikungunya which translates as ‘that which bends up’ 
from the native Makonde language to describe the painful, contorted posture of those 
infected by it. CHIKV was not traditionally believed to be life-threatening; although, in 
contrast to other arboviral infections only 5 - 25 % of infections are asymptomatic and 
patients are known to exhibit symptoms including headaches, vomiting, rashes, fevers, 
myalgia and severe arthralgia. The disease can be highly debilitating and the pain can last 
for several months to years. As the symptoms and geographic spread are similar to that of 
DENV it is likely that the diseases were often confused and that CHIKV was under-
diagnosed (Carey, 1971). However, more recently, CHIKV has become recognised as one 
of the most dangerous re-emerging pathogens, largely due to two substantial epidemics 
infecting naive populations. Unusually, these outbreaks have reported a considerable 
number of human deaths which may suggest that newly emerged strains of CHIKV are 
more virulent in humans (Mavalankar et al., 2008, Robin et al., 2008). The first apparently 
appeared from Kenya in 2004 and spread to islands of the Indian Ocean, most notably to 
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La Reunion (discussed in Chapter 1.2.1). The second was a closely related strain that 
appeared in India from East Africa and has caused in the region of 1 - 6 million cases. A 
major fear was the spread of CHIKV to Europe and the Americas, both of which have 
become a reality as the virus arrived in Italy in 2007 (Rezza et al., 2007) and in the 
Caribbean at the end of 2013 (Cauchemez et al., 2014, Leparc-Goffart et al., 2014, Noel 
and Rizzo, 2014, Powers, 2014, Weaver, 2014). Cases of the virus, including 
autochthonous transmissions, later appeared in the continental United States, South and 
Central America from June 2014 and according to the Centres for Disease Control and 
Prevention (CDC) as of the 12
th
 September 2014 there were over 706,000 suspected cases, 
8,650 confirmed cases and 113 fatalities; although, these were restricted to Latin 
Caribbean. The disease is spread by Ae. aegypti and Ae. albopicus both of which are highly 
established in these areas (discussed further in Chapter 1.2). This, coupled with a naive 
resident population, high level of travel into and out of these areas and the lack of an 
effective vaccine means that these numbers may only continue to increase in the future 
unless appropriate prevention strategies can be implemented.  
 
1.1.2.4.2 Genome Organisation  
Alphaviruses consist of a ss(+)RNA genome surrounded by an envelope. The viral genome 
is approximately 11.5 kb which is capped at the 5’ end and polyadenylated (poly(A) tail) at 
the 3’ end. This allows it to function like a cellular messenger RNA (mRNA) and be 
directly translated by the host cell translation machinery whilst protecting it from 
degradation (Strauss et al., 1983). It is separated into two open reading frames (ORFs) 
which encode the nine viral proteins (Strauss and Strauss, 1994). The larger ORF at the 5’ 
end encompasses approximately two-thirds of the genome and produces the four non-
structural proteins (nsP1, nsP2, nsP3 and nsP4) from the nsP1234 polyprotein (Figure 
1.3). The remaining third encodes a separate polyprotein from which the five structural 
proteins (the capsid protein [C], the 6 kDa protein [6K] and three envelope glycoproteins 
[E1, E2 and E3]) are generated under the control of the internal subgenomic (26S) 
promoter (Kaariainen et al., 1987) (Figure 1.4). E2 and E3 are produced from a precursor 
termed p62. The nsPs are known to be multi-functional (Strauss and Strauss, 1994, 
Kaariainen and Ahola, 2002) and Table 1.2 summarises their known actions.  
Alphavirus particles are in the region of 70 nm in diameter and have a spherical 
appearance. The surrounding envelope is composed of a lipid bilayer derived from the host 
cell plasma membrane. On the surface, three E1-E2 heterodimers form each of the eighty 
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spikes embedded in the envelope surrounding the nucleocapsid (Ziemiecki and Garofff, 
1978, Vaux et al., 1988, Metsikko and Garoff, 1990, Owen and Kuhn, 1997). The 
nucleocapsid is arranged in a T = 4 icosahedral arrangement of 240 copies of the C 
proteins (Coombs and Brown, 1987, Paredes et al., 1993). The known role that each of the 
structural proteins plays in the virus life cycle is described in Table 1.2.  
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Table 1.2: The function of each of the nine alphavirus proteins.   
 
Protein 
Size 
(aa) 
Function Reference 
N
o
n
-S
tr
u
ct
u
ra
l 
P
ro
te
in
s 
nsP1 537 
Anchors the replication complex to the host 
cell membrane. 
 
Instigates the production of (-) sense RNA 
from the (+) sense genome RNA. 
 
Part of the RNA capping complex.   
 
(Kujala et al., 2001, Spuul et al., 
2007) 
 
(Hahn et al., 1989, Wang et al., 
1991) 
 
(Ahola et al., 1997, Vasiljeva et 
al., 2000) 
nsP2 799 
Acts as a nucleoside triphosphatase and an 
RNA helicase 
 
 
Directs nuclear localisation  
 
 
Possesses protease activity to cleave the 
non-structural polyprotein  
 
 
Regulates subgenomic RNA synthesis  
(Rikkonen et al., 1994, Gomez de 
Cedrón et al., 1999, Vasiljeva et 
al., 2001)  
 
(Peranen et al., 1990, Rikkonen et 
al., 1992, Rikkonen, 1996) 
  
(Hardy and Strauss, 1989, 
Takkinen et al., 1991, Merits et 
al., 2001) 
  
(Suopanki et al., 1998)  
nsP3 482 Regulates RNA synthesis  
(Hahn et al., 1989, Li et al., 1990, 
LaStarza et al., 1994, Vihinen et 
al., 2001)  
nsP4 614 
An RNA-dependent RNA polymerase  
 
 
Possesses protease activity and processes 
nsP3 from nsP4 from within the polyprotein  
(Kamer and Argos, 1984, Hahn et 
al., 1989, Tomar et al., 2006) 
  
(Takkinen et al., 1990, Takkinen 
et al., 1991) 
S
tr
u
ct
u
ra
l 
P
ro
te
in
s 
 
C 267 
Forms nucleocapsid core by encapsidating 
the genomic RNA 
 
Carboxyl domain is an autocatalytic serine 
protease  
(Weiss et al., 1989, Owen and 
Kuhn, 1996) 
 
(Aliperti and Schlesinger, 1978, 
Melancon and Garoff, 1987)  
E3 66 Undefined 
(Garoff et al., 1974, Simizu et al., 
1984) 
E2 422 
Involved in receptor binding  
 
 
Major epitope for neutralizing antibodies  
 
 
 
Interacts with nucleocapsid  
(Garoff et al., 1980, Liu and 
Brown, 1993, Smith et al., 1995) 
 
(Roehrig et al., 1990, Hunt et al., 
2010, Hunt et al., 2011, Kam et 
al., 2012) 
 
(Metsikko and Garoff, 1990, 
Owen and Kuhn, 1997)  
6K 60 
E1 leader peptide  
 
 
Putative Ion Chanel  
 
 
Essential for new virion assembly  
(Lusa et al., 1991, Sanz and 
Carrasco, 2001)  
 
(Sanz et al., 1994, Sanz et al., 
2003, Melton et al., 2002) 
  
(Gaedigk-Nitschko and 
Schlesinger, 1990, Ivanova et al., 
1995)  
E1 438 Responsible for membrane fusion 
(Omar and Koblet, 1988, Boggs 
et al., 1989) 
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1.1.2.4.3 Replication  
Alphavirus replication occurs in the cytoplasm (Figure 1.2) (Leung et al., 2011). They 
enter the cell via receptor mediated endocytosis through the action of the E2 glycoprotein 
binding to the cellular receptor. The exact receptor involved is not known but due to the 
wide host range that alphaviruses can infect it is suggested that 1) the receptor is highly 
conserved across vertebrate and invertebrate host species or 2) the E2 protein has multiple 
receptor binding sites and can enter via a number of cellular molecules (Kuhn, 2013). 
Following attachment, the virus is taken up through clathrin-mediated endocytosis forming 
a vesicle which fuses first with an endosome and then with a lysosome to permit the 
breakdown of the outer viral components (Helenius et al., 1980, Marsh and Helenius, 1980, 
Marsh et al., 1983, DeTulleo and Kirchhausen, 1998, Strous and Govers, 1999). This 
occurs due to the decreasing pH within the maturing vesicles creating an acidic 
environment. As a result, the glycoprotein spike complexes undergo a conformational 
change promoting E1-mediated fusion of the virus envelope with the lysosome membrane 
(Wahlberg et al., 1989, Wahlberg and Garoff, 1992, Gibbons et al., 2004). This produces a 
fusion pore through which the nucleocapsid core is ejected into the cytoplasm, 
disassociates and releases the viral genome (Fuller et al., 1995). 
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Figure 1.2: The Alphavirus life cycle. Starting at the top left, the virus enters the cell by attaching 
to the cellular receptor. It is taken up by clathrin-mediated endocytosis before the membranes fuse 
causing the disassembly of the viral coat. The genome replicates in cytoplasmic replication 
complexes (bottom left) before associating with the capsid proteins. These come together with the 
processed glycoproteins and bud as mature virions from the plasma membrane (top right). Taken 
from Kuhn, 2013.  
 
Translation is initiated at the 5’ end and so produces the non-structural P1234 polyprotein 
first (Takkinen, 1986) (Figure 1.3 and Figure 1.4). The presence of an opal stop codon 
(UAG) has been determined between the nsP3 and nsP4 genes in a number of alphaviruses 
including SINV. The result of this is the generation of a greater concentration of P123 
polyprotein compared to P1234. However, some P1234 polyprotein is produced as this 
codon is slightly ‘leaky’ and allows read-through to occur at an occurrence of 5 – 20 % 
(Strauss et al., 1983). However, in other alphaviruses, such as SFV and ONNV, this 
termination codon has been replaced with an arginine codon (CGA) allowing only P1234 
to be produced (Strauss et al., 1983, Takkinen, 1986, Tuittila et al., 2000, Myles et al., 
2006). The individual proteins are cleaved from the polyprotein through the action of the 
nsP2 protease which has a papain-like protease domain at its C-terminal (Merits et al., 
2001). The proteolytic process always occurs in the same order with nsP4 being released 
almost immediately followed after a lag by nsP1 and finally nsP3 (Figure 1.3) (Kim et al., 
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2004). The cleaved non-structural proteins align with each other to form a replication 
complex which associates with cellular membranes (Friedman et al., 1972, Grimley et al., 
1972, Kujala et al., 2001, Salonen et al., 2005, Spuul et al., 2007). A number of inward 
invaginations termed spherules form at the plasma membrane and it is here that negative 
sense full length antigenome is transcribed from the template positive sense genome 
mediated by the viral RdRP, nsP4 and P123 (Spuul et al., 2010) (Figure 1.4). Following 
the cleavage of P123 into its constituent parts, less antigenome is produced and instead 
new viral positive sense RNA (42S RNA) is generated from the antigenome template, 
modulated by the cleaved non-structural proteins.   
 
 
Figure 1.3: Alphavirus polyprotein processing. The non-structural proteins (nsP1, nsP2, nsP3 
and nsP4, shown in purple) are translated first and proteolytically cleaved into the individual 
replicase proteins. The structural proteins (shown in blue) are translated from the subgenomic RNA 
under the control of the subgenomic promoter and subsequently cleaved into the capsid (C), 6K and 
glycoproteins (E1, E2, E3).  Cleavage sites are indicated with small black arrows.   
   
The structural genes are translated late in the infection cycle from the subgenomic (26S) 
RNA) which is produced following transcription from the internal subgenomic promoter 
(Kaariainen et al., 1987, Kim et al., 2004) (Figure 1.4). The C protein is autoproteolytic 
and is rapidly cleaved from the remaining polyprotein, ready to associate with newly 
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synthesised viral genomes by interacting with the packaging signal (Aliperti and 
Schlesinger, 1978, Melancon and Garoff, 1986, Weiss et al., 1989, Owen and Kuhn, 1996). 
Its cleavage exposes the N-terminal signal of p62 which results in the transport of the 
remaining polyprotein to the endoplasmic reticulum (ER) where host cellular signalases 
cleave the remaining polyprotein, with the exception of E2 which is processed later in the 
secretory pathway by furin-like proteases (Bonatti et al., 1984, de Curtis and Simons, 1988, 
Garoff et al., 1990, Sariola et al., 1995, Zhang et al., 2003). Both p62 and E1 become 
embedded in the ER membrane due to their transmembrane domains and are modified by 
the ER and Golgi through the addition of fatty acids, carbohydrate chains and side chains 
(Melancon and Garoff, 1986). The processed E1 and E2 glycoproteins interact to form 
heterodimers which are transported to the cell surface via the Golgi apparatus (Figure 1.2) 
(Ziemiecki et al., 1980, Green et al., 1981, de Curtis and Simons, 1988, Sariola et al., 
1995). In some alphaviruses, such as SFV, E3 interacts with the viral spikes; however, in 
others, like SINV, it remains in the cell cytoplasm (Strauss and Strauss, 1994). The 
nucleocapsid, formed of the C protein and viral genome, associates with the cytoplasmic 
tail of the E2 glycoprotein which stimulates budding (Vaux et al., 1988, Metsikko and 
Garoff, 1990, Strauss and Strauss, 1994, Owen and Kuhn, 1997). Release by budding 
allows the new viral progeny to acquire a membrane derived from the host cell plasma 
membrane (Acheson and Tamm, 1967, Laine et al., 1973, Vogel et al., 1986, Fuller, 1987).  
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Figure 1.4: Replication of an alphavirus genome. The 5’ Open Reading Frame (ORF) encodes 
the non-structural polyprotein and is translated directly from the positive sense genomic RNA 
strand. The complete viral genome is transcribed into a full-length, negative sense RNA copy, 
termed the antigenome which is used to generate further copies of the positive sense genome, as 
well as producing subgenomic RNA. The structural genes encoded in the 3’ ORF of the genome 
are translated directly from the subgenomic mRNA under the control of an internal subgenomic 
promoter located in the antigenome. 
 
1.1.2.4.4 Semliki Forest Virus (SFV) as a Model Alphavirus  
SFV originates from sub-Saharan Africa and is transmitted by Aedes spp. mosquitoes 
(Fazakerley, 2002). It was first isolated in 1942 in female Ae. abnormalis from Semliki 
Forest in Uganda (Smithburn and Haddow, 1944). Infected patients in the Central African 
Republic exhibited mild febrile illnesses with symptoms such as fever, myalgia, arthralgia 
and severe, persistent headaches (Mathiot et al., 1990). Despite being detected in humans, 
equines, small mammals and primates, the natural host of SFV has yet to be determined.   
Along with SINV, SFV is one of the most commonly studied viruses used for alphavirus 
research for a number of reasons. Firstly, its genome is manipulated easily which allows 
mutations or foreign reporter genes, such as those encoding fluorescent proteins or 
luciferase, to be inserted. SFV can also be used as a vector for the delivery of genes for 
vaccine and therapeutic treatments (Atkins et al., 1996, Atkins et al., 1999, Hoffmann et 
al., 2001, Lundstrom, 2003, Lundstrom and Ehrengruber, 2003). These genes can be 
inserted into a number of regions within the genome as required, with varying degrees of 
expression and stability. For instance, insertion within the replicase acts as an indirect 
marker of replication, whereas if inserted before, into or after the structural ORF, the 
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protein will be expressed by the viral progeny (Fragkoudis et al., 2007, Tamberg et al., 
2007, Kiiver et al., 2008, Rodriguez-Andres et al., 2012). If required, the subgenomic 
promoter can also be duplicated to allow a greater quantity of foreign genes to be 
expressed (Tamberg et al., 2007). Alternatively the structural genes can be removed 
entirely and replaced with the foreign gene of interest resulting in the production of a 
replicon. These can be packed into virus replicon particles (VRPs) which have an increased 
level of biosafety (Liljestrom and Garoff, 1991, Berglund et al., 1993, Smerdou and 
Liljestrom, 1999). Several examples of reporter strains of SFV and SFV VRPs are used 
throughout this thesis and are described in Table 2.4 and Figure 2.1. The use of SFV 
VRPs is also discussed in detail in Chapter 5.  
Secondly, a number of SFV strains have been produced for laboratory use including the 
molecular clone of the prototype strain, SFV4. These are either virulent or avirulent in 
adult mice (Seamer et al., 1967, Bradish et al., 1971, Pusztai et al., 1971, Atkins, 1983, 
Fazakerley, 2002, Fazakerley, 2004) and these have been used to successfully infect 
multiple animal models in addition to mice, such as rats, rabbits, guinea pigs and voles, as 
well as several vertebrate and invertebrate cell lines (Seamer et al., 1967, Bradish et al., 
1971, Peleg, 1971, Leake et al., 1980, Atkins et al., 1990). However, none of these strains 
are considered to result in disease following human infection, with the exception of one 
fatal case of an immunocompromised scientist who died of encephalitis in 1978 from a 
strain that has since been removed from use (Willems et al., 1979). As SFV is closely 
related to CHIKV but lacks the same level of pathogenicity, it can be used as a safer 
alternative to accurately model its biology and infectivity. Moreover, its rapid replication 
cycle and easy propagation further add to its appeal for use in arboviral studies.     
SFV infections of vertebrate and invertebrate cells differ substantially. Generally, infected 
mammalian cells exhibit a rapid cytotoxity or cytopathic effect (CPE); although this is not 
observed in mosquito or tick cells (Peleg, 1968, Leake et al., 1980, Brown, 1984). 
Infection in mosquito cells is characterised by an initial peak of virus production 
subsequently followed by a steady decrease into a low level, persistent infection 
(Fragkoudis et al., 2008). SFV has been previously proven to be an excellent model for 
studying the innate immune responses in mosquitoes (Fragkoudis et al., 2008, Rodriguez-
Andres et al., 2012) and is used exclusively for the analysis of mosquito antiviral RNAi 
responses in this thesis.   
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1.2 Mosquito Vectors  
 
1.2.1 Important Vectors of Disease Transmission 
Mosquitoes belong to the family Culicidae in the order Diptera. The Culicidae is divided 
into two subfamilies which contain over 3,500 species. As the work described as part of 
this thesis focuses on Ae. aegypti and Ae. albopictus derived cell lines only these two 
species shall be discussed.   
Aedes along with Culex spp. are among the small number of animals that are distributed 
globally. The yellow fever mosquito or Aedes (Stegomyia) aegypti (Figure 1.5A) 
originated in Africa and is involved in the transmission of prominent arboviruses to 
humans, particularly DENV and YFV. Human transport, mainly the slave trade, is believed 
to be the cause of its dispersal out of Africa and it now inhabits many temperate, 
subtropical and tropical regions across the planet (Tabachnick, 1991, Soumahoro et al., 
2010, Powell and Tabachnick, 2013). It is well known to be highly anthropogenic (i.e. 
feeding on humans) and has adapted to human-inhabited areas to become highly 
domesticated, laying its eggs in artificial containers. Its propensity for feeding on humans 
and rarely flying beyond 100 meters enhances its ability to maintain urban cycles of 
arboviruses (Powell and Tabachnick, 2013). As a result of this capacity to maintain 
epidemics of DENV and YFV around urbanised areas, many control measures have 
focused on the eradication of this species. Mosquito control measures are of particular 
importance given the lack of vaccines against many arboviral infections. Eradication 
campaigns saw the complete removal of Ae. aegypti from the Americas (Soper, 1967, 
Kouri et al., 1989) and control strategies in southern Asia greatly reduced the incidence of 
disease (Gratz, 1967, Lofgren et al., 1970, Pant et al., 1971, Bang and Pant, 1972, Ooi et 
al., 2006). Unfortunately, these programmes were unsustainable and since they ended Ae. 
aegypti have returned to these countries (Gubler, 1998a) and over 50 % of homes in many 
endemic areas are found to harbour their larvae (Nathan and Knudsen, 1991, WHO, 2000). 
In addition, Ae. aegypti has largely developed resistance to multiple insecticides making 
alternative control strategies necessary (Hemingway et al., 2004).       
Aedes (Stegomyia) albopictus (Figure 1.5B), commonly known as the Asian tiger 
mosquito (Skuse, 1894), is a highly invasive species that has spread outside its origins in 
the forests of Southeast Asia (Smith, 1956) and is now found additionally in Africa 
(Savage et al., 1992, Fontenille and Toto, 2001, Coffinet et al., 2007), the Americas 
(Forattini, 1986, Hawley et al., 1987, Nawrocki and Hawley, 1987, O'Meara et al., 1995, 
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Moore, 1999, Braks et al., 2003), Europe (Dalla Pozza and Majori, 1992, Knudsen et al., 
1996, Adhami and Reiter, 1998, Romi et al., 1999, Schaffner and Karch, 2000, Schaffner 
et al., 2004, Aranda et al., 2006, Klobucar et al., 2006, Romi et al., 2006, Roiz et al., 2008, 
Lambrechts et al., 2010, Medlock et al., 2012, Werner et al., 2012) and several locations in 
the Indian and Pacific Oceans (Elliott, 1980, Laille et al., 1990, Delatte et al., 2008, Bagny 
et al., 2009, Guillaumot et al., 2012). Ae. albopictus has been shown to be more adaptable 
to temperate climates than Ae. aegypti and is found to survive in much more northern 
regions, where their eggs enter dormancy to survive low temperatures (Nawrocki and 
Hawley, 1987, Hanson and Craig, 1994, Tran et al., 2013, Capinha et al., 2014, Liu-
Helmersson et al., 2014). Its rapid and widespread dispersal is mainly attributed to the 
international trade of used tires and bamboo harbouring dormant eggs in trapped rain water 
(Reiter, 1998, Linthicum, 2001, Madon et al., 2002, Benedict et al., 2007). Ae. albopictus 
also demonstrates a high degree of ecological plasticity and is likely to have adapted from 
being zoophilic (i.e. feeding on wild animals) in its original forest habitat to  anthropogenic 
in human-dominated habitats (rural, urban and suburban areas) through the process of 
‘domestication’ (Paupy et al., 2009). Although it was initially suggested to be a ‘bridge 
vector’ and be involved in the transmission of emerging viruses between animals and 
humans, it is now understood to be a significant vector in its own right (Moore and 
Mitchell, 1997, Gratz, 2004, Paupy et al., 2009).   
As these species continue to spread, they are subjected to interspecies competition which 
may result in the displacement of the native species. This has implications for the 
incidence of disease in that area through the disruption of the vector: virus system 
(Chevillon et al., 2008). Ae. aegypti and Ae. albopictus are major public health problems, 
most notably as vectors for both DENV and CHIKV (Gratz, 2004, Manore et al., 2014). 
Although DENV is primarily transmitted by Ae. aegypti, which is present in most areas 
were DENV is endemic, Ae. albopictus is an important secondary vector and is responsible 
for DENV epidemics in Japan in 1942-1945 (Hotta, 1998, Kuno, 2007) and for outbreaks 
in Hawaii in 2001-2002 (Effler et al., 2005) and La Reunion and other Indian Ocean 
islands in 1977-1978 (Coulanges et al., 1979, Michault, 1998, Paupy et al., 2001). 
Similarly, it was responsible for outbreaks of CHIKV in Central Africa in 2007 (Peyrefitte 
et al., 2007, Leroy et al., 2009, Paupy et al., 2010). The emergence of CHIKV in 2005-
2006 on La Reunion produced clinical cases in almost 40 % of the population (Enserink, 
2007b). This epidemic was unusual as the virus was shown to have undergone a point- 
mutation which altered a single amino acid (A226V) in the E1 glycoprotein (Page xix). 
This facilitated a selective advantage and a greater degree of infectivity for Ae. albopictus 
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over the more common Ae. aegypti, making it the sole vector during the epidemic (Reiter 
et al., 2006, Tsetsarkin et al., 2007, Vazeille et al., 2007, de Lamballerie et al., 2008, Arias-
Goeta et al., 2013, Arias-Goeta et al., 2014). Following this mutation dissemination rates 
were shown to be enhanced from 7 - 15 days to 2 - 6 days and transmission was also 
improved as viral concentrations were one hundred-fold greater in the salivary glands. The 
geographical range of the virus could thus be expanded across the Indian Ocean to other 
areas inhabited by Ae. albopictus (Paupy et al., 2012). The first outbreak of CHIKV in 
Europe occurred in Italy in 2007 and is understood to have been imported from a vireamic 
individual returning from India and introducing the virus to local Ae. albopictus 
mosquitoes (Enserink, 2007a, Rezza et al., 2007, Angelini et al., 2008). Ae. albopictus 
have also been reported to play a prominent role in the spread of CHIKV and DENV in 
southern France in 2010 (Grandadam et al., 2011, Vega-Rua et al., 2013), including 
autochthonous cases of both infections in France (Gould et al., 2010, Grandadam et al., 
2011) and emerging cases in Central Africa (Paupy et al., 2010).  
Changes in vector distribution and the dominant local vector populations are likely to 
affect the characteristics of arbovirus emergence. Therefore, there is a growing need to 
discern the factors involved in the transmission and spread of these important pathogens 
and develop effective methods of control and prevention.   
   
 
Figure 1.5: Adult female Ae. aegypti (A) and Ae. albopictus (B) (taken from www.vectorbase.org) 
 
 
1.2.2 Mosquito Cell Lines  
The use of mosquito-derived cell lines has been instrumental in uncovering some of the 
basic molecular mechanisms involved in understanding arbovirus: mosquito interactions. 
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To date, over 20 mosquito-derived cell lines have been generated from 13 species of 
mosquito and are successfully used as an efficient alternative to in vivo models for 
immunity studies (Walker et al., 2014). In contrast to work with whole mosquitoes, in vitro 
models provide a cheaper, safe and convenient system in which to test virus:vector 
relationships. In some cases they have proved to be more sensitive and reproducible than in 
vivo studies. The cell lines used as part of this work are described in Table 2.1 and below 
in Table 1.3.  
 
Table 1.3: Aedes spp. mosquito cell lines used during this project.  
Cell type Species Source 
Exogenous RNAi 
activity? 
References 
Aag2 
Aedes 
aegypti 
Embryos Yes 
(Peleg, 1968, Lan and Fallon, 
1990, Sanchez-Vargas et al., 
2009, Siu et al., 2011, Barletta 
et al., 2012) 
U4.4 
Aedes 
albopictus 
Larvae Yes 
(Sarver and Stollar, 1977, 
Igarashi, 1978, Condreay and 
Brown, 1986, Fragkoudis et al., 
2008, Attarzadeh-Yazdi et al., 
2009, Brackney et al., 2010, 
Fallon and Gerenday, 2010)  
C6/36 
Aedes 
albopictus 
Larvae No  
C7-10 
Aedes 
albopictus 
Larvae No 
 
Each of these cell lines were first characterised by Singh in the 1960s (Singh, 1967) and 
have been used extensively for arboviral research with a number of different viruses. The 
Ae. albopictus cell lines are subclones from the original Singh cultures. Due to the fact that 
they have arisen from homogenised larvae, the specific tissues from which they derive are 
unknown. The Ae. aegypti-derived Aag2 cell line is non-clonal and is expected to be an 
amalgamation of the various embryonic tissues.  
Both the Aag2 and the U4.4 cell lines have been proven to be immunocompetent and have 
a functional antiviral response (Riedel and Brown, 1979, Condreay and Brown, 1986, 
Condreay and Brown, 1988, Miller and Brown, 1992, Attarzadeh-Yazdi et al., 2009, 
Sanchez-Vargas et al., 2009, Scott et al., 2010, Siu et al., 2011, Barletta et al., 2012, 
Morazzani et al., 2012, Vodovar et al., 2012, Leger et al., 2013, Schnettler et al., 2013a, 
McFarlane et al., 2014). They are therefore considered to be an accurate representation for 
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antiviral responses in their respective species. On the other hand, both the C6/36 and the 
C7-10 cell lines are described as having a defective RNAi pathway due to a truncation of 
the Dicer-2 (Dcr-2) protein, a property which is discussed further in Chapter 5 (Brackney 
et al., 2010, Scott et al., 2010, Morazzani et al., 2012).  
 
1.2.3 Vector Competence: Intrinsic Factors  
The ability of arboviruses to replicate within the mosquito is governed by a suite of factors 
which alter the insect’s competence or capacity to transmit arthropod-borne viruses. These 
determinants include both genetic and environmental influences and the complexity of the 
interplay between them is only just beginning to be unravelled.    
Following the ingestion of a vireamic blood meal by an immune competent mosquito, the 
virus is passed to the midgut where the blood meal is digested. The virus must then 
traverse into the lining epithelial cells and replicate (Myles et al., 2004, Khoo et al., 2010). 
Once it reaches sufficient titres, the infection disseminates to secondary tissues and organs 
such as nerve tissue, fat bodies, haemocytes, malphighian tubules and the muscles 
surrounding the alimentary tract (Beerntsen et al., 2000, Black et al., 2002). When it finally 
reaches the salivary glands several days later the virus can be transmitted to susceptible 
vertebrates by the mosquito when it takes its next blood meal. The time interval between 
ingestion of the virus and its transmission is known as the extrinsic incubation period (EIP) 
and in order to complete it the virus must first overcome a number of restriction barriers 
(Figure 1.6).  
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Figure 1.6: Schematic representation of virus transmission barriers in mosquitoes. Taken 
from Black et al., 2002.  
 
Several alphaviruses and flaviviruses are known to be affected by the midgut escape 
barrier (MEB) and the midgut infection barrier (MIB) (Hardy et al., 1983, Mellor, 2000, 
Khoo et al., 2010, Arias-Goeta et al., 2013). Firstly, the MIB impedes virus access to the 
mesenteronal cells and prevents replication while the MEB restricts the movement of virus 
particles from the midgut to surrounding tissues in the haemocoel (Hillyer, 2010). The 
success of these barriers has been shown to be dose-dependent as the virus must pass the 
required threshold in order to disseminate and high virus titres are known to overcome the 
MIB (Kramer et al., 1981, Weaver et al., 1984, Miller and Mitchell, 1991, Bosio et al., 
1998, Seabaugh et al., 1998, Myles et al., 2004, Mahmood et al., 2006, Pierro et al., 2007). 
There is therefore an inverse correlation between the infecting dose and EIP. The initial 
viraemia present in the blood meal varies depending on the vertebrate and the virus; 
however, it can be around 10
7
 PFU/ml of blood (Weaver, 1997).  
How the virus is able to evade the midgut barrier is largely unknown but it is understood 
that the virus population is subjected to two bottlenecks; the first in the midgut and the 
second upon reaching the salivary glands (Forrester et al., 2012a). Other digestive, 
intracellular and immunological factors influencing vector competence and pathogen 
infectivity are innate immune pathways, up-regulation of proteolytic enzymes, the 
formation of the peritrophic matrix and an influx of antimicrobial molecules (Shahabuddin 
et al., 1996, Brackney et al., 2008, Kato et al., 2008, Khoo et al., 2010). This is in addition 
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to the natural microflora present in the midgut and the physical barrier of the midgut lining 
(Lindh et al., 2008). Further barriers then await the virus progeny that makes it to the 
salivary glands as they are subjected to the salivary gland infection barrier (SIB) and the 
salivary gland escape barrier (SEB) which also affects transmission (Sriurairatna and 
Bhamarapravati, 1977, Takahashi and Suzuki, 1979, Paulson et al., 1989). If successful the 
virus will replicate in the salivary glands to higher titres than in any other tissue in 
preparation for exportation in the saliva (Valenzuela et al., 2002, Arca et al., 2007). In 
relation to the differences between Ae. aegypti and Ae. albopictus to transmit either DENV 
or CHIKV, studies have indicated that both share a similar level of competency in specific 
regions (with the notable exception of the La Reunion outbreak of CHIKV discussed in 
Chapter 1.2.1) (Paupy et al., 2010, Richards et al., 2012). In addition, meta-analysis of the 
susceptibility of both species suggests that Ae. albopictus is more disposed to midgut 
infections compared to Ae. aegypti, whereas viral infections in Ae. aegypti are better able 
to disseminate which may aid their onward transmission (Lambrechts et al., 2010).  
There is a substantial degree of variation between vector species and their competency for 
arboviruses and several phenotypic variations have been documented both inter- and intra-
specifically (Gubler and Rosen, 1976, Hardy et al., 1976, Tesh et al., 1976, Hardy et al., 
1978, Gubler et al., 1979, Tabachnick et al., 1985, Boromisa et al., 1987, Tardieux et al., 
1990, Armstrong and Rico-Hesse, 2001, Paupy et al., 2001, Bennett et al., 2002, Paupy et 
al., 2003, van den Hurk et al., 2010). Specific MEB, MIB, SEB and SIB have been 
observed which are refined for specific pathogens and influence an individual’s 
competency (Reisen et al., 1996, Dohm et al., 2002, Mahmood et al., 2006, Alto et al., 
2008, Behura and Severson, 2012, Richards et al., 2012). The genetic make-up of both 
virus and vector are important factors in determining the relationship formed between them 
and variations within the phenotype of arboviral isolates/genotypes to circumvent barriers 
and disseminate have been well documented (Reisen et al., 1996, Dohm et al., 2002, 
Mahmood et al., 2006, Alto et al., 2008, Lambrechts et al., 2009, Fansiri et al., 2013, 
Lambrechts et al., 2013). The mechanisms which prejudice these differences between 
populations of the same species are vast and largely undefined. However, it is likely that 
the genetics of the indiviual has a considerable influence in tandem with environmental 
factors (Tabachnick, 2013). Implementing genomic analysis, transcriptomic and proteomic 
studies is expected to identify candidate genes which influence vector competency and 
may benefit future arboviral control studies (Bosio et al., 1998, Bosio et al., 2000, Bennett 
et al., 2005b, Bennett et al., 2005a, Chen et al., 2008, Girard et al., 2010, Tchankouo-
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Nguetcheu et al., 2010, Behura et al., 2011, Colpitts et al., 2011, Bonizzoni et al., 2012, 
Campbell et al., 2014, Esquivel et al., 2014). 
 
1.2.4 Vector Competence: Extrinsic Factors  
Arboviral infections are dynamic and are constantly expanding their geographical 
boundaries. This has been largely facilitated by the increase of vector ranges as areas that 
were once free of these significant pests have now seen an influx of these often invasive 
species (Gratz, 2004, Benedict et al., 2007, Enserink, 2007a, Paupy et al., 2009, Medlock 
et al., 2012). Human travel and transport patterns have substantially changed resulting in 
an enhanced level of international traffic, most crucially from viral endemic to naive areas.   
Temperature is considered to be one of the most prominent factors affecting vector 
permissiveness and it is well known that the earth is warming. A slight rise in temperature 
allows vector populations to migrate and establish new colonies in immunologically naive, 
more northern regions, potentially bringing disease with them (Githeko et al., 2000). 
Indeed, climatic influences and virus outbreaks are so closely linked, analysis of weather 
patterns allows disease incidences to be predicted, for instance with RVFV (Davies et al., 
1985, Linthicum et al., 1999). Alterations in weather patterns are also likely to lengthen 
transmission seasons, increase breeding grounds and influence vector activity further 
enhancing the threat of disease spread. A positive correlation between temperature and 
infection rates in mosquitoes exists – mainly the lower the temperature the longer it takes 
for the virus to replicate to high enough titres to permit transmission, whereas at higher 
temperatures the virus is able to replicate proficiently and the extrinsic incubation time 
may decrease in some cases (Watts et al., 1987, Reisen et al., 1993, Turell, 1993, Brubaker 
and Turell, 1998, Thu et al., 1998, Dohm et al., 2002, Reisen et al., 2006, Rohani et al., 
2009, Lambrechts et al., 2011, Carrington et al., 2013b). There are upper and lower 
temperature limits which vary depending on the species involved. If the temperature 
exceeds the upper limit, the mosquitoes lifespan is reduced and they demonstrate a 
decrease in flight activity (Carrington et al., 2013a). Extremes of temperatures are also 
deleterious to virus replication and when temperatures are too high, virus replication will 
accelerate too rapidly, whereas if they are too low the infection will remain dormant 
(Hurlbut, 1973). Extrinsic temperature variations may also influence the vectors capacity 
to modulate infections. Only recently has variation in vector competence over a range of 
temperatures been investigated to reflect more natural conditions (Lambrechts et al., 2011, 
Xiao et al., 2014). 
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Larval nutrition and population density are also believed to affect vector competency of the 
adult insects. Studies on Culex and Aedes spp. demonstrated that larvae fed on poorer 
quality diets were more likely to generate higher viral titres (Takahashi, 1976, Baqar et al., 
1980, Grimstad and Haramis, 1984, Grimstad and Walker, 1991). In addition, larval 
density can impact at both the individual and population level affecting development, 
growth, fecundity and survival into adulthood (Ho et al., 1989, Juliano, 1998, Reiskind and 
Lounibos, 2009). It is also believed to affect infectivity as female Ae. aegypti subjected to a 
high-density environment at the larvae stage demonstrated a higher susceptibility to SINV 
than those from low density environments (Muturi et al., 2011b). Just as temperature 
impacts upon the adults so too does it affect the physiology of mosquito larval stages 
(Mourya et al., 2004, Muturi and Alto, 2011) and alters the extrinsic incubation time (Kay 
et al., 1989, Kay and Jennings, 2002). Exposure to insecticides at both the larval and adult 
stages has also been shown to be important (Mourya et al., 2004, Yadav et al., 2005, 
Muturi and Alto, 2011, Muturi et al., 2011a). Combined, these factors may intensify adult 
insect susceptibility to some infections (Takahashi, 1980, Alto et al., 2005, Alto et al., 
2008, Bevins, 2008, Westbrook et al., 2010, Muturi and Alto, 2011, Muturi et al., 2011b, 
Muturi et al., 2012).    
Another aspect which is currently lacking understanding is host seeking behaviour. A 
fundamental part of virus transmission is that it is ultimately passed on to a suitable naive 
host completing the virus life cycle. It is known that mated females exhibit increased host 
seeking behaviour over unmated females due to the need to develop eggs (Macdonald, 
1956, Jones, 1981, Rossignol et al., 1985, Lima-Camara et al., 2014). Similarly, some 
pathogens are able to manipulate the biology and behaviour of their vector in order to 
infect a host (Werren et al., 2008, Qualls et al., 2011). In addition to CO2 production and 
certain chemicals released in the breath, mosquitoes are known to be attracted to body 
temperature. It may be hypothesised that uninfected mosquitoes are attracted to a high 
body temperature caused by a fever as a result of a virus infection while an infected insect 
may be manipulated to be more attracted to people with a lower body temperature (i.e. 
those which are not infected). Infected mosquitoes may also be lead to feed more 
frequently thus increasing the number of hosts infected, a trait which is observed in LACV 
infected Ae. triseriatus females (Jackson et al., 2012). Further studies are required to 
determine if this can be extrapolated to other serious arboviruses such as DENV or 
CHIKV.  
Chapter 1  Introduction 
29 
 
The findings described come together to confirm that there are a plethora of influences on 
mosquito competency which make natural infections almost impossible to accurately 
replicate artificially in laboratory conditions. The complexity of factors, both intrinsic and 
extrinsic, interact in non-linear ways and different populations respond differently. As such 
great care must be taken when interpreting competency observations.    
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1.3 Insect Innate Immunity and Immune Signalling Pathways  
 
1.3.1 Overview of the Classical Innate Immune Pathways 
We are only starting to understand the interplay between arboviruses and arthropod 
immunity and how this interaction influences vector competence and virus transmissibility. 
Our understanding of the mechanisms and processes involved in mediating viral infections 
in the vector is substantially reduced compared to what is known to occur during a host 
infection. The immune system of vertebrates can be divided into two branches: innate and 
adaptive. However, the adaptive response is lacking from arthropods which rely solely on 
their innate immune responses to control bacterial, fungal, protozoa and viral infections. 
Several pathogen recognition signalling pathways have been identified in Drosophila, 
many of which are highly conserved across both vertebrates and invertebrates; including 
mosquitoes.  
The first step of any signalling pathway is the recognition of the pathogen via pattern 
recognition receptors (PRRs) which identify the alien entity by its pathogen associated 
molecular patterns (PAMPs). PAMPs are conserved components of different infectious 
agents such as: viral nucleic acids or debris; bacterial cell wall components, such as 
peptidoglycan and lipopolysaccharides (Michel et al., 2001, Ramet et al., 2003); and fungal 
complex carbohydrates in the cell wall including beta-glucans and possibly chitin (Sorrell 
and Chen, 2009). Vertebrates are known to encode distinct classes of PRRs such as those 
that act on the cellular membrane (including Toll-like receptors [TLRs] and C-type lectin 
receptors [CLRs]) or cytoplasmic receptors (including Retinoic acid-inducible gene (RIG)-
I like receptors [RLRs] and NOD-like receptors [NLRs]) (Takeuchi and Akira, 2010). 
Following pathogen recognition, the host signalling pathway relays the information to 
stimulate an effector response through the transcriptional activation of certain genes. In 
mammals these genes mostly constitute those which are interferon-dependent and encode 
for molecules such as type 1 interferons (IFNs), chemokines, pro-inflammatory cytokines 
and antimicrobial peptides (AMPs). AMPs, such as defensins, attacin, drosocin, 
drosomycin and diptericin, are produced in the fat body, which functions as the equivalent 
to the mammalian liver, and are secreted into the haemolymph in high concentrations to 
facilitate immunomodulation against the invading pathogen (Hoffmann and Reichhart, 
2002). Genetic studies indicate that insects do not encode an interferon response; however, 
they do encode PRRs homologous to TLRs. The Toll, immunodeficiency (IMD) and the 
Janus kinase/signal transducer activator of transcription (JAK/STAT) are canonical and 
Chapter 1  Introduction 
31 
 
share similarities with their counterparts in mammals. The Toll and IMD pathways are 
homologues to the nuclear factor-κB (NF-κB) transcription factor found in mammals, 
whereas JAK/STAT is an important part of the mammalian IFN response. Each of the 
three pathways are known to be involved in development and immune responses in 
Drosophila where they have been intensively studied. Less work has been performed to 
establish their action in mosquitoes and other arthropods and many details are still to be 
ascertained. However, several reviews have also been published recently which discuss 
what is currently known about their roles in insect immunity and antiviral defence 
(Fragkoudis et al., 2009, Kingsolver et al., 2013, Merkling and van Rij, 2013, Rueckert et 
al., 2014, Xu and Cherry, 2014). These signal transduction pathways have been shown to 
be affected by virus infections in mosquitoes and other invertebrates and a number of 
interesting differences between the pathways, and their roles in other invertebrates, have 
emerged (Lin et al., 2004, Dostert et al., 2005, Waterhouse et al., 2007). It is widely 
believed that their involvement in antiviral defence against arboviruses is highly complex 
and may be vector and virus specific.  
Due to the lack of data generated in mosquitoes, the mechanisms of the signalling 
pathways described are based upon what is understood from Drosophila. Any distinctions, 
where known, are indicated.                 
 
Chapter 1  Introduction 
32 
 
 
Figure 1.7: Model of innate immune signalling pathways in mosquitoes extrapolated from 
what is known in Drosophila. Toll pathway: The detection of PAMPs initiate the proteolytic 
signalling cascade resulting in the cleavage of the precursor form of Spätzle, a dimeric cytokine. 
Active spätzle binds to the toll receptor, induces dimerisation and triggers the recruitment of 
downstream intracellular proteins. This leads to the phosphorylation of the negative regulator 
cactus signalling for its degradation. Following this, Relish 1 (REL1) is able to translocate to the 
nucleus and activates the transcription of effector genes. IMD pathway: Detection of 
diaminopimelic (DAP)- type peptidoglycan from Gram negative bacteria by peptidoglycan 
recognition  proteins (PGRP)-like receptors triggers the IMD pathway and leads to the cleavage of 
REL2 which translocates to the nucleus and initiates immune gene transcription. JAK/STAT 
pathway: The cytokine Vago binds to an unknown receptor activating the Janus kinase (JAK) 
which in turn phosphorylates signal transducers and activators of transcription (STAT). STAT is 
then able to dimerise and translocate to the nucleus and transcribes target genes. Exogenous RNAi: 
Viral-derived dsRNA is recognised by Dicer-2 (Dcr-2) which cleaves it into 21 nt viral derived 
small RNAs (viRNAs) which are transported to the RNA induced silencing complex (RISC). 
Argonaute-2 (Ago-2) uses one strand of the viRNA to cleave sequence specific mRNA. Vago 
production is upregulated following virus infections and is mediated by Dcr-2. Adapted with 
permission from Rückert et al., 2014.  
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1.3.2 The Toll Pathway  
The most ancient and conserved innate immune response in both animals and plants is 
thought to be the Toll pathway and associated signalling via NF-κB related proteins. The 
Toll receptor gives its name to TLRs in mammals as they were initially discovered in 
Drosophila (Lemaitre et al., 1996, Fitzgerald and Chen, 2006, Lemaitre and Hoffmann, 
2007). Drosophila are known to encode nine Toll receptors; however, unlike mammalian 
TLRs, arthropod Toll receptors do not act as PRR and are not activated directly through 
PAMP interactions. Instead they are indirectly stimulated by an endogenous cytokine 
known as Spätzle (Spz) (Figure 1.7). This extracellular ligand is cleaved into its active 
form following the detection of a pathogen and interacts with the Toll receptor causing the 
cross linking of two Toll ectodomains (Arnot et al., 2010). This triggers the intracellular 
association of a receptor-adaptor complex composed of the myeloid differentiation 
primary-response gene 88 (MyD88), which interacts with the Toll receptor through its 
Toll/Interleukin-1 receptor domains (Tauszig-Delamasure et al., 2002) and recruits Tube 
and the protein kinase Pelle, a homologue of IL-1R-associated kinase (IRAK) (Towb et al., 
2001). As a result, the downstream IκB orthologue Cactus becomes phosphorylated which 
targets it for degradation by the proteasome. The NF-κB orthologues Relish 1 (REL1), 
Dorsal and Dorsal-related immunity factor (Dif) then become activated and translocate to 
the nucleus causing the transcription of AMPs to be initiated (Lemaitre et al., 1996, Shin et 
al., 2005, Ferrandon et al., 2007, Lemaitre and Hoffmann, 2007).  
Important vector mosquito species have been shown to encode orthologues to a number of  
Drosophila NF-κB proteins. Both Anopheles gambiae and Ae. aegypti express orthologues 
to Dorsal, Rel1 and Rel1A/Rel1B respectively, as well as Relish orthologue, Rel2 
(Christophides et al., 2002, Shin et al., 2002, Waterhouse et al., 2007). These are known to 
be involved in innate immunity in these mosquito species and therefore; although, the 
effector genes involved may be slightly different, the signalling pathways operate in a 
similar fashion.  
The Toll pathway is historically triggered by Gram-positive bacteria and fungi (Lemaitre et 
al., 1996, Rutschmann et al., 2002, Ferrandon et al., 2007, Kemp and Imler, 2009). In 
addition to this, recent evidence has been accumulating to indicate that it is also involved 
in protection against some viral infections in insects; although, our understanding of the 
processes and mechanisms involved are not yet well established. The Toll pathway has 
been shown to be activated following Drosophila X virus (DXV) infections in Drosophila 
and is involved in the antiviral response against DENV infection of Ae. aegypti mosquitoes 
(Zambon et al., 2005, Xi et al., 2008, Ramirez and Dimopoulos, 2010). Despite this, 
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transcriptional induction of NF-κB dependent genes is not observed following infection 
and is impaired following bacterial stimulation (Sim and Dimopoulos, 2010). This suggests 
that its antiviral mechanism functions differently from the classical control exhibited over 
other invading microbes. It also implies that DENV actively restricts rather than evades the 
Toll immune response in mosquitoes. Certainly, autophagy was stimulated following the 
detection of vesicular stomatitis virus (VSV) in Drosophila which is independent of NF- 
κB (Shelly et al., 2009, Nakamoto et al., 2012). However, DENV has also been shown to 
cause an up-regulation of immune genes, including Toll pathway components Toll and 
Cactus, following infection of the Ae. aegypti-derived Aag2 cell line, further highlighting 
its role in mediating DENV replication (Sim and Dimopoulos, 2010).  
On the other hand, studies on alphaviruses have indicated that they are not mediated by the 
Toll pathway. Replication of SFV was not inhibited by the expression of a constitutively 
expressed active Toll receptor in the Ae. albopictus-derived U4.4 cell line and signalling 
was found to be reduced (Fragkoudis et al., 2008). Similarly, prior stimulation of Toll 
before CHIKV infection of the Ae. aegypti-derived Aag2 cell line failed to act antivirally 
but was actively repressed by virus-mediated host cell shut off (McFarlane et al., 2014). 
SINV is also hypothesised to inhibit Toll signalling following an initial activation stage in 
in vivo Ae. aegypti systems (Sanders et al., 2005). Furthermore, ONNV infection of An. 
gambiae did not show an up-regulation of Toll; although, other immune genes were 
stimulated and acted antivirally against the infection (Waldock et al., 2012). Interestingly, 
silencing of Cactus, a negative regulator of Toll, permitted an increase in viral replication 
compared to controls, although the opposite would have been expected if Toll was 
involved in viral repression. These findings may be because Toll does not act antivirally 
against alphavirus infections or may be as a result of viral inhibition of any antiviral 
activity overriding these effects and future work is required to unravel these complexities.    
 
1.3.3 The IMD Pathway  
The second NF-κB-related pathway is the IMD pathway which is essential for the 
activation of the NF-κB orthologue Relish 2 (REL2). IMD signalling is stimulated by 
diaminopimelic (DAP)- containing peptidoglycan on the cell wall of Gram negative 
bacteria in addition to some Gram positive Bacilli spp. (Kaneko et al., 2004). Pathogen 
recognition is mediated by two receptors: the external peptidoglycan recognition protein 
(PGRP)-LC and the internal PGRP-LE protein (Takehana et al., 2002, Choe et al., 2005, 
Kaneko et al., 2006) (Figure 1.7). This is subsequently followed by the activation of IMD 
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and the initiation of the two branches of the signalling pathway which act synchronously 
(Choe et al., 2002, Gottar et al., 2002, Ramet et al., 2002). The first branch involves IMD 
binding to the Drosophila FAS-associated death-domain protein (dFADD) which in turn 
recruits the caspase DREDD, a homologue of caspase-8 in mammals (Leulier et al., 2000). 
DREDD cleaves IMD allowing it to interact with the Drosophila inhibitor of apoptosis-2 
(IAP-2) resulting in the ubiquitination of IMD (Paquette et al., 2010). IMD is then able to 
act as a scaffold for association with downstream components. The second pathway 
involves Drosophila transforming growth factor activated kinase-1 (dTAK1) activating the 
IκB-kinase (IKK) for the phosphorylation of REL2 (Erturk-Hasdemir et al., 2009). 
Following phosphorylation REL2 is cleaved by DREDD separating the N-terminal DNA 
binding domain which translocates to the nucleus and regulates effector gene transcription 
(Leulier et al., 2000, Silverman et al., 2000, Leulier et al., 2002, Naitza et al., 2002, Stoven 
et al., 2003, Erturk-Hasdemir et al., 2009).  
As with the Toll pathway, IMD signalling is involved in antiviral immunity against both 
arboviruses and pathogenic viruses. In Drosophila, IMD mutants showed an increase in 
viral RNA and lower survival rates following cricket paralysis virus (CrPV) infection 
(Costa et al., 2009). Similarly, transcripts of IMD pathway components and IMD 
stimulated AMPs increased following Sigma virus (SIGMAV) infection; although, this 
appeared to be dependent on the strain of flies involved (Tsai et al., 2008, Carpenter et al., 
2009). Nora virus also affected gene expression of an alternative IMD signalling branch 
(Boutros et al., 2002, Cordes et al., 2013). In contrast to Toll signalling, stimulation of 
IMD was observed following alphavirus infections. Transgenic Drosophila expressing a 
SINV replicon generated greater levels of genomic viral RNA loads when IMD 
components were silenced (Avadhanula et al., 2009). Viral replication resulted in an 
increase in IMD component expression and downstream gene transcription while 
knockdown of the IMD associated AMP, DptB, generated developmental defects in the 
transgenic flies and increased virus replication and titres in mutant flies infected with 
SINV (Huang et al., 2013). In mosquitoes, An. gambiae demonstrated that ONNV 
infection affected IMD component expression; however, silencing of Rel2 did not 
significantly alter virus replication suggesting another pathway was contributing to virus 
control (Avadhanula et al., 2009, Waldock et al., 2012, Huang et al., 2013). Certainly, 
another study indicated that there was no significant immune gene induction 14 days post 
ONNV infection (Sim et al., 2005). Pre-stimulation of the IMD pathway in Ae. albopictus-
derived U4.4 cells through heat-inactivated E.coli allowed a reduced level of SFV 
replication and the infection did not successfully activate the pathway (Fragkoudis et al., 
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2008). This result is mirrored in CHIKV infection of Ae. aegypti-derived Aag2 cells which 
similarly did not result in any pathway activation (McFarlane et al., 2014).  
 
1.3.4 The JAK/STAT Pathway 
The JAK/STAT pathway was initially characterised in insects for its role in development, 
embryonic segmentation and haemocyte proliferation (Binari and Perrimon, 1994, Zeidler 
et al., 2000, Luo and Dearolf, 2001, Arbouzova and Zeidler, 2006) but is also known for 
responding to pathogenic infections (Barillas-Mury et al., 1999). The Drosophila pathway 
relies on four key components; the ligands, their receptors, a single Janus kinase and a 
single STAT transcription factor. As with the Toll pathway, JAK/STAT pathway 
signalling is activated by the binding of a secreted ligand to its receptor. Three unpaired-
related (Upd1-3) ligands are known to be involved and interact with their receptor, 
Domeless (Dome), inducing its dimerization and allowing transphosphorylation of the 
Janus kinase, Hopscotch (Hop), which is homologous to the human JAK2 protein (Binari 
and Perrimon, 1994, Yan et al., 1996, Harrison et al., 1998, Brown et al., 2001, Hombria et 
al., 2005). This action subsequently allows the recruitment and transphosphorylation of the 
transcription factor STAT (STAT92E/Marelle) on the conserved C-terminal tyrosine 
residue. The phosophorylated STATs dimerize and translocate the nucleus to regulate 
transcription of downstream effector genes.  
Orthologues of proteins which attenuate the pathway in mammals are known in Drosophila 
including SOCS proteins (Socs44F, Scos36E and Socs16D), the phosphatase protein 
PTP61F and a PIAS orthologue (Su(var)2-10) (Baeg et al., 2005, Waterhouse et al., 2007, 
Souza-Neto et al., 2009). Comparative genomic studies have also revealed that key 
mosquito vectors Ae. aegypti, Cx. tritaeniorhynchus and An. gambiae share some major 
homologues of the JAK/STAT pathway, including dome, hop, STAT, PIAS and SOCS 
(Barillas-Mury et al., 1999, Lin et al., 2004, Waterhouse et al., 2007, Souza-Neto et al., 
2009, Zou et al., 2011). However, the Upd ligands have only been found in the Drosophila 
genome and as a result the JAK/STAT pathway in Aedes, Culex and Anopheles mosquitoes 
is believed to be initiated by Vago, a novel ligand (discussed in Chapter 1.3.5.2) (Figure 
1.7). It is interesting to note that Vago does not bind to the dome receptor and its true 
receptor is as yet unknown which contributes to the large number of questions still 
unanswered regarding mosquito antiviral immunity.  
Several studies have demonstrated the involvement of JAK/STAT signalling in antiviral 
defence in Drosophila and mosquitoes (Dostert et al., 2005, Souza-Neto et al., 2009, 
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Paradkar et al., 2012, Kemp et al., 2013). Secreted Vago has been shown to activate the 
JAK/STAT pathway following WNV infection of the Cx. quinquefasciatus-derived Hsu 
cell line (Paradkar et al., 2012). Furthermore, only WNV-related dsRNA generated 
stimulation, unlike bluetongue virus (BTV)-related dsRNA or poly I:C (a structurally 
similar synthetic analogue of dsRNA). This implicates a degree of virus specificity and a 
tailored immune system mirrored in the other classical immune signalling pathways 
(Paradkar et al., 2012). In addition, DENV infection of Ae. aegypti mosquitoes stimulates 
the signalling response resulting in the production of JAK/STAT associated genes as well 
as DENV restriction factors (DVRF1 and DVRF2) (Souza-Neto et al., 2009, Behura et al., 
2011). RNAi knockdown of the major pathway components also resulted in an increase in 
virus titres (Souza-Neto et al., 2009). As observed with the Toll pathway, neither SFV 
infection of Ae. albopictus-derived U4.4 or CHIKV infection of Ae. aegypti-derived Aag2 
cells resulted in pathway activation (Fragkoudis et al., 2008, McFarlane et al., 2014). This 
is in contrast to what has been shown for a further alphavirus infection in Drosophila were 
SINV appears to activate JAK/STAT signalling resulting in an increase in expression of 
STAT associated genes; although, the survival of hop mutant flies is not significantly 
different to wildtype flies (Avadhanula et al., 2009, Huang et al., 2013, Kemp et al., 2013). 
In the Ae. aegypti-derived Aag2 cell line, SINV infection resulted in an increase in the 
transcription factor STAT but no other genes from any of the pathways investigated 
(Barletta et al., 2012).   
 
1.3.5 Other Immune Mechanisms in Arthropods 
There are a number of alternative immune responses which contribute to antiviral defence 
in arthropods (Kingsolver et al., 2013, Merkling and van Rij, 2013, Rueckert et al., 2014). 
For instance, the autophagy pathway is responsible for the degradation of cellular 
components through the lysosome. It is evolutionarily conserved in eukaryotic organisms 
and is activated in response to cellular stress. Several studies have shown that it plays a 
role in inhibiting the replication of a number of intracellular pathogens, including bacteria 
and viruses (Yano et al., 2008, Seay et al., 2009, Shelly et al., 2009, Dreux and Chisari, 
2010, Orvedahl et al., 2010, Yordy and Iwasaki, 2011, Nakamoto et al., 2012). The heat-
shock response is also believed to be involved as induction of heat shock proteins 
following a pathogenic attack may trigger an immune response (Matzinger, 2002, Sim et 
al., 2007, Santoro et al., 2010). However, its exact involvement requires further 
characterisation. Other factors which pertain to innate immunity in mosquitoes are 
discussed below.    
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1.3.5.1 Phenoloxidase Activity  
The extracellular phenoloxidase (PO) cascade is a complex humoral immune component in 
insects and is involved in the production of melanin, a brown-black pigment. The process 
of melanisation involves a number of sequential enzymatic and non-enzymatic reactions 
(Christensen et al., 2005, Cerenius et al., 2008). It is initiated through cuticular damage or 
the recognition of PAMPs; such as lipopolysaccharides (LPS) and peptidoglycans on 
microbial cell walls. These PAMPs stimulate the serine protease cascade which involves 
multiple clip-domain serine proteases (cSPs) which cleave phenoloxidase activating 
proteins (Pro-PAPs) to their active form (PAPs), allowing them to generate PO by 
proteolysis of the zymogen prophenoloxidase (proPO/PPO). PO catalyses the conversion 
of mono- and di- phenolic substrates available in the haemolymph to dopamine or 5,6- 
dihydroxyindole (DHI) that are further processed into melanin (Figure 1.8). The melanin 
builds up at cuticular wound sites and around invading pathogens which aids healing. 
Other cytotoxic products are also produced such as reactive oxygen species (ROS) which 
are antimicrobial (Cerenius and Soderhall, 2004, Nappi and Christensen, 2005). The 
pathway is regulated by the action of serpins acting as serine protease inhibitors to prevent 
sustained, deleterious effects caused by the production of toxic intermediates (Jiang and 
Kanost, 2000, Gorman and Paskewitz, 2001).         
The role of the PO cascade in defence against fungal, parasitic and bacterial assaults in 
arthropods has been well documented (Ashida and Brey, 1997, Soderhall and Cerenius, 
1998, Hillyer et al., 2003a, Hillyer et al., 2003b, Infanger et al., 2004, Christensen et al., 
2005, Hillyer et al., 2005, Leclerc et al., 2006, Yassine et al., 2012). Antiviral activity was 
determined by Popham and colleagues as haemolymph derived from Heliothis virescens 
(tobacco budworm) was shown to be virucidal against Helicoverpa zea single capsid 
nucleopolyhedrovirus (HzSNPV; Baculoviridae) and that there was an increase in virus 
titres following the inhibition of PO (Ourth and Renis, 1993, Popham et al., 2004, Shelby 
and Popham, 2006). Similarly, Autographa californica multicapsid nucleopolyhedrosis 
virus (AcMNPV; Baculoviridae) was inactivated by DHI (Zhao et al., 2011). The 
involvement of the PO cascade in the control of arboviruses has been highlighted as 
suppression of PPO in Armigeres subalbatus mosquitoes during infection with a 
recombinant strain of SINV expressing dsRNA against PPO resulted in a decrease in PO 
activity and enhanced SINV replication (Tamang et al., 2004). This effect was also 
observed following the infection of Ae. aegypti mosquitoes and the Ae. albopictus-derived 
U4.4 cell line with a recombinant SFV expressing the PO cascade inhibiter, Egf1.0 which 
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allowed an increase in SFV titres (Rodriguez-Andres et al., 2012). It will be of interest to 
determine if this phenomenon is observed for other vector: virus interactions.    
 
Figure 1.8: The Serine Protease Cascade. PAMPs, such as lipopolysaccharides (LPS) and 
peptidoglycans on bacterial cell walls stimulate the pathway to produce active phenoloxidase 
activating proteins (PAPs). PAPs are required to cleave and activate phenoloxidase (PO) from 
prophenoloxidase (PPO) to catalyse the conversion of mono- and di- phenolic substrates to 
dopamine and quinines. These products are eventually converted to melanin, produce cytotoxic 
products and facilitate the encapsulation of pathogens.    
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1.3.5.2 Vago  
In Drosophila, the vago gene encodes an 18 kDa cysteine-rich polypeptide which is 
induced following a viral infection. Its induction has been shown to be dependent on Dcr-2 
but none of the other RNAi components (Deddouche et al., 2008). Furthermore, it was 
shown to be up-regulated following infection by Drosophila C virus (DCV) and SINV in 
Drosophila. It has since been determined to have an antiviral role as it controls the viral 
load in Drosophila fat bodies and vago null mutants permit a higher level of virus 
replication (Dostert et al., 2005, Deddouche et al., 2008). In mosquitoes, Vago has been 
shown to act as a secreted signalling molecule to trigger STAT transcription and stimulate 
the up-regulation of STAT-dependent virus inducible genes (Chapter 1.3.4). Although 
Vago is not believed to be highly conserved in other insects, recent work in mosquitoes has 
shown that an orthologue is present in the genome of Culex and Aedes mosquitoes which is 
up-regulated following WNV or DENV infection in Culex and Aedes-derived cell lines 
(Paradkar et al., 2012, Paradkar et al., 2014). These studies also suggest that dsRNA 
recognition and cleavage by the DExD/H-box helicase domain of the RNAi initiator 
protein Dcr-2 activates tumour necrosis factor (TNF) receptor-associated factor (TRAF) 
which then causes cleavage and release of the amino terminus of REL2, an orthologue of 
NF-κB. It is then suggested that REL2 induces Vago production by binding to the NF-κB 
binding site which is conserved on the promoter domain of vago (Paradkar et al., 2014).  
Vago was described as providing a protective paracrine response as it is able to trigger a 
signalling cascade and induce an antiviral state in uninfected cells following secretion from 
infected cells. The identification of a cytokine function is reminiscent of IFN signalling in 
mammals which also involves the JAK/STAT pathway (Platanias and Fish, 1999, 
Subramaniam et al., 2001). Vago activation in insects is also analogous with PAMP 
recognition by RIG-I and MDA-5. This induces TRAF/NF-κB stimulated IFN pathway 
and is involved in viral control in mammalian systems (Saha et al., 2006, Brass et al., 
2009). These findings imply a level of communication between RNAi and JAK/STAT 
pathways in insects and, although Vago activation appears to be pathogen specific, 
responding only to replicating viral infections, further work will establish if assaults by 
other infectious agents result in the stimulation of multiple pathways.     
 
1.3.5.3 Wolbachia Endosymbiotic Bacteria   
The α-proteobacteria Wolbachia is predicted to be found within 60 % of all insect species 
around the globe. It is inherited by maternal transmission and has been documented as 
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being capable of manipulating the gene expression of its host by a mechanism termed 
cytoplasmic incompatibility (CI). CI occurs during the mating of infected males with 
females. Wolbachia modifies the sperm and prevents efficient embryogenesis unless the 
egg also contains the bacterium (Werren et al., 2008, Rainey et al., 2014). This places 
infected females at an evolutionary advantage as they may mate with all available males, 
unlike uninfected females which can only mate successfully with uninfected males and any 
matings with infected males will produce few or no progeny (Yen and Barr, 1971, Turelli 
and Hoffmann, 1991, Turelli and Hoffmann, 1995).   
It was serendipitously discovered that Wolbachia infections reduce vector competency and 
present a number of advantages towards a new biological application for the control of 
mosquito-borne diseases (Hancock et al., 2011). Certain strains of Wolbachia are known to 
reduce the life span of their insect host, indirectly inhibiting transmission of the pathogen 
(Min and Benzer, 1997, Evans et al., 2009, Kambris et al., 2009, McMeniman et al., 2009, 
Yeap et al., 2011). Wolbachia has been shown to interfere with the expression of ferritin 
(involved in the storage and regulation of iron homeostasis) and iron metabolism in insects 
(Kremer et al., 2009). This protects the cell from oxidative stress and apoptosis and 
reduces resources available to invading pathogens. Furthermore, a link has been 
established between Wolbachia and the Toll and melanisation pathways (Pan et al., 2012, 
Rances et al., 2012). It has been documented that Wolbachia infections in mosquitoes 
generate a reduced susceptibility to mosquito-borne pathogens, such as filarial nematode 
parasites and plasmodium malaria parasites in both Ae. aegypti and An. gambiae (Kambris 
et al., 2009, Moreira et al., 2009). In addition, a number of studies have demonstrated the 
induction of DENV resistance following Wolbachia infection (Hedges et al., 2008, Moreira 
et al., 2009, Bian et al., 2010, Hoffmann et al., 2011, Walker et al., 2011, Rances et al., 
2012, Zhang et al., 2013a). During a Wolbachia infection of Ae. aegypti, the bacterium has 
been shown to utilise miRNAs to regulate host methyltransferases which may impact 
DENV replication (Zhang et al., 2013a, Zhang et al., 2014). This is in contrast to DENV 
which induces methyltransferase expression. Wolbachia infections were also shown to 
inhibit WNV replication in Cx. quinquefasciatus and CHIKV in Ae. aegypti, the major 
vectors of these pathogens (Moreira et al., 2009, Glaser and Meola, 2010). 
It is surprising that Wolbachia is not known to naturally infect the key arbovirus vector Ae. 
aegypti, although other important vectors, Ae. albopictus, Ae. bromeliae and Cx. pipiens, 
do harbour some strains (Kittayapong et al., 2000, Armbruster et al., 2003, Osei-Poku et 
al., 2012) and a recent publication has identified a strain in the malarial vector An. gambiae 
(Baldini et al., 2014). However, laboratory strains can be successfully transferred from 
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Drosophila (Rainey et al., 2014). For instance the Drosophila strain wMel reduces the 
transmission of DENV (Blagrove et al., 2012). As a result of intense research in recent 
years, several cage field trials have been successfully used to maintain Ae. aegypti 
populations demonstrating a lower susceptibility to DENV infections and no evident 
negative impact to the environment or public health (Hoffmann et al., 2011, Walker et al., 
2011).  
 
1.4 RNA interference: Small RNA Mediated Regulation of Gene 
Expression 
 
1.4.1 History and Discovery of RNA interference (RNAi) 
Invertebrates have been shown to be deficient in an adaptive immune response which is 
well characterised in vertebrates. However, their innate immune responses are capable of 
efficiently defending against viral infections. The mechanism which has been recognised 
as playing a significant role in antiviral defence is RNA interference (RNAi). The RNAi 
response was first described in plants in the 1990s when transgenic tobacco plants were 
found to ‘recover’ from a viral infection and also developed resistance against that specific 
pathogen (Lindbo et al., 1993). A relationship between this antiviral activity and its 
involvement in endogenous gene expression was identified (Ratcliff et al., 1997) and so it 
was termed ‘post-transcriptional gene silencing’ when involved in transcriptional control 
of aberrant genes and ‘virus-induced gene silencing’ in viral defence (Angell and 
Baulcombe, 1997, Ruiz et al., 1998). Since its discovery, it has been shown to be highly 
conserved and exists in a wide range of eukaryotic organisms including plants, fungi, 
worms, insects and mammals, where it is involved in modulating gene expression, 
epigenetic control and pathogen defence.  
Fire and colleagues are credited with the first report of the inducer of the pathway being 
long double stranded RNA (dsRNA) molecules through their work in C. elegans (Fire et 
al., 1998). The injection of dsRNA into Drosophila embryos recognised a corresponding 
effect and much of our understanding of insect antiviral RNAi stems from initial work 
carried out in Drosophila systems (Kennerdell and Carthew, 1998, Galiana-Arnoux et al., 
2006, van Rij et al., 2006, Wang et al., 2006, Zambon et al., 2006). As mosquitoes transmit 
a number of both medically and veterinary important viral pathogens, understanding their 
antiviral immune responses has been paramount to disease control. RNAi in mosquitoes 
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was identified through the use of recombinant strains of SINV expressing sequences from 
DENV-2. The infected mosquitoes were refractory to subsequent infection by DENV-2 
due to RNA-dependent processing (Gaines et al., 1996, Olson et al., 1996, Adelman et al., 
2001). This effect was also evident when mosquitoes were infected with a further 
recombinant SINV expressing sequences derived from RVFV; although, this was not 
clearly understood to be due to RNAi at the time (Billecocq et al., 2000). Drosophila 
studies recognised the principal proteins in the RNAi pathway in particular Dicer (Dcr) and 
Argonaute (Ago) which have been shown to be highly conserved in a wide range of 
eukaryotes including plants, mammals and invertebrates.   
Recently, the use of RNAi has become commonplace in many research areas as a 
biological tool for the study of gene expression and function.  The consequences of gene 
knockdown on elucidating the role of particular genes in a variety of systems has vastly 
accelerated understanding in a number of fields.  
 
1.4.2 Introduction to RNAi in Insects  
In terms of anti-arbovirus immunity, mosquitoes are the best studied organism. Although it 
has been demonstrated that arboviruses are able to replicate efficiently within their 
mosquito vectors, they display minor pathology and fitness costs (Lambrechts and Scott, 
2009). This implies that the viral infection is successfully controlled by the antiviral 
response. RNAi is a highly conserved process in multicellular organisms and is regarded as 
the preeminent antiviral mechanism in plants (termed post-transciptional gene silencing 
[PTGS]), fungi (termed quelling) and C. elegans; however, its involvement in insect 
immunity has only been established over the past decade. Recently several reviews have 
highlighted the essential role of RNAi in the mosquito innate immune responses and it is 
suggested that the mechanisms are similar to that described in Drosophila (Blair, 2011, 
Donald, 2012, Vodovar and Saleh, 2012, Lucas and Raikhel, 2013, Vijayendran et al., 
2013, Bronkhorst and van Rij, 2014, Rueckert et al., 2014). It has four known branches 
with vital roles in controlling normal growth and development, restricting the mobility of 
transposable elements and mediating viral infections. These pathways are characterised by 
the production of small RNA molecules which can be distinguished based on the template 
they originate from, their size, biochemistry and targets, as well as their distinctive 
functions in their respective pathways. There are three key small RNA molecules which 
have been recognised in eukaryotes to date; small interfering RNAs (siRNAs), microRNAs 
(miRNAs) and PIWI-interacting RNAs (piRNAs) (Figure 1.9). These pathways have been 
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implicated in antiviral defence as evidenced by small RNAs found to match and be derived 
from viral genomes (Aliyari et al., 2008, Myles et al., 2008, Brackney et al., 2009, 
Brackney et al., 2010, Flynt et al., 2009, Scott et al., 2010, Hess et al., 2011, Siu et al., 
2011, Morazzani et al., 2012, Vodovar et al., 2012, Leger et al., 2013, Schnettler et al., 
2013a, Schnettler et al., 2013b).    
 
 
Figure 1.9: Schematic representation of the small RNA pathways present in insects as 
described for Drosophila melanogaster. A) Exogenous siRNA, B) Endogenous siRNA, C) 
microRNA (miRNA) and D) PIWI-interacting RNA (piRNA). dsRNA, double stranded RNA; 
ssRNA, single stranded RNA; siRNA, small interfering RNAs; viRNAs, virus-derived small 
interfering RNAs; piRNA, PIWI-interacting RNA; Dcr, Dicer, RISC, RNA induced silencing 
complex; Ago, Argonaute; Aub, Aubergine; loq, loquacious. Figure adapted from Donald et al., 
2012.         
 
1.4.3 siRNA Pathway  
Small interfering RNAs can be separated into two classes; endogenous (endo-siRNAs) or 
exogenous (exo-siRNAs) based on their template of origin (Figure 1.9). The production of 
endo-siRNAs results from the detection of retrotransposons, sites of convergent 
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transcription, overlapping transcripts or structured genomic RNA, such as inverted repeats 
or hairpin structures (differentiated from miRNA targets due to their restricted stem 
lengths). Their role is the protection of the genome by repressing transposons and other 
aberrant mobile transcripts and maintaining heterochromatin (Chung et al., 2008, Czech et 
al., 2008, Ghildiyal et al., 2008, Watanabe et al., 2008, Fagegaltier et al., 2009, Lucchetta 
et al., 2009, Lim et al., 2011). Exogenous RNAi is provoked by the presence of long, non-
cellular dsRNA molecules produced as a result of RNA virus replication or convergent 
overlapping transcriptional complexes of DNA viruses (Bronkhorst et al., 2012). These 
dsRNA triggers are discriminated from ‘self’ entities and recognised as PAMPs which are 
then cleaved into shorter duplex fragments known as exo-siRNAs or virus-derived small 
interfering RNAs (viRNAs) which restrict the incoming viral infection. The resulting 
viRNAs are not biased towards a particular base at position one, suggesting that Dcr-2 
cleaves the dsRNA molecules in a non-sequence specific manner. Both the endo- and the 
exo-siRNA pathways are believed to function in a similar manner in Drosophila and utilise 
the same proteins, with the exception of Loquacious isoform PD (Loqs-PD) which is only 
known to be involved in the endo-siRNA pathway (Hartig et al., 2009, Marques et al., 
2013).  
The detection of the dsRNA trigger molecules is performed by the RNase III enzyme, Dcr-
2 (Bernstein et al., 2001, Kim et al., 2006, Aliyari and Ding, 2009, Kemp and Imler, 2009), 
associated with the dsRNA binding protein R2D2 (so named due to the presence of two 
dsRNA binding domains [R2] and its interaction with Dcr-2 [D2]). Dcr-2 therefore 
functions as a cellular PRR (Takeuchi and Akira, 2008). The siRNAs/viRNAs are fed into 
the RNA induced silencing complex (RISC), a ribonucleoprotein complex, containing 
several components including the second Argonaute protein, Ago-2 (Hammond et al., 
2001, Meister et al., 2004, Okamura et al., 2004, Kawamura et al., 2008). Ago-2 has 
catalytic slicer activity and directly moderates gene silencing. In Drosophila, other 
associated proteins are VIG (Vasa intronic gene) and dFXR (Drosophila ortholog of fragile 
X mental retardation protein) (Caudy et al., 2002). Further components are involved in the 
assembly of the active RISC which include Component 3 Promoter of RISC (C3PO) (a 
multimeric complex of Trax and Translin) (Liu et al., 2009, Tian et al., 2011), aubergine 
(Specchia et al., 2008) and heat-shock protein 90 (Hsp90) (Miyoshi et al., 2010). 
Once incorporated into the active RISC, the siRNA/viRNA duplex is unwound and one 
strand (termed the passenger strand) is discarded while the other (the guide strand) is used 
by Ago-2 to detect and cleave target mRNAs. This causes the degradation of any mRNA 
present in the cytoplasm with a high sequence homology to the siRNA loaded into RISC 
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making RNAi highly sequence specific and siRNA dependent (Ender and Meister, 2010). 
For the virus this means the inhibition of gene expression and a reduction in progeny 
produced.   
Dcr-2 is fundamental in the antiviral immune response in insects and, in principle, its 
action alone is sufficient to restrict viral infections. Incidentally it is a member of the same 
DExD/H box helicase family to which the mammalian PRR RIG-I –like receptors belong 
(Deddouche et al., 2008). The structure of Dcr-2 has been shown to include in order from 
the N- to the C- terminus; 1) a DExH/D (DEAD) box helicase ATPase domain, 2) a 
dsRNA-binding domain, 3) a Piwi/Argonaute/Zwille (PAZ) domain and 4) two tandem 
RNaseIII domains (Aliyari et al., 2008, Welker et al., 2011, Morazzani et al., 2012) 
(Chapter 5). The PAZ domain is responsible for interacting with the dsRNA molecule 
while the two RNaseIII domains are known to be implicated in its processing into 
siRNAs/viRNAs (Blaszczyk et al., 2001, Lee et al., 2004, Flynt et al., 2009). This action 
generates the characteristic 5’ monophosphate and 2 nt 3’ overhang viRNA ends and 
immediately reduces the quantity of RNA encoding viral proteins available for the creation 
of new viral genomes. It is the distance between the PAZ and RNaseIII domains that 
determines the 21 nt length of the siRNA molecules which is characteristic of Dcr-2 
processing (Zhang et al., 2004, Macrae et al., 2006). The ATPase domain provides the 
energy necessary for dicing. In Drosophila, further molecules implicated in effective 
dsRNA cleavage are Loqs-PD and Arsenic resistance protein 2 (Ars2) which are thought to 
augment the affinity Dcr-2 has for dsRNA (Sabin et al., 2009, Zhou et al., 2009a, Marques 
et al., 2010). Dcr-2 has also been implemented in downstream signalling as its action 
generates increased expression of the mosquito cytokine, Vago (discussed in Chapter 
1.3.5.2) (Deddouche et al., 2008, Paradkar et al., 2012) and other genes are also expected 
to be induced.  
Ago-2 in Drosophila was the first pathway protein identified as being antiviral in higher 
eukaryotes (Li et al., 2002). As with Dcr-2, it also contains a PAZ domain, in addition to a 
Piwi_ago-like domain (Lingel et al., 2003, Kim et al., 2009). The PAZ domain secures the 
guide strand of the siRNA molecule by the 2 nt 3’ overhang within its hydrophobic cleft 
while the Piwi_ago-like domain possess endonucleolytic activity and is able to cleave the 
phosphodiester bond of the passenger strand between the 9
th
 and 10
th
 nt from the 5’ end 
(Lingel et al., 2003, Lingel et al., 2004, Ma et al., 2004, Okamura et al., 2004, Rand et al., 
2004, Rand et al., 2005, Matranga et al., 2005, Miyoshi et al., 2005). The resulting 
molecules of 9 and 12 nt are believed to be degraded by C3PO which has exonuclease 
activity (Liu et al., 2009). Selection of the guide strand depends on the internal 
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thermodynamic stability of the siRNA duplex, with the strand with the lowest 5’ stability 
being irreversibly incorporated into the RISC (Khvorova et al., 2003, Schwarz et al., 
2003). The rapid evolution of antiviral RNAi genes (dcr2, r2d2 and ago2) compared to 
non-immune linked genes (dcr1, r3d1 and ago1) in Drosophila indicates a constant arms 
race between the virus and the host (Obbard et al., 2006, Obbard et al., 2009). However, a 
study in Ae. aegypti indicates that unlike Drosophila, both miRNA and exo-siRNA 
pathway genes undergo accelerated evolution highlighting the differences between the two 
insect species (Bernhardt et al., 2012). 
 
1.4.4 miRNA Pathway  
MicroRNAs (miRNAs) have been shown to be conserved in many organisms, such as 
plants, mammals and invertebrates, and are important for the regulation of gene expression 
in different tissues and during different stages of development (Jones and Newbury, 2010, 
Schnall-Levin et al., 2010, Chawla and Sokol, 2011, Asgari, 2013). They are confirmed to 
be involved in a number of biological processes such as fat metabolism, cardiogenesis, 
stress regulation, muscle growth, neurogenesis and immune responses (Jin et al., 2004, Xu 
et al., 2004, Kwon et al., 2005, Sokol and Ambros, 2005, Liu et al., 2007, Parrish et al., 
2009, Choi and Hyun, 2012, Hussain et al., 2013). miRNAs are produced from cellular 
transcripts and modulate expression at the translational level by controlling the availability 
of messenger RNAs (mRNAs) for translation to proteins (Figure 1.9). In general the effect 
of miRNA function is the down-regulation of their target gene; although, some positive 
interactions have been described (Lagos-Quintana et al., 2001, Bushati and Cohen, 2007, 
Henke et al., 2008, Voinnet, 2009, Berezikov, 2011, Choi and Hyun, 2012, Hussain et al., 
2012).  
Their biogenesis is understood to be conserved within insect species and bioinformatic 
studies have indicated the existence of genes involved in the miRNA pathway between 
Drosophila and several mosquito species such as Ae. aegypti, An. gambiae, and Cx. pipiens 
(Campbell et al., 2008). Some of the mechanistic features also share some similarity to the 
siRNA pathways; for instance, the miRNA pathway is also instigated by the cleavage of 
dsRNA molecules; however, this is through Dcr-1 rather than Dcr-2 processing. Dcr-1 
lacks a DExH helicase domain and so cannot produce siRNAs (Lee et al., 2004). The 
source of the dsRNA also differs between the two systems as unlike the siRNA pathways 
which are concentrated in the cytoplasm, the miRNA pathway has phases in both the 
cytoplasm and nucleus. Primary miRNAs (pri-miRNAs) result from transcripts produced 
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in the nucleus by the cellular RNA polymerase II. These transcripts fold back on 
themselves forming an incomplete dsRNA stem-loop structure. The pri-miRNAs are then 
further processed to precursor miRNAs (pre-miRNAs) of around 70 nt by the nuclease 
Drosha in combination with Pasha (or DGCR8 in mammals) before being transported to 
the cytoplasm. Following cleavage by Dcr-1 in association with loq (or the dsRNA binding 
protein TRBP in mammals) the mature miRNA/miRNA* duplex which is ~21 - 22 nt long 
is produced. The guide strand of the duplex is finally loaded into RISC (also referred to as 
miRISC), which contains Ago-1 rather than Ago-2, and can be used to target near-perfect 
complementarily cellular mRNAs (Okamura et al., 2004). Although, the passenger 
miRNA* strand is usually degraded, it has been shown to also be incorporated in some 
situations (Lagos-Quintana et al., 2001; Zeng et al., 2003; Schwarz et al., 2004). The result 
of Ago-1 targeting is either translational suppression, mRNA degradation or both. The 
defining properties dictating which of these outcomes occurs are not yet understood; 
although, it is believed to be related to the degree of complementary between the two 
strands (Hutvagner and Zamore, 2002, Forstemann et al., 2007, Pillai et al., 2007, 
Brodersen et al., 2008, Iwasaki et al., 2009, Iwasaki and Tomari, 2009). miRNAs are also 
the only small RNAs not to be 2’-O-methylated which affects their biological stability and 
endurance, vital for tightly regulated gene control during development. This method of 
gene regulation is highly energy efficient as the expression of a small RNA in a specific 
tissue is able to sufficiently shut down unnecessary gene expression and can act 
systemically (Choi and Hyun, 2012).  
Several miRNAs have been identified in a number of mosquito and tick species and their 
derived cell lines; although, they have still to be confirmed in midges (Winter et al., 2007, 
Mead and Tu, 2008, Li et al., 2009, Mendes et al., 2010, Skalsky et al., 2010, Barrero et 
al., 2011, Hussain et al., 2011, Gu et al., 2013, Zhang et al., 2013a, Zhou et al., 2013). 
Some of these miRNAs are species specific while some have been shown to be conserved 
between insects and mammals. The involvement of miRNAs during a viral infection has 
been better studied in mammalian systems where it has been demonstrated as being highly 
complex with many factors influencing the cellular response and driving the outcome of 
the infection. These factors include host miRNAs modulating viral transcripts, viral 
miRNAs modulating host transcripts, in addition to viral miRNAs regulating viral 
transcripts using host miRNA mechanisms (Pfeffer et al., 2004, Jopling et al., 2006, 
Ouellet and Provost, 2010, Cullen, 2011, Grundhoff and Sullivan, 2011). Much less is 
currently known about the influence the miRNA pathway has on a viral infection in 
mosquitoes and other invertebrates as only a small number of studies have been performed 
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to date (Vijayendran et al., 2013, Hussain and Asgari, 2014, Asgari, 2014). WNV infection 
of Cx. quinquefasciatus resulted in the up-regulation of one host miRNA (miR-989) but the 
down regulation of another (miR-92); although, the specific targets of the miRNAs are not 
yet known (Skalsky et al., 2010). These results were not observed in the Ae. albopictus 
derived C7-10 cell line suggesting that there is a level of pathogen: host specificity 
involved in the interactions which have been previously determined in other systems (Zhou 
et al., 2009b, Zeiner et al., 2010). DENV infection of Ae. aegypti altered the expression of 
35 separate miRNAs up to nine days post infection, four of which were up-regulated 
(Campbell et al., 2014). Similarly, CHIKV infection of Ae. albopictus significantly 
affected 41 miRNAs and again four of these were up-regulated (Shrinet et al., 2014). Both 
miR-2b and miR-1000 have been shown to be suppressed by both DENV and CHIKV in 
Aedes mosquitoes signifying that they may be common to viral control in these insects. In 
the Ae. albopictus-derived C6/36 cell line, DENV infection causes a greater than 3-fold 
increase in miR-252 which is thought to be involved in the antiviral response (Yan et al., 
2014). Although, this effect was not observed in whole mosquitoes.  
Viral suppressors of RNAi (VSR) proteins are known to interfere with miRNA pathway 
components, such as the Cucumber mosaic virus-encoded VSR protein 2b which 
physically inhibits Ago-1 slicing and causes a build up of cellular miRNA targets in plants 
(Zhang et al., 2006, Gonzalez et al., 2010). However, in Drosophila engineered to express 
a VSR, there were no changes observed in the pattern of miRNAs detected (Berry et al., 
2009). Similarly, knockdown of Ago-1 did not enhance the replication of ONNV in An. 
gambiae (Keene et al., 2004) or SFV and CHIKV in Ae. aegypti-derived Aag2 cells 
(Schnettler et al., 2013a, McFarlane et al., 2014). An interaction between viral proteins and 
host miRNAs has been suggested for the non-structural protein 3 (NS3) of rice hoja blanca 
tenuivirus which is known to bind to plant-derived miRNAs and results in the suppression 
of an RNAi knockdown in Drosophila-derived cells (Hemmes et al., 2007). This may 
implicate NS3 as being able to bind insect miRNAs.  
DENV-2 infection of both Ae. aegypti-derived Aag2 and Ae. albopictus-derived RML12 
cell lines results in the production of six miRNA-like small RNAs, one from the 5’ UTR 
and the rest from the 3’ UTR (Hussain and Asgari, 2014). When these were silenced only 
one, designated vsRNA-5, resulted in a significant increase in viral replication. It is 
believed to regulate DENV infection though its association with its target sequence found 
in NS1. However, this sequence is currently only known for DENV-2 and no other 
serotypes (Finol, 2014). Likewise, it has been shown that WNV expresses a miRNA 
molecule from the subgenomic RNA corresponding to the 3’ UTR in the Ae. aegypti 
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derived Aag2 and Ae. albopictus derived C6/36 cell lines (Hussain et al., 2012). By up-
regulating the synthesis of the host GATA4 transcription factor mRNA, the virus induced a 
pro-viral cellular state and GATA4 was shown to be necessary for its replication. Whether 
these functions are related to the RNAi suppressor activity of the subgenomic flavivirus 
RNA (sfRNA) (discussed in Chapter 1.4.6, Chapter 3 and Chapter 5) is yet to be 
determined.    
 
1.4.5 piRNA Pathway  
Piwi-interacting RNA (piRNA) molecules have a size range of between 25 - 30 nt and 
interact with PIWI clade proteins consisting of PIWI, Argonaute 3 (Ago-3) and Aubergine 
(Aub) (Sarot et al., 2004; Siomi et al., 2011; Luteijin and Ketting, 2013). Although they 
were originally believed to be specific to germ line and surrounding cells, they have 
recently been identified in the somatic cells of mosquitoes and vertebrates.  
Their biogenesis is poorly understood and the source elements responsible, in addition to 
the location of the process (nuclear or cytoplasmic) are largely unknown. The mechanism 
is believed to be Dicer independent (Vagin et al., 2006; Houwing et al., 2007; Zamore, 
2007) (Figure 1.9). Primary piRNAs are believed to be asymmetrical and generated in 
antisense from (ss)RNA molecules transcribed from a specific chromosomal loci 
containing inactive transposable elements (TE) within a region of the genome called a 
piRNA cluster (Brennecke et al., 2007; Ghildiyal and Zamore, 2009; Senti and Bennecke, 
2010; Kawaoka et al., 2013; Mohn et al., 2014; Sapetschnig and Miska, 2014; Zhang et al., 
2014). The ss-specific nuclease Zucchini (Zuc) cleaves the ssRNA precursors into primary 
piRNAs (Ipsaro et al., 2012; Nishimasu et al., 2012) which are then 2’-O-methylated at the 
3’-terminal (Horwich et al., 2007; Kawaoka et al., 2011; Vodovar et al., 2012) and 
incorporated into RISC, associated with Aub and PIWI proteins (Brennecke et al., 2007; 
Gunawardane et al., 2007). The production of secondary piRNAs occurs following the 
cleavage that occurs when these primary molecules combine with sense RNAs derived 
from transposons (van Rij and Berezikov, 2009; Saito and Siomi, 2010; Senti and 
Bennecke, 2010; Siomi et al., 2010 and 2011). Ago-3 is understood to interact with the 
secondary molecules and use them as a guide for recognising complementary antisense 
strands of RNA which are cleaved to become new primary piRNAs. As a result, the 
proceeding ten nucleotides of the primary molecule correspond to the complementary 
sequence of the Ago-3-associated secondary molecule and this in turn determines the 
sequence of the succeeding secondary piRNAs (Saito et al., 2006; Brennecke et al., 2007; 
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Gunawardane et al., 2007). Therefore, the production of primary piRNAs drives the 
creation of secondary piRNAs and vice versa. This production pathway results in the 
characteristic ‘ping-pong’ piRNA signature corresponding to a Uridine at position 1 (U1) 
on the antisense primary molecules and an Adenine at position 10 (A10) on sense secondary 
piRNA molecules (Brennecke et al., 2007; Gunawardane et al., 2007; van Rij and 
Berezikov, 2009; Haase et al., 2010; Saito and Siomi, 2010; Senti and Bennecke, 2010; 
Siomi et al., 2010 and 2011).   
 A number of differences between Drosophila and mosquito piRNA pathways are evident. 
Ago-3 and Aub are exclusively found in the Drosophila germline, while PIWI is only 
additionally found in the adjacent follicular cells (Brennecke et al., 2007, Gunawardane et 
al., 2007; Nishida et al., 2007; Lau et al., 2009; Saito et al., 2009). Some studies report that 
piRNA molecules may be present more widely in somatic tissues of Drosophila (Yan et 
al., 2011). However, detection of these molecules in the soma surrounding the ovary 
indicated their biogenesis was via a more simplistic pathway which was Aub/Ago-3 
independent but PIWI dependent. This was referred to as the primary pathway (Li et al., 
2009; Malone et al 2009). Phylogenetic analysis indicates that in the Aedes and Culex 
genomes there is an expansion of the PIWI family genes compared to what is known in 
Drosophila (Ae. aegypti- seven Piwi proteins and one Ago-3, Cx. pipiens- six Piwi proteins 
and Ago-3, Drosophila- one Piwi, Ago-3 and Aub only) (Campbell et al., 2008a). 
Furthermore, these proteins are more widespread and are not limited to the germline as 
PIWI transcripts and piRNAs have been shown in the head and thorax somatic tissues of 
Aedes mosquitoes (Morazzani et al., 2012). Bioinformatic analysis has also indicated that 
fewer piRNAs map to TEs in Ae. aegypti compared to those in Drosophila (Arensburger et 
al., 2011) suggesting there may be an alternative role in these insects.     
The first suggestion that piRNAs may be involved in processing viral RNAs occurred 
following the observation that PIWI and Aub null mutants were more sensitive to DXV 
infection (Zambon et al., 2006). Viral RNAs of the expected size of piRNAs were later 
discovered in Drosophila ovarian somatic sheet (OSS) cells (Wu et al., 2010; van Mierlo et 
al., 2010). Similar molecules of the expected size have since been observed in Ae. aegypti 
mosquitoes infected with DENV (Scott et al., 2010; Hess et al., 2011) and the Ae. 
albopictus –derived C6/36 cell line infected with WNV, SINV and LACV (Brackney et al., 
2010). Deep sequencing analysis of Aedes mosquitoes and their derived cell lines revealed 
that following infection by viruses of the Togaviridae and Bunyaviridae families viral-
derived piRNAs (vpiRNAs) were produced displaying an enriched A10 (positive polarity 
vpiRNAs) or U1 (negative polarity vpiRNAs) signature (Morazzani et al., 2012; Vodovar 
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et al., 2012; Leger et al., 2013; Schnettler et al., 2013a and b). This indicates vpiRNAs are 
produced from important arboviruses through the ping-pong biogenesis pathway. Indeed, 
expression of the VSR protein, B2, in CHIKV was shown to target the piRNA machinery 
and restrict antiviral activity (Morazzani et al., 2012). Furthermore, the knockdown of 
piRNA-related proteins, like Ago-3 in the case of ONNV in An. gambiae (Keene et al., 
2004) and PIWI 4 for SFV in Ae. aegypti-derived Aag2 cells (Schnettler et al., 2013a) 
result in an increase in viral titres. This further emphasises the role that these small RNA 
molecules play in the antiviral response of mosquitoes.  
The production of antiviral small RNA populations has been documented to change during 
the course of an infection. It has been shown that subsequent to RVFV infection of Ae. 
aegypti-derived Aag2 cells it was observed that while the overall number of small RNAs 
generated against the infection increased, the initial dominant population of 21 nt viRNA 
molecules decreased as the infection progressed into persistence and the vpiRNA 
molecules become preponderant (Léger et al., 2013). This is in contrast to the Ae. 
albopictus-derived C6/36 cell line which is known to be RNAi deficient and allows high 
levels of virus replication to occur (Brackney et al., 2010; Morazzani et al., 2012) 
(Chapter 5). This cell line does not produce Dcr-2 siRNA products but immediately 
results in the generation of vpiRNAs. As a result, the lesser antiviral response exhibited by 
these cells suggests that although the piRNA pathway may act antivirally, it may not be as 
robust as the exo-siRNA in modulating viral replication and may be redundant in viRNA 
competent tissues.    
 
1.4.6 Viral RNAi Countermeasures  
Some viruses have evolved specific countermeasures to evade or antagonise the RNAi 
response. By encoding viral suppressors of RNAi the antiviral response can be targeted at 
specific steps of the pathway as demonstrated by both plant and insect viruses (reviewed Li 
and Ding, 2006; Ding and Voinnet, 2007; Kemp and Imler, 2009; Blair, 2011; van Mierlo 
et al., 2011; Donald et al., 2012; Bronkhorst and van Rij, 2014). Many of them act on two 
levels: targeting dsRNA or siRNA molecules which instigate and determine the sequence 
specific target of the defence response respectively; and interacting with an RNAi 
component, often Ago-2 (Figure 1.10). These are believed to have co-evolved along with 
the antiviral responses of the host and a recent publication suggests that in some cases, 
suppressor activity may be limited to the natural virus vector (van Mierlo et al., 2014). 
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Examples of VSRs include that of DCV (Dicistroviridae), a natural pathogen affecting 
flies, which encodes a VSR termed protein 1A. It functions to prevent dsRNA cleavage by 
Dcr-2 (van Rij et al., 2006) and may also affect siRNA loading into RISC (Bonning and 
Miller, 2010; Nayak et al., 2010). The 1A protein encoded by the closely related CrPV 
(Dicistroviridae) has a slightly different mode of function and acts by directly interacting 
with Ago-2 resulting in its inhibition (Nayak et al., 2010). This action of Ago-2 inhibition 
is also observed for viral protein 1 (VP1) encoded by the unrelated Drosophila pathogen 
Nora virus (a novel virus within the order Picornavirales) (van Mierlo et al., 2012). The 
B2 suppressor protein is encoded by members of the Alphaodavirus genus, such as flock 
house virus (FHV) or Wuhan nodavirus (WhNV). Not only does B2 bind dsRNA but it 
also interacts with siRNA molecules and therefore inhibits Dcr-2 cleavage and siRNA 
incorporation into RISC (Li et al., 2002; Chao et al., 2005; Lingel et al., 2005; Aliyari et 
al., 2008; Qi et al., 2012).  
Arboviruses were not believed to encode RNAi suppressor proteins (Li and Ding, 2006; 
Blakqori et al., 2007; Attarzadeh-Yazdi et al., 2009; Fragkoudis et al., 2009; Donald et al., 
2012). It was hypothesised that suppression of the antiviral defences would be detrimental 
to the survival of the vector and would therefore be counterintuitive to the replicative 
fitness of the virus (Myles et al., 2008; Cirimotich et al., 2009). However, the putative 
arbovirus Nodamura virus (NoV, Nodaviridae) encodes a B2 protein which binds dsRNA 
and siRNA molecules and cannot replicate without it (Li and Ding, 2006; Aliyari et al., 
2008; Myles et al., 2008; Han et al., 2011). Furthermore, a recent published paper by van 
Rij and colleagues suggests that the mosquito specific Culex Y virus (CYV, 
Entomobirnavirus) viral protein 3 (VP3) acts as an RNAi antagonist protein and binds both 
dsRNA and siRNA molecules. Despite this, CYV is able to establish a non-pathogenic, 
persistent infection implicating the possibility of undiscovered VSRs in other non-lethal 
viruses (van Cleef et al., 2014).   
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Figure 1.10: Schematic overview of the RNAi pathway in insects and the stages that RNAi 
suppressor proteins inhibit. Drosophila C virus (DCV 1A), flock house virus (FHV B2), Cricket 
paralysis virus (CrPV 1A), Culex Y virus (CYV VP3), Nodamura virus (NoV B2), dengue virus 
(DENV NS4B).  
 
To date, flaviviruses are the only arboviruses known to express an RNAi antagonist in the 
form of sfRNA molecules. These are produced from the 3’ UTR-derived RNA molecule of 
DENV and WNV (Pijlman et al., 2008; Schnettler et al., 2012). These molecules inhibit 
RNAi through an RNA decoy mechanism whereby high levels of non-coding RNAs are 
produced to restrict efficient silencing by occupying the active site of Dcr-2 and preventing 
the incorporation of coding sequences. sfRNAs are not specific to mosquito-borne 
flavivirus infections as they are also generated during Langat virus (LGTV) and TBEV 
infections of tick-derived cell lines (Schnettler et al., 2014). Moreover, the non-structural 
protein 4B (NS4B) of DENV is also suggested to be an inhibitor of Dcr-2; although, the 
mechanism is currently unknown (Kakumani et al., 2013). The relative strength of these 
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inhibitors compared to those described previously is not known. However, it is clear from 
previous work that overcoming RNAi completely inevitably leads to the death of the 
vector.  
In the absence of a VSR arboviruses are understood to circumvent the antiviral response 
rather than directly impede it (Uchil et al., 2003; Geiss et al., 2005; Siu et al., 2011; Sabin 
et al., 2013). This evasion or decoy strategy may indirectly decrease the potency of the 
antiviral response by restricting or delaying access to the viral genome or by offering 
regions of the genome that would be less destructive to the virus. The genomes of most 
dsRNA viruses replicate behind the protection of the viral core which encompasses the 
genome during replication. Similarly positive stranded RNA viruses, including members of 
the Togaviridae and Flaviviridae, are known to replicate within cytoplasmic vacuoles in 
mammalian cells preventing access to dsRNA replication intermediates which would 
trigger the immune pathway (Diamond et al., 2003; Geiss et al., 2005; Campbell et al., 
2008a; Sanchez-Vargas et al., 2009; Spuul et al., 2010 and 2011). Decoy viRNAs have 
been shown to be produced against specific regions of the genome following SFV infection 
of mosquito cells (Siu et al., 2011) (discussed further in Chapter 3) as well as for the 
hairpin structure of the S segment of RVFV and the defective interfering particle of VSV 
(Rhabdoviridae) (Sabin et al., 2013). The introduction of VSRs into viruses not believed to 
harbour them naturally can be detrimental to the vector. For instance, the outcome of 
infection by alphaviruses SINV and ONNV engineered to express the B2 VSR was an 
increase in virus replication, dissemination and viral titre as well as higher mortality rates 
in Ae. aegypti, Ae albopictus and C. tritaeniorhynchus following in vivo injection 
(Cirimotich et al., 2009; Myles et al., 2008). These findings emphasise the delicate balance 
that must be established between vector survival and virus transmission.      
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1.5 Aims and Objectives 
 
Aim  
The aim of this project is to expand our understanding of the innate antiviral immune 
responses of mosquitoes, in particular the RNAi response. Due to the increasing 
understanding that data collected from the model insect organism, Drosophila 
melanogaster, does not always directly correlate with that obtained from mosquitoes, the 
natural vectors for major arboviruses, it is important to establish functional assays and 
biological tools to allow the correct responses of these animals to be ascertained.   
     
Objectives 
1. To establish an efficient assay for the silencing of the major proteins involved in 
the antiviral RNAi response of Aedes aegypti –derived cell lines.  
2. To investigate the production of viral-derived small RNAs in Aedes aegypti-derived 
Aag2 and Aedes albopictus-derived U4.4 cell lines. 
3. To investigate the function of an orthologue of Drosophila Elp-1 as a potential 
RNA dependent RNA polymerase in the Aedes aegypti-derived Aag2 cell line.   
4. To design and develop molecular tools for the study of Aedes mosquito RNAi 
proteins.  
5. To characterise the antiviral defences of the Toxorhychites amboinensis-derived 
cell line TRA-171 following SFV infection and determine the antiviral activity of a 
non-haematophagous mosquito which may potentially serve as safe model for 
arboviral studies.   
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2.1 Bacterial Techniques  
2.1.1 Culturing  
Two laboratory strains of Escherichia coli (E. coli) were used for the growth and 
amplification of DNA plasmids. Amplification of toxic virus plasmids was achieved by 
transforming SURE 2 competent cells (Stratagene). All other plasmids were amplified 
using DH5α chemically competent cells (Invitrogen). Both strains of bacteria were grown 
in sterile Luria-Bertani (LB) broth (E&O Laboratories Ltd) containing the appropriate 
plasmid selection antibiotic; 100 µg/ml ampicillin (Amp) (Melford Laboratories Ltd.), 50 
µg/ml kanamycin (Kana) (Sigma Aldrich) or 20 µg/ml zeocin (Life Technologies). Agar 
plates were made by pouring melted sterile LB agar (E&O Laboratoriess Ltd) 
supplemented with the appropriate antibiotic into 10 cm
2
 Petri dishes (Greiner Bio One). 
Following transformation, bacteria were streaked onto the surface of the cooled agar with a 
plastic spreader (VWR) and allowed to dry before the plate was inverted and incubated 
overnight (approximately 16 h) at 37 °C. Single colonies were selected and inoculated into 
LB broth containing the appropriate antibiotic. Cultures were again incubated overnight at 
37 °C with orbital shaking at 225 rpm for approximately 16 h. Amplified DNA plasmids 
were purified from the bacteria by Miniprep (Chapter 2.3.1.1) or Maxiprep (Chapter 
2.3.1.2).           
 
2.1.2 Transformation  
Transformation of both strains of bacteria was done according to the respective 
manufacturer’s instructions. Briefly, 50 µl of DH5α bacteria were thawed on ice and 
transferred to a sterile 1.5 ml tube (Axygen). Approximately 10 ng/µl of plasmid DNA was 
added to the bacteria suspension and mixed by gently flicking the tube. The bacteria were 
left on ice for 30 min in advance of heat shocking at 42 °C for 20 sec. Cultures were then 
returned to ice for a further 2 min to induce plasmid uptake after which 950 µl LB broth 
pre-warmed to 37 °C was added and the tubes were incubated for 60 min at 37 °C with 
orbital shaking at 225 rpm. Following incubation, 70 µl of the culture was applied to the 
surface of the LB agar plates containing the appropriate antibiotic. The remaining culture 
was then spun at 2,000 rpm for 2 min and 80 % of the supernatant removed. The pellet was 
resuspended in the remaining supernatant and plated on a second LB agar plate. 
Transformation efficiency was verified using the pUC19 control DNA (Invitrogen). Once 
dry, plates were inverted and incubated at 37 °C overnight.  
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SURE 2 Supercompetent bacteria were first mixed with 2 µl of β-mercaptoethanol (Sigma 
Aldrich) and incubated on ice for 10 min with agitation every 2 min. After the incubation 
was complete, 1 µl of plasmid DNA (0.1- 50 ng/µl) was added to the cells and incubated 
on ice for a further 30 min. Cells were heat shocked for at 42 °C for 20 sec before 
returning to ice for 2 min. Following this the bacteria were mixed with 900 µl pre-warmed 
super optimal culture (SOC) media (Invitrogen) and incubated for 60 min at 37 °C with 
orbital shaking at 225 rpm. The bacteria were plated out onto LB agar plates as described 
in Chapter 2.1.1.  
 
2.1.3 Glycerol Stock Preparation   
A single colony expressing the desired plasmid was selected from an agar plate and used to 
inoculate 5 ml LB broth supplemented with the appropriate selection antibiotic. The 
culture was incubated overnight at 37 °C with orbital shaking at 225 rpm for 
approximately 16 h. Subsequently, the culture was spun for 2 min at 2,000 rpm and the 
bacteria pellet resuspended in 1 ml of 50 % sterile glycerol (Sigma Aldrich) (1 glycerol: 1 
H2O). The suspended bacteria were transferred to a sterile 1.5 ml tube, snap frozen on dry 
ice and transferred to long term storage at -80 °C. When required, the stock could be used 
to inoculate sterile LB broth without allowing the bacteria to thaw. 
 
2.2 Eukaryotic Cell Culture  
2.2.1 Cell Line Maintenance     
Each cell line was maintained in sterile plastic flasks (Nunc) and is described in Table 2.1. 
All tissue culture was carried out under sterile conditions in a Class II biological safety 
cabinet to avoid microbiological contamination.  
 
2.2.1.1 Insect Cells  
Aedes aegypti-derived Aag2, Aedes albopictus-derived U4.4, C6/36  and C7-10 mosquito 
cells were grown in L-15 (Leibovitz) growth culture medium (Life Technologies) 
supplemented with 10 % (v/v) foetal calf serum (FCS), 10 % tryptose phosphate broth 
(TPB) (Sigma-Aldrich) and antibiotics (100 U/ml penicillin/100 µg/ml streptomycin 
(Pen/Strep) (Life Technologies)). Toxorhynchites amboinensis-derived TRA-171 mosquito 
cells were grown in L-15: Mitsuhashi and Maramorosch insect growth medium 
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(Promocell) (1:1) supplemented with 10 % FCS, 0.05 % Bovine Serum Albumin (BSA) 
(Sigma-Aldrich), 1 % non essential amino acids and Pen/Strep. Towards the end of this 
project this media was required to be made in-house using the formulation found in 
Chapter 2.8. Schneider (S2) drosophila cells were grown in Schneider’s media (Life 
Technologies) with added 10 % FCS and Pen/Strep. Spodoptera frugiperda-derived Sf21 
cells were maintained in TC100 (Life Technologies) media plus 5 % FCS and Pen/Strep.  
All insect cells were maintained at 28 °C with no additional CO2. 
When cells were approximately 80 % confluent, the old growth media was removed and 
the cell monolayer was covered with an appropriate volume of fresh media. Cells were 
detached from the plastic using a cell scraper (Falcon) and transferred to a sterile 15 ml 
universal tube (Corning). The cells were thoroughly resuspended and 10 µl removed and 
diluted in 90 µl with sterile phosphate buffered saline (sPBS) (Sigma-Aldrich) and counted 
using a haemocytometer. The mean number of cells was calculated by the following 
formula: 
 
                           
                                                                
 
The required number of cells were then transferred to a fresh flask with the appropriate 
growth medium and returned to the incubator. Cells were passaged for approximately 40- 
50 passages before their growth was observed to slow and they were replaced with fresh 
stocks from liquid nitrogen storage.     
 
2.2.1.2 Mammalian Cells   
Baby hamster kidney (BHK-21) cells were maintained for the propagation and titration of 
viruses. They were grown at 37 °C in a humid environment with 5 % CO2 in Glasgow 
Minimum Essential Medium (GMEM) (Life Technologies) enriched with 10 % Newborn 
Calf serum (NBCS), 10 % TPB and Pen/Strep.   
When cells were approximately 80 % confluent, the old growth media was removed and 
the monolayer was washed once with 5 ml versene in PBS (E&O Laboratories Ltd) which 
was replaced with an appropriate volume of 1 x trypsin/EDTA (Invitrogen). Cells were 
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incubated at 37 °C until the monolayer detached from the plastic before the trypsin 
reaction was neutralised by the addition of 10 ml fresh GMEM. The cells were then 
transferred to a 15 ml universal tube and pelleted by centrifugation at 1,500 rpm for 5 min. 
The supernatant was discarded and the cells thoroughly resuspended in 10 ml fresh growth 
media.  A 10 µl aliquot was removed and diluted in 90 µl sPBS and the cells counted using 
a glass haemocytometer. The mean number of cells was calculated by the formula 
described in Chapter 2.2.1.1.  The required number of cells were transferred to a fresh 175 
cm
2
 flask with fresh growth medium and returned to the 37 °C incubator. Cells were 
passaged for approximately 30 - 40 passages before they were replaced with fresh stocks 
from liquid nitrogen storage.     
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Table 2.1: Cell lines used in this project 
Cell Name 
Organism of 
origin 
Growth Media 
Growth 
Conditions 
Reference 
Aag2 
 
Aedes aegypti 
 
L-15 (Leibovitz) growth 
culture medium 
supplemented with 10 % 
(v/v) foetal calf serum (FCS) 
8 % tryptose phosphate broth 
(TPB) and antibiotics (100 
U/ml penicillin/100 µg/ml 
streptomycin [Pen/Strep]) 
28 °C 
Peleg, 1968 
U4.4 
 
Aedes 
Albopictus 
 
 
Condreay 
and Brown, 
1986 C6/36 
C7-10 
Received 
from Prof. 
R. Hardy 
TRA-171 
Toxorhynchites 
amboinensis 
L-15: Mitsuhashi and 
Maramorosch insect growth 
medium (1:1) supplemented 
with 10 % FCS, 0.05 % BSA, 
1 % non essential amino acids 
and Pen/Strep. 
Kuno, 1980 
S2
+ 
(infected 
with Flock 
house virus 
(FHV)) 
Drosophila 
melanogaster 
Schneider’s media with added 
10 % FCS and Pen/Strep 
Czech et al., 
2008 
S2
-
 
(uninfected) 
Schneider, 
1972 
Sf21 
Spodoptera 
frugiperda 
 
TC100 media plus 5 % FCS 
and Pen/Strep 
 
Vaughn et 
al., 1977 
BHK-21 
Mesocricetus 
auratus 
Glasgow Minimum Essential 
Medium (GMEM) with added 
10 % Newborn Calf serum 
(NBCS), 10 % TPB and 
Pen/Strep 
37 °C with 
5 % CO2 
Macpherson 
and 
Stocker, 
1962 
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2.2.2 Freezing and Recovery of Eukaryotic Cell Lines    
Cells were frozen to ensure availability of all cell lines. When they were in an active 
growth stage and < 80 % confluency they were harvested and counted as described prior to 
being pelleted by centrifugation and the supernatant discarded. The cell pellet was 
resuspended thoroughly in freezing media (90 % FCS and 10 % dimethylsulphide (DMSO) 
(BDH Prolabo), a cryoprotective agent) to give approximately 8 x 10
6
 /ml insect cells and 
5 x 10
6 
/ml mammalian cells. Aliquots of 1 ml of the cell suspension were transferred to 
1.5 ml cyrovials (Greiner Bio One) which were placed in a freezing canister (Mr. Frosty, 
Nalgene) containing isopropanol (VWR). This was placed at -80 °C overnight were the 
combination of the cyroprotective agent and the isopropanol allowed gradual freezing of 
the cells at approximately 1 °C/min, reducing the formation of damaging ice crystals which 
would cause cell damage. Finally the cyrovials were placed in the vapour phase above 
liquid nitrogen at -130 °C for long term storage.  
Resurrection of cell lines was achieved by removing a cryovial from liquid nitrogen 
storage and placing it on dry ice to avoid gradual defrosting. The lid of the cryovial was 
slightly loosened to allow the escape of any gases and the cells were rapidly thawed by 
submerging the cryovial in a water bath at 37 °C. Once completely defrosted, 1 ml of the 
appropriate pre-warmed growth media was added. The total volume of the cryovial was 
transferred into a 25 cm
2
 flask containing 15 ml warm growth media. The flask was placed 
in the appropriate incubator for 24 h after which the media was replaced to remove the 
freezing media. When the cells reached confluency they were then passaged as described.     
 
2.3 Nucleic Acid Techniques  
2.3.1 Plasmid DNA Extraction from Transformed Bacteria  
2.3.1.1 Mini-Preparation of Plasmid DNA  
Bacteria cultures were grown as described to allow amplification of plasmid DNA. Small 
scale isolation of plasmid DNA was achieved by using the Isolate Plasmid mini kit 
(Bioline) following the manufacturer’s guidelines. Briefly, 1.5 ml of the 5 ml culture was 
transferred to a clean RNase/DNase 1.5 ml tube and pelleted by centrifuging at full speed 
for 1 min at room temperature. This was then repeated with a further 1.5 ml aliquot so that 
the final pellet was equivalent to 3 ml of bacterial culture. Any remaining supernatant was 
removed and replaced with 250 μl re-suspension buffer. This was mixed thoroughly by 
pipetting to ensure a complete removal of any cell clumps prior to the addition of 250 μl 
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Lysis buffer P to cause SDS/alkaline lysis of the bacteria cells. The sample was mixed 
again by inverting the tube six times. After ≤ 5 min, 350 μl Neutralisation buffer was 
added to halt the reaction and the tube was again inverted six times. The sample was then 
centrifuged for 10 min at maximum speed at room temperature to clear the lysate of 
cellular debris. The supernatant was transferred to the silica membrane of a spin column P 
assembled in a 2 ml collection tube and centrifuged at 12,000 rpm for 1 min. The filtrate 
was discarded and the spin column returned to the collection tube before 500 μl Wash 
buffer AP was added. The sample was then centrifuged as before. The filtrate was disposed 
off and replaced with 700 μl Wash buffer BP supplemented with 100 % ethanol (EtOH) 
(Fisher Scientific) as directed before the sample was centrifuged as before. To dry the 
membrane and remove any remaining traces of EtOH, the sample was centrifuged for a 
further 2 min at maximum speed. Finally, the spin column was transferred to a clean 1.5 ml 
tube and 30 - 100 μl Elution buffer added, incubated for 1 min at room temperature and 
spun at 12,000 rpm for 1 min. The eluted DNA was recovered and quantified (as described 
in Chapter 2.3.23) prior to storage at -20 °C.  
  
2.3.1.2 Maxi-Preparation of Plasmid DNA 
Large scale isolation of plasmid DNA from bacteria cultures was achieved by using a 
plasmid Maxi kit (Qiagen) following the manufacturer’s guidelines with a slight deviation. 
Briefly, one colony of transformed bacteria was used to inoculate 100 ml LB broth in a 2 L 
conical flask. After incubating overnight for approximately 18 h at 37 °C with shaking at 
250 rpm, the bacteria were harvested by centrifuging at 6,000 rpm for 20 min at 4 °C. The 
pellet was completely re-suspended in 10 ml chilled buffer P1 and transferred to a 50 ml 
universal tube (Corning). The bacteria were lysed by adding 10 ml of buffer P2 and 
vigorously inverting the tube six times. Following incubation at room temperature for 5 
min, 10 ml of chilled buffer P3 was added and mixed by inverting the tube a further six 
times. The tube was placed on ice and incubated for 20 min. To purify the lysate, a coffee 
filter was placed in a QIAGEN-tip 500 and equilibrated by passing 11 ml buffer QBT 
through. The lysate was transferred from the universal into the coffee filter. The cleared 
supernatant containing the DNA passed through the coffee filter into the QIAGEN-tip 
while the cell debris remained in the coffee filter. Once all the supernatant has passed 
through the resin of the QIAGEN-tip, it was washed with 60 ml buffer QC. The bound 
DNA was eluted with 15 ml buffer QF and collected in a clean 50 ml universal tube. To 
this, 10.5 ml room temperature isopropanol was added to precipitate the DNA and the 
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sample was centrifuged at 5,000 rpm for 60 min at 4 °C. The pellet was washed with 5 ml 
70 % EtOH to remove traces of the isopropanol and centrifuged as before. After this, the 
supernatant was carefully decanted and the pellet air -dried for approximately 10 min. The 
pellet was re-suspended in 100 - 120 μl RNase/DNase free H2O (Sigma Aldrich), measured 
as described and stored until required at -20 °C.  
    
2.3.2 DNA Digestion by Restriction Endonucleases  
Restriction enzyme digests were performed by mixing approximately 1 μg DNA with one 
unit (U) of enzyme. One U of enzyme signifies the concentration of a specific enzyme that 
will cleave 1 μg DNA at its optimum temperature in 1 h. Various restriction endonucleases 
were used throughout this project. Digestion reactions contained the appropriate volume of 
10 x restriction enzyme buffer (New England Biolabs), 10 x acetylated bovine serum 
albumin (BSA) (New England Biolabs), 1 U/μl restriction enzyme (New England Biolabs) 
and the desired concentration of DNA. The reaction was made up to an appropriate volume 
of RNase/DNase free H2O. For example, a digest in a final volume of 20 μl would contain 
2 μl 10 x digestion buffer, 2 μl 10 x BSA, 1 μl enzyme, X μl DNA and made up to 20 μl 
with H2O. Reactions were incubated for 2 - 4 h or overnight at the optimum cleavage 
temperature for each endonuclease. Digestion products were analysed by agarose gel 
electrophoresis and purified for further use as described (Chapter 2.3.5).  
Potentially three separate DNA topologies could result from an incomplete restriction 
digest and these would migrate at different rates depending on the efficiency of the 
digestion. In order from the furthest – nearest migration rate these are; uncut supercoiled 
plasmid, linearised plasmid and nicked plasmid. For completely digested DNA a single 
band would be present for the linearised DNA, or more depending on the number of 
restriction sites present.  
  
2.3.3 Agarose DNA Gel Electrophoresis  
Separation of DNA fragments was achieved by gel electrophoresis on an agarose gel. Gels 
were prepared by adding agarose (Promega) to Tris-acetate-EDTA (TAE) buffer (Severn 
Biotech Ltd) to give a final concentration of 0.8 - 2 % agarose depending on the fragment 
sizes to be separated. The preparation was heated to allow the agarose to dissolve and then 
allowed to cool till just warm to the touch before the addition of Ethidium Bromide (EtBr) 
(Promega) to a final concentration of approximately 0.5 μg/ml. EtBr binds to DNA and 
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allows the visualisation of the nucleic acids under UV light. The preparation was swirled to 
ensure equal distribution of EtBr and poured into a gel tray with a comb and any bubbles 
removed with a pipette tip before it was allowed to solidify. The gel tray was then placed 
into a horizontal gel electrophoresis tank (Bio-Rad), submerged in TAE buffer and the 
comb removed. DNA samples were mixed with 6 x loading dye (New England Biolabs) 
and loaded into the wells alongside a DNA ladder of the appropriate size (New England 
Biolabs) either 100 bp or 1 kb. An electric current was applied to the gel to separate the 
different nucleic acid fragments. Typically gels were run at 100 V for 30 - 40 min 
depending on gel percentage, size of the gel tray and size of fragments to be distinguished. 
Nucleic acid products were visualised using a UV transilluminator (Bio-Rad).          
 
2.3.4 DNA Purification from Solution    
DNA products from PCR reactions or enzymatic digestions were purified using the Illustra 
GFX PCR DNA and Gel Band purification Kit (GE Healthcare) following the 
recommended protocol. Briefly, 500 μl Capture buffer 3 was mixed gently with ≤ 100 μl 
sample before the total volume was loaded onto a microspin column. The microspin 
column was placed in a collection tube and spun at 14,000 rpm for 60 sec. The flow-
through was then discarded and replaced with 500 μl Wash buffer type 1. The spin column 
was again spun as before. To increase the purity of the sample, the wash step was repeated 
twice. The spin column was transferred to a clean 1.5 ml tube. Between 10 - 50 μl Elution 
buffer was applied and incubated on the spin column at room temperature for 1 min. 
Samples were either eluted in RNase/DNase free H2O (for sequencing only) or in Elution 
buffer type 4 (10 mM Tris-HCl [pH 8]) for all other applications. The column was then 
spun as before and the eluted DNA recovered, quantified as described and stored until 
required at -20 °C.          
Large linearised DNA fragments were purified for in vitro transcription using high pure 
PCR product purification kit (Roche) following an adapted procedure to the 
manufacturer’s recommended protocol. Approximately 7 µg viral plasmid DNA was 
digested in a 100 µl digestion reaction as described and successful linearisation confirmed 
by loading a small volume onto an agarose gel. Purification of DNA from the remaining 
reaction was carried out by mixing 500 µl binding buffer with the sample and loading it 
onto the membrane of a high pure filter tube assembled in a collection tube. Tubes were 
spun for 1 min at 10,000 rpm. The flow-through was returned to the filter and the tube 
spun a second time as before. The flow-through was now discarded and the filter washed 
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twice with Wash buffer. The first application was 500 µl and the second was 200 µl. The 
tube was spun as before after each application. Following the second wash step the filter 
was dried by centrifuging for 5 min at 10,000 rpm. The DNA was eluted by transferring 
the filter to a clean 1.5 ml tube and applying 40 µl Elution buffer pre-warmed to 70 °C. 
This was allowed to incubate on the column for 2 min before it was centrifuged at 
maximum speed for 2 min. The elution step was repeated and the purified DNA quantified 
as described and stored until required at -20 °C.              
 
2.3.5 DNA Extraction and Purification from Agarose Gel   
DNA extracted from agarose gel slices was purified using the Illustra GFX PCR DNA and 
Gel Band purification Kit (GE Healthcare) following the recommended protocol.  Briefly, 
following separation of the DNA products by agarose gel electrophoresis as described the 
results were visualised using a long wavelength (365 nm) UV transilluminator. The band 
of interest was excised from the gel using a clean scalpel. This was done with minimal 
exposure time to reduce the risk of DNA damage. The gel slice was transferred to a clean 
1.5 ml tube and weighed. The required volume of Capture buffer was applied at the ratio of 
10 μl/10 mg of gel slice for a minimum of 300 mg. The tube was mixed by inversion and 
heated to 60 °C for 15 - 30 min with further mixing at 3 min intervals. Once the agarose 
had melted 800 μl of the gel/capture mix was transferred to a microspin column placed in a 
collection tube. The gel/capture mix was allowed to incubate for 1 min at room 
temperature before centrifuging at 14,000 rpm for 1 min. This was repeated until the total 
volume of gel/capture mix had passed though the column. The samples were now treated 
as described, from the addition of the Wash buffer.     
  
2.3.6 Acrylamide RNA Gel Electrophoresis 
A 0.75 mm 12 % denaturing acrylamide gel was prepared by dissolving 4.8 g urea (Sigma 
Aldrich) in 0.5 ml 10 x Tris-Borate-EDTA Buffer (TBE) (Life Technologies), 3 ml 
acrylamide/bis-acrylamide (40 %) (Sigma Aldrich) and 1 ml RNase/DNase free H2O to 10 
ml. This was incubated at 37 °C with shaking at 225 rpm until all the urea had dissolved 
before it was placed on ice for 5 - 10 min. This was then transferred and allowed to 
polymerise between two glass plates pre-washed overnight with 1 % sodium dodecyl 
sulfate (SDS) (VWR) and wiped with isopropanol to remove protein and nucleic acid 
contaminants. Polymerisation occurred following the addition of 100 µl 10 % ammonium 
Chapter 2  Materials and Methods 
 
70 
 
persulfate (APS) (Bio-Rad), 7.5 µl tetramethylethylenediamine (TEMED) (Sigma Aldrich) 
and RNase/DNase free H2O to a final volume of 10 ml. Gels were assembled in a tank 
which had also been pre-washed. Gel slots were rinsed by syringe with 0.5 x TBE running 
buffer and the gel pre-run for 10 min at 40 V. The slots were then rinsed a second time 
prior to loading the samples. Each sample was diluted 1:1 with 2 x denaturing RNA 
loading dye (Fermentas) and boiled for 5 min at 65 °C followed by incubating for 1 min on 
ice. The samples were then loaded into the gel slots and a current of 150 V passed through 
the gel until the bromophenol blue dye front almost ran off the bottom of the gel.  
 
2.3.7 Polymerase Chain Reaction (PCR) 
Specific regions of DNA were amplified by polymerase chain reaction (PCR). Different 
sequences required specific primers (described in Chapter 2.9) and reaction cycles as. All 
primers were manufactured by Sigma Aldrich. Furthermore, two separate DNA 
polymerases, Go Taq® (Promega) or KOD (Novagen), were utilised for this project. Due 
to its capability for proof reading resulting in a low DNA mutation rate, KOD DNA 
polymerase was used to generate accurate DNA sequences for cloning and sequencing 
purposes while Go Taq DNA polymerase, which has no proof reading ability, was used for 
diagnostic PCRs.  The reaction volume for both enzymes was 50 μl prepared on ice in 0.2 
ml thin walled PCR tubes (Axygen). 
The reaction mix for KOD DNA polymerase consisted of 5 μl 10 x enzyme buffer, 3 μl 
MgSO4 (25 mM), 5 μl dNTP mix (2 mM each), 1.5 μl sense primer (10 μM), 1.5 μl 
antisense primer (10 μM), 1 μl KOD DNA polymerase (1 U/μl), X μl DNA template (~ 10 
ng) made up to a final volume of 50 μl. Reactions were incubated in a PCR thermal cycler 
(Veriti®, Applied Biosystems) with the following protocol: 1) an initial denaturation step 
for 2 min at 95 °C, 2) denaturing at 95 °C for 20 sec, 3) annealing at 5 °C below the lowest 
primer melting temperature for 10 sec, 4) extension step at 70 °C, the duration of which 
was target length dependent and 5) a final extension step of 7 min at 70 °C. Steps 2 - 4 
were repeated over 25 - 35 cycles depending on the template. Where required, β-actin was 
used as a house keeping control to indicate successful transcription of cDNA from RNA 
and to demonstrate relative gene expression.   
The reaction mix for Go Taq DNA polymerase contained the following; 10 µl 10 x PCR 
buffer (Promega), 3 µl MgCl2 (25 mM) (Promega), 1 µl dNTPs (10mM) (Bioline), 1.5 µl 
sense primer (10 μM), 1.5 μl antisense primer (10 μM), 1 μl Taq DNA polymerase (1 
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U/μl), X μl DNA template (~ 10 ng) made up to a final volume of 50 μl.  Reactions were 
incubated in a PCR thermal cycler with the following protocol: 1) an initial denaturation 
step for 2 min at 95 °C, 2) denaturing at 95 °C for 30 sec, 3) annealing at 5 °C below the 
lowest primer melting temperature for 30 sec, 4) extension step at 72 °C, the duration of 
which was target length dependent and 5) a final extension step of 7 min at 72 °C. Steps 2- 
4 were repeated over 25 - 35 cycles depending on the template.  
A non-template (H2O) negative control reaction was run alongside samples for each PCR 
to test for contamination. All PCR products were analysed by agarose gel electrophoresis 
(Chapter 2.3.3) and temporarily stored at 4 °C prior to downstream applications.   
 
2.3.8 Reverse Transcription PCR (RT-PCR) 
Reverse transcription Polymerase Chain Reaction (RT-PCR) was performed to synthesise 
complimentary DNA (cDNA) from messenger RNA (mRNA) templates using the 
SuperScript III kit (Invitrogen) according to the manufacturer’s instructions. Each reaction 
was performed in 0.2 ml thin walled PCR tubes and contained; 1 µl Oligo(dT)  (50 µM) 
(Promega), 1 µl dNTP (10mM), maximum 5 µg total RNA (Chapter 2.3.18) and sterile, 
RNase/DNase free H2O to 13 µl. Reactions were incubated for 5 min at 65 °C and further 
incubated on ice for a minimum of 1 min. Following a brief centrifugation the following 
was added; 4 µl 5 x First Strand buffer (Invitrogen), 1 µl dithiothreitol (DTT, 0.1 M) 
(Invitrogen), 1 µl RNase Inhibitor (Promega), 1 µl Superscript III reverse transcriptase  
(RT, 200 U/ml) (Invitrogen). The reaction was mixed and incubated at 50 °C for 60 min, 
in-activated at 70 °C for 15 min and stored at -20 °C.    
 
2.3.9 PCR using Dig-dNTPs 
PCR was also carried out using Digoxigenin- labelled dNTPs (Dig-dNTPs) (Roche) to 
generate probes for Northern blot analysis (Chapter 2.4.2.4.1). The reaction was prepared 
for a reaction using Go Taq® DNA Polymerase as described in Chapter 2.3.7; however, 
normal dNTPs were substituted with 5 µl Dig-dNTPs.  
 
2.3.10 Production of Long dsRNA 
DNA for the production of dsRNA molecules was generated by PCR using KOD 
polymerase (Novagen) using either plasmid template for Rluc, Fluc or eGFP dsRNA or 2 
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µl of the cDNA reaction from isolated Aag2 RNA (Chapter 2.3.8). Primers contained T7 
polymerase recognition sites (described Chapter 2.9). The resulting PCR products were 
cloned into the pJet1.2 plasmid (Chapter 2.3.22.1) and sent for sequencing. Correct 
sequences were used to produce dsRNA using a T7 DNA dependent RNA polymerase as 
part of the MegaScript RNAi kit (Ambion) as described in the manufacturer’s guidelines. 
Briefly, the reaction was prepared at room temperature in a RNase/DNase free 1.5 ml tube 
combining the following; 2 µl of each ribonucleotide solution (ATP, CTP, GTP and UTP), 
2 µl 10 x reaction buffer, 2 µl T7 enzyme mix, 1 - 2 µg DNA template and RNase/DNase 
free H2O to final volume of 20 µl. The reaction was mixed by gently flicking the tube and 
placing at 37 °C for 2 - 6 h. Annealing of the sense and antisense RNA strands was 
achieved by incubating the reaction at 75 °C for 5 min before allowing it to gradually cool 
to room temperature (approximately 3 h).  Following this, the digestion of contaminant 
DNA and ssRNA was catalysed by DNase I and RNase A digestion. The tube was placed 
on ice and 2 µl of DNase I, 2 µl of RNase, 5 µl of 10 x Digestion buffer and 21 µl 
RNase/DNase free H2O was added. The reaction was mixed again before a further 
incubation step at 37 °C for 60 min. Purification of the dsRNA was carried out by adding 
50 µl 10 x Binding buffer, 150 µl RNase/DNase free H2O and 250 µl 100 % EtOH to the 
dsRNA solution. The total volume was mixed gently by pipetting and applied to the 
membrane of a filter cartridge placed in a collection tube. It was allowed to pass through 
the membrane by centrifuging at maximum speed for 2 min and the resulting filtrate 
disposed of. The membrane was then washed twice with 500 µl Wash solution containing 
the required volume of EtOH. Centrifugation was carried out as before to allow both wash 
steps to pass through the filter. A final centrifugation step was completed following the 
second wash step to dry the membrane. The filter cartridge was transferred to a clean 1.5 
ml tube and between 50 - 100 µl Elution solution pre-warmed to 95 °C was applied 
directly to the membrane. Following centrifugation as before, the flow through was 
collected and a second volume applied and centrifuged a final time. Quantification was 
carried out as described (Chapter 2.3.23) and the dsRNA stored at -20 °C.    
 
2.3.11 Production of Long, Fluorescently Labelled dsRNA 
DNA for the production of fluorescent dsRNA molecules was again generated by a PCR 
reaction using KOD polymerase (Novagen), a plasmid template encoding eGFP and eGFP 
specific primers encoding T7 polymerase recognition sites (described in Chapter 2.9). 
Correct sequences generated by PCR were used to produce dsRNA using a T7 DNA 
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dependent RNA polymerase (Invitrogen). This involved combining the following in a 1.5 
ml RNase/DNase free microcentrifuge tube: 5 µl DNA template (0.1 – 1 µg), 4 µl 5 x T7 
Reaction buffer (Invitrogen), 2 µl DTT, 1 µl RNase inhibitor, 2 µl Fluorescein RNA 
labelling mix (Roche), 1 µl T7 RNA polymerase and made to a total volume of 20 µl with 
RNase/DNase free H2O. The reaction was incubated in the dark at 37 °C for 4 h followed 
by heating to 70 °C for 10 min and then allowing it to gradually cool to room temperature 
over a period of approximately 2 - 4 h. Finally, 1 µl of DNase (1 U/ml) (Ambion) and 1 µl 
RNase (Ambion) were added to remove contaminating DNA and ssRNA and the reaction 
was incubated for a further 30 min at 37 °C.  
Purification was carried out by ethanol precipitation. The total volume of dsRNA was 
mixed with 20 µl RNase/DNase free H2O, 4 µl 5 M Ammonium Acetate (NH4Ac) (Sigma 
Aldrich) and 100 µl 96 % chilled EtOH. This was incubated for 30 min at -70 °C before 
the reaction was centrifuged for 15 min at 14,000 rpm at 4 °C. The resulting pellet was 
washed with 500 µl 70 % EtOH and centrifuged again for 5 min as before. Following this 
the pellet was air dried and re-suspended in 25 µl RNase/DNase free H2O and stored in the 
dark at -20 °C.    
 
2.3.12 Production of Long, Radio-labelled dsRNA 
Molecules of dsRNA incorporating a radio-labelled dNTP were produced for the in vitro 
dicer cleavage assay. All work involving radioactive material was performed behind 
Perspex shields in the designated radiation area wearing appropriate personal protective 
equipment. The reaction was prepared at room temperature in a RNase/DNase free 1.5 ml 
tube combining the following; 5 µl of 114 nt eGFP PCR product (0.1 - 1 µg) with T7 
polymerase sites, 4 µl 5 x Transcription buffer, 2 µl DTT (0.1 M), 1 µl rNTPs (10 mM of 
each ATP, GTP and UTP and 0.1 mM CTP) (Promega), 3 µl α-32P rCTP (Perkin Elmer), 1 
µl T7 RNA polymerase, 1 µl RNase inhibitor and 3 µl RNase/DNase free H2O. The 
reaction was mixed by flicking the tube gently and placed at 37 °C for 1 - 3 h. Denaturing 
and annealing of both the sense and antisense strands was achieved by incubating the 
reaction at 65 °C for 5 min before allowing it to gradually cool to room temperature 
(approximately 3 h). Following this, the digestion of contaminant DNA and ssRNA was 
catalysed by RNase digestion. The tube was placed on ice and 2 µl of DNase I and 1 µl of 
RNase A were added. The reaction was mixed again preceding a further incubation step at 
37 °C for 30 min.  
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The total volume was then loaded onto a 0.75 mm 8 % native acrylamide gel which was 
prepared as described in Chapter 2.3.6. Each sample was diluted with 6 x loading dye 
(0.25 % bromophenol blue, 40 % glycerol and RNase/DNase free H2O to final volume) 
and loaded into the gel slots before a current of 100 V was passed through the gel for 
approximately 3 h at 4 °C. The dsRNA molecules could then be purified from the gel as 
described (Chapter 2.3.15).  
 
2.3.13 Production of Radio-labelled siRNAs 
Molecules of 21 nt siRNA incorporating a radio-labelled dNTP were produced as a size 
marker for the in vitro dicer cleavage assay. The reaction was prepared at room 
temperature in a RNase/DNase free 1.5 ml tube combining the following in a 20 µl 
reaction; 1.7 µl of 21 nt Fluc siRNA (500 ng) (Qiagen), 4 µl 5 x kinase exchange buffer 
(Invitrogen), 2 µl γ-32P ATP, 1 µl T4 polynucleotide kinase (PNK) (Invitrogen), 0.5 µl 
RNase inhibitor and 10.8 µl RNase/DNase free H2O. The reaction was mixed by gently 
flicking the tube and placed at 37 °C for ≥ 1 h. The total volume was then loaded onto a 
0.75 mm 12 % native acrylamide gel. Each sample was diluted with 6 x loading dye and 
loaded into the gel which was run at 4 °C at 100 V for approximately 3 h. The siRNA 
molecules could then be purified from the gel as described.  
 
2.3.14 Production of Radio-labelled DNA Oligonucleotides 
 DNA oligonucleotide probes for RNA detection by Northern blotting were radio-labelled 
with γ-32P ATP by assembling the following components: 1 μl DNA oligonucleotide (5 
pmol), 4 μl 5 x kinase forward buffer, 2 μl γ-32P ATP, 1 μl PNK made to a final volume of 
20 μl with 12 μl H2O. The reaction was incubated for > 1 h at 37 °C before the kinase was 
deactivated by heating to 70 °C for 10 min. Probes were column purified to remove any 
unincorporated nucleotides using Mini Quick Spin Oligo columns (Roche) following the 
manufacturer’s instructions. Briefly the column was gently flicked to collect the Sephadex 
matrix in the base of the column and ensure it was evenly re-suspended. The cap was 
removed followed by the tip and the column then placed in a sterile 1.5 ml microcentrifuge 
tube. Following centrifugation at 5,500 rpm for 1 min to pull the matrix away from the 
sides of the column and to remove residual buffer, it was transferred to a fresh 1.5 ml 
microcentrifuge tube and the total volume of sample (20 μl) applied to the matrix in the 
middle of the column. The tube was centrifuged for 4 min at 5,500 rpm and the eluate 
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containing the labelled oligonucleotides was collected. Radioactivity was measured by 
exposing 1 µl to a Geiger counter (approximately 100 - 200 counts per second (cps)/μl) 
and 5 μl added to each hybridization reaction.  Samples were stored in a Perspex box at -20 
°C.       
         
2.3.15 RNA Extraction and Purification from Acrylamide Gel 
After the radio-labelled RNA had successfully passed into the acrylamide gel, the gel was 
dissembled from one of the glass plates and wrapped securely in cling film and placed in a 
tin tray on absorbent paper. In the dark room, the gel was exposed to photosensitive film 
(Kodak) for approximately 1 min. Following exposure of the film to the gel, the areas 
where the radio-labelled RNA molecules were detected were excised from the film to 
allow it to be used as a template for their removal from the gel. The gel fragments 
containing the RNA molecules were placed into clean RNase/DNase free 1.5 ml tubes and 
each ground using micro-pestles (Sigma Aldrich) in 100 µl 2 x PK buffer (200 mM Tris 
(pH 7.5) (Fisher Scientific), 300 mM NaCl (VWR), 5 mM Ethylenediaminetetra-acetic 
acid (EDTA) (VWR) and 2 % SDS). A further 900 µl 2 x PK buffer was added and the 
tube was tightly secured and incubated at room temperature with shaking for 
approximately 16 h. Samples were then centrifuged for 10 min at 10,000 rpm at room 
temperature and the supernatant transferred to a fresh 1.5 ml tube. The centrifugation step 
was repeated and the supernatant was distributed between two fresh 1.5 ml tubes, each 
contained a final volume of approximately 400 µl. To each tube, 1 µl glycogen (10 µg/µl) 
and 400 µl phenol/chloroform (Ambion) were added followed by vortexing for 30 sec. 
Samples were then centrifuged once more as before to allow phase separation. 
Subsequently, 75 % of the upper aqueous phase was transferred to a clean 1.5 ml tube, 2.5 
x volume (1 ml) 96 % EtOH added and samples incubated at -80 °C for ≥ 30 min. 
Following the incubation, tubes were centrifuged for 10 min at 14,000 rpm at room 
temperature. The supernatant was disposed of and the pellet washed with 2 x volume (800 
µl) 70 % EtOH prior to repeating the centrifugation step. On completion, the supernatant 
was carefully discarded and the pellet dried in a flow cabinet for approximately 10 min. 
Finally the pellets were re-suspended in 20 µl RNase/DNase free H2O. Radioactivity was 
measured by exposing 1 µl to a Geiger counter and the sample stored in a Perspex box at -
20 °C.    
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2.3.16 In vitro Transcription of Capped Virus Replicon RNA 
Approximately 1 µg of linearised infectious DNA plasmid was used in the reaction. All 
Semliki Forest virus (SFV) plasmids were linearised by digestion with SpeI restriction 
endonuclease (New England Biolabs), with the exception of the modified SFV1 plasmids 
which were cut with PacI (New England Biolabs). All capped SFV RNAs were produced 
by the SP6 RNA polymerase kit (Ambion). The RNA was synthesised at 37 °C for at least 
4 h, using cap analogue m7G(5’)ppp(5’)G (Ambion) to produce capped viral genomic 
RNA transcripts. The composition of the reaction prepared at room temperature in a 1.5 ml 
tube was: X μl Enzyme-digested plasmid ( approximately 1 μg), 3.0 μl 10 x SP6 Reaction 
buffer, 2.0 μl 10 mM m7G(5’)ppp(5’)G (cap), 8.0 μl rNTP mix (10 mM ATP, CTP and 
UTP, 2 mM GTP), 2 μl SP6 RNA Polymerase (50 U/μl) and X μl H2O (RNase/DNase free) 
to a total volume of 30 μl. RNA transcripts were typically used immediately; however, 
when kept they were stored at -80 °C. 
 
2.3.17 Transfection of Nucleic Acids by Liposome Uptake   
Transfection procedure was carried out as previously described (Attarzadeh-Yazdi et al., 
2009) Briefly, approximately 0.8 x 10
5 
BHK-21 cells, 1.8 x 10
5
 Aag2 cells, 2 x 10
5
 TRA-
171 cells, 2.7 x 10
5
 S2 cells or 1.6 x 10
5
 U4.4 or C6/36 cells/well were seeded in 24-well 
plates and incubated for approximately 16 h. Prior to transfection the growth medium was 
replaced with 500 µl fresh medium. The transfection reagent, Lipofectamine 2000™ 
(Invitrogen), was prepared in 5 ml round bottom tubes (BD Falcon) by adding 1 µl to 49 
µl/well Opti-MEM serum free medium (Life Technologies) for dsRNA and siRNAs or 2 µl 
to 48 µl/well Opti-MEM for plasmid DNA and gently mixed. This was allowed to incubate 
at room temperature for 5 min. In a separate tube the required concentration of nucleic 
acids was prepared and added to 50 µl/well Opti-MEM and mixed gently by flicking. To 
this 50 µl/well of the Lipofectamine/Opti-MEM preparation was added, mixed gently by 
flicking and incubated at room temperature for 20 - 30 min as per the manufacturer’s 
guidelines. On completion, the preparation was gently mixed a final time and a total of 100 
µl/well applied drop wise to each appropriate well. The plate was then returned to the 
incubator at the appropriate temperature for 5 h following which the medium was removed 
and replaced with fresh complete growth medium.     
    
Chapter 2  Materials and Methods 
 
77 
 
2.3.18 Extraction of Total Cellular RNA- Trizol®  
Isolation of cellular RNA was achieved using Trizol® reagent (Life Technologies) using 
the manufacturer’s instructions. Cell monolayers were grown in 24-well plates and were 
treated by transfection of nucleic acids as appropriate. Following incubation the growth 
media was removed and an appropriate volume of Trizol was added. Monolayers were 
allowed to homogenise for 5 min to allow the dissociation of nucleic acid and protein 
complexes. Lysates were mixed by pipetting and transferred to a sterile RNase/DNase free 
1.5 ml tube. Following this, 200 µl/1 ml Trizol chloroform was added to the lysates and the 
tubes shaken vigorously by hand for 15 sec. Samples were then incubated for 2 - 3 min at 
room temperature ahead of centrifugation at 14,000 rpm for 15 min at 4 °C. Phase 
separation was achieved whereby high weight DNA, fat, polysaccharides, proteins and 
extracellular membranes collected in an organic phase in the lower portion of the tube 
separated from the RNA present in the upper aqueous phase by a thin interphase. The 
aqueous phase was collected and transferred to a new RNase/DNase free 1.5 ml tube.  
Precipitation of the RNA was completed by the addition 500 µl/1 ml Trizol molecular 
grade isopropanol and 0.5 µl RNase free glycogen (10 mg/ml) followed by an incubation at 
room temperature for 10 min and centrifugation at 14,000 rpm for 10 min at 4°C. The 
supernatant was removed and the RNA pellet washed with 1 ml 75 % EtOH/1 ml Trizol. 
The tube was then vortexed and spun a final time at 14,000 rpm at 4 °C. The resulting 
pellet was air dried for approximately 10 min and re-suspended in 30 µl sterile 
RNase/DNase free H2O.                   
 
2.3.19 Separation of Small and Large RNA Molecules from Total RNA- PEG  
The total volume of RNA which had been previously isolated by Trizol as described in 20 
µl  RNase/DNase free H2O were mixed with 20 µl EDTA (0.2M, pH8) and 250 µl PEG 
(10 % PEG 8000 (Promega), 1 M NaCl) and incubated for 60 min on ice. This was then 
centrifuged for 20 min at 4 °C maximum speed to pellet large RNAs and leave the small 
RNAs in the supernatant. Small RNAs were isolated by transferring the supernatant to a 
clean 1.5 ml RNase/DNase free tube and filled with 100 % EtOH. This was incubated 
overnight at -20 °C prior to centrifuging at maximum speed for 30 min at 4 °C. The pellet 
was washed twice with 500 µl 70 % EtOH and centrifuged for 10 min at 10,500 rpm at 4 
°C between each one. The resulting pellet of small RNAs was finally air dried and re-
suspended in 15 µl RNase/DNase free H2O. The PEG pellet, containing the large RNAs, 
was washed twice with 500 µl EtOH and centrifuged for 10 min at 10,500 rpm at 4 °C 
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between each one. As before the resulting pellet of large RNAs was air dried and re-
suspended in 15 µl RNase/DNase free H2O. Isolated RNAs were stored at -80 °C.        
 
2.3.20 Separation of Small and Large RNA molecules from Total RNA- mirVana™ 
miRNA Isolation Kit   
Small RNA molecules were also isolated from total RNA samples using the mirVana™ 
miRNA Isolation Kit (Ambion) following the manufacturer’s instructions. Briefly, 50 - 
100 μg isolated total RNA was mixed with 5 x volumes lysis/binding buffer and 1/10 x 
volume miRNA homogenate additive by vortexing in a 1.5 ml RNase/DNase free 
microcentrifuge tube. This was then incubated on ice for 10 min before 1/3 x volume of 
100 % EtOH was added and mixed thoroughly. The total volume was then transferred to a 
filter cartridge assembled in a collection tube. Following a centrifugation step at 5,000 rpm 
for 1 min, the eluate containing the small RNA molecules was collected in a fresh 1.5 ml 
tube and mixed with a further 2/3 x volume 100 % EtOH. The mixture was passed through 
a second filter cartridge as before and the eluate from this stage was discarded. The filter 
cartridge was returned to the collection tube and washed with 700 μl miRNA Wash 
solution 1. The cartridge was centrifuged as before and eluate discarded. The collection 
tube was reused for two sequential wash steps with 2 x 500 μl miRNA Wash solution 2/3 
and centrifuged as before. After disposing the flow-through the cartridge was returned to 
the collection tube and centrifuged a final time as before to remove any residual Wash 
solution. The cartridge was then placed in a fresh 1.5 ml tube and 50 μl elution solution 
(pre-heated to 95 °C) applied, incubated at room temperature for 2 min and centrifuged 
10,000 rpm for 1 min. The eluate containing the small RNAs was retained and stored at -80 
°C for Northern blot analysis. 
 
2.3.21 Isolation of Small RNAs for Deep Sequencing 
Total cellular RNA was isolated by Trizol following the manufacturer’s instructions as 
described. Approximately 6 x 10
5
 Aag2 and 8 x 10
5
 U4.4 cells/well were seeded in 6-well 
plates and were either transfected with 1 µg specific dsRNA against eGFP (720 nt) or 
mock transfected. The purity and concentration were obtained as described. The total RNA 
was loaded onto an acrylamide urea denaturing gel (15 %) as described in Chapter 2.3.6 
and RNA molecules between 18 - 37 nt were gel purified, linked to adapters and reverse 
transcribed prior to sequencing. Illumina Solexa deep sequencing was carried out at ARK 
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Genomics, University of Edinburgh (http://www.ark-genomics.org/) following 
manufacturer’s protocol (Illumina Inc.) as previously described (Siu et al., 2011).  
    
2.3.22 Plasmid Cloning  
2.3.22.1 pJet1.2/blunt Vector Cloning  
pJet1.2/blunt (Thermo Scientific) was used for blunt end cloning PCR products for 
sequencing or for subcloning of DNA sequences of interest. The reaction was carried out 
according to the manufacturer’s instructions using 10 µl 2 x reaction buffer, 1 µl 
pJet1.2/blunt cloning vector (50 ng/µl), 1 µl DNA, 1 µl T4 DNA Ligase and made to a 
final volume of 20 µl. The reaction was spun briefly and incubated at room temperature for 
5 min or ≤ 30 min for DNA products of > 3 kb. The ligation reaction was transformed into 
DH5α bacteria as described in Chapter 2.1.2 using 2.5 µl of the reaction.       
 
2.3.22.2 Plasmid Cloning by Restriction Digest  
Cloning into plasmid backbones (pIB/V5-His (Invitrogen) or pSP64 Poly A (Promega)) 
was done by digesting both the plasmids and the DNA inserts with appropriate restriction 
enzymes (New England Biolabs). Reactions were carried as described (Chapter 2.3.2). 
Following digestion, the samples were run on an agarose gel, extracted and purified as 
described (Chapter 2.3.3 and Chapter 2.3.5). Ligation of the insert into the new plasmid 
backbone was performed by T4 DNA ligase (Promega) in a reaction containing 1 µl T4 
DNA ligase, 2 µl buffer, and H2O to a final volume of 20 µl. DNA insert and plasmid were 
mixed together at different ratios; either 3 insert: 1 plasmid or 2 insert: 1 plasmid. The 
reactions were incubated for 30 min at room temperature before immediately transforming 
2.5 µl of the reaction into DH5α bacteria as described.            
    
2.3.22.3 Viral Plasmid Cloning by Restriction Digest 
The original pSFV1 plasmid received from Professor Peter Liljeström (Karolinska 
Institute, Sweden) was kindly modified by Margit Ool (Institute of Technology, University 
of Tartu, Estonia) for the insertion of recombinant Ae. aegypti Argonuate-2 (Ago-2) and 
Dicer-2 (Dcr-2) proteins. While SFV1-Ago-2-zsGreen and SFV1-Dcr-2-mCherry were 
received along with the modified pSFV1, SFV1-Ago-2-V5 and SFV1-Dcr-2-V5 were 
cloned in house. This was achieved by digesting the modified pSFV1 with NruI and SpeI 
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(New England Biolabs). Ago-2-V5 and Dcr-2-V5 were previously subcloned into 
pJet1.2/blunt as described and cut with either NruI and XbaI or HindIII and XbaI (New 
England Biolabs) respectively. Ligation of Ago-2-V5 could be carried out directly as the 
XbaI site is complementary to the SpeI site. The Dcr-2-V5 cDNA was first treated with 
Klenow (New England Biolabs) which has 3’→5’ exonuclease activity. The reaction was 
performed according the manufacturer’s guidelines where Dcr-2-V5 inserted into 
pJet1.2/blunt was digested with HindIII prior to blunting by Klenow (1 U/µg DNA). The 
reaction was incubated for 15 min at 25 °C before the enzyme was inactivated at 75 °C for 
20 min. Finally pJet1.2/blunt-Dcr-2-V5 was digested with XbaI. Ligation of both tagged 
proteins into the modified SFV1 plasmid was performed by T4 DNA ligase as described 
before immediately transforming 2.5 µl of the reaction into DH5α bacteria as described.               
 
2.3.22.4 pGL3-PUb Vector Modification   
 pGL3-PUb was gratefully received from Professor Zach Adelman (Fralin Life Science 
Institute and Department of Entomology, Virginia Polytechnic Institute and State 
University, United States) and has been described previously (Anderson et al., 2010). The 
vector did not contain a multiple cloning site (MSC) for the insertion of foreign genes and 
therefore one was designed containing the following sites: 5’ NheI, XhoI, BglII, SacII, 
PacI, XbaI 3’. These sites were inserted after the PUb promoter by performing a 
mutational PCR using the primers described in Chapter 2.9. Following PCR the products 
were run, extracted and purified from an agarose gel as described in Chapter 2.3.5. The 
purified DNA was treated with DpnI (New England Biolabs) to remove methylated DNA. 
Ligation of the PCR products was achieved by T4 ligase as described in Chapter 2.3.22.2. 
Following ligation, 2.5 µl of the reaction were transformed into DH5α bacteria as 
described.             
 
2.3.23 Quantification of Nucleic Acids 
The yields of all nucleic acids (dsRNA, ssRNA and dsDNA) were quantified using a 
NanoDrop ND-1,000 spectrophotometer (Thermal Fisher Scientific). An aliquot of 2 μl 
from each sample was placed on the measurement pedestal and a reading made to obtain 
purity and concentration. Samples were considered ‘pure’ if the 260/280 ratio was ~1.8 for 
DNA and ~2.0 for RNA.     
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2.3.24 Sequencing of Plasmid DNA and PCR Products  
Verification of successful amplification and cloning of the gene of interest was achieved 
by sending DNA plasmid or PCR samples, along with appropriate primers, to DNA 
Sequencing & Services at the University of Dundee (http://www.dnaseq.co.uk/home.html). 
The resulting sequences were analysed using BioEdit software and Basic Local Alignment 
search Tool (BLAST, http://blast.ncbi.nlm.nih.gov/Blast.cgi).       
 
Further details of the recipes of common solutions can be found in Chapter 2.8.  
 
2.4 Molecular Techniques  
2.4.1 Western Blot  
2.4.1.1 Sample Preparation  
The appropriate cell lines were seeded in 24-well plates and infected or transfected as 
required. They were incubated as appropriate following which they were lysed by 
removing  the growth media and directly adding 30 μl/well of either Laemmli buffer (Bio-
Rad) with 5 % β-mercaptoethanol or 2 x loading buffer (0.125 M TRIS HCl (pH 6.8), 4 % 
SDS, 20 % glycerol, 10 % β-mercaptoethanol, 10 mg bromophenol blue). The lysates were 
transferred to a 1.5 ml tube, boiled for 10 min at 100 °C before centrifugation for 5 min at 
14,000 rpm. If necessary, samples were placed in temporary storage at -20 °C until all 
those required were prepared.  
 
2.4.1.2 Sodium Dodecyl Sulphate- Polyacrylamide Gel Electrophoresis  
Unless stated, all gels used were NuPAGE® 4 - 12 % Bis-Tris Mini gels (Life 
Technologies). When SDS-PAGE gels were prepared in house a 10 % gel was set up using 
Bio-Rad’s Mini-Protean II apparatus. These consisted of two parts; the upper stacking gel 
and the lower resolving gel. The resolving gel was prepared by combining 2.43 ml distilled 
H2O, 1.25 ml acrylamide/bis-acrylamide (40 %), 1.25 ml 1.5 M Tris-HCl (pH 8.8), 50 μl 
10 % SDS per gel. Just prior to use polymerisation was initiated by adding 50 μl 10 % APS 
and 5 μl TEMED. The solution was transferred between two glass plates approximately 
0.75 mm apart. A gap of approximately 2 cm was left between the top of the gel and the 
top of the plates. This was filled with H2O to ensure the gel set level. Once the resolving 
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gel had set (approximately 20 min) the H2O layer was discarded and replaced with the 
stacking gel. This consisted of 1.598 ml distilled H2O, 252 μl acrylamide/bis-acrylamide 
(40 %), 625 μl 0.5 M Tris-HCl (pH 6.8), 25 μl 10 % SDS per gel. As with the resolving 
gel, polymerisation was initiated by adding 75 μl 10 % APS and 5 μl TEMED shortly 
before transferring to the two gel plates on top of the resolving gel. A 10 well comb was 
immediately inserted to create the lanes and the gel was allowed to polymerise for 
approximately 20 min.  
The gel was placed into an electrophoresis tank and covered with the appropriate running 
buffer (for in house gels 1 x SDS-PAGE running buffer (25 mM Tris, 0.25 M Glycine 
(Calbiochem), 0.1 % SDS) was used, while NuPAGE gels were run in 1 x NuPAGE 
MOPS SDS running buffer (Life Technologies)). The samples were prepared as described 
and loaded into the gel (30 μl/well) alongside 5 μl Hyperpage Pre-stained Protein Marker 
(Bioline). The voltage was initially set to 100 V until the samples past into the gel where 
after it was increased to 120 V until the bromophenol blue dye front had run off the 
resolving gel.  
 
2.4.1.3 Protein Transfer  
The gel was removed from between the two glass plates and the stacking gel was disposed 
of. Two protein transfer techniques were used; wet transfer for large proteins > 100 kDa or 
semi-dry for smaller proteins. Unless otherwise stated wet transfer was carried out. This 
involved assembling the transfer cassette submerged in a tray flooded with 1 x wet transfer 
buffer (50 mM Tris, 375 mM Glycine, 20 % Methanol (VWR)). The transfer cassette 
contained, in order from the cathode to the anode; a sponge, an extra thick Whatman paper 
(Bio-Rad), the gel, a Hybond ECL nitrocellulose membrane (GE Healthcare) (previously 
activated in distilled H2O), a second Whatman paper and a second sponge. Once assembled 
the transfer cassette was orientated within the electrophoresis tank (Bio-Rad) to allow the 
proteins to transfer from the gel to the membrane. An ice pack was added and the tank 
filled with 1 x wet transfer buffer. A current of 250 mA was applied for 3 h.  
Semi-dry transfer was performed by soaking 2 extra thick whatman papers, cut to the size 
of the gel, in semi dry transfer buffer (48 mM Tris, 39 mM Glycine, 0.0375 % SDS, 20 % 
Methanol). One was placed on the blotting plate of the semi-dry blotting machine (Bio-
Rad) followed by the layer of Hybond ECL nitrocellulose membrane, cut to the appropriate 
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size and soaked in distilled water, the gel and finally the second whatman paper. A steady 
voltage of 15 V with a maximum current of 0.31 A was applied for 30 min.  
 
2.4.1.4 Immuno-Detection  
Following transfer, the blotted nitrocellulose membranes were washed (3 x 5 min in PBS + 
0.1 % Tween®20 (Sigma Aldrich) (PBST) with rocking to remove residual transfer buffer 
prior to blocking in 2 % blocking buffer (2 % (w/v) milk powder (Sigma Aldrich) in 
PBST) with rocking at 4 °C overnight or at room temperature for 1 h. The membrane was 
washed as before prior to covering with an appropriate volume of primary antibody diluted 
in blocking buffer. The antibodies used are described in Table 2.2. All primary antibodies 
were incubated overnight at 4 °C. Following incubation, the membranes were washed as 
before (3 x 5 min) and covered with secondary antibody diluted in blocking buffer. This 
was allowed to incubate at room temperature for approximately 1 h. Following this, the 
membrane was washed a final time as described. The secondary antibody used was 
conjugated to horse radish peroxidise (HRP) which could be detected by using either 
Pierce ECL Western Blotting Detection kit (Thermo Scientific) or Pierce West Pico 
Western Blot kit ECL (Thermo Scientific). Due to the increased sensitivity of the Pierce 
West Pico kit it was used to detect the endogenous RNAi proteins where as the ECL 
Advance kit was used for detection of transfected V5 protein or SFV-nsP3. With both kits 
the membranes were removed from the PBST and excess buffer carefully removed before 
covering the membrane in an appropriate volume of ECL solution (reagent one 1: 1 reagent 
two). After an incubation of 5 min any excess detection reagents were removed before the 
membrane was placed between two pieces of Melinex® polyester film (PSG Group Ltd). 
In the dark, a sheet of photosensitive film was placed over the membrane and allowed to 
incubate before developing with a Konica Minolta SRX-101-A film processor.         
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Table 2.2: Description of antibodies used for Western Blot 
Target Obtained Host Isotype Label Dilution 
Incubation 
time 
V5 Sigma  
Mouse 
 
Monoclonal 
IgG 
- 
1 in 2,000 
4 °C 
overnight 
Ago-1 
Abmart 1 in 100 Ago-2 
Dcr-1 
Dcr-2 
mCherry Abcam 1 in 2,000 
ZsGreen CloneTech 
Rabbit Polyclonal 
1 in 1,000 
SFV-
nsP3 
Dr. Tero 
Ahola, 
University 
of 
Helsinki, 
Finland 
1 in 2,000 
Rabbit 
IgG 
Abcam Goat 
Monoclonal 
IgG 
Horse 
Radish 
Peroxidase 
1 in 5,000 Room 
temperature 
for 1 h  
Mouse 
IgG 
Sigma Rabbit Polyclonal 1 in 3,000 
 
2.4.2 Northern Blot  
All the procedures described involve RNase free conditions.   
 
2.4.2.1 Sample Preparation  
Tissue culture samples were prepared as appropriate and following a sufficient incubation 
period the cells were detached by scraping and centrifuged at 2,500 rpm for 6 min at room 
temperature. The supernatant was removed and 2 ml of Trizol reagent added to the pellet. 
This was then divided between two 1.5 ml RNase/DNase free microcentrifuge tubes. Total 
RNAs were isolated and purified as described in Chapter 2.3.18. Equal concentrations and 
volumes of isolated cellular RNA samples were prepared by diluting 1:1 with 2 x RNA 
loading dye and were loaded onto a 12 % denaturing acrylamide RNA gel and separated as 
described in Chapter 2.3.6. The gel was removed from between the two glass plates and 
the presence of RNA molecules were visualized with EtBr staining prior to transferring to 
membrane. The gel was placed in approximately 70 ml 0.5 x TBE with 4 μl EtBr and 
incubated for 20 min with rocking at room temperature.  
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2.4.2.2 Blotting of Acrylamide RNA Gel   
The RNA was transferred by semi-dry blotting to a nitrocellulose (Hybond™-N+) 
membrane (GE Healthcare) placed on top of three Whatman papers soaked in 0.5 x TBE. 
The acrylamide RNA gel was placed on top of the membrane followed by a further three 
soaked whatman papers. A steady voltage of 10 V with a maximum current of 0.33 A was 
applied for 1 h. 
 
2.4.2.3 Cross linking RNA to Nitrocellulose Membrane  
Transferred RNA was either UV cross linked (by placing it on a UV screen for 1 min each 
side of the membrane) or chemically cross- linked with carbodiimide as described by (Pall 
et al., 2007). Briefly, 122.5 μl Methlimidazole (Sigma Aldrich) and 10 ml RNase/DNase 
free H2O were combined in a 50 ml falcon tube and the pH adjusted to 7.5 - 8.2 with HCl. 
To this, 0.373 g 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (Sigma Aldrich) 
was added and the final volume of the solution was adjusted to 12 ml with RNase/DNase 
free H2O. The entire volume of solution was applied to a piece of Whatman paper, cut to 
slightly larger than the membrane, placed on a sheet of cling film. The membrane was 
added on top of the Whatman paper with the RNA side facing upwards. The orientation of 
the gel on the membrane was marked with a pencil and the area between the two dye fronts 
was denoted. The membrane and the paper were quickly wrapped in cling fim to prevent 
the membrane drying and placed on a tray inside the hybridisation oven for approximately 
1 h (< 2 h) at 60 °C. Once this was completed the membrane was washed twice with 
RNase/DNase free H2O for 5 min per wash and allowed to dry fully. The membrane was 
then wrapped in cling film and stored at -20 °C until hybridisation was carried out.   
 
2.4.2.4.1 DIG-labelled DNA Probe Hybridization  
Membranes were pre-hybridised for > 5 min at 68 °C in a small hybridisation tube 
containing 7 ml of PerfectHyb™ Plus hybridization buffer (Sigma Aldrich). Probes were 
denatured by heating to 100 °C for 10 min followed by placing on ice for 2 min. In this 
instance a mix of five probes were added per membrane (SFV-nsP1, -nsP2, -nsP3, E1, 
C/E3).  A total volume of 25 μl DIG-labelled probes (5 μl of each) was directly added into 
the hybridization buffer and incubated at 68 °C overnight. Following this, the buffer and 
probe were discarded and the membrane washed once with a low stringency wash buffer (2 
x saline- sodium citrate (SSC) (Life Technologies) and 0.1 % SDS) at room temperature 
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for 5 min. Blots were then transferred to small plastic boxes to be washed with 
approximately 10 ml Washing buffer (Maleic acid buffer (100 mM Maleic acid (Sigma 
Aldrich), 150 mM NaCl, adjusted to pH 7- 8 with NaOH pellets (Fisher Scientific)) with 
0.3 % Tween) for 15 min at room temperature with rocking. Following this detection was 
performed by pre-incubating membrane in approximately 25 ml 1 % blocking buffer 
(maleic acid buffer with blocking reagent (Roche)) for 1 h. The blocking buffer was then 
discarded and replaced with fresh 1 % blocking buffer containing anti-DIG antibody 
conjugated to alkaline phosphatase (AP) (1: 20,000) (Roche) for 1 h at room temperature. 
The membrane was then washed four times in washing buffer as described followed by a 
final wash in AP buffer (100 mM NaCl, 5 mM MgCl (VWR), 100 mM Tris- HCl) for 5 
min. Detection was performed by applying 10 ml AP buffer containing 200 μl NBT-BCIP 
detection agent (Roche). This was allowed to incubate in the dark with rocking until a 
signal was detected. Development was halted by washing the membrane in distilled H2O. 
Images were acquired using the gel doc system (Bio-Rad).  
 
2.4.2.4.2 Radio-labelled DNA Probe Hybridisation  
Hybridisation with a radio-labelled oligonucleotide probe by first pre-hybridizing the 
membrane for > 5 min at 42 °C in a small hybridization tube containing 7 ml of 
PerfectHyb™ Plus hybridisation buffer. The radio-labelled oligonucleotide probe was then 
directly added to the hybridization buffer and incubated at the appropriate temperature 
overnight. Following this, the buffer and probe were discarded and the membrane washed 
as described for DIG probed membranes. Following this step, blots probed with radio-
labelled oligonucleotides were dried before being wrapped in cling film, placed in a 
development cassette and exposed in the dark to photosensitive film. The cassette was then 
placed at -70 °C for 4 days to allow signal detection to develop.   
 
2.4.3 In vitro Translation by TNT Coupled Reticulocyte Lysate  
A coupled transcription/translation approach to protein production was attempted using the 
TNT® SP6 coupled Rabbit Reticulocyte Lysate System (Promega) following the 
manufacturer’s protocol. Briefly, the following components were added and mixed 
together in a RNase/DNase free 1.5 ml tube; 25 µl TNT Rabbit reticulocyte lysate, 2 µl 
TNT Reaction buffer, 1 µl TNT SP6 RNA polymerase, 1 µl amino acid mixture minus 
methionine (1 mM), 2 µl 
35
S methionine (1,000 Ci/mmol at 10 mCi/ml, Perkin Elmer), 1 µl 
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RNasin ribonuclease inhibitor (40 U/µl), 2 µl DNA template (0.5 µg/µl) and RNase/DNase 
free H2O to a final volume of 50 µl. The reaction was incubated at 30 °C for 90 min. The 
translation products were diluted in 2 x loading dye (0.125 M TRIS HCl (pH 6.8), 4 % 
SDS, 20 % glycerol, 10 % β-mercaptoethanol, 10 mg bromophenol blue), boiled for 3 min 
at 90 °C then 5 µl run on a NuPAGE® NOVEX® Bis-Tris denaturing protein gel 
(Invitrogen). Gel electorphoresis was carried out at 30 mA until the bromophenol blue dye 
front reached the bottom of the gel. Subsequently, the gel was disengaged from the 
supporting plates and placed in a plastic box with fixing solution (50 % methanol, 10 % 
acetic acid, to final volume with H2O) to cover it. This was agitated slowly on an orbital 
shaker for 30 min before replacing the fixing solution with drying solution (7 % acetic 
acid, 7 % methanol, 1 % glycerol, to final volume with H2O) which was applied for 5 min 
to prevent the gel from cracking during drying. The gel was placed on three sheets of 
whatman paper, covered in a plastic film and placed on gel dryer (Bio- Rad) to dry at 80 
°C for 2 h. The gel was not removed from the gel dryer until it had completely cooled, 
after a further 1 h. Detection was performed by exposing the fixed gel to a phosphor 
imaging screen (Bio-Rad) for ≥ 16 h.    
 
2.4.4 In vitro Dicer Cleavage Assay  
Tissue culture samples were prepared as necessary. Following the required incubation 
time, the media was removed, the cells re-suspended in sPBS and centrifuged at 1,500 rpm 
for 5 min. The supernatant was removed and the pellet washed and centrifuged as before. 
The resulting pellet was re-suspended in 200 µl 1 x lysis buffer (10 mM Magnesium 
acetate (MgAc) (Sigma Aldrich), 150 mM Hepes-KOH (pH 7.5) and homogenised with a 
micro-pestle. Cell debris was removed by a further centrifugating at 14,000 rpm at 4 °C for 
20 min. The supernatant was transferred to a clean tube and the samples were then stored 
with minimal freeze thawing at -80 °C. The following were combined and mixed gently in 
an RNase/DNase free 1.5 ml tube using RNase/DNase free tips; 0.3 µl 20 mg/ml creatine 
phosphate kinase in 1 x storage buffer (40 mg/ml lyophilized creatine kinase (Calbiochem) 
in 2 x storage buffer (ice-cold 40 mM tris-acetate (pH 6.8), 200 mM EDTA, 20 mM β-
mercaptoethanol) diluted 1:1 in an equal volume of 100 % ice-cold glycerol), 1 µl DTT (1 
M), 10 µl creatine phosphate (12 mg/100 µl) (Calbiochem), 20 µl 5 x lysis buffer, 20 µl 
glycerol, 2 µl RNase Inhibitor, 2 µl ATP (100 mM) (Thermo Scientific) and 4.7 µl 
RNase/DNase free H2O. In separate clean 1.5 ml tubes the following were assembled and 
mixed gently; 5 µl cell extract, 3 µl creatine mix, 3 µl 
32
P labelled dsRNA (~16.2 pCi), 1 µl 
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H2O. A reaction was also prepared with the cell extract component omitted and the 
remaining volume made up with H2O for the purification of dsRNA alone. The reactions 
were incubated overnight at 28 °C. Following this 200 µl 2 x PK buffer (200 mM Tris (pH 
7.5), 300 mM NaCl, 5 mM EDTA, 2 % SDS), 1 µl glycogen (10 mg/ml) (Roche) and 0.3 
µl proteinase K (10 mg/ml) (Sigma Aldrich) were added and reactions further incubated 
for 10 min at 65 °C. To this, 200 µl phenol/chloroform/isoamylalcohl (25:24:1) (Ambion) 
were added prior to the tubes being vortexed for 15 sec and centrifuged 10,000 rpm for 10 
min. The water phase was transferred to a new 1.5 ml tube containing 450 µl ice-cold 96 % 
EtOH and the tube centrifuged for 10 min at 13,000 rpm. Subsequently, the supernatant 
was removed and replaced with 400 µl ice cold 70 % EtOH. Samples were centrifuged as 
before and the supernatant removed. Pellets were air dried in a fume cabinet for 
approximately 5 min, resuspended in 15 µl 1 x FDE loading buffer and boiled for 5 min at 
65 °C before placing on ice for ≥ 2 min. Samples were loaded onto a 0.75 mm 12 % 
acrylamide denaturing gel as described (Chapter 2.3.6). Electrophoresis of the RNA was 
performed at 200 V while the gel was chilled by submerging the tank in ice cold water. 
The gel was placed on three sheets of whatman  paper, covered in Melinex® polyester film 
and placed on gel dryer to dry at 80 °C for 2 h. Detection was performed by exposing the 
gel to a phosphor imaging screen for ≥ 16 h and viewed using a personal molecular imager 
(PMI) (Bio-Rad).    
 
2.4.5 Immunostaining  
Cells were either seeded in glass bottom 24-well plates (Greiner Bio-One) or on 13 mm 
diameter glass coverslips (VWR) in plastic 24-well plates. These were left overnight after 
which they were either infected or transfected and incubated as required. Neutral buffered 
10 % formalin solution (Sigma Aldrich) was gently applied to each well and incubated for 
1 h for BHK-21 or 30 min for insect cells. The formaldehyde was discarded and the 
monolayer was washed three times with PBS (3 x 5 min) with rocking at room 
temperature. Cell membranes were permeabilised by applying 0.3 % Triton®X-100 
(Sigma Aldrich)/PBS for 20 min with rocking. Monolayers were washed as before and 700 
µl of blocking agent (either Cas-block (Invitrogen) or 5 % FCS/PBS) applied for 30 min 
with rocking at room temperature. The blocking agent was removed and replaced with 700 
µl primary antibody diluted in the blocking agent to the appropriate dilution (Table 2.3). 
The primary antibody was allowed to incubate with rocking for 2 h at room temperature or 
overnight at 4 °C. Cells were washed with PBS (3 x 10 min) and the appropriate Alexa 
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Fluor® labelled secondary antibody applied, diluted appropriately in the blocking agent, 
for 1.5 h with rocking at room temperature protected from the light. This was discarded 
and the cells washed a final time with PBS (3 x 10 min). Coverslips in plastic 24-well 
plates were removed, dried briefly and mounted on glass slides using VECTASHIELD® 
Mounting media plus DAPI (4’,6-diamidino-2-phenylindole) (Vectro Laboratories) to 
allow visualisation of the cell nuclei. These were then permanently sealed with clear nail 
polish around the perimeter. Monolayers grown directly in glass well dishes were covered 
with a drop of mounting media and a coverslip applied. Samples were stored at 4 °C in the 
dark until the results were viewed with the Zeiss LSM 710 or LSM 510 confocal 
microscopes using the appropriate lasers as described (Chapter 2.6).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3: Description of antibodies used for Immunostaining. 
 
2.5 Virus Techniques 
2.5.1 Semliki Forest virus (SFV) and Virus Replicon Particles (VRPs)  
Both Semliki Forest virus (SFV) and virus replicon particles (VRPs) were used as part of 
this project. All recombinant strains of SFV were based on the SFV4 backbone (Liljeström 
and Garoff, 1991). These were prepared from cDNA plasmids gratefully provided by Prof. 
Andres Merits (University of Tartu, Institute of Technology, Estonia). Details can be found 
in Table 2.4 and Figure 2.1. Amplification of the plasmid DNA was achieved by 
transforming into chemically competent DH5α E.coli (Chapter 2.1.2), preparing growth 
cultures and purifying the DNA (described in Chapter 2.3.1.2). All plasmids, with the 
exception of one, were linearised with an appropriate endoribonucleases and used as a 
template for in vitro transcription to produce capped RNA (described in Chapter 2.3.16). 
Antibody Target Obtained Host Isotype Label Dilution Incubated 
Primary 
SFV-
nsP3 
Dr. Tero 
Ahola, 
University of 
Helsinki, 
Finland 
Rabbit Polyclonal - 1/800 2 h or over 
night 
 
dsRNA 
(J2) 
Scicons Mouse 
Monoclonal 
IgG1 
- 1/500 
Secondary 
Rabbit 
Molecular 
Probes, Life 
Technologies 
Goat 
Polyclonal 
IgG 
Alexa 
Fluor 
594 
1/1,000 1.5 h 
Mouse 
Donkey Rabbit Alexa 
Fluor 
488 
Mouse 
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Plasmid DNA or in vitro transcribed RNA was electroporated in BHK-21 cells as 
described. As SFV4(3H)-Fluc contains a Cytomegalovirus (CMV) promoter the infectious 
mRNA transcript can be transcribed directly following electroporation into BHK-21 cells 
so no cap is required.     
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Table 2.4: Description of viruses and VRPs used as part of this project 
Virus / VRP Feature 
SFV4(3H)-Rluc Renilla luciferase gene (Rluc) is encoded at the 3’ end of the SFV 
nsP3 gene. Rluc is cleaved following translation and replication of 
the SFV4 genome. Therefore the expression of Rluc is an indirect 
measure of SFV4 replication.    
SFV4(3H)-Fluc Firefly luciferase gene (Fluc) is encoded at the 3’ end of the SFV 
nsP3 gene. Fluc is cleaved following translation and replication of 
the SFV4 genome and is therefore an indirect measure of SFV4 
replication. It is transcribed from the CMV promoter.      
SFV4(3H)-Rluc-p19 As SFV4(3H)-Rluc with the addition of the tombusvirus p19 
protein inserted after a duplicated subgenomic promoter following 
the structural proteins.    
SFV4-steGFP The gene encoding enhanced Green Florescent Protein (eGFP) is 
inserted between the capsid and p62 (E2/E3) coding regions in the 
structural ORF.  
SFV4(3F)-ZsGreen The gene which encodes zsGreen is fused to the nsP3 gene at the 
3’ terminus. During viral replication nsP3 is translated fused to 
zsGreen and can be used to indicate the location of nsP3.   
SFV1-Rluc SFV1 replicon expressing Rluc under the control of the 
subgenomic promoter.   
SFV1-ZsGreen SFV1 replicon expressing zsGreen fluorescent protein under the 
control of the subgenomic promoter.  
SFV1-Dcr-2-mCherry  SFV1 replicon expressing Ae. aegypti Dcr-2 fused to mCherry 
under the control of the subgenomic promoter. See Chapter 5. 
SFV1-Ago-2-ZsGreen SFV1 replicon expressing Ae. aegypti Ago-2 fused to zsGreen 
under the control of the subgenomic promoter. See Chapter 5. 
SFV1-Ago-2-V5/N SFV1 replicon expressing Ae. aegypti Ago-2 fused to V5 tag on 
the N terminus under the control of the subgenomic promoter. See 
Chapter 5. 
SFV1-Ago-2-V5/C SFV1 replicon expressing Ae. aegypti Ago-2 fused to V5 tag on 
the C terminus under the control of the subgenomic promoter. See 
Chapter 5. 
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Figure 2.1: Schematic illustration of some of the viruses and VRPs used as part of this project. 
Viral non-structural proteins (nsP1- 4) are shown in purple and the structural proteins (capsid, C; 
the envelope glycoproteins, E1-3; and the 6K protein) are in pale blue. nsP2 cleavage sites for the 
release of Rluc during replication of SFV4(3H)-Rluc and SFV4(3H)-Rluc-p19 are indicated (↓). 
Example structures are given. SFV4(3H)-Rluc and SFV4(3H)-Fluc are similar with the appropriate 
reporter gene substitution as are  SFV1-Rluc, SFV1-ZsGreen and SFV1-Ago-2-ZsGreen/SFV1-
Ago-2-V5/C. 
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2.5.2 Propagation of Recombinant SFV strains and Production of VRPs 
BHK-21 cells were grown until approximately 80 % confluent in an appropriate number of 
175 cm
2
 tissue culture flask. Once confluent the BHK-21 cells were trypsinized and 
counted as described (Chapter 2.2.1.2). A density of 1 x 10
7
 cells/800 μl was prepared per 
flask and thoroughly resuspended in ice cold PBS. The in vitro transcribed RNA (prepared 
as described in Chapter 2.3.16) or DNA (in the case of the CMV based plasmid) was 
mixed with 800 μl of the cell suspension in sterile 1.5 ml tubes. Viral RNA was 
electroporated as a single plasmid. However, the VRP production required the combination 
of two capped RNAs using the split helper system; the first RNA contained the SFV4 non-
structural proteins and the gene insert of interest while the second RNA encoded the SFV4 
structural proteins. There were two options available for delivery of the structural proteins; 
either by the helper system (using the Helper 1 plasmid providing all of the structural 
proteins; C-E3-E2-6K-E1) (Berglund et al., 1993), or the split-helper system (were the 
capsid and envelope glycoproteins are separately encoded by different plasmids) (Smerdou 
and Liljeström, 1999). The helper system was used to generate SFV1-Dcr-2-mCherry and 
SFV1-Ago-2-ZsGreen, while all other VRPs were produced by the split-helper system. 
The capped RNAs from the in vitro transcription of these two plasmids were mixed 
together before the cell suspension was added. The RNA/cell preparation was allowed to 
incubate on ice for 2 - 3 min. A 400 μl aliquot of the mixture was then transferred to a 0.4 
cm electroporation cuvette (Flowgen Bioscience) and pulsed using a Bio-Rad Gene Pulser 
Xcell electroporator. Electroporation consisted of two pulses of a square wave of 850 V for 
0.4 ms with an interval of 5 sec between pulses. The electroporated BHK-21 cells were 
carefully transferred to a fresh 175 cm
2
 tissue culture flask containing 20 ml pre-warmed 
GMEM with 10 % NBCS. The process was repeated with the remaining 400 μl aliquot 
which could then be transferred to the same flask. Each flask was returned to the 37 °C 
incubator and the supernatant containing the viral particles was harvested after 24, 48 and 
72 h post electroporation. Cytopathic effect (CPE) was expected after 24 - 48 h post virus 
electroporation but no pathogenic effect was observed during the production of SFV VRPs. 
The supernatant was stored temporarily at 4 °C prior to purification.    
 
2.5.3 Purification of SFV Recombinant viruses and VRPs 
BHK-21 supernatant containing virus or VRPs was clarified by centrifuging at 2,000 rpm 
for 30 min at 4 °C. The supernatant was then transferred into a sterile bottle of appropriate 
volume containing 23 g/l NaCl and 70 g/l PEG 8000 and incubated overnight at 4 °C with 
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stirring. Following this it was centrifuged again at 8,000 rpm for 30 min at 4 °C. The 
supernatant was then discarded and the precipitate containing the PEG-virus pull down was 
re-suspended in 10 ml GMEM with no additional supplements. The PEG-virus suspension 
could then be transferred to an ultracentrifuge tube (Beckman Coulter) and 24 ml 20 % 
sucrose cushion was added below it. The sucrose cushion consisted of 20 % (w/v) sucrose 
(Sigma Aldrich) in sterile 1 x TNE buffer (pH 7.5) (50 mM Tris (pH 7.5), 140 mM NaCl 
and 5 mM EDTA (pH 8)). This was balanced and ultracentrifuged at 25,000 rpm for 1.5 h 
at 4 °C. Following this the supernatant was decanted and the pellet at the bottom of the 
tube was re-suspended in an appropriate volume of sterile 1 x TNE buffer. For virus this 
was 400 μl but for VRPs this was 200 μl. Tubes were covered with lab film (Sigma 
Aldrich) and incubated on ice with rocking at 4 °C for at least 18 h. Afterwards the re-
suspended viruses or VRPs were transferred to a sterile 1.5 ml tube and the ultracentrifuge 
tube rinsed with 50 μl 1 x TNE buffer to collect any residual virus which was then pooled 
in the 1.5 ml tube. All stocks were snap frozen on dry ice and stored in aliquots of 20 μl in 
sterile 1.5 ml tubes at -80 °C. When required one aliquot was removed and fast thawed at 
37 °C and any remaining stock frozen as described.  
 
2.5.4 Titration of Virus by Standard Plaque Assay  
SFV titres were determined by standard plaque assay using BHK-21 cells. Cells were 
seeded at a density of 3 x 10
5
 cell/well of a 6-well plate or 0.8 x 10
5
 cell/well of a 24-well 
plate and incubated at 37 °C. The virus was serially diluted in 10- fold dilutions in PBS 
with bovine serum albumin (BSA) (PBSA, 0.75 % (w/v) BSA in PBS). The albumin 
inhibits virus binding to the charged plastic surface of the tissue culture plasticware. The 
growth media was removed from each well and replaced with an appropriate volume of 
each dilution in duplicate, starting with the most dilute sample. The plate was incubated at 
37 °C for 1 h with gentle rotation approximately every 10 min to ensure an equal 
distribution of virus.      
A choice of two overlies were used during this project, Avicel or molten agar. The Avicel 
overlay was used with 24-well plates and 1.2 % (w/v) Avicel (FMC BioPolymer) in 
distilled H2O (sterilised by autoclaving) was mixed 1:1 with 2 x MEM (Life Technologies) 
(supplemented with 4 % FCS). To each well 1 ml was gently applied and the plates were 
carefully returned to 37 °C for three days. As the plates were sensitive to motion they were 
placed at the back of the incubator and not moved prior to fixing. Molten agar was only 
used with 6-well plates. The agar was prepared by mixing 4 g of Bacto-agar/100 ml PBS 
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(sterilised by autoclave) and heated to 90 °C, cooled to below 55 °C prior to adding on top 
of the cell monolayer. The agar was mixed 10 agar: 3 GMEM with pre-warmed GMEM 
supplemented with 2 % NBCS (v/v). The agar/GMEM solution was carefully applied to 
the cell monlayer in a drop-wise manner and was allowed to solidify before the plates were 
returned to the 37 °C incubator for 3 days.  
Following the incubation with both overlays, the plates were fixed by carefully applying 10 
% formalin solution and incubated at room temperature for 1 h. The overlay and the 
fixative were discarded and 0.1 % Toluidine blue stain (Sigma Aldrich) applied to each 
well. The cells were rocked for approximately 30 min before the stain was removed and 
each well washed gently with tap water. Round areas without stain were considered to be 
plaques. These were counted and virus plaque forming units (PFU)/ml calculated by the 
following formula:  
 
                               
                         
                       
                  
 
Viral MOI was calculated based on the virus titre in BHK-21 cells.            
 
2.5.5 Titration of VRPs 
As VRP do not produce progeny virus particles no plaques (regions of cell death) are 
formed in the cell monolayer. Therefore a standard plaque assay cannot be used and VRP 
titration was done by immunostaining. Where no florescent marker was expressed, 
visualisation was achieved through immunostaining with anti-SFV-nsP3 antibody 
following the protocol described in Chapter 2.4.5.  However, some VRPs expressed a 
florescent protein marker, for example ZsGreen or mCherry, which could be used for 
direct visualisation. BHKs were seeded at a density of 8 x 10
4
 cells/well of a 24-well glass 
plate and incubated overnight. As with the standard plaque assay, the growth media was 
removed and replaced with 200 μl of the VRP stock diluted in ten-fold serial dilutions in 
PBSA. Each dilution was done in duplicate. The cells were then returned to the 37 °C 
incubator for 1 hr with rocking every 10 min to ensure an equal distribution of VRPs. 
Following this incubation, the PBSA/VRP solution was removed, 1 ml fresh growth media 
applied gently to the monolayer and the cells were returned to 37 °C incubator for 20 h.  
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The cells were then fixed by carefully applying 10 % formalin solution and incubated at 
room temperature for 1 h. Immunostaining was then performed if required or the results 
viewed immediately if the VRPs expressed a fluorescent marker gene. Coverslips were 
mounted using VECTASHIELD® Mounting media plus DAPI, and allowed to dry before 
being sealed with clear nail polish. Using a Zeiss 710 confocal microscope, the average 
number of fluorescent (infected) cells in fifteen fields were counted and the VRP titre 
calculated with the following formula:  
 
                       
                                  
                                                 
                      
 
Where the microscope constant is calculated as:  
                    
                 
           
  
Where: 
                           
 
2.5.6 Infection of Cell Monolayers with Virus or VRPs  
The appropriate MOI of virus or VRPs was prepared by diluting in the correct volume of 
PBSA. The cell growth media was removed and replaced with either 400 μl virus in PBSA 
for 6-well plates or 200 μl for 24-well plates. This was added carefully to each well so as 
not to disrupt the cell monolayer. The cells were then incubated at the appropriate 
temperature for the cell line (either 37 °C for BHK-21 cells or 28 °C for insect cells) for 1 
h with rocking approximately every 10 min to ensure an equal distribution of virus. 
Following the incubation the virus/PBSA was discarded and the correct volume of fresh 
cell-specific growth media applied. Cells were then returned to the appropriate growth 
conditions for the required incubation time.   
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2.6 Confocal Microscopy  
Visualisation of infected or transfected cells expressing fluorescent constructs was 
achieved through confocal microscopy. Fixed cells were mounted with VECTASHIELD® 
Mounting media with DAPI for nuclear staining, however, live cells could also be viewed 
with no DAPI staining. Fluorescence was viewed using either the Zeiss LSM 710 or LSM 
510 confocal microscopes using the appropriate lasers. Fluorophores used during this 
project are shown below in Table 2.5. 
 
Table 2.5: Fluorophores detected by confocal microscopy during this project 
Fluorophores Colour Excitation (nm) Emission (nm) Laser (nm) 
DAPI Blue 358 463 405 Diode 
mCherry Red 587 610 561 
eGFP Green 488 509 488 Argon 
ZsGreen Green 496 506 488 Argon  
Alexa 488 Green 498 520 488 Argon 
Alexa 594 Red 590 619 561 
 
      
2.7 Dual Luciferase Assay  
Cells seeded in a 24-well plate were lysed by replacing the growth media with 100 µl/well 
passive lysis buffer (Promega) and incubated on a shaker at room temperature for at least 
30 min to allow disruption of the cellular membranes. Relative luciferase light units of 
both Renilla (Rluc) and Firefly (Fluc) luciferase expression were measured by dual 
luciferase kit (Promega) using a GloMax®-Multi+ Microplate Multimode Reader 
(Promega). To each well of a 96-well plate 25 µl of lysate was added. The luminometer 
then added 70 µl Fluc detection reagent followed by 70 µl Stop and Glo Rluc detection 
reagent with a 2 sec delay, at 200 µl/sec with 10 sec integrals. Both detection reagents 
were diluted ten times. If non diluted reagents were used only 10 µl of lysate was required.      
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2.8 Commonly Used Solutions   
 
Cell Culture 
Mitsuhashi and Maramorosch 1 x media (without L-glutamine) 
Calcium Chloride [CaCl2 2H2O] Dihydrate    250 mg/lt  
Magnesium Chloride [MgCl2 6H2O]Hexahydrate    125 mg/lt  
Potassium Chloride [KCl]      250 mg/lt  
Sodium Bicarbonate [NaHCO3]     150 mg/lt 
Sodium Chloride [NaCl]      8750 mg/lt  
Sodium Phosphate monobasic [NaH2PO4H2O] Monohydrate  250 mg/lt  
D-glucose         5000 mg/lt 
Lactalbumin Hydrolysate       8125 mg/lt 
Yeastolate        6250 mg/lt 
 
 
Western Blot 
2 x Loading Buffer  
0.125 M TRIS HCl (pH 6.8), 4 % SDS, 20 % glycerol, 10 % β-mercaptoethanol, 10 mg 
bromophenol blue 
 
Resolving Gel  
2.43 ml distilled H2O, 1.25 ml acrylamide/bis-acrylamide (40 %), 1.25 ml 1.5 M Tris-HCl 
(pH 8.8), 50 μl 10 % SDS, 50 μl 10 % APS and 5 μl TEMED 
 
Stacking Gel  
1.598 ml distilled H2O, 252 μl acrylamide/bis-acrylamide (40 %), 625 μl 0.5 M Tris-HCl 
(pH 6.8), 25 μl 10 % SDS, 75 μl 10 % APS and 5 μl TEMED 
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1 x SDS-PAGE Running Buffer 
25 mM Tris, 0.25 M Glycine, 0.1 % SDS  
 
1 x Wet Transfer Buffer  
50 mM Tris, 375 mM Glycine, 20 % Methanol 
 
Semi- Dry Transfer Buffer  
48 mM Tris, 39 mM Glycine, 0.0375 % SDS, 20 % Methanol 
 
Antibody Reconstitution Buffer  
0.05 % NaN3 in H2O 
 
Stripping Buffer  
3 ml 1 M TRIS HCl (pH7), 5 ml 20 % SDS, 350 μl β-mercaptoethanol, to final volume 50 
ml with H2O 
 
 
Northern Blot 
2 x FDE Loading Buffer 
10 ml de-ionised formamide, 10 mg xylene cyanol, 10 mg bromophenol blue, 200 µl 0.5 
mM EDTA (pH 8)  
 
12 % Denaturing Acrylamide RNA Gel  
4.8 g urea, 0.5 ml 10 x TBE, 3 ml acrylamide/bis-acrylamide (40 %) and 1 ml 
RNase/DNase free H2O to 10 ml 
 
Low Stringency Northern Blot Wash Buffer 
 2  x SSC and 0.1 % SDS  
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Maleic Acid Buffer  
100 mM Maleic acid, 150 mM NaCl, adjusted to pH 7- 8 with NaOH pellets  
 
Washing Buffer  
Maleic acid buffer, 0.3 % Tween  
 
AP Buffer 
 100 mM NaCl, 5 mM MgCl, 100 mM Tris- HCl 
 
 
TNT Coupled Reticulocyte 
Gel Fixing Solution  
50 % methanol, 10 % acetic acid, to final volume with H2O 
 
Gel Drying Solution  
7 % acetic acid, 7 % methanol, 1 % glycerol, to final volume with H2O 
 
 
In vitro Dicer assay 
5 x Lysis Buffer  
10 mM MgAc, 150 mM Hepes-KOH (pH 7.5)  
 
2 x PK Buffer  
200 mM Tris (pH 7.5), 300 mM NaCl, 5 mM EDTA, 2 % SDS 
 
2 x Storage Buffer  
Ice-cold 40 mM tris-acetate (pH 6.8), 200 mM EDTA, 20 mM β-mercaptoethanol 
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Virus Purification 
1 x TNE Buffer (pH 7.5)  
50 mM Tris (pH 7.5), 140 mM NaCl and 5 mM EDTA (pH 8) 
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2.9 Primer List    
NAME Details PRIMER SEQUENCE 5’→3’ 
Fragment 
size (bp) 
Ae. aegypti-Elp1-1 
FWD Recognise the first unique site of Elp1 from the Aag2 
genome 
GTAATACGACTCACTATAGGGAGGACGACACTTTCGGTGATCG 
94 
Ae. aegypti-Elp1-1 
RV  
GTAATACGACTCACTATAGGGCGCGCTGCACTCTTCCCC 
Ae. aegypti-Elp1-2 
FWD Recognise the second unique site of Elp1 from the Aag2 
genome 
GTAATACGACTCACTATAGGGCTCAGATATTGAAGGACAA 
138 
Ae. aegypti-Elp1-2 
RV  
GTAATACGACTCACTATAGGGCCAGCACTTCCGAATCAT 
Ae. aegypti-Elp1-3 
FWD Recognise the third unique site of Elp1 from the Aag2 
genome 
GTAATACGACTCACTATAGGGAGCTTCTTTAAACCTGACTTCACA 
257 
 Ae. aegypti-Elp1-3 
RV 
GTAATACGACTCACTATAGGGTTGATTGGTTCTATGCAACCA 
Rluc FWD 
Primers for Rluc with T7 promoter 
TAATACGACTCACTATAGGGATGACTTCGAAAGTTTATGATCCAG 
700 
Rluc RV TAATACGACTCACTATAGGGCTGCAAATTCTTCTGGTTCTAACTTTC 
eGFP-720nt FWD 
Primers for eGFP with T7 promoter 
GTAATACGACTCACTATAGGGATGGTGAGCAAGGGCGAGGAGCTGTTC 
720 
eGFP-720nt RV  GTAATACGACTCACTATAGGGCTGGGTGCTCAGGTAGTGGTTGTCGGGC 
eGFP-400nt FWD 
Primers recognising eGFP with T7 promoter 
GTAATACGACTCACTATAGGGGGCGTGCAGTGCTTCAGCCGC 
400 
eGFP-400nt RV  GTAATACGACTCACTATAGGGGTGGTTGTCGGGGCAGCAGCAC 
eGFP-114nt FWD 
Recognise a shorter fragment of eGFP with T7 promoter  
GTAATACGACTCACTATAGGGGGCGTGCAGTGCTTCAGCCGC 
114 
eGFP-114nt RV GTAATACGACTCACTATAGGGGCCGTCCTTGAAGAAGATGG 
Fluc FWD 
Primers for Fluc with T7 promoter 
GTAATACGACTCACTATAGGGACTTACGCTGAGTACTTC 
330 
Fluc RV  GTAATACGACTCACTATAGGGGAAATCCCTGGTAATCCG 
SFV-nsP1 FWD 
Recognise the nsP1 gene of SFV 
GGGAAGGTGCTGGATAGAGA 
244 
SFV- nsP1 RV CAAACATAAACGGGGTGGTG 
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SFV-nsP2 FWD 
Recognise the nsP2 gene of SFV 
AGCTTGACGTCCTGCGACTAGGCCGCGCGGGTGCAG 
220 
SFV-nsP2 RV  AATTCGCCAGTGTCCGAGGAGAAAATACCTGCACCC 
SFV-nsP3 FWD 
Recognise the nsP3 gene of SFV 
GCAAGAGGCAAACGAACAGA 
205 
SFV-nsP3 RV GGGAAAAGATGAGCAAACCA 
SFV-E1 FWD 
Recognise the E1 gene of SFV 
CGCATCACCTTCTTTTGTG 
173 
SFV-E1 RV CCAGACCACCCGAGATTTT 
SFV-C/E3 FWD 
Overlap the C/E1 genes of SFV 
TGACAACAAGGGGAGGGTAG 
190 
SFV-C/E3 RV CTGGAAGCACGGGAAGGTAG 
Ae. aegypti-Ago-1 FWD 
Recognise Ago-1 from the Aag2 genome 
GTAATACGACTCACTATAGGGACAGGTTTCACTGTTCAACCT 
2844 
Ae. aegypti-Ago-1 RV  GTAATACGACTCACTATAGGGGGTTTGACCGTTTTCTAGCTGC 
Ae. aegypti-Ago-2 FWD 
Recognise Ago-2 from the Aag2 genome 
GTAATACGACTCACTATAGGGGCCCTCAACAAGAAACACC 
3255 
Ae. aegypti-Ago-2 RV  GTAATACGACTCACTATAGGGGGCGTTGATCTTGAGCCA 
Ae. aegypti-Dcr-1 FWD 
Recognise Dcr-1 from the Aag2 genome 
GTAATACGACTCACTATAGGGCCACGCCTAAAGTGCTGCGATTAC 
6887 
Ae. aegypti-Dcr-1 RV  GTAATACGACTCACTATAGGGGCACTTCCTCCTGTTTCCTGTGTTC 
Ae. aegypti-Dcr-2 FWD 
Recognise Dcr-2 from the Aag2 genome 
GTAATACGACTCACTATAGGGATGCTAAAAATTCACAAATTCGATC 
5924 
Ae. aegypti-Dcr-2 RV  GTAATACGACTCACTATAGGGAGCCGAGCGCAGATCTGTTAACTG 
Ae. aegypti-Actin FWD 
Recognise actin in the Aag2 genome 
AACACCCAGTCCTGCTGACAGA 
217 
Ae. aegypti-Actin RV  TTCGTAGATTGGGACTGTGTGCGA 
Ae. albopictus-Actin FWD 
Ae. albopictus-Actin RV 
Recognise actin in Ae. albopictus-derived cell lines 
AGAGCACCCAGTTCTCCTGA 
CAGGGCATAACCCTCGTAGA 
216 
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Ae. aegypti-Dcr-2-V5/N 
FWD 
Recognises Dcr-2 contains HindIII 
AAGCGCAAGCTTATGGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCT
ACGATGGATATGATTATGCCACAGC 
5966 
Ae. aegypti-Dcr-2-V5/N RV1 
Recognises Dcr-2 contains XhoI for cloning 
into pIB 
AACCGGCTCGAGTTACTTAGCACTGCGGTAGTGCT 
Ae. aegypti-Dcr-2-V5/N RV2 
Recognises Dcr-2 contains XbaI for cloning 
into modified pSFV1 
AACCGGTCTAGATTACTTAGCACTGCGGTAGTGCT 
 Ae. aegypti-Dcr-2-V5/C 
FWD 
Recognises Dcr-2 contains HindIII AAGCGCAAGCTTATGGATATGATTATGCCACAGC 
Ae. aegypti-Dcr-2-V5/C RV1 
Recognises Dcr-2 contains XhoI for cloning 
into pIB 
AACCGGCTCGAGTTACGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCT
TACCCTTAGCACTGCGGTAGTGCT 
Ae. aegypti-Dcr-2-V5/C RV2 
Recognises Dcr-2 contains XbaI for cloning 
into modified pSFV1 
AACCGGTCTAGATTACGTAGAATCGAGACCGAGGAG 
 Ae. aegypti-Ago-2-V5/N 
FWD 
Recognises Ago-2 contains NruI for cloning 
into modified pSFV1 
AAGCGCTCGCGAATGGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCT
ACGATGATACTAAACGCGAGATATC 
3297 
Ae. aegypti-Ago-2-V5/N RV 
Recognises Ago-2 contains XbaI for cloning 
into modified pSFV1 
AACCGGTCTAGATTAAACAAAGAACATCGGGTGAC 
 Ae. aegypti-Ago-2-V5/C 
FWD 
Recognises Ago-2 contains NruI for cloning 
into modified pSFV1 
AAGCGCTCGCGAATGATACTAAACGCGAGATATC 
Ae. aegypti-Ago-2-V5/C RV 
Recognises Ago-2 contains XbaI for cloning 
into modified pSFV1 
AACCGGTCTAGATTACGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCT
TACCAACAAAGAACATCGGGTGAC 
SFV Hot Spot 7305-7326bp Recognises SFV genome position 7305-7326 TGGCGAGGGACATTAAGGCGT   
SFV Hot Spot 1268-1289bp Recognises SFV genome position 1268-1289 TGGGCGAGGGAATACAAGGCA   
SFV Hot Spot 3549-3570bp Recognises SFV genome position 3549-3570 CGGTTAAAGGCAGTAGGGTTG   
CFAV-3UTR-FW (CFAV 
Set 1) 
Recognise a unique region of CFAV 3'UTR 
TAGACGTGATCGAATAGAGCCG 
559 
CFAV-3UTR-RV (CFAV 
Set 1) 
GCGCATCTATGGTATAGAAAAGATAAT 
CFAV-FW-3359 (CFAV Set 
2) 
Recognise a unique region of CFAV  
GTTGACGACATATTGAAGAGATACG 
701 
CFAV-RV-4060 (CFAV Set 
2) 
GCCAAGGATACAGTCCAAAAC 
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CFAV-3UTR-FW-100 (CFAV Set 3) 
Recognise a unique region of CFAV 3'UTR 
CCTGGCAACAGGGTGTGT 
330 
CFAV-3UTR-RV-400 (CFAV Set 3) CTGCCATTTTATAAGAGCACTGG 
pGL3-PUb new MCS FWD 
Inserts a MCS into pGL3-PUb 
GGGACAGATCTACCCGCGGACTTAATTAAACTTCTAGAGTCGGGGCGGC   
pGL3-PUb new MCS RV GGGGTCTCGAGGTGCTAGCGTGGTTGAAATCTCTGTTGAGCAG   
Chapter  
  Introduction 
 
 
Chapter 3: RNAi-mediated Antiviral 
Defence in Ae. aegypti-derived cells   
Table of Contents 
3.1 Introduction .............................................................................................................. 107 
3.2 Objectives ................................................................................................................. 113 
3.3 Results ...................................................................................................................... 114 
3.3.1 The Effect of Silencing Key RNAi Proteins on the Replication of SFV in Aag2 
Cells ........................................................................................................................... 114 
3.3.2 Detection of SFV-derived viRNAs Produced in Aag2 and U4.4 Cells by 
Northern Blot Analysis .............................................................................................. 119 
3.4 Discussion ................................................................................................................ 124 
3.5 Future Work ............................................................................................................. 129 
3.6 Principle Findings .................................................................................................... 131 
 
 
 
 
Chapter 3  RNAi-mediated antiviral defence 
   in Ae. aegypti-derived cells 
 
107 
 
3.1 Introduction  
 
In insects, RNA interference (RNAi) is known to be integral in modulating the replication 
for a number of important viruses. It is induced through the detection of dsRNA generated 
during virus accumulation. Although Drosophila are the traditionally established model for 
the study of innate immunity in insects, more recently the focus has been to expand our 
understanding of the mechanisms involved in the antiviral defence of arboviral vectors and 
this had lead to increasing momentum in this area. Thanks to the evolution of whole-
genome sequencing, the genomes of some of the most significant vector species, such as 
Ae. aegypti, An. gambiae and Cx. pipiens quinquefasciatus, have been unravelled 
(Christophides et al., 2002; Holt et al., 2002; Nene et al., 2007; Waterhouse et al., 2007; 
Arensburger et al., 2010; Bartholomay et al., 2010). Thanks to this, bioinformatic analysis 
has revealed that orthologues of the focal RNAi proteins are found in the genomes of these 
vectors (Hoa et al., 2003; Campbell et al., 2008a) suggesting that key features of the 
pathway may be conserved between Drosophila, aedine, anopheline and culex mosquitoes.  
Recent findings are contributing to an already extensive body of evidence that the 
interactions between the invading virus and the arthropod’s immune responses are highly 
complex. The biology of arboviruses has been shown to be different from pathogenic 
insect viruses as they are modulated by the antiviral response but are still able to establish a 
low- level, non-pathogenic persistent infection. Any pathogenicity induced through 
infection in the vector decreases the potential for transmission and so it is vital for the virus 
to incite minimal fitness costs. RNAi is believed to be the principle virus-specific innate 
immune response in arthropods. The exogenous branch of the RNAi response is 
characterised by the production of virus-derived small interfering RNAs, or viRNAs, 
which are pivotal to its sequence-dependent targeting mechanism. These are believed to be 
generated by a Dicer-2 (Dcr-2) dependent mechanism as Dcr-2 recognises alien, base- 
perfect, long dsRNA molecules and cleaves them into shorter duplex 21 nt fragments. The 
production of dsRNA molecules has been observed during the course of replication for 
members of all major RNA arbovirus families, with the exception of negative strand RNA 
viruses (Weber et al., 2006). It has been suggested that these dsRNA molecules are the 
substrates for Dcr-2 cleavage and the production of viRNAs following infection by 
members of the Flaviviridae (Stollar et al., 1967; Stollar and Stollar, 1970; Westaway et 
al., 1997 and 1999; Sánchez-Vargas et al., 2009; Brackney et al., 2009 and 2010; Scott et 
al., 2010; Hess et al., 2011), Bunyaviridae (Patterson et al., 1983; Brackney et al., 2010; 
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Léger et al., 2013; Sabin et al., 2013; Schnettler et al., 2013b), Togaviridae (Pfefferkorn et 
al., 1967; Stollar and Stollar, 1970; Stollar et al., 1972; Myles et al., 2008 and 2009; 
Brackney et al., 2010; Siu et al., 2011; Morazzani et al., 2012), and Reoviridae (Schnettler 
et al., 2013b).  
In the case of ssRNA viruses, these dsRNA molecules were speculated to arise from three 
origins; 1) secondary structures within the viral genome or transcripts, 2) through 
complementary binding of RNA molecules to the single stranded genome, or 3) duplexes 
of replication intermediates (Molnar et al., 2005; Ho et al., 2006; Myles et al., 2008 and 
2009). As described in Chapter 1.1.2.4.3, replication of single stranded (ss) (+) sense 
RNA viruses consists of the (+) sense RNA viral genome serving as a template for the 
production of a (-) sense antigenome. In turn this (-) sense strand acts as a template for 
further (+) sense genomes (Westaway, 1987; Strauss and Strauss, 1994). The reverse is 
true during the replication of (-) ssRNA viruses where the (-) sense genome is a template 
for the (+) sense antigenome (Guu et al., 2012). Although in both cases concentrations of 
genomic RNA outweigh antigenomic RNA, recent findings have shown that viRNA 
populations exist in approximately equal quantities of (+) and (–) polarities for both (+) 
and (-) strand RNA viruses. In addition, the lack of any correlation between viRNA 
production and genomic secondary structure or region specificity, has strengthened the 
hypothesis that the source of the dsRNA during (+) and (-) ssRNA virus infections in 
insects is replication intermediates (Aliyari et al., 2008; Brackney et al., 2009 and 2010; 
Myles et al., 2008 and 2009; Sánchez-Vargas et al., 2009; Mueller et al., 2010; Scott et al., 
2010; Siu et al., 2011; Marques et al., 2013; Schnettler et al., 2013a; reviewed in 
Bronkhorst and van Rij, 2014) (Chapter 5). For alphaviruses this is consistent with the 
understanding that their genomes incorporate few areas of secondary structure and is 
therefore unlikely to be the source of dsRNA structures (Ou et al., 1983; Davis et al., 2008; 
Logue et al., 2008; Nickens and Hardy, 2008; Kulasegaran-Shylini et al., 2009; Siu et al., 
2011).  
The alphavirus Semliki Forest virus (SFV) of the Togaviridae family has previously been 
shown to be a good model for arbovirus control by insect innate immunity (Garcia et al., 
2005; Fragkoudis et al., 2008; Attarzadeh-Yazdi et al., 2009; Siu et al., 2011; Barry et al., 
2013). As with other alphaviruses, SFV infection is known to stimulate the production of 
small RNA molecules from the exogenous RNAi pathway (Myles et al., 2008; Siu et al., 
2011), as well as piRNA molecules (Schnettler et al., 2013a). Production of these 
molecules confirms that the virus is targeted by an active immune response as both these 
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mechanisms have been implemented in antiviral regulation. Alphaviruses are not believed 
to express an active RNAi antagonist protein and so replication intermediates would be 
readily available as a source of viRNA biogenesis (Myles et al., 2009). Deep sequencing 
analysis has allowed several interesting aspects of these small RNAs to be determined. For 
instance, the viRNA molecules produced following SFV infection of Ae. aegypti-derived 
Aag2 and Ae. albopictus-derived U4.4 cell lines were primarily 21 nt long as expected for 
Dcr-2 processing (Aliyari et al., 2008). Moreover, compared to the global number of small 
RNAs isolated from SFV infected mosquito-derived cell lines, these viral-derived small 
RNAs make up a tenuous proportion (Sui et al., 2011). This has also been documented 
following infection by other alphaviruses and flaviviruses (Campbell et al., 2008b; Myles 
et al., 2008 and 2009; Brackney et al., 2009; Scott et al., 2010; Morazzani et al., 2012). 
Furthermore, the viRNAs are produced across both the genome and antigenome of SFV 
and are not found to be biased towards a particular base at position one suggesting that 
Dcr-2 cleaves the dsRNA molecules in a non-specific manner (Siu et al., 2011). The 
distribution of these molecules is not random and regions of high production frequency or 
‘hot spots’ compared to regions of no/few viRNA reads or ‘cold spots’ are evident. These 
‘cold spot’ viRNAs were found to be significantly more efficient at targeting the virus for 
degradation compared to ‘hot spot’ viRNA molecules. The determining factors influencing 
the different biology exhibited between ‘hot’ and ‘cold’ spot alphavirus-derived viRNAs 
and their ability to mediate RNAi is currently not known and there is no evident correlation 
to sequence content, base pairing or their genomic location. Future research is required to 
understand if the consistent pattern of ‘hot’/‘cold’ spots is due to a difference in 
availability, either spatially or temporally, where some regions are more easily accessed by 
Dcr-2 than others during the stages of virus replication. On the other hand it may be 
suggested that the viral genome is under selective pressure from RNAi activity to generate 
a high number of viRNAs against ‘decoy’ regions to restrict detrimental effects on virus 
replication and thereby evade the immune response. This method of RNAi avoidance has 
previously been shown for Drosophila cells infected with flock house virus (FHV) where 
most of the 21 nt viRNAs mapped to the 5’ region of both RNA segments. In addition, the 
majority of viRNAs were not loaded into RISC and therefore did not result in silencing 
(Aliyari et al., 2008; Flynt et al., 2009; van Rij and Berezikov, 2009). Restricted loading of 
RISC has also been noted for other arboviral infections in mosquitoes and it is believed to 
reduce the capacity for silencing as the majority of viRNA complementary sequences 
would not be targeted. A decoy strategy has also been observed following Arabidopsis 
thaliana infection with Cauliflower mosaic pararetrovirus (CaMV) as small RNAs of 21, 
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22 and 24 nt are generated by each Dicer-like (DCL) protein from both strands of a non-
coding viral region (Blevins et al., 2011). Although high numbers of viRNAs are produced, 
they do not result in virus inhibition suggesting this strategy is not specific to insect 
infections.   
The ‘hot’/‘cold’ spot viRNA production pattern has been shown to be a key feature of 
many viral infections in insects (Myles et al., 2008 and 2009; Brackney et al., 2010; Scott 
et al., 2010; Hess et al., 2011; Morazzani et al., 2012). Unlike other arboviruses, 
flaviviruses are the only ones known to express an RNAi antagonist which is produced 
from the 3’ UTR-derived RNA molecule of dengue virus (DENV) and West Nile virus 
(WNV) and is known as subgenomic flavivirus RNA (sfRNA) (Pijlman et al., 2008; 
Schnettler et al., 2012). These molecules have been described as inhibiting RNAi through 
an RNA decoy mechanism similar to that of FHV and CaMV discussed previously, where 
high levels of non-coding RNAs inhibit efficient silencing. In addition, the non-structural 
protein 4B (NS4B) of DENV is also suggested to be an inhibitor of Dcr-2 through an 
unknown mechanism (Kakumani et al., 2013). However, RNAi and viRNA distribution 
have not been shown to particularly prejudice these regions (Brackney et al., 2009 and 
2010; Scott et al., 2010). Conversely, following Langat virus (LGTV) and tick-borne 
encephalitis virus (TBEV) infection in tick-derived cell lines, viRNA production was 
highly biased towards the 5’ and 3’ terminals, although these similarly do not impact virus 
replication (Schnettler et al., 2014). A second key feature of insect RNAi is that, as 
mentioned, the predominant size of viRNAs produced are 21 nt long, and this has been a 
consistent finding through deep sequencing analysis following a number of RNA viral 
infections of both Drosophila and mosquitoes (Brackney et al., 2009 and 2010; Flynt et al., 
2009; Scott et al., 2010; Sui et al., 2011; Morazzani et al., 2012; Vodovar et al., 2012; 
Schnettler et al., 2013a). Indeed, 21 nt viRNAs are the major size detected following the 
infection of Drosophila with the DNA virus invertebrate iridescent virus 6 (IIV6), 
evidence that DNA viruses are also actively targeted by the RNAi pathway (Bronkhorst et 
al., 2012; Kemp et al., 2013).  
Following Dcr-2 cleavage of dsRNA, the resulting viRNA molecules have a 5’ 
monophosphate and an overhang of 2 nt on the 3’ hydroxyl end necessary for functional 
RNAi (Zamore et al., 2000; Bernstein et al., 2001; Elbashir et al., 2001a and b; Nykanen et 
al., 2001; Tang et al., 2003; Zang et al., 2004; Okamura and Lai, 2008; van Rij and 
Berezikov, 2009). The phosphate group is a characteristic of Dcr-2 processing and is 
required for enhanced binding to the Dcr-2/R2D2 heterodimer and for subsequent loading 
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into RISC (Liu et al., 2003; Tomari et al., 2004; Marques et al., 2010). It is understood that 
R2D2 binds to the most thermodynamically stable end of the siRNA molecule which 
dictates its orientation (Tomari et al., 2004). The siRNAs have a functional asymmetry and 
the strand selected to perform as the guide strand is determined by the stability of the 5’ 
end. Therefore, the strand that is bonded less tightly to its complement at this end is 
incorporated into RISC and becomes the guide strand which is then bound by the PAZ 
domain of Ago-2 and retained (Khvorova et al., 2003; Lingel et al., 2003 and 2004; 
Schwarz et al., 2003; Ma et al., 2004). In Drosophila RISC, the guide strand is 2’-O-
methylated at its 3’ terminus through the action of the S-adenosylmethionine-dependent 
methyltransferase Hen-1 (DmHen-1) which protects that strand from degradation 
(Hammond et al., 2001; Horwich et al., 2007; Saito et al., 2007). The mature, active RISC 
is now able to target base-perfect mRNAs for degradation through Ago-2 slicing. As with 
endo-siRNAs, it has been shown that some viRNAs are resistant to Beta (β) elimination 
treatment which degrades RNAs presenting unmodified 2’ and 3’ hydroxyl groups at the 3’ 
terminus. This implies that a proportion of the viRNA population must also be associated 
with Ago-2 and have been 2’-O-methylated at their 3’ end (Aliyari et al., 2008; Czech et 
al., 2009). Methylation of small RNAs has been documented in plants and some plant 
viruses have been confirmed as actively inhibiting this methylation or removing the methyl 
group from their siRNAs through the action of an encoded viral suppressor protein 
(Ebhardt et al., 2005; Blevins et al., 2006; Csorba et al., 2007; Vogler et al., 2007). In this 
way they prevent siRNA stabilisation within RISC and the resulting sequence targeted 
silencing. This chemical modification can therefore be considered to be a key factor in 
effective RNAi processing. During the persistent infection of Drosophila cells with FHV, 
it has been shown that the majority of its viRNAs are not methylated (Flynt et al., 2009); 
however, it is not fully understood if the methyl group is actively removed or if the 
viRNAs are not taken up by RISC and are therefore not methylated originally. Moreover, 
there are still a large number of open questions relating to the methylation and 
phosphorylation of viRNAs/siRNAs during mosquito RNAi which are required to be 
answered in order to improve our awareness of the biochemical nature of the RNAi 
response.  
The establishment of a number of continuous mosquito-derived cell lines has provided 
valuable research tools for the study of innate immunity in mosquitoes. They present an 
easily handled, homogeneous system which is often more sensitive and reproducible than 
the whole organism. Through work mainly carried out on alphaviruses and flaviviruses, the 
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Ae. aegypti-derived Aag2 and Ae. albopictus-derived U4.4 cell lines have been determined 
to be RNAi competent and are able to mount an RNAi response against a number of 
significant arboviruses (Riedel and Brown, 1979; Condreay and Brown, 1986 and 1988; 
Miller and Brown, 1992; Attarzadeh-Yazdi et al., 2009; Sánchez-Vargas et al., 2009; Scott 
et al., 2010; Siu et al., 2011; Barletta et al., 2012; Morazzani et al., 2012; Vodovar et al., 
2012; McFarlane et al., 2014). Ae. aegypti cell lines in particular have become of 
substantial importance since the landmark publication of their complete genome sequence 
seven years ago (Nene et al., 2007) and this has vastly contributed to the expansion of 
knowledge concerning virus:vector interactions in this important vector species. This 
project aims to utilise these cell lines in order to establish a robust system of RNAi protein 
knockdown and to determine the effect this - and subsequently the RNAi machinery - 
really has on SFV replication. Additionally, the combination of existing techniques, as well 
as establishing new methods was used to further our understanding of siRNA biology 
during SFV infection.     
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3.2 Objectives  
 
1. Establish an efficient silencing assay for the knockdown Dicer-1, Dicer-2, 
Argonaute-1 and Argonaute-2 proteins in the Ae. aegypti-derived Aag2 cell line.  
2. Determine the role these proteins have on the replication of SFV and SFV replicon.  
3. Investigate the production of SFV-derived viRNAs in both the Ae. aegypti-derived 
Aag2 cell line and the Ae. albopictus-derived U4.4 cell line by Northern blot 
analysis.   
4. Analyse siRNA production patterns from dsRNA transfection in the Ae. aegypti-
derived Aag2 cell line and the Ae. albopictus-derived U4.4 cell line by deep 
sequencing.  
5. Determine if the production of the ‘hot spot’ and ‘cold spot’ siRNA pattern results 
from viral or cellular processing.   
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3.3 Results 
 
3.3.1 The Effect of Silencing Key RNAi Proteins on the Replication of SFV in Aag2 
Cells  
To understand the extent that the key RNAi proteins play in the control of alphavirus 
infection it was necessary to develop a transient silencing assay. The difficulties faced in 
using the silencing pathway to knockdown its own components are evident and complete 
knockdown of these key proteins is never achieved, as by its own nature it is self-limiting. 
Furthermore, genetic mutants do not exist for mosquitoes and so transient silencing assays 
were developed based on those already established for Drosophila-derived cell lines 
(Caplen et al., 2000; Hammond et al., 2000). Genetic knockouts of Ago-1 and Dcr-1 
proteins in Drosophila can reduce their viability while knockouts of Ago-2 and Dcr-2 
enhance their susceptibility to infection highlighting the vital role these proteins play in the 
life of the organism (Galiana-Arnoux et al., 2006; van Rij 2006; Wang et al., 2006; 
Mueller et al., 2010; Han et al., 2011; Marques et al., 2013). The RNAi response is 
triggered when Dcr-2 detects dsRNA molecules present in the cell cytoplasm and injection 
of dsRNA into insects has been shown to artificially stimulate the RNAi response. It has 
been documented to be an effective method of gene silencing in vivo and is capable of 
transiently silencing RNAi pathway proteins (Keene et al., 2004; Franz et al., 2006; 
Sánchez-Vargas et al., 2009). However, although in vitro silencing assays were developed 
for Drosophila (Bernstein et al., 2001; Li et al., 2002; Hoa et al., 2003; Chotkowski et al., 
2008; Mukherjee and Hanley, 2010) this was not the case for mosquito systems which 
were not well established until recently (Schnettler et al., 2012 and 2013; McFarlane et al., 
2014; Paradkar et al., 2014). This project aimed to expand this technique for use with the 
Ae. aegypti-derived Aag2 cell line.    
Silencing cellular protein expression was carried out using specific dsRNA molecules 
produced by in vitro transcription against the exogenous RNAi components Dcr-2 and 
Ago-2, as well as the miRNA pathway proteins Dcr-1 and Ago-1. The primers used to 
generate the dsRNAs against these regions are described in Chapter 2.9. Ae. aegypti-
derived Aag2 cells were seeded at a density of 1.8 x 10
5 
cells/well in 24-well plates and 
transfected 24 h later with 500 ng/well of dsRNA against the appropriate protein. These 
results were compared to cells which received 500 ng/well dsRNA specific to eGFP as a 
control. Efficient silencing of the target transcripts was established by RT-PCR 24 h post 
transfection. Transcript knockdown efficiency in three repeats was normalised to actin and 
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quantified by densitometry using the ImageJ software (Figure 3.1A and 3.1B). Values 
recorded for control eGFP dsRNA treated samples were set to 100 % and the results for the 
other dsRNA treatments viewed as a percentage of this. The transcripts for Dcr-1, Dcr-2, 
Ago-1 and Ago-2 were shown to be reduced compared to control eGFP dsRNA by 40 %, 
58 %, 32 % and 67 % respectively.      
Once successful knockdowns of these transcripts had been achieved the effect that this had 
on SFV replication was established. This was determined by treating the cells with dsRNA 
as described prior to infecting with a reporter strain of SFV, SFV4(3H)-Rluc, which 
expresses Renilla luciferase (Rluc) after the nsP3 gene as a marker of virus replication. The 
infection was performed at either a high (10) or a low (0.05) multiplicity of infection 
(MOI) 24 h post transfection to achieve the maximum level of silencing prior to infection. 
Following a further 24 h incubation, the cells were lysed and luciferase activity determined 
by luciferase assay. The results are presented as a correlation between eGFP control treated 
cells (100 %) and Rluc expression. Luciferase expression for both MOI 10 (Figure 3.2A) 
and 0.05 (Figure 3.2B) indicate there is only a slight, non-significant increase in SFV 
replication when Dcr-1, Dcr-2 and Ago-1 were silenced. However, when cells were treated 
with Ago-2 specific dsRNA there was a significant increase in luciferase expression at a 
high MOI. 
A similar experiment was performed substituting SFV with SFV VRPs also expressing 
Rluc (SFV1-Rluc) at an MOI of 10. As discussed in Chapter 2.5.2 and Chapter 5.3.4, 
during the production of VRPs the replicon RNA is encoded separately from the structural 
proteins and as a result VRPs are unable to produce viral progeny which could be released 
and spread throughout the culture. Their use is therefore beneficial to study the effects of 
infection at an individual cellular level. The Aag2 cells were seeded and infected with the 
SFV replicons packaged into VRPs as described. Again the luciferase results for cells 
treated with control eGFP dsRNA were set to 100 % and the effect of transcript silencing 
shown as a percentage of eGFP expression. Figure 3.3 shows that there was no effect on 
VRP replication when Dcr-1, Dcr-2 and Ago-1 where silenced. However, when cells were 
treated with Ago-2 specific dsRNA there was an increase in replication; although, this was 
less efficient than was observed following SFV infection at an MOI of 10.  
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Figure 3.1: Silencing of key RNAi component proteins in Aag2 cells by dsRNA treatment. Ae. 
aegypti-derived Aag2 cells treated with specific dsRNA against Dicer-1 (Dcr-1), Dicer-2 (Dcr-2), 
Argonaute-1 (Ago-1) and Argonaute-2 (Ago-2) (+) were compared to cells which received a 
control eGFP (ctrl) dsRNA. A) Knockdown was confirmed by RT-PCR using gene specific 
primers with actin as a loading control. Representative images of the three independent 
experiments are shown. B) dsRNA treated samples were normalised against actin and the pixel 
density measured using Image J software. Error bars show the standard deviation of three 
independent experiments performed in triplicate.  
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Figure 3.2: Knockdown of exogenous RNAi and miRNA pathway proteins and the 
subsequent effect on SFV(3H)-Rluc replication in Ae. aegypti-derived Aag2 cells. Cells were 
transfected with specific dsRNA against the RNAi proteins Dicer-2 (Dcr-2) and Argonaute-2 (Ago-
2) or the miRNA proteins Dicer-1 (Dcr-1) and Argonaute-1 (Ago-1). Cells which received dsRNA 
specific to eGFP were used as a control. Each condition was then infected with a recombinant 
strain of SFV expressing Renilla (Rluc) luciferase (SFV(3H)-Rluc) at a A) high (10) or B) low 
(0.05) MOI. Rluc expression was detected by luciferase assay and measured in relative luciferase 
light units. Error bars represent the standard deviation of three independent experiments performed 
in triplicate. * represents p < 0.05, Student’s t-test.  
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Figure 3.3: Knockdown of exogenous RNAi and miRNA pathway proteins and the 
subsequent effect on SFV VRP replication in Ae. aegypti-derived Aag2 cells. Cells were 
transfected with specific dsRNA against the RNAi proteins Dicer-2 (Dcr-2) and Argonaute-2 (Ago-
2) or the miRNA proteins Dicer-1 (Dcr-1) and Argonaute-1 (Ago-1). Cells which received dsRNA 
specific to eGFP were used as a control. Each condition was then infected with SFV VRPs 
expressing Renilla (Rluc) luciferase (SFV1-Rluc) at a high (10) MOI. Rluc expression was detected 
by luciferase assay and measured in relative luciferase light units. Error bars represent the standard 
deviation of three independent experiments performed in triplicate.  
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3.3.2 Detection of SFV-derived viRNAs Produced in Aag2 and U4.4 Cells by Northern 
Blot Analysis 
Previously, the characterisation of viRNA molecules produced following SFV infection of 
the Ae. aegypti-derived Aag2 and Ae. albopictus-derived U4.4 cell lines was carried out by 
deep sequencing analysis which allowed an analytical examination to be performed (Siu et 
al., 2011). A further method not utilised prior to this project was Northern blot analysis. 
This method offers many benefits over deep sequencing as it allows identification of the 
size and quantity of small RNAs of a specific sequence, as well as providing the ability to 
distinguish certain viRNA features such as the presence of a mono- or tri-phosphate or 
their methylation state. This technique is also cheap, comparable, reliable and reproducible 
and provides immediate results. In addition, deep sequencing is known to be biased 
towards certain small RNAs due to their ligation capacity (Jayaprakash et al., 2011; Jones 
et al., 2012; Sorefan et al., 2012; Zhuang et al., 2012; Raabe et al., 2014) and comparisons 
between deep sequencing and other methods of analysis commonly result in discrepancies 
(Baker, 2010; Git et al., 2010). For instance, detection of WNV-derived viRNAs in 
Drosophila S2 cells by Northern blotting indicted they were predominantly 25 nt 
(Chotkowski et al., 2008); although, deep sequencing analysis determined they were 21 nt 
(Brackney et al., 2010). Currently, no literature exists for the use of Northern blotting for 
the detection of arboviral or mosquito-infecting viral small RNAs for mosquito cells in 
culture, nor was this technique established in the laboratory yet. Therefore, optimisation 
was required for this technique to be adequately applied.     
Both U4.4 and Aag2 cell lines were seeded at a density of 5.1 x 10
6
 or 5.3 x 10
6
 cells/well 
respectively. They were subsequently infected with SFV(3H)-Rluc at an MOI of 5 and the 
total RNA was isolated by Trizol extraction after 24, 48 and 72 hours post infection (hpi). 
Small RNAs were separated from the total isolated RNAs by PEG precipitation and run on 
an acrylamide gel alongside a small RNA ladder. Prior to blotting and detection by DIG-
labelled SFV specific probes the acrylamide gel was stained with Ethidium Bromide (Et 
Br) to confirm equal quantities of all RNA samples were loaded (Figure 3.4A). A band 
can be detected at the approximate weight  for small RNAs of 21 nt in length.  
The RNAs from the gel were then transferred to a positively charged nitrocellulose 
membrane and stained with five probes for specific independent regions of the SFV 
genome to increase the sensitivity of detection. Previous attempts to establish detection 
with a single probe had failed (data not shown) and so a combination of probes were used 
which recognised regions of SFV- nsP1, nsP2, nsP3, E1 and C-E3 proteins. The primers 
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designed against these regions are described in Chapter 2.9. It was observed that after 
detection with the SFV specific probes the band detected at 21 nt with Et Br was no longer 
recognised, indicating that these small RNAs are not produced against these viral regions 
(Figure 3.4B). It is therefore suggested that the previously detected 21 nt small RNAs are 
cellular-derived RNAs, for example endo-siRNAs produced by the endogenous RNA 
pathway. Another possibility is that they are miRNAs as it is impossible to distinguish 
between 21 nt and 22 nt small RNAs on this kind of gel.  
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Figure 3.4: Detection of viRNAs derived from SFV infected Aag2 and U4.4 cells by Northern 
blot analysis. Small RNAs were isolated from SFV infected Ae. aegypti-derived Aag2 or Ae. 
albopictus-derived U4.4 cells and separated by gel electrophoresis. A) Prior to blotting the gel was 
stained with Ethidium Bromide to detect all RNAs present in each sample. B) The RNAs from this 
gel were transferred to a membrane and hybridised with a combination of SFV-specific, DIG 
labelled DNA oligonucleotide probes. Anti-DIG antibodies conjugated to alkaline phosphatase 
were used to detect the probes and the signal developed using NBT-BCIP detection reagent. The 
weight of the small RNA fragments is indicated by arrows.  
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3.3.3 Production and Mapping of siRNAs in Aedine Cell Lines Against Non-Viral 
Exogenous dsRNA  
As previously mentioned the pattern of ‘hot’ and ‘cold’ spot RNAs has been well 
characterised following viral infection of insect cells (Myles et al., 2008 and 2009, 
Brackney et al., 2009; Sánchez-Vargas et al., 2009; Siu et al., 2011). However, it has not 
been shown that this arrangement occurs following the introduction of non-viral exogenous 
dsRNA molecules. To discover if transfected dsRNA alone is capable of inducing the 
RNAi response and generating ‘hot’ and ‘cold’ spot siRNAs, both U4.4 and Aag2 cells 
were seeded in a 6-well plate at 5 x10
5
 and 6 x10
5
 cells/well respectively. Each well was 
then transfected with 1 µg specific dsRNA generated against a 720 nt eGFP sequence and 
incubated at 28 °C for 24 h. Following this, the RNA was isolated by Trizol extraction and 
small RNAs of < 40 nt were analysed by Illumina Solexa deep sequencing technology to 
determine the frequency of reads at each genetic loci (Figure 3.5A and B). The results 
generated indicate that dsRNA resulting from a non-viral exogenous template also produce 
21 nt siRNAs as the predominant length in both cell types consistent with Dcr-2 
processing. These siRNAs also mapped to both the sense and antisense original eGFP 
template stands and where distributed across the full length of both strands with evident 
‘hot’ and ‘cold’ spots. 
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   Aag2 cells      U4.4  cells 
A
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Figure 3.5: Mapping of siRNAs produced against non-cell specific dsRNA in Ae. aegypti-
derived Aag2 cells and Ae. albopictus-derived U4.4 cells. A) The size distribution of small RNA 
molecules produced between 18 - 37 nt which map to an eGFP sequence (720 nt) following 
transfection of Aag2 cells with eGFP dsRNA. Red indicates siRNAs arising from the coding strand 
of the input dsRNA, while green denotes those which map to the non-coding strand. B) The 
abundance distribution of 21 nt small RNAs generated against either the coding strand (red, 
positive numbers, 5’→3’ direction) or the non-coding strand (green, negative numbers, 3’→5’ 
direction) of the eGFP input sequence in Aag2 or U4.4 cells. The x-axis denotes the nucleotide 
position of the eGFP sequence for each 21 nt siRNA. The frequency of reads for siRNAs at each 
position is shown on the y-axis.    
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3.4 Discussion 
 
The innate immune responses in mosquitoes are known to be important in the control and 
regulation of arbovirus infections. While the involvement of the Toll, IMD and JAK/STAT 
pathways have been shown to be virus-dependent (Fragkoudis et al., 2008; Xi et al., 2008; 
Avadhanula et al., 2009; Souza-Neto et al., 2009; Sabin et al., 2010; Kingsolver et al., 
2013; Merkling and van Rij, 2013; McFarlane et al., 2014), the exogenous RNAi response 
has been recognised as the pivotal antiviral defence against a number of different 
arboviruses and has become the focus of concentrated research (Keene et al., 2004; 
Attarzadeh-Yazdi et al., 2008; Campbell et al., 2008b; Myles et al., 2008; Sánchez-Vargas 
et al., 2009; Scott et al., 2010; Hess et al., 2011; Siu et al., 2011; Lambrechts et al., 2012; 
Léger et al., 2012; Vodovar et al., 2012; Schnettler et al., 2013a; McFarlane et al., 2014). 
Initial experiments in Drosophila indicated that silencing of the RNAi proteins resulted in 
hypersensitivity of Drosophila-derived cells and null mutant lines to insect-specific 
infections; such as FHV, Drosophila C virus (DCV), Drosophila X virus (DXV) (Li et al., 
2002; Galiana-Arnoux et al., 2006; van Rij et al., 2006; Wang et al., 2006; Zambon et al., 
2006; Lim do et al., 2008; Flynt et al., 2009; Han et al., 2011) and arboviral infections 
(Chotkowski et al., 2008; Mueller et al., 2010; Mukherjee and Hanley, 2010). These results 
were later found to translate into mosquitoes, and Ago-2 in particular was recognised as 
being essential for the regulation of both alphaviruses in vivo (Keene et al., 2004; 
Campbell et al., 2008b; McFarlane et al., 2014) and in vitro (Li et al., 2004; Schnettler et 
al., 2013a; McFarlane et al., 2014) as well as in vivo (Franz et al., 2006; Sánchez-Vargas et 
al., 2009) and in vitro (Sánchez-Vargas et al., 2009) control of flaviviruses replication. 
This project has shown that approximately equal levels of gene silencing could be achieved 
for both Ago-2 and Dcr-2 RNAi genes in Aag2 cells. However, it was also observed that 
the greatest increase in viral replication was detected following the knockdown of Ago-2. 
These results suggest that even reduced levels of Dcr-2 are sufficient to detect and cleave 
an adequate level of dsRNA to initiate the RNAi pathway to a certain degree. Therefore, it 
can be implied that Dcr-2 cleavage of viral genome molecules alone is not sufficient to 
prevent virus replication; although, Ago-2 activity is required and plays a crucial and 
central role in the antiviral immune response. This finding is in agreement with previous 
results which showed that Dcr-2 silencing in Drosophila-derived S2 cells continued to 
restrict the replication of recombinant FHV deficient in B2 despite it being achieved in 
dcr-2 null mutant Drosophila embryos (Wang et al., 2006). Similarly, silencing of Dcr-2 in 
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the midgut of transgenic Ae. aegypti facilitated an enhanced Sindbis virus (SINV) infection 
and an increase in viral dissemination, although mortality rates were not affected 
(Campbell et al., 2008b; Khoo et al., 2010).  
It was necessary to determine the effect knockdown has on SFV replication following 
infection at two MOIs. Studying the silencing of the RNAi proteins with a high MOI 
certifies the effect this has on an individual level as every cell in the culture should be 
infected synchronously. In contrast, at a low MOI the virus undergoes multiple rounds of 
replication as only a few cells are infected initially and we can ascertain the effect that 
silencing these key RNAi proteins has on the spread of the virus from an infected cell to its 
neighbours. However, the MOI is based on that established in BHK-21 mammalian cells 
and does not translate effectively to what is observed in insect cells in culture (unpublished 
observations). Although a high proportion of cells can be infected, as a result of the MOI 
equivalent in insect cells being slightly less, global infection is not achieved without some 
degree of spread. A substantial increase in viral replication was only observed following 
the knockdown of Ago-2 during a viral infection at a high MOI (Figure 3.2A). Work 
carried out following these experiments has established that an Ago-2 knockdown in Aag2 
cells is capable of allowing significantly high levels of virus replication following a low 
MOI viral infection (Schnettler et al., 2013a) as well as infection with SFV VRPs (personal 
communication with Dr. Esther Schnettler). Suggested reasons why this was not the case 
during this project may include some of the common technical hurdles encountered during 
these experiments. The age of the cells and the age, composition and batch quality of the 
transfection reagent can all impact the success of these highly sensitive assays. In addition 
the weak inhibitory effect at the low MOI is due to the fact that many of the cells will not 
have been transfected with dsRNA which only reaches ~28 % of Aag2 cells in culture 
(Schnettler et al., 2013a). However, the consistent lack of enhanced virus replication 
following the knockdown of miRNA pathway proteins Ago-1 and Dcr-1 suggests that the 
miRNA pathway is not involved in the control of SFV replication and is consistent with 
what has been shown for other arbovirus infections (Hoa et al., 2003; Keene et al., 2004; Li 
et al., 2004; Schnettler et al., 2013a; McFarlane et al., 2014).  
Numerous reports have stressed the importance of RNAi and its influence on the 
interaction between the virus and its vector altering the outcome of the infection. 
Following the knockdown of RNAi proteins in Ae. aegypti, DENV-2 replication was 
enhanced by a greater than four-fold increase and the extrinsic incubation period before the 
vector could transmit the virus to a susceptible vertebrate was decreased from 10 - 12 days 
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to as few as 7 days (Sánchez-Vargas et al., 2009). This in turn allows a greater number of 
individuals to become infected over the course of the lifetime of the mosquito. The 
population size of viRNAs has been shown to increase as viral infections progress in both 
Drosophila and mosquitoes. This indicates continued detection and cleavage of viral RNAs 
by Dcr-2 and highlights that there is maintained control during persistent infections (Li et 
al., 2002; Sánchez-Vargas et al., 2004; Aliyari et al., 2008; Myles et al., 2008; Brackney et 
al., 2009; Flynt et al., 2009; Wu et al., 2010). In an RNAi deficient situation, such as loss- 
of-function mutants, vector viability may be compromised due to unrestricted virus 
replication (van Rij et al., 2006). As a result, antiviral RNAi is integral to the control of 
viral infections and protects the arthropod from excessive replication and the associated 
pathology, while on the other hand the virus also benefits as it is maintained and can 
complete its transmission cycle when the insect feeds.  
Previous findings have suggested it would be counterintuitive to the replicative fitness of 
the virus to interfere with the immune pathway and may likely explain the lack of RNAi 
suppressor proteins encoded by the majority of arboviruses (Li and Ding, 2006; Blakqori et 
al., 2007; Attarzadeh- Yazdi et al., 2009; Fragkoudis et al., 2009; Donald et al., 2012). 
Unlike true pathogenic viruses, such as DCV, which are known to encode proteins to 
enhance their virulence, most arboviruses are understood to circumvent the antiviral 
response rather than directly impede it (Uchil et al., 2003; Geiss et al., 2005; Siu et al., 
2011). The seclusion of viral-derived RNAs was eluded too following the results generated 
by Northern blot analysis. The lack of detection of viRNAs by SFV-specific probes 
indicated that the virus was able to sequester its dsRNA and restrict access to the RNAi 
mechanism. As a result of the lack of detection it was suggested that a potential pit fall was 
the level of sensitivity. Therefore, it was decided to use radio-labelled oligonucleotide 
probes to enhance any potential signal. The probes were designed based on the three SFV 
sequences which gave the highest reads during previous deep sequencing analysis (Siu et 
al., 2011, Chapter 2.9). The use of these probes was to further strengthen the chance of 
detection as they should be present in the highest quantities following viral replication. 
Unfortunately, this method also failed to generate a result and no signal was detected (data 
not shown). This is in contrast to what has been shown in plants where this method of 
detection is highly successful due to the vast quantity of viral-derived small RNAs 
generated following RdRP amplification (Dalmay et al., 2000; Lakatos et al., 2004; Molnar 
et al., 2005; Sunpapao et al., 2009; Miozzi et al., 2013). Northern blot analysis has also 
been used to successfully to identify viRNAs produced in Drosophila and their derived cell 
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lines following infections by FHV (Aliyari et al., 2008; Han et al., 2011), WNV 
(Chotkowski et al., 2008) and Rift Valley fever virus (RVFV) (Sabin et al., 2013). The 
findings described here contribute to the suggested hypothesis that alphavirus replication in 
invertebrate cells occurs in membrane-bound vesicles away from the antiviral response 
mechanism. In this way it is theorised that Dcr-2 access to its substrate dsRNA would be 
restricted and therefore the generation of viral-derived viRNA molecules would be 
impeded. This form of evasion defence strategy has been observed following alphavirus 
infection in both vertebrate and invertebrate-derived cell lines (Friedman et al., 1972; 
Salonen et al., 2005; Spuul et al., 2007; Frolova et al., 2010) and similar replication 
compartments are also evident following flavivirus infection of mammalian and tick cell 
lines (Senigl et al., 2006; Offerdahl et al., 2012). Such a strategy could explain why viRNA 
molecules consist of minor proportion of the total small RNA population isolated from 
infected mosquito cell lines as established by several deep sequencing experiments using a 
number of different viruses (Campbell et al., 2008b; Myles et al., 2008 and 2009; Brackney 
et al., 2009; Scott et al., 2010; Siu et al., 2011; Léger et al., 2012; Morazzani et al., 2012).  
A decoy strategy as a method for RNAi evasion was also suggested when deep sequencing 
analysis revealed that although viRNAs are produced across both the genome and anti-
genome of SFV, certain regions were more intensely targeted than others. The viRNAs 
produced in high numbers were shown to be highly ineffective at restricting SFV 
replication in contrast to those producing lower reads. Therefore, viRNAs which cannot be 
used for virus repression are suggested to saturate RISC and restrict access to functional 
viRNAs. This ‘hot’/‘cold’ spot pattern is in line with that observed with other arboviruses 
such as RVFV (Léger et al., 2013), WNV (Brackney et al., 2009) and chikungunya 
(CHIKV) (Morazzani et al., 2012). However, it is yet to be established if ‘cold’ spot 
viRNAs are more successful at targeting the viral sequences than ‘hot’ spot viRNAs 
derived from these viruses. As expected, this pattern was also observed following 
transfection of dsRNA specifically targeting the eGFP sequence consistent with processing 
via the exo-siRNA pathway. Therefore, the exogenous RNAi response is triggered 
regardless of the source of dsRNA. This indicates that the pattern of high and low siRNA 
production from different loci is as a result of endogenous cellular processing and is not 
due to factors involved in virus replication or secondary structures in the viral genome. 
Why some sequences are targeted more than others is not yet understood and a number of 
hypotheses have been suggested which require further study. Currently, Dcr-2 is believed 
to attach to the end of a nucleic acid and cut 21 nt from the start and so on until reaching 
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the end of the sequence. If this was indeed the case then no siRNA bias would be observed. 
Therefore, it can be suggested that Dcr-2 may function in a different manner resulting in a 
variation in the number of siRNAs against specific sequences. The stability of some siRNA 
molecules may be different due to factors which have not yet been fully explored. 
Certainly, as described previously, deep sequencing has been shown to display some 
degree of ligation bias which may alter the outcome from its natural state. It is also of note 
that piRNAs are not detected following the treatment of eGFP-specific dsRNA which is 
unlike samples infected with virus and so it can be suggested that the generation of 
piRNAs requires another stimulant other than the detection of dsRNA (Schnettler et al., 
2013a).    
The advent of advanced, high through-put techniques such as deep sequencing and micro 
array expression analysis has greatly contributed to the field of arbovirology. In addition, 
by combining the viRNA molecules generated in invertebrates, virtually entire virus 
genomes can be compiled which opens up new avenues for virus discovery (Wu et al., 
2010). These results, together with what is already known in the literature, has proven that 
viRNAs are paramount to RNAi and therefore to the life and wellbeing of vector 
mosquitoes. Further research is required to fully assess their biochemistry and mode of 
production. In addition, the rapid technical advances in the field have greatly accelerated 
our understanding of the antiviral genes involved in blocking virus dissemination and 
transmission. Thanks to a number of recent key findings our knowledge of how mosquitoes 
handle arboviral infections has substantially improved; although, many outstanding 
questions still remain to be answered.      
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3.5 Future Work  
 
The function of the antiviral proteins Ago-2 and Dcr-2, as well as miRNA- pathway 
proteins in mosquitoes have been determined by in vivo injections and transfections in 
vitro. However, these types of knockdowns are only transient and often inconsistent. It 
would be ideal to have a stable mosquito line, such as those developed for Drosophila, 
which are genetic null mutants or where there is at least a stable protein knockdown. These 
would allow the direct experiments which verify their action and are still missing to be 
completed.  
Further modifications could still be made to the Northern blot protocol. In particular, the 
use of a recombinant strain of FHV which did not encode the B2 RNAi silencing 
suppressor protein could provide a valuable insight into siRNA production during 
infection. As this protein acts to inhibit siRNA biogenesis, its removal would increase the 
number of siRNA available for detection and so would act as a positive control for the 
experimental set up. However, due to the genetically modified nature of the virus, this 
could not have been completed during this project due to licensing restrictions. An 
alternative strategy for the detection of viral RNA that has been successful with 
Bunyamwera virus (BUNV) requires the in vitro transcription of a plasmid containing the 
viral genome sequence and incorporating radio-labelled nucleotides for detection (Dr. 
Agnieszka Szemiel, Personal communication). This would result in the creation of a probe 
recognising the entirety of the viral genome and would detect each viral viRNA rather than 
a selected few. A further difference is that this probe would be an RNA probe compared to 
the previously tested DNA probes.  
Little has been determined with regards to the involvement of immunity molecules in 
persistence and transmission of mosquito-borne infections. Further biochemical analysis of 
small RNAs is required to answer many unknown factors, in particular those relating to 
their methylation and phosphorylation. Therefore, it is necessary to ascertain the nature of 
viRNAs derived from SFV during infection in Aag2 cells and to establish if there are any 
viral proteins which affect their function and therefore the timing and kinetics of the 
antiviral response. The use of β-elimination assays, Northern blot analysis and deep 
sequencing would distinguish between methylated and unmethylated viRNAs through 
changes in molecular weight and would determine if this has any biological relevance to 
the biochemical differences observed between ‘hot’ and ‘cold’ spot viRNAs. Further 
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analysis would then be necessary to establish if this is as a result of active demethylation 
by arboviruses. In addition, the biological relevance of ‘hot’ and ‘cold’ spots is still 
unknown as is the significance of the specific biases across both (+) and (-) strands and 
therefore further work is necessary to fully characterise them.  
There is also very little information available regarding the relationship between the RNAi 
response and negative strand RNA viruses, such as bunyaviruses and rhabdoviruses, or 
dsRNA viruses, such as reoviruses. Therefore, the integral differences in their replication 
kinetics and the strategies used by these viruses is not fully understood and further work is 
required to investigate this alternative avenue of interest.   
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3.6 Principle Findings  
 
1. Major Ae. aegypti RNAi proteins Dicer-1, Dicer-2, Argonaute-1 and Argonaute-2 
can be efficiently silenced by treating cells with transcript-specific dsRNA 
molecules. 
2. The knockdown of Argonaute-2 in Ae. aegypti-derived Aag2 cells results in a 
strong and significant increase in SFV replication, defining this as the key protein 
in antiviral RNAi.  
3. Despite the presence of small RNAs of 21 nt in Ae. aegypti-derived Aag2 cells, 
these are not detected with SFV specific probes by Northern blot analysis.  
4. Small RNAs of 21 nt are the majority population produced following transfection 
of non-viral dsRNA in the Ae. aegypti-derived Aag2 and Ae. albopictus-derived 
U4.4 cell lines.  
5. These 21 nt small RNAs produced from an artificial dsRNA Dcr-2 substrate 
emulate the distribution of viral-derived small RNAs with the variation in ‘hot’ and 
‘cold’ spots along the coding sequence. 
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4.1 Introduction 
 
Several studies have shown that intracellular RNA-dependent RNA Polymerases (RdRPs) 
are required for RNA silencing in fungi, yeast, nematodes and plants (Cogoni and Macino, 
1999; Dalmay et al., 2000; Smardon et al., 2000, Mourrain et al., 2000; Sijen et al., 2001; 
Makeyev and Bamford; 2002; Wassenegger et al., 2006). The conservation of RdRP gene 
sequences in these organisms is thought to be central in maintaining the integrity of the 
genome from transposon mobilisation and viral infection. There is also an integral 
interaction between RdRPs and the RNA interference (RNAi) response necessary for 
effective gene regulation in at least some of these organisms. RdRPs facilitate the spread of 
the RNAi response by catalysing the generation of new RNA molecules from existing 
RNA template strands (Figure 4.1). RdRP action has been shown in lower eukaryotes to 
be linked to the systemic spread of RNAi signalling molecules (siRNAs/dsRNAs) to 
prepare uninfected neighbouring cells against the invading infection (Smardon et al., 2000; 
Sijen et al., 2001; Voinnet, 2005). In plants, amplification occurs by two known 
mechanisms. Firstly, RdRPs are involved in the physical amplification of aberrant single 
stranded (ss) RNA populations generating full-length dsRNA molecules which can be 
further targeted by Dicer for cleavage into more siRNA molecules. Aberrant RNAs may 
result from a viral infection, sense transgenes or from mobile genetic elements. A second 
model which has been described is de novo synthesis of dsRNA by primer extension of 
siRNAs which are perfectly complementary to the target RNA sequence (Tang et al., 
2003). The siRNA-primed dsRNA molecules produced are later cleaved by Dicer into 
siRNA molecules. These two mechanisms are not mutually exclusive from each other and 
demonstrate that RdRPs can act in either a primed or un-primed manner (Schiebel et al., 
1993; Makeyev and Bamford; 2002). Conversely in C. elegans, RdRPs are Dicer 
independent and can synthesize siRNAs directly from the mRNA target (Smardon et al., 
2000; Sijen et al., 2001 and 2007; Pak and Fire; 2007). Targeted processing of the Dicer-
catalysed siRNAs by the Argonaute protein, RDE-1, recruits and directs the action of the 
RdRP complex for the biogenesis of siRNAs by un-primed de novo synthesis.  
To date, no canonical RdRP homolog has been detected in the genome of insects or higher 
eukaryotic organisms (Gordon and Waterhouse, 2007; Zong et al., 2009); although, this 
has not appeared to handicap the RNAi mechanism. On the contrary, studies have 
suggested that the silencing mechanism is less efficacious against virus control in plants 
compared to insects. Mutant plant viruses deficient for a functional RNAi suppressor 
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protein are incapable of causing a systemic infection, although localised cellular infections 
are not affected (Voinnet et al., 2000; Silhavy et al., 2002). This is not the case in fruit flies 
infected with flock house virus (FHV) lacking a functional B2 suppressor protein as the 
virus is rapidly cleared from infected cells unless the RNAi response is compromised (Li et 
al., 2002). This may suggest that there is a greater reliance on an efficient RISC in these 
organisms.     
Recently, RdRP-like activity was described in Drosophila (Lipardi et al., 2001, 2003, 2005 
and 2009) and other vertebrates (Sam et al., 1998; Maida et al., 2009; Pelczar et al., 2010).  
In Drosophila, transgene co-suppression assays identified a correlation between the 
emergence of alcohol dehydrogenase (Adh) specific siRNAs and a decrease in mRNA 
transcript levels once transgene copies surpassed a threshold (Pal-Bhadra et al., 2002). The 
reputed RdRP-substitute enzyme was identified through an RNAi inhibition screen by 
Lipardi and Paterson (2009) as elongator subunit 1 (D-elp1), or iκb kinase complex 
associated protein (IKAP), which is the largest subunit of the Drosophila polymerase (pol) 
II core elongator complex. In contrast to the canonical RdRP, this gene is highly conserved 
in all eukaryotes, including those which are known to express putative RdRP enzymes and 
RNA pol II has been independently shown to possess intrinsic RdRP activity (Lehmann et 
al., 2007). Evidence was established through in vitro RNA silencing experiments carried 
out in Drosophila embryo cell-free extracts that siRNAs stimulated a silencing response in 
addition to initiating template dependent de novo dsRNA synthesis (Lipardi et al., 2001 
and 2005). D-elp1 was hypothesised to generate new dsRNA molecules as substrates for 
Dicer-2 (Dcr-2) using either siRNA molecules as primers or by a primer-independent 
mechanism to allow the propagation of the siRNA population and enhancing targeted 
silencing in an action similar to that of known RdRPs in plants, fungi and worms 
(Hutvagner and Zamore, 2002) (Figure 4.1). An additional role for RdRPs, such as EGO-1 
in C. elegans (Smardon et al., 2000; Maniar and Fire, 2011) is their involvement in the 
control of the germline stability, defending against ‘selfish’ nucleic acids or transposons. 
Deep sequencing analysis of endogenous siRNAs (endo-siRNAs) indicated a high 
proportion were derived from transposons and were dependent on Dcr-2 and Argonaute-2 
(Ago-2) processing. These were derived from both the sense and antisense strands of 
transposon RNA (Chung et al., 2008; Ghildiyal et al., 2008) which could indicate the 
manufacture of dsRNA from transposable elements. Transposons may be controlled by an 
association between the aberrant RNAs and the RNA silencing components and the 
knockdown of D-elp1 had a similar effect as that seen with Dcr-2 on increasing a 
Chapter 4  A study of the role of an orthologue 
  of D-elp1 in Ae. aegypti RNAi 
 
135 
 
population of retrotransposons (Lipardi and Paterson, 2009). Levels of antisense siRNAs 
were seen to decrease only when D-elp1 was silenced strongly suggesting that D-elp1 is 
acting as an RdRP by producing the complementary antisense molecule.   
Unfortunately, following the initiation of this work, Lipardi and Paterson published a 
retraction to their 2009 publication (Lipardi and Paterson, 2011) and the interpretations 
remain controversial. The authors revoked their statement that D-elp1 was an RdRP, 
although they maintain that it is involved in RNAi, endogenous siRNA production and the 
suppression of transposable elements.  
Due to its widespread nature throughout the eukaryotic kingdom it was interesting to 
determine if a homologue of D-elp1 existed within the genome of Ae. aegypti. This species 
of mosquito is a major vector for a number of pathogenic arboviruses and their complete 
genome has been published (Nene et al., 2007). They are also known to have a competent 
RNAi response, which can successfully limit viral titres within the insect (Blair, 2011; 
Donald et al., 2012).  As it was shown that D-elp1 localised in the cytoplasm (Svejstrup, 
2007; Johansen et al 2008), the site of replication of important arboviruses and the site of 
RNA processing, it could potentially form an interaction with Dcr-2. Lipardi stated (2009) 
that when both Dcr-2 and D-elp1 were over-expressed they were able to interact and form 
a complex and that recombinant Dcr-2 was capable of using dsRNA molecules generated 
from both purified and recombinant D-elp1 as substrates for cleavage. This association was 
maintained following the retraction of the article. RdRP amplification of dsRNAs would be 
beneficial to mosquitoes to enhance the RNAi signal and its vital role in cellular 
interactions with arboviruses. In addition to augmenting the quantity of siRNAs available 
for uptake into RISC, dissemination of an amplified signal to adjacent cells would be 
permitted to limit arbovirus spread (Attarzadeh-Yazdi et al., 2009). As the movement of 
siRNAs over short distances has been demonstrated for mosquitoes, RdRP action may be 
advantageous but not essential for spread of antiviral activity within the organism.    
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Figure 4.1: Schematic illustration of the involvement of an RNA dependent RNA polymerase 
(RdRP) in the RNAi pathway. Amplification of substrate dsRNA by the RdRP generates more 
targets for Dicer-2 and subsequently increases the siRNA population available for loading into 
RISC.  dsRNA, double stranded RNA; Dcr-2, Dicer-2; RISC, RNA induced silencing complex; 
Ago-2, Argonaute-2; siRNA, small interfering RNA; ssRNA, single-stranded RNA; mRNA, 
messenger RNA. 
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4.2 Objectives 
 
1. Identify the presence of a homolog of D-elp1 in the Ae. aegypti derived Aag2 cell 
line.  
2. Investigate the effect this homolog has on SFV infection and dsRNA mediated 
silencing in the Ae. aegypti derived Aag2 cells.     
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4.3 Results  
 
4.3.1 The Presence of an RNA-dependent RNA Polymerase Homologue in Ae. aegypti 
Aag2 Cells  
In order to establish the existence of a homologue of D-elp1 within the genome of Ae. 
aegypti a search of the  National Center for Biotechnology Information (NCBI) protein 
database was carried out using the Basic Local Alignment Search Tool (BLAST) online 
tool with the D-elp1 sequence (AAF54670) as the query against the Ae. aegypti reference 
genome. This generated eight potential matches with the dominant hit, identified as the iκb 
kinase complex associated protein (AAEL001036-PA/XP_001657869), showing 38 % 
homology with 97 % coverage. The two sequences have been aligned using EMBOSS 
Needle6.6.0 (Figure 4.2). This was designated as the most likely homologue for D-elp1 in 
comparison to the other identified hits and shall hereafter be referred to as Aa-elp1.  
To determine if Aa-elp1 is expressed in the Ae. aegypti-derived Aag2 cell line, it was 
detected using specific primers to amplify regions of the gene by RT-PCR. These regions 
were selected as they appeared to be unique within the Ae. aegypti genome and could later 
be used for the production of multiple Aa-elp1-specific dsRNAs. Distinction of novel 
sequences is vital as this restricts the number of potential dsRNA recognition sites and 
therefore minimises off-target effects. This approach revealed three unique regions of 
varying lengths for amplification by PCR (Region 1: 94 bp, Region 2: 138 bp, Region 3: 
257 bp long, Figure 4.2). Primers were designed (Chapter 2.9) which contained T7 
polymerase promoter sites to later allow the generation of specific long dsRNAs using the 
MegaScript RNAi kit. Total cellular RNA was isolated from untreated Aag2 cells and 
cDNA generated by first strand cDNA synthesis by reverse transcription for partial gene 
amplification by the specific primers in the PCR. DNA products from the PCR were 
analysed by agarose gel electrophoresis to confirm specificity, fragment size and gene 
expression levels (Figure 4.3). The size of the fragment was expected to be 42 bp larger 
than the region described due to the addition of the T7 promoter region. Each primer set 
successfully amplified fragments of the desired size from the Aag2 cDNA and did not 
detect anything in the RNA (No RT) control samples confirming that Aa-elp1 is expressed 
in Ae. aegypti-derived Aag2 cells.  
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Prior to the production of dsRNA, each fragment was cloned into the pJet1.2/blunt cloning 
vector and sent for sequencing to validate the sequence was correct. Although dsRNA 
molecules were successfully generated against both regions 2 and 3, this was not possible 
for region 1 due to its failure to clone successfully. Therefore, only dsRNA molecules 
against regions 2 and 3 were used for Aa-elp1 silencing experiments.    
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Figure 4.2: Alignment of elp1 in Drosophila melanogaster (D-elp 1) to ikappab kinase complex-associated protein from Ae. aegypti (Aa-elp1). A comparison between 
the sequence of D-elp1 to the genome of Ae. aegypti revealed a single protein with 97 % coverage and an identity score of 38 %. Purple underlined sequences indicate 
regions of primer design. Single letters (amino acids, see Page xix), identical amino acid match (|), conserved substitution (:), semi-conserved substitution (.).      
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Figure 4.3: Detection of Aa-elp1 gene transcripts in Aag2 cells. Expression of Aa-elp1 in Ae. 
aegypti-derived Aag2 cells was determined by RT-PCR. Cellular mRNA was reverse transcribed to 
cDNA using oligo-dT primers and the PCR was carried out using three different sets of Aa-elp1 
specific primers. No RT control samples were prepared by omitting the superscript III enzyme 
from the reaction.   
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4.3.2 The Effect of Aa-elp1 Knockdown on dsRNA Induced Silencing in Aag2 Cells  
Prior to the characterisation of Aa-elp1 it was first necessary to establish an efficient 
knockdown in Aag2 cells. Aag2 cells were seeded in 24-well plates at a density of 1.8 x 
10
5
 cells/well and transfected 24 h later with 50 ng/well of dsRNA, either both specific 
dsRNA to Aa-elp1 together (50 ng of dsRNA against region 2 plus 50 ng dsRNA against 
region 3), or control dsRNA (eGFP). Successful silencing of Aa-elp1 transcripts was 
established by RT-PCR 24 h post transfection and quantified by densitometry using the 
ImageJ software (Figure 4.4A and B). Both sets of primers designed against regions 2 and 
3 showed a reduction in the level of Aa-elp1 transcripts detected compared to control 
samples treated with eGFP dsRNA (23.3 % and 20.8 % reduction respectively).    
The involvement of Aa-elp1 in dsRNA induced silencing was first determined using 
plasmids expressing luciferase reporter genes in a more controllable experimental setup 
compared to a viral infection. As the transfected dsRNA molecules are recognised and 
processed by the exogenous RNAi pathway, this mimics the detection of a viral infection 
and is a useful technnique. Aag2 cells were seeded in 24-well plates as before and 
transfected 24 h later with 50 ng/well of dsRNA, either both specific dsRNA against Aa-
elp1 together, control eGFP dsRNA or were mock transfected. Cells were incubated for 24 
h post transfection prior to a second treatment where all conditions received reporter 
plasmid co-transfected with specific dsRNA against that reporter sequence. In these 
experiments each well received 5 ng/well plasmid pRL-CMV (Promega) that expresses 
Renilla luciferase (Rluc) under the control of the cytomegalovirus immediate-early 
promoter as an internal control and 30 ng/well plasmid pEGFP/VDV-1s/Fluc expressing 
firefly luciferase (Fluc) under the baculovirus OpIE2 promoter which has been described 
previously (Ongus et al., 2006). Further to this, half the samples in each condition were 
then treated with 0.01 ng/well Fluc-specific dsRNA and the other half with 0.01 ng/well 
control eGFP-specific dsRNA (Figure 4.5).  
Aag2 cells have been shown to have a transfection efficiency of 28.6 % for dsRNA 
(Schnettler et al., 2013a) and 23.4 % for plasmid (unpublished observations). Cells were 
lysed 24 h post transfection and the ratio of Fluc:Rluc expression measured by luciferase 
assay. As expected, samples treated with Fluc-specific dsRNA indicated a decrease in 
luciferase light units compared to control eGFP dsRNA treated samples (Figure 4.6). 
Nevertheless, although dsRNA knockdown was successful, cells treated with Aa-elp1-
specific dual dsRNAs showed similar levels of Fluc silencing compared to non-silenced 
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cells. This suggests that Aa-elp1 is not important in dsRNA induced transient gene 
silencing.  
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Figure 4.4: Silencing of Aa-elp1 transcripts in Aag2 cells by treating them with Aa-elp1-
specific dsRNAs. Ae. aegypti-derived Aag2 cells were treated with dsRNA to specifically target 
Aa-elp1 at two unique regions and these results were compared to control eGFP dsRNA treated 
cells. A) Transcript knockdown was confirmed by RT-PCR using primer sets for each region which 
are compared to actin primers as an internal control. A representative image is shown. B) Three 
independent experiments were performed and the average pixel density measured using Image J 
software. The graph shows the results relative to control eGFP dsRNA treated cells. Error bars 
show standard deviation of the mean.  
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Figure 4.5: A schematic illustration of the experimental set up for the results described in 
Figure 4.6. Ae. aeguypi-derived Aag2 cells seeded in 24-well plates were transfected 24 h post 
seeding with either dsRNA (Aa-elp1 or eGFP) or were mock transfected. Further to this, 24 h later 
cells received reporter plasmids (pFluc and pRL-CMV) co-transfected with either Fluc-specific 
dsRNA against that reporter sequence or eGFP-specific control dsRNA.  
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Figure 4.6: The effect of silencing Aa-elp1 in Aag2 cells on dsRNA induced silencing. Ae. 
aegypti-derived Aag2 cells were treated with either the combination of dsRNA against Aa-elp1 
(dark grey), eGFP control dsRNA (pale grey) or were mock transfected (light grey). Following an 
incubation of 24 h, the cells were transfected in parallel with two plasmids (pFluc and pRL-CMV 
as an internal control), and either specific dsRNA against Fluc or control eGFP dsRNA. Cells were 
incubated for a further 24 h were after the ratio of Fluc:Rluc expression was measured in relative 
luciferase light units. Values recorded for control eGFP dsRNA were set to 100 % and the specific 
Fluc dsRNA viewed as a percentage of this. Error bars represent the standard deviation of three 
independent experiments performed in triplicate.  
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4.3.3 The Effect of Aa-elp1 Silencing on SFV Replication in Aag2 Cells  
As D-elp1 was reputed to be involved in the antiviral RNAi response, the potential role of 
Aa-elp1 in the control of an SFV infection in Aag2 cells in culture was examined. SFV, as 
with other alphaviruses and flaviviruses is effectively targeted by the RNAi machinery 
resulting in the production of virus-derived small RNAs (viRNAs) (Keene et al., 2004; 
Campbell et al., 2008a and b; Myles et al., 2008 and 2009; Attarzadeh- Yazdi et al., 2009; 
Sanchez-Vargas et al., 2009; Siu et al., 2011). If Aa-elp1 does display RdRP activity in 
Aag2 cells and is able to amplify biologically active viRNAs targeting SFV, it would be 
expected that Aa-elp1 knockdown would allow an increase in virus replication to occur.  
To determine the contribution that Aa-elp1 has on the regulation of virus replication, Aag2 
cells were seeded in 24-well plates and Aa-elp1 silenced as described. Furthermore, Rluc-
specific dsRNA was included to confirm the ability of the RNAi machinery in Aag2 cells 
to target a reporter strain of SFV expressing Rluc as a marker of replication (SFV4(3H)-
Rluc) (Fragkoudis et al., 2008; Attarzadeh-Yazdi et al., 2009). Cells were infected with 
SFV4(3H)-Rluc at either a high multiplicity of infection (MOI, 10) or a low MOI (0.005) 
24 h post transfection. Following a 48 h incubation the cells were lysed and luciferase 
activity determined by luciferase assay. As expected, cells treated with Rluc-specific 
dsRNA showed a decrease in Rluc activity at both the high and low MOIs (Figure 4.7A 
and B) validating the efficiency of the assay. However, where Aa-elp1 transcripts had 
been knocked-down the level of Rluc expression closely resembled that detected in control 
treated cells (eGFP dsRNA or mock transfected). Again this was observed at both MOIs 
used and demonstrates that there was no effect on virus replication or spread. Details of the 
effect of silencing key RNAi proteins which do affect SFV replication in Aag2 cells are 
discussed previously in Chapter 3.      
 
  
Chapter 4            A study of the role of an orthologue 
              of D-elp1 in Ae. aegypti RNAi 
 
148 
 
  A  
 
B  
 
Figure 4.7: The effect of silencing Aa-elp1 in Aag2 cells on SFV replication. Ae. aegypti-
derived Aag2 cells were treated with either dsRNA (Aa-elp1, Renilla luciferase (Rluc) or eGFP 
specific) or were mock transfected. Following an incubation of 24 h, the cells were infected with 
SFV4(3H)-Rluc at either MOI 10 (A) or MOI 0.005 (B). Cells were incubated for a further 24 h 
were after they were lysed and Rluc expression was measured in relative luciferase light units. 
Values recorded for control eGFP dsRNA were set to 100 % and the results for the other dsRNA 
treatments were viewed as a percentage of this. Error bars represent the standard deviation of two 
independent experiments performed in triplicate.  
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4.4 Discussion  
 
It has been determined that in lower eukaryotes RdRPs are required for a robust RNAi 
response through the amplification and spread of silencing molecules within organisms 
such as worms and plants (Cogoni and Macino, 1999, Smardon et al., 2000; Dalmay et al., 
2000; Mourrain et al., 2000; Wassenegger et al., 2006). The action of an RdRP in those 
organisms may in part account for the potency of the silencing response and presence of a 
large population of siRNAs when only a few molecules are needed to induce the response 
(Fire et al., 1998; Kennerdell and Cathew, 1998; Yang et al., 2000). Furthermore, the 
generation of secondary siRNAs by RdRP activity is responsible for the spread of the 
silencing signal from infected to non-infected cells, resulting in a systemic antiviral RNAi 
response which inhibits an incoming virus infection (Fire et al., 1998; Himber et al., 2003; 
Voinnet, 2005).  
Studies have indicated that there is a lack of efficient spread of RNAi between tissues in 
insects and higher eukaryotes. It was believed that RNAi was cell autonomous in higher 
eukaryotes and viral dissemination could not be limited systemically (Kennerdell and 
Cathew, 1998; Roignant et al., 2003). However, more recently it has been demonstrated 
that a degree of systemic gene silencing does occur (Tomoyasu et al., 2008; Karlikow et 
al., 2014) through the translocation of dsRNA molecules in vivo in Drosophila (Saleh et 
al., 2009) and siRNA molecules in vitro in Ae. albopictus-derived cells (Attarzadeh-Yazdi 
et al., 2009). Systemic RNAi is also evident in some tick species and they have been 
shown to be capable of dsRNA uptake both in vitro and in vivo (Nijhof et al., 2007; Kocan 
et al., 2007). However, despite the existence of an RdRP homologue in their genome its 
involvement in RNAi and systemic spread has not yet been established (Kurscheid et al., 
2009). This stresses the level of divergence within the Arthropoda lineages. Non-cell 
autonomous RNAi has also been demonstrated in mammalian cells in culture through both 
cell-to-cell contact and contact-independent means (Rechavi et al., 2009; Cohen and 
Xiong, 2011). Therefore, with the exception of ticks where an RdRP has been suggested, 
functional silencing molecules can be passed from infected cells to their neighbours in 
higher eukaryotes and can propagate the antiviral response within the local vicinity of the 
infection resulting in systemic RNAi without the known assistance from a definitive RdRP 
(Hoa et al., 2003).  
Chapter 4            A study of the role of an orthologue 
              of D-elp1 in Ae. aegypti RNAi 
 
150 
 
Although amplification of the RNAi signal may be beneficial to these organisms, these 
findings are suggestive that RdRp action may be superfluous or play a reduced role, in the 
spread of RNAi molecules over short distances between cells of higher animals. Indeed, 
although RdRP amplification is obligatory for RNAi in C. elegans, it is not required for 
short distance movement of silencing molecules in plants although wider transport was 
affected (Himber et al., 2003). It has also been suggested that RdRp action may not be 
necessary for dissemination in organisms with efficient circulatory systems where fluids, 
such as the haemolymph and coelomic fluids, are in contact with the majority of body cells 
and are able to provide a prolonged, stable signal to various tissues within the body 
(Blandin et al., 2002; Tijsterman et al., 2004). Certainly an in silico analysis between both 
D-elp1 and Aa-elp1 sequences revealed that there was no significant similarly to other 
recognised RdRPs detected, something which is stated in Lipardi and colleagues original 
publication. The lack of identifiable domains or catalytic residues important for RdRP 
activity, such as the DXDGD motif, further detracts from the statement that D-elp1 
functions as an RdRP.   
Further to the role of D-elp1 in the primer-dependent or primer-independent dsRNA 
production model of RNAi suggested by Lipardi and colleagues, alternative proposals by 
Zamore and colleagues suggested that RNAi may succeed in Drosophila without the action 
of an RdRP (Zamore et al., 2000; Hammond et al., 2000; Nykänen et al., 2001; Schwarz et 
al., 2002; Roignant et al., 2003). Despite the absence of a determined RdRP orthologue, 
mosquitoes and Drosophila encode the key enzymes involved in RNAi and have 
demonstrated a strong silencing capacity (Kennderdell and Carthew, 1998; Hammond et 
al., 2000; Yang et al., 2000; Zamore et al., 2000). From the observations made in this 
chapter it can be inferred that although a homologue of D-elp1 exists within the Ae. aegypti 
genome, there is no evidence to suggest that it has an active role in the RNAi response. If 
Aa-elp1 possessed RdRP activity to enhance exogenous siRNA based RNAi in the Aag2 
cell line then it would be expected that RNA silencing would be inhibited when Aa-elp1 
was knocked-down. As a result expression levels of Rluc from SFV(3H)-Rluc virus 
infection would be expected to increase due to the reduction in the population of viRNAs 
presented to Ago-2. However, results demonstrated that there was no evident inhibition of 
the exogenous RNAi pathway following the knockdown of Aa-elp1 transcripts in vitro. 
These are inconsistent with Lipardi’s findings that RNAi was impaired following D-elp1 
knockdown which is upheld despite the retraction. It could be argued that the knockdown 
efficiency of ~20 % was not sufficient to remove an adequate level of the protein to 
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produce an effect and that the outstanding protein remaining could function unaffected. 
Alternatively, if as suggested, Aa-elp1 plays a minor role or has become completely 
dispensable as RNAi evolved in these organisms, the principle population of siRNAs 
following the initial infection may be sufficient without amplification to efficiently silence 
SFV replication. It should therefore be noted that the abundance of siRNA molecules has 
been shown to differ in certain systems and that siRNAs are more prevalent in Drosophila 
and plants than in C. elegans in spite of the activity of their confirmed RdRP (Parrish et al., 
2000, Yang et al., 2000; Li et al., 2002). On the other hand, experiments with an alternative 
virus may generate a different result due to variations in the manner in which they 
circumvent the antiviral response. Although these results suggested that Aa-elp1 does not 
affect receptivity of Aag2 cells to SFV infection or a reporter system based on exogenous 
RNAi induction, a comparison between cell lines and cell-free extracts should also be 
examined to gain a more complete insight into the functions of Aa-elp1. In particular, it 
should be noted that cell-to-cell movement of silencing molecules has not been studied in 
the Aag2 cell line and therefore it has not been shown to exist in these cells despite spread 
being observed in the Ae. albopictus-derived U4.4 cell line (Attarzadeh-Yazdi et al., 2009).    
Lipardi stated that when both Dcr-2 and D-elp1 were over-expressed they were able to 
interact and form a complex, an association which was maintained after this article was 
retracted. This is in agreement with other canonical RdRPs in lower eukaryotes that have 
been shown to associate with Dicer enzymes in the cytoplasm (Lee and Collins, 2007). 
There may therefore be an alternative role for Aa-elp1 in a Dcr-2 dependent mechanism 
which is yet to be established and would merit further studies. Moreover, the involvement 
of an insect RdRP in endo-siRNA production and transposon suppression where not 
investigated and more research is required to further understand these avenues of interest.     
Further evidence for the lack of an active RdRP in insects and higher eukaryotes is that the 
RNAi response in C. elegans and plants is not only systemic but transitive. Transitivity 
results from the production of RdRP-directed dsRNA synthesis which is driven by primary 
siRNA molecules. The dsRNA molecules are processed into further siRNAs, termed 
secondary siRNAs which are produced from a different, non-overlapping region of the 
transcript. In this way the silencing of a gene which was not present in the original dsRNA 
sequence can be achieved. This is useful in antiviral defence as regions of the viral genome 
which do not produce/produce low numbers of viRNAs can be targeted. In C. elegans 
transitive RNAi requires an RdRP to amplify the silencing signal through the generation of 
siRNAs derived against regions further upstream towards the 5’ terminus of the original 
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dsRNA target sequence. These act as primers for primer-dependent de novo dsRNA 
synthesis which is extended from the siRNA binding site on the sense RNA into the 
flanking sequences upstream in the transcript, although only over a limited distance (Sijen 
et al., 2001; Alder et al 2003). Further siRNAs, termed secondary siRNAs, that recognise 
regions upstream of the original target are then produced and accumulate to greater 
numbers than primary siRNAs; although, their population numbers remain lower than 
those against the original trigger sequence and decrease in quantity with increasing 
distance from that sequence (Sijen et al., 2001; Alder et al 2003). These secondary siRNAs 
will also target other RNA transcripts to which they are complementary. Primary and 
secondary siRNA molecules can be distinguished from each other in C. elegans by the 
chemical structure of their 5’ terminus. Primary siRNAs are generated by Dicer and so 
have a monophosphate on their 5’ terminus. RdRPs add ribonucleotides to the 3’ terminus 
of an RNA molecule and their 5’ triphosphate has been preserved which gives the 
secondary siRNAs a recognisable characteristic polarity (5’→3’ on the antisense strand) 
(Ruby et al., 2006; Pak and Fire, 2007; Sijen et al., 2007). In addition, primary siRNAs are 
predominantly 22 nt while secondary siRNAs are largely 26 nt.  
In plants, transitive RNAi is bidirectional and can spread larger distances from the dsRNA 
inducer sequence towards either the 5’ or 3’ ends, suggesting a primer-independent 
mechanism or the use of full-length antisense RNA as a template (Vaistij et al., 2002; 
Petersen and Albrechtsen, 2005). Secondary siRNAs are not able to be differentiated from 
primary siRNAs based on structure as both populations are Dicer dependent and so have a 
5’ monophosphate in contrast to C. elegans secondary siRNAs. However, siRNAs are 
different lengths depending on which of the four dicer-like proteins (DCL) generates them. 
siRNAs are either 21, 22 or 24 nt long when produced from DCL4, DCL2 or DCL3 
respectively, while DCL1 produces microRNAs in a range of sizes (Voinnet, 2008). DCL1 
and DCL3 are exclusively located in the cell nuclease, unlike DCL2 and DCL4 which are 
found in the cytoplasm. The major population of secondary siRNAs are believed to be as a 
result of DCL4 and DCL2 processing downstream of RdRP action and these are involved 
in the systemic spread of the silencing signal (Himber et al., 2003; Mlotshwa et al., 2008; 
Wang et al., 2011). However, definitive clarification of each mechanism is not possible 
due to the large degree of cross-talk between the pathways and dual protein functions. The 
knockdown of one protein is easily compensated by a second and therefore the two 
pathways are not clearly distinguished from each other.  
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Transitive RNAi is considered to be a distinguishing feature of RdRP function and is 
thought to be lacking in organisms where no canonical RdRP is present. Certainly 
transitive RNAi has not been documented in mammals or Drosophila either in vitro and in 
vivo (Pal-Bhadra et al., 1999 and 2002; Zamore et al., 2000, Nykänen et al., 2001; Celotto 
and Graveley, 2002; Hutvagner and Zamore, 2002; Schwarz et al., 2002; Roignant et al., 
2003; Adelman et al., 2008). An in vitro assay showed that Drosophila were able to digest 
dsRNAs into functional siRNAs; however, these were generated against the original 
dsRNA molecule and not for regions upstream as would be expected for transitive RNAi 
(Zamore et al., 2000). Lipardi and colleagues suggested that de novo dsRNA synthesis was 
observed in Drosophila extracts (Lipardi et al., 2001); however, the authors rescinded this 
finding (Lipardi and Paterson, 2011). A possible explanation for these controversial 
findings could lie with the viruses that infect the cells. RNA viruses are known to encode 
their own RdRP which could account for the detection of signal amplification in some 
experiments and not in others. In addition, endogenous viruses which ‘contaminate’ some 
cultures are only now being unravelled and may provide the answers to erroneous 
discrepancies (Chapter 6). However, transitive RNAi has not been observed in plants and 
C. elegans in vitro either and therefore current lysate preparation methods may not be 
adequate to represent the mechanism in the whole organism system. Although with this in 
mind, to date no siRNAs have been identified in Drosophila which present with a 
biochemical signature consistent with the suggestion that they are secondary siRNAs. 
Much less has been determined for mosquitoes; although, infection of mosquitoes with 
SINV was shown to produce a new class of endo-siRNAs (Adelman et al., 2012). 
Therefore much more work is required to definitively state transitive RNAi does not exist 
in these organisms.    
As it is implied that at a cellular level the RNAi response alone, without additional input 
from an RdRP, provides adequate protection against infection pathology in these 
organisms compared to those with a canonical RdRP it could be suggested that evolution 
has exonerated the requirement of an RdRP. Drosophila are able to defend against an 
infection from a virus lacking their virus-encoded RNAi suppressor (VSR) protein while 
plants remain susceptible to it (Voinnet et al., 2000; Li et al., 2002; Silhavy et al., 2002; 
Ryabov et al., 2004). In these organisms the enzymatic properties of the RISC may negate 
the need for amplification to achieve sufficient silencing. However, unlike many viruses 
which infect plants and Drosophila, arboviruses are not understood to express an efficient 
VSR protein which interferes with RNAi components to diminish the silencing response 
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(Attarzadeh-Yazdi et al., 2009, Kemp and Imler, 2009; Murray et al., 2013). In this case 
RNA silencing may not require amplification to contain the infection. A recombinant strain 
of SFV expressing tombusvirus siRNA-binding protein, p19, which selectively binds to the 
siRNA duplexes and prevents them being loaded into RISC for targeted silencing was also 
investigated. This has been previously shown to enhance virus spread in mosquito cell 
lines (Scholthof, 2006; Attarzadeh-Yazdi et al., 2009). A recombinant strain of SFV 
encoding p19 (SFV(3H)-Rluc-p19) was used in parallel experiments alongside SFV(3H)-
Rluc to establish the extent a reduction in siRNA availability to Aa-elp1 affected RNA 
silencing. You would expect that in the absence of an RdRP amplifying siRNAs, 
SFV(3H)-Rluc-p19 would do much better as there would be a great reduction in the 
number of siRNA molecules available to RISC for silencing. This was indeed the case; 
however, the outcome was extensive cell death under all conditions infected with the p19 
SFV mutant (results not included). Therefore, it can be suggested that the addition of a 
VSR in arboviruses is selected against due to its deleterious effects. It would have been 
beneficial to test the effect of the B2 dsRNA binding protein to determine the effects that it 
has on the RNAi in mosquito cells. However, the creation of a B2 mutant was not 
permitted due to licensing and could not be completed.    
Drosophila melanogaster was one of the first organisms to have its genome sequenced and 
is arguably the most genetically well known eukaryote. Despite its wide use in research, 
the work of Lipardi and colleagues is unique in its description of the presence of an RdRP 
in the Drosophila genome. As a result, it generated some scepticism over its disputed 
findings (Birchler, 2009; Förstemann, 2010). Despite the controversy surrounding the 
existence of an RdRP in insects, it is possible that alternative mechanisms involved in 
sustaining and amplifying the RNAi signal occur but are as yet unresolved. This study goes 
some way to add to the growing evidence that information generated for Drosophila, the 
model insect organism, is not easily translated to mosquitoes. The lineages to which 
Drosophila and mosquitoes belong are evolutionarily divergent and there is strong degree 
of variability of expression within their range of immune genes (Adams et al., 2000; 
Waterhouse et al., 2007). In particular, work carried out by our group have shown that 
important genes identified by screens in Drosophila do not translate, at least efficiently, to 
functional RNAi proteins in mosquitoes (Zhou et al., 2008; McFarlane et al., In 
preparation). The development of tools to accurately study immunity within the mosquito 
organism are necessary for investigations into antiviral defence in the natural virus/vector 
model and will reduce our reliance on the Drosophila system while compensating for the 
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number of immune mutants available for the Drosophila model (Chapter 5).  The results 
described suggest that despite overlaps in some functions and proteins, such as Dcr-2 and 
Ago-2, other components of the RNAi pathway may not play identical roles.  
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4.5 Future Work  
 
The challenges present highlight the undefined nature of many aspects of RNAi in 
different organisms. Due to the conserved nature of elp-1 in all eukaryotes, further work is 
necessary to fully determine its function within this wide range of organisms. The work 
described in this chapter focused on its activity in the exogenous siRNA pathway in Ae. 
aegypti-derived Aag2 cells and investigated its role in the RNAi antiviral immune response 
against SFV infection. The data generated indicated that there was no obvious 
disadvantage following SFV infection; however, it would be of interest to confirm this 
result with another virus to compare the responses. Similarly, different systems should also 
be investigated such as in vivo studies, cell-free extracts or an in vitro system derived from 
an alternative mosquito species as variations in the system may prove more suitable to 
establishing the potential role of elp1 in the mosquito RNAi response.      
Furthermore, Lipardi stated that there was an association between Dcr-2 and D-elp1 which 
they maintained after this article was retracted. Further advances with the detection of Dcr-
2, in addition to other important RNAi proteins (Chapter 5) would be useful to employ to 
define the other proteins and co-factors which are involved in RNAi complexes. There may 
be an alternative role for elp1 in a Dcr-2 dependent mechanism which could yet be 
established.  
Other aspects of D-elp1 which were not refuted by Lipardi and colleagues were not 
investigated and merit further studies. The potential role of elp-1 in endo-siRNA 
production, transposon suppression or the piRNA pathway, in addition to any RdRP 
function, may reveal some activity in other aspects of gene control.   
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4.6 Principle Findings  
  
1. A sequence similar to that known in Drosophila (D-elp1), a potential RdRP, was 
identified in the Ae. aegypti-derived Aag2 cell line (Aa-elp1) and could be silenced 
by treating the cells with specific dsRNA molecules.   
2. Despite the suggestion that Aa-elp1 could have a role in accentuating the 
exogenous siRNA signal, evidence of this was not observed in the experiments 
performed. No difference in luciferase activity was detected from virus replication 
or plasmid expression when Aa-elp1 was silenced.      
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5.1 Introduction  
 
The fruit fly, Drosophila melanogaster, has recently celebrated 100 years as a model 
organism. It is a well established model for the study of innate immune responses, small 
RNA biology and antiviral responses in insects and as such there are a considerable 
number of sophisticated genetic tools available which have allowed a detailed 
understanding of these processes to be attained (Adams et al., 2000; Huszar and Imler, 
2008; Kemp and Imler, 2009; Ding, 2010). As a result, the basis of RNAi research in 
insects has been founded on the findings generated in Drosophila and their derived cell 
lines (Galiana-Arnoux et al., 2006; van Rij et al., 2006; Wang et al., 2006; Zambon et al., 
2006). In the field of arbovirology, the need to further our understanding of mosquito 
immunity in order to discern the crucial role RNAi plays in the control of arboviral 
infections has lead to a necessary shift from Drosophila towards the natural vectors of such 
pathogens. The extensive advantages of genetic mutants in Drosophila are sadly lacking in 
mosquitoes and a growing body of evidence has suggested that a certain degree of 
information obtained in Drosophila is not necessarily able to be translated to the mosquito 
system. As Drosophila and mosquitoes belong to evolutionarily distinct phylogenetic 
lineages and show a high degree of variability in the level of immune genes expression, it 
is not entirely surprising that this is the case (Adams et al., 2000; Myers et al., 2000; 
Waterhouse et al., 2007). It is therefore essential that similar tools are developed and 
implemented to accurately appreciate immunity and the antiviral defence in the natural 
virus/vector model. These advancements will reduce our current reliance on the 
Drosophila model system and facilitate the generation of veracious results in the mosquito 
model. Recent findings have emphasised the importance of performing RNAi analysis in 
an applicable host species by demonstrating that the RNAi response and viral counter 
measures can be species specific and that the outcome of an infection by a particular 
pathogen can differ, even between closely related species (van Mierlo et al., 2014).   
A turning point in enhancing our awareness of the fundamentals of innate immunity in 
mosquitoes was the generation of complete genetic sequences for some of the most 
significant vector species such as An. gambiae, Ae. aegypti and Cx. quinquefasciatus 
(Christophides et al., 2002; Holt et al., 2002; Nene et al., 2007; Waterhouse et al., 2007; 
Arensburger et al., 2010; Bartholomay et al., 2010). Further to this, the development of 
high-throughput sequencing technology has facilitated the characterisation of small RNAs 
from samples infected with several important viruses; including those from the 
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Bunyaviridae, Togaviridae and Flaviviridae families, which have rapidly advanced the 
RNAi field (Aliyari et al., 2008; Myles et al., 2008 and 2009; Brackney et al., 2009; van 
Rij and Berezikov, 2009; Parameswaran et al., 2010; Wu et al., 2010; Blair et al., 2011; 
Hess et al., 2011; Siu et al., 2011; Donald et al., 2012; Morazzani et al., 2012; Vodovar et 
al., 2012; Schnettler et al., 2013a; Vijayendran et al., 2013; Bronkhorst and van Rij, 2014; 
Karlikow et al., 2014). The detection of viral specific small RNAs have confirmed the 
importance of Dicer-2 (Dcr-2) mediated processing in the antiviral response and has 
allowed its substrate virus sequences to be elucidated through mapping them back to the 
genome (Scott et al., 2010; Wu et al., 2010).  
Undoubtedly one of the greatest questions still to be answered in insect systems is when 
and where the RNAi pathway is initiated. Dcr-2 is vital for the launch of the antiviral 
RNAi mechanism through its action as a pathogen recognition receptor (PRR) and the 
recognition of dsRNA molecules following infection before the RNAi response can be 
employed. Most studies have focused on (+) RNA virus infections during which it is 
believed that this dsRNA substrate is due to replication intermediates formed during the 
amplification of the viral genome (Chapter 3) (reviewed Blair, 2011 and Donald et al., 
2012). Little is known about the RNAi target following infections by (-) RNA, dsRNA or 
DNA viruses. Low quantities of dsRNA have been observed in vescicular stomatitis virus 
(VSV) infections of Drosophila cells (Weber et al., 2006; Mueller et al., 2010). However, 
functional 21 nt small RNAs are detected matching both the full-length of the genome and 
antigenome in a similar fashion to the pattern generated by (+) RNA virus infection 
suggesting replication intermediates might again be the target for Dcr-2 cleavage 
(Brackney et al., 2010; Mueller et al., 2010; Leger et al., 2013; Sabin et al., 2013; 
Schnettler et al., 2013a; Marques et al., 2013). More research is required in this area to 
understand the source of Dcr-2 substrates during a (-) RNA virus infection. The recognised 
scope of the RNAi defence has recently been broadened as it has also been shown to target 
DNA viruses. Drosophila RNAi has been shown to target the dsDNA virus Invertebrate 
iridescent virus 6 (IIV-6) and the authors suggest that dsRNA is produced by overlapping 
transcripts which act as  Dcr-2 substrates (Bronkhorst et al., 2012; Kemp et al., 2013). In 
wild-caught Cx. pipiens molestus a novel ssDNA densovirus was detected through deep 
sequencing of viRNAs. Although their biogenesis and function is unknown, it suggests 
mosquito Dcr-2 is also able to target ssDNA viruses (Ma et al., 2011). Similarly, RNAi 
targeting, specifically Dcr-2 action, acts antivirally against the dsDNA virus white spot 
syndrome virus (WSSV) in the economically important shrimp species Marsupenaeus 
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japonicus (Huang and Zhang, 2013). These reports emphasise how sophisticated and 
powerful the RNAi response is and how little we currently understand of this mechanism 
of defence.   
Despite the theory that functional Dcr-2 processing is sufficient to impede a viral infection 
alone by reducing the number of RNA strands capable of forming new viral progeny, this 
has been shown to not be entirely true. The essential part that Argonaute-2 (Ago-2) plays 
in the antiviral response in Drosophila was demonstrated through the increased sensitivity 
of Ago-2 mutant flies and cell lines (Zambon et al., 2006; Chotkowski et al., 2008; Mueller 
et al., 2010; Han et al., 2001). Dcr-2 failed to inhibit infection by flock house virus (FHV) 
in Ago-2 mutant Drosophila embryos (Wang et al., 2006), while Ago-2 mutants had 
increased sensitivity to Drosophila C virus (DCV) and Drosophila X virus (DXV) (van Rij 
et al., 2006; Zambon et al., 2006). These findings have been reiterated successfully in Ago-
2 knockdown mosquitoes and their derived cell lines (both in the literature and presented 
as part of this thesis) where similar conclusions have been generated highlighting the 
importance of Ago-2 in the antiviral control responses of these organisms (Hoa et al., 
2003; Keene et al., 2004; Franz et al., 2006; Campbell et al., 2008a; Sanchez-Vargas et al., 
2009; Schnettler et al., 2013a; McDonald et al., 2014).  
Accelerated evolution of antiviral dcr2, r2d2 and ago2 RNAi genes in comparison to non-
immune genes (dcr1, r3d1 and ago1) in Drosophila signifies a sustained battle between the 
virus and its vector (Obbard et al., 2006 and 2009); although, this may not be the case in 
mosquitoes as a study in Ae. aegypti indicates that unlike Drosophila, both miRNA and 
exo-siRNA pathway genes undergo accelerated evolution highlighting the differences 
between the two insect species (Bernhardt et al., 2012). True insect viruses are commonly 
known to encode viral suppressors of RNAi (VSR) as a counter defence against RNAi 
antiviral activity (reviewed Li and Ding, 2006; Ding and Voinnet, 2007; Kemp and Imler, 
2009; van Mierlo et al., 2011) (Chapter 1.4.6). Many of them target dsRNA as the 
pathway initiator or siRNA molecules which determine the sequence specific target. 
Examples of these include the DCV (Dicistroviridae) protein 1A which prevents dsRNA 
cleavage by Dcr-2 (van Rij et al., 2006) and may also affect siRNA loading into RISC 
(Bonning and Miller, 2010; Nayak et al., 2010). The 1A protein encoded by Cricket 
paralysis virus (CrPV) on the other hand acts by directly interacting with Ago-2 and 
inhibiting its function (Nayak et al., 2010). Members of the Alphaodavirus genus, such as 
FHV or Nodamura virus (NoV) express the B2 protein which not only binds dsRNA but 
siRNAs as well and therefore inhibits Dcr-2 cleavage in addition to preventing siRNA 
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incorporation into RISC (Li et al., 2002; Chao et al., 2005; Lingel et al., 2005; Aliyari et 
al., 2008; Qi et al., 2012). Other RNAi suppressor proteins such as p19 from tombusviruses 
(Tombusviridae), p21 from beet yellow virus (BYV) (Closteroviridae) and HC-Pro from 
potyviruses (Potyviridae) all selectively bind duplex siRNA molecules (Voinnet et al., 
1999; Lakatos et al., 2006). Moreover, evidence has shown the independent evolution of 
Ago-2 suppressor proteins within two unrelated pathogenic insect viruses emphasising the 
importance of Ago-2 in the RNAi pathway (Nayak et al., 2010; van Mierlo et al., 2012). 
This myriad of countermeasures with different mechanistic actions indicates the whole 
pathway is involved in viral control. In some cases, however, RNAi suppressor activity 
may be limited to the natural virus vector. This was identified through the action of viral 
protein 1 (VP1) that is encoded by the Drosophila Nora virus and suppresses Ago-2 
cleavage (van Mierlo et al., 2014). A degree of species specificity was observed between 
different Nora-like viruses suggesting specific co-evolution between the virus and its host.    
Recent publications have characterised the activity of RNAi suppressors in a broader range 
of viruses than previously thought. The first description of an RNAi inhibitor in a 
mosquito-specific virus was shown in Culex Y virus (CYV) which encodes its own VSR 
capable of binding both long dsRNA and siRNA duplex molecules (van Cleef et al., 2014). 
This is also the first example of a link between viral persistence and RNAi antagonism 
which requires further investigations in the future. Among arboviruses, few are known to 
encode RNAi inhibitors. This lead to the theory that their absence allowed arboviruses to 
progress to a persistent, low level infection necessary for their continued transmission. 
However, two members of mosquito-borne flaviviruses, West Nile virus (WNV) and 
dengue (DENV) have been shown to suppress RNAi through the production of non-coding 
subgenomic flavivirus RNAs (sfRNAs) (Pijlman et al., 2008; Schnettler et al., 2012). 
These are generously produced during viral replication and act as competitive substrates 
for Dcr-2 and so inhibit processing of coding RNAs. The action of non-structural protein 
4B (NS4B) of DENV is also thought to inhibit Dcr-2, although the mechanism is unclear 
(Kakumani et al., 2013). Moreover, a further study by Schnettler and colleagues has 
demonstrated that the RNAi silencing suppressor activity of sfRNA is also present for the 
tick-borne flaviviruses Langat virus (LGTV) and tick-borne encephalitis virus (TBEV) 
(Schnettler et al., 2014).   
The strategy that is traditionally believed to be employed by arboviruses is passive evasion 
rather than an active attack on the RNAi mechanism. Host cell membranes have been 
shown to have a major role in the replication of (+) RNA viruses (Tao and Ye, 2010). The 
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majority of all eukaryotic single stranded, (+) sense RNA viruses, including members of 
the Flaviviridae and Togaviridae families, have been shown to replicate within membrane-
bound vesicles within mammalian host cells (Grimly, 1968; Strauss and Strauss, 1994; 
Westaway et al., 1997; Mackenzie et al., 1998; Diamond, 2003; Uchil and Stchidanandam, 
2003; Geiss et al., 2005; Spuul et al., 2007, 2010 and 2011; Campbell et al., 2008a; 
Sanchez-Vargas et al., 2009). These cytoplasmic replication complexes are surrounded by 
a double membrane derived from the host cell itself and provide the optimal environment 
for virus replication (Friedman et al., 1972; Grimley et al., 1972; Peranen et al., 1995; 
Welsch et al., 2009; Gillespie et al., 2010; Chatel-Chaix and Bartenschlager, 2014). The 
current belief is that the replicating viral genome is protected, hidden behind a ‘cell-self’ 
barrier, making it less accessible, to the RNAi machinery. This aids evasion by restricting 
or delaying the immune response, at least during a vertebrate infection (Keene et al., 2004; 
Geiss et al., 2005, Frolova et al., 2010). Studies with TBEV and WNV have indicated that 
this method also functions to delay the stimulation of interferon induction (Hoenen et al., 
2007; Overby et al., 2010). There is also evidence of replication complexes observed in a 
tick cell line for TBEV (Senigl et al., 2006) and LGTV (Offerdahl et al., 2012; personal 
communication with Dr. Lesley Bell-Sakyi and Dr. Claudia Rückert, Pirbright Institute). 
However, although there is currently little evidence for these structures in the case of 
alphavirus infection of mosquitoes and their derived cell lines, a recent paper has 
demonstrated DENV- induced membrane remodelling in C6/36 cells (Junjhon et al., 2014). 
Previous work has shown that punctate co-localised staining was observed between SFV 
replication complexes and anti-dsRNA antibody detection suggesting a primary association 
between the two during the early acute stages of infection in Ae. albopictus-derived U4.4 
cells (Siu et al., 2011). This is in agreement with results for other alphaviruses, in addition 
to SFV, in both vertebrate and invertebrate cells (Salonen et al., 2005; Spuul et al., 2007; 
Fragkoudis et al., 2008; Frolova et al., 2010). Viral dsRNA is therefore concentrated in 
specific loci throughout the cytoplasm; although whether this is within cytoplasmic 
vacuoles in mosquito cells has yet to be confirmed. Currently little is known about the 
localisation of the RNAi proteins during infection in mosquitoes. It is hypothesized that 
Dcr-2 will locate at these sites in order to detect and interact with its substrate viral dsRNA 
produced during viral replication. Studies have shown that Dcr-2 and Ago-2 can be co-
immunoprecipitated from Drosophila-derived S2 cells but that they are also biologically 
separate (Hammond et al., 2001). Therefore, the biochemical properties of their 
interactions need to be fully investigated in order to acquire an insight into the dynamic 
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association between these proteins as well as any additional protein: protein/ protein: 
molecule interactions. Unfortunately, unlike the Drosophila system, very few tools exist to 
allow thorough investigations into the interactions between arboviruses and their natural 
vectors to be carried out. The provision of tools and assays designed around the mosquito 
vector are necessary to answer some fundamental questions of arbovirology.    
RNAi studies have so far benefited from the wide range of in vivo and in vitro tools in 
Drosophila. Drosophila research has provided a catalogue of readily available genetic 
mutants and conditional drivers for in vivo host-virus interaction analysis. These are 
currently lacking for mosquitoes although new methods such as ‘Clustered Regularly 
Interspaced Short Palindromic Repeats’ (CRISPR) and ‘Transcription Activator-like 
Effector Nucleases’ (TALENs) may provide a valuable resource for the creation of 
transgenic knockdown/knockout mosquitoes in the future (Windbichler et al., 2011; Aryan 
et al., 2013 and 2014; DeGennaro et al., 2013; Joung and Sander, 2013; Smidler et al., 
2013; Bassett and Liu, 2014; Esvelt et al., 2014; Franz et al., 2014; Galizi et al., 2014; Oye 
et al., 2014; Reeves et al., 2014). Drosophila studies further benefit from genome wide 
microarray analysis for global transcriptional profiling as well as proteomic analysis to 
monitor protein-protein/ virus-host interactions, protein abundance and post-translational 
modifications. However, many of these technologies are yet to be fully implemented in 
mosquito research. In addition to advances in modern methods, progress in traditional 
molecular cell culture techniques (Fallon and Sun, 2001), as well as the adaptation of 
Drosophila cell-free systems for studying mosquito RNAi in vitro (Tuschl et al., 1999; 
Haley et al., 2003; Yang and Li, 2011; Vodovar et al.,2012) has initiated work into 
defining the complexities of mosquito immunity within controlled environments.  
Cell culture systems have been invaluable in the advancement of arboviral research and the 
study of host-virus interactions. Cell culture-based RNAi screening is widely used and 
many Drosophila cell lines are available (embryonic, larval, neuronal and haemocyte). 
They are easy to maintain and many are considered to be an accurate mimic of the whole 
organism environment. One cell culture system which has proved to be invaluable for 
mosquito RNAi research is the Ae. albopictus-derived C6/36 cell line generated from 
homogenised mosquito larvae (Igarashi, 1978). It was selected based on its ability to 
propagate chikungunya and dengue viruses to high titres. Since then it has been shown to 
be highly permissive to many virus infections and this has been linked to a deficiency in 
their RNAi pathway (Brackney et al., 2010; Scott et al., 2010; Morazzani et al., 2012). 
Studies into the biochemical nature of the Dcr-2 protein present in the C6/36 cell line 
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revealed that the dcr2 gene which encodes Dcr-2 is 79 % identical to that found in Ae. 
aegypti and is expressed at a reduced level in C6/36 cells compared to the Ae. aegypti-
derived Aag2 cell line; although, not significantly enough to explain the reduced immune 
response (Scott et al., 2010). Furthermore, dcr2 encoded by the C6/36 cell line is shown to 
contain a homozygous frameshift mutation due to the deletion of a single nucleotide at 
position 1508 (Scott et al., 2010). This results in a premature termination sequence and 
produces a truncated protein devoid of a fragment of the PAZ domain and both RNase III 
domains (Figure 5.1). However, even with this nonsense mutation, the full-length mRNA 
is detected in these cells suggesting that it has not been targeted for degradation as would 
be expected in the case of early translation termination (Harigaya and Parker, 2010). For 
this reason, the C6/36 cell line is not considered to be an accurate model for vector/virus 
interactions unlike a second Ae. albopictus-derived cell line, U4.4, which are known to be 
a suitable, true to life in vitro model which exhibit functional Dcr-2 activity and are RNAi 
competent (Davey and Dalgarno, 1974; Fragkoudis et al., 2008; Attarzadeh-Yazdi et al., 
2009; Vodovar et al., 2012; Léger et al., 2013). As such, the C6/36 and U4.4 cell lines can 
be used in parallel and provide an opportunity to investigate the role and importance of 
Dcr-2 in lieu of a complete Dcr-2 mosquito knockout; although, difficulties in comparing 
the results still exist.     
 
 
Figure 5.1: Schematic illustrations of the comparison between the Dicer-2 proteins from Ae. 
albopictus mosquitoes and the C6/36 derived cell line. The arrow indicates the point of mutation. 
DEAD, DExH/D protein family domain; Helicase, helicase domain; dsRNAb, dsRNA binding 
domain; PAZ, Piwi/Argonaute/Zwille domain; and two RNaseIII domains (Morazzani et al., 2012).  
 
Although antibodies have been developed against the key RNAi proteins in Drosophila 
(Liu et al., 2003; Miyoshi et al., 2005; Hammond et al., 2001) these have been lacking in 
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mosquito systems. Therefore, to add a further dimension to what is already understood 
from Drosophila, a major aim of this project was to generate a number of tools with which 
to answer many of the questions still to be solved in mosquitoes. In particular, a substantial 
number of unknowns regarding the kinetics and dynamics of Dcr-2 and Ago-2 exist. 
Therefore, the creation of antibodies against these proteins, as well as the production of 
recombinant- tagged enzymes, should facilitate a considerable contribution towards 
enhancing our awareness of the key principles involved in the antiviral innate immune 
response in mosquitoes. The currently employed plasmid expression systems are still weak 
and often unstable, resulting in the required use of viral vectors for protein expression; 
although, the development of sufficient plasmid vectors would be preferable. Advances in 
the capacities of these molecular tools will aid the characterisation of the mechanistic 
action leading to the degradation of viral RNAs. Understanding how these important 
processes are modulated should go some way to clarifying these and many other mysteries 
still surrounding the RNAi response in vectors of important human pathogens.   
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5.2 Objectives  
 
1. Generate and test antibodies designed to recognise Ae. aegypti Dicer-1, Dicer-2, 
Argonaute-1 and Argonaute-2 proteins. 
2. To generate recombinant Ae. aegypti Dicer-2 and Argonaute-2 proteins fused to 
molecular tags.  
2.1. Determine if these tagged constructs are expressed by Ae. aegypti and Ae. 
albopictus-derived cell lines and can be detected using an appropriate 
assay.  
2.2. Perform an in vitro dicer cleavage assay to ascertain if the Dicer-2 
construct is functional.  
2.3. Establish the kinetics of Dicer-2 during detection of viral dsRNA and 
determine when and how this occurs. 
3. Compare the efficiency of the Ae. aegypti polyubiquitin promoter with prevailing 
insect expression promoters. 
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5.3 Results  
 
5.3.1 Development of Antibodies Against Major RNAi Proteins  
It is commonly accepted that alien dsRNA is the trigger for the initiation of RNAi and that 
these molecules are a substrate for Dcr-2. However, there is a void in the information 
available regarding how, when and where Dcr-2 interacts with the dsRNA molecules, 
where the dsRNA comes from and how is it recognised. Furthermore, the kinetics of the 
subsequent protein-protein/protein-molecule interactions which complete the pathway are 
also currently unknown. To go some way towards answering these questions antibodies 
targeting the endogenous RNAi enzymes Ago-2 and Dcr-2 and the endogenous miRNA 
pathway proteins Ago-1 and Dcr-1 were designed and developed. Prior to this, no 
antibodies against these proteins in Ae. aegypti were available and their production would 
be a major advantage to the work carried out by the lab and the wider RNAi field by 
generating vital tools which would allow the properties of these poorly understood key 
enzymes to be elucidated. This work was gratefully funded by a Medical Research Council 
Centenary Award grant.  
Production of these antibodies was performed by Abmart (http://www.ab-mart.com) using 
their monoclonal SEAL™ (Protein Surface Epitopes Targeted by Monoclonal Antibody 
Library) technology. The library was specially designed against Ago-1 (XP_001662664), 
Ago-2 (ACR56327), Dcr-1 (AAW48724) and Dcr-2 (AAW48725) sequences from the Ae. 
aegypti genome. Six independent linear peptide antigens were selected based on 
algorithmic predictions from Abmart’s antigen design software. These were recommended 
as they were in agreement with a number of configuration and property criteria (Table 
5.1), in addition to the caveat that they could not recognise any of the other target proteins.  
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Table 5.1: Criteria used in Abmart validation of epitope selection. 
Parameter Specific Aspects 
Secondary Structure Loops 
Helixes 
Sheets  
Specific Regions N-Terminal  
C-Terminal  
Signal Peptide 
Trans-membrane domains  
Disordered Regions  
Solvent Accessibility  
BLAST Query species compared to mouse  
Amino Acid Properties Antigenic Enhancement Amino Acids 
Flexibility  
Evolution Positive Selection  
Discrimination 
Requests Protein Specificity  
Region Specificity 
 
 
The epitopes selected were all 10 amino acids long (see Page xix). Abmart cloned each 
into an expression vector that was transformed into bacteria and purified by Nickle-affinity 
chromatography by means of a polyhistidine (6 x His) affinity tag (Figure 5.2). Following 
purification the antigens were used to immunise three 8 - 12 week old female Balb/c mice. 
The mouse which presented the greatest immune response was sacrificed and its spleen 
cells isolated and fused with murine myeloma SP2/O cells to produce hybridomas. The 
cells were diluted and clones grown from single parent cells in hypoxanthine-aminopterin-
thymidine (HAT) medium in microtitre plates. Secreted antibodies were collected from 
each clone and analysed by enzyme-linked immunosorbent assay (ELISA) to determine 
their ability to recognise the target antigen. Clones were selected based on efficient 
antibody production and stability. Finally, the hybridomas were placed back into a mouse 
host by injection into the peritoneal cavity. The resulting tumours that developed 10 - 14 
days post injection contained antibody rich ascites fluid which was collected. The final 
antibodies were shipped to the UK as lyophilized ascite fluids along with the lyopholized 
decamer peptides. These were all restored in reconstitution buffer upon arrival in the lab 
(Table 5.2).      
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Figure 5.2: Schematic representation of the procedures involved in the production of the anti-
RNAi antibodies carried out by Abmart. Target epitopes were selected based on computational 
analysis and cloned into an expression vector containing a 6 x His tag. This allows peptide 
purification by Ni-affinity chromatography. Purified peptides were injected into mice hosts which 
were then sacrificed and their spleen cells harvested. Clonal hybridomas were generated and those 
which secreted the most antibodies were placed back into a mouse host. The fluid surrounding the 
resulting tumour was collected and delivered for testing.     
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Table 5.2: Selected epitopes for the production of antibodies against RNAi proteins. For each 
RNAi protein; Argonaute-1, Argonaute-2, Dicer-1 and Dicer-2, six target epitopes were selected 
for the immunisation of mice. Their sequence and position within the protein is noted. Antibodies 
capable of generating an immune response are indicated and these were collected for testing.    
Target 
Protein 
Accession 
Number 
Index Target Epitope 
Start 
amino 
acid  
End 
amino 
acid 
Successful 
production 
Argonaute- 
1 
XP_001662554 
1 EHDSGEGSHQ 909 918 
2 KKEQSGKSGN 808 817 
3 PVSTTAGAQN 66 75 
4 PPSPTQSQTS 15 24 
5 SNPRTDAKRT 38 47 
6 GVVPATPPAP 82 91 

Argonaute- 
2 
ACR56327 
1 QIRTEIQDGH 978 987   
2 IKIDKQKIHS 156 165   
3 KIHSSALLPV 162 171 
4 GQSWRPQSHD 117 126   
5 KDRPLNMNNL 961 970   
6 SHDPSPASGS 124 133   
Dicer-1  AAW48724 
1 PIKDPKEAEI 538 547 
2 KKMGLINKRR 2183 2192   
3 EMPPSETNKI 1258 1267   
4 KESDKSAAIE 1277 1286 
5 KPEKLADGRR 2138 2147 
6 QIVIENSEPR 871 880   
Dicer-2  AAW48725 
1 DDGKSTRSKH 939 948 
2 GKTINRPDPL 529 538 
3 KNDWQPPLAT 1255 1264   
4 RAAGSPKREP 1132 1141 
5 GQNKDDAKRA 1632 1641   
6 DVEYKERKGK 1014 1023 
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5.3.2 Dot Blot Analysis of Anti-Argonaute-1 Antibodies  
As the antigen peptides had also been received along with the antibodies designed to 
recognise them, a dot blot assay was performed. This is an efficient method for screening a 
large number of antibodies quickly. Only Ago-1 antibodies were screened using this 
method . The dot blot involved repeatedly spotting a small volume of sample (3 x 10 µl) 
onto a piece of membrane lining the bottom of a 96-well plate. The samples used for the 
dot blot screening were Aag2 cell lysates treated with either dsRNA against 1) Ago-1 or 2) 
eGFP (negative control). The results obtained from the cellular samples were compared to 
the supplied peptides used to generate each antibody. The cellular extracts were prepared 
by seeding Aag2 cells at a density of 1.8 x10
5 
cells/well in a 24-well plate. These were 
incubated for 24 h at 28 °C prior to transfection with 500 ng/well dsRNA specific to the 
appropriate sequence (Ago-1 or eGFP). Samples were incubated for a further 24 h before 
the cells were lysed with 100 µl/well passive lysis buffer and denatured prior to applying to 
the membrane. The peptide samples were expected to generate the strongest signal of the 
three reactions as they should be recognised explicitly. Each of the anti-Ago-1 antibodies 
tested were diluted as described for a Western blot procedure with identical incubation 
times. This was followed by primary antibody recognition with anti-mouse secondary 
antibodies and detection by chemiluminescence. Following antibody detection it was noted 
that there was no clear pattern of recognition and often the antibodies inconsistently gave a 
stronger signal in the dsRNA treated samples and a poor response to the peptide (Figure 
5.3). Following these results it was decided to forgo dot blot testing of the other supplied 
RNAi enzyme antibodies and each group of antibodies was analysed by Western blot 
analysis only.  
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Figure 5.3: Dot blot assay of Argonaute-1 antibodies. Ae. aegypti-derived Aag2 cells were 
treated with either specific dsRNA against eGFP (eGFP) or Ago-1 (Ago-1 knockdown). The cells 
were lysed and a small volume dropped onto squares of membrane and tested against the provided 
peptide (Peptide). Each antibody was applied to the membrane and detection was determined using 
anti-mouse secondary antibody and chemiluminescence.      
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5.3.3 RNAi Antibody Screening by Western Blotting    
All antibodies generated against Ago-1, Ago-2, Dcr-1 and Dcr-2 were tested to determine 
the degree of specificity against their target protein. Due to the large expected sizes of 
Ago-1, Ago-2, Dcr-1 and Dcr-2 (93, 114, 250, and 190 kDa respectively) pre-cast gradient 
(4 - 12 %) gels were used (Chapter 2.4.1). Protein electrophoresis was carried out to 
permit the separation of molecules of different sizes by initially passing a current of 100 V 
into the gel until samples left the wells whereafter it was increased to 120 V until the 
bromophenol blue dye front had run off the resolving gel. Proteins were transferred to a 
nitrocellulose membrane by wet transfer and blotted with antibodies diluted 1:100 to 
ensure maximum detection proficiency.   
To establish successful target recognition by anti-Ago-1 and anti-Dcr-1 antibodies Aag2 
cells were treated with dsRNA specific to the appropriate protein (Ago-1 or Dcr-1). The 
dsRNA used for the protein knockdowns has previously been shown to effectively target 
their specific transcripts (Chapter 3). Proficient detection could be determined by the 
disappearance of a band(s) at the expected weight in the knockdown samples compared to 
the controls. Aag2 cell samples were prepared as described previously (Chapter 5.3.2) 
with the exception that the cells were lysed with 100 µl/well 2 x Laemmli sample buffer 
and denatured prior to gel electrophoresis. Detection of Ago-1 by the 17 supplied 
antibodies revealed a potential specific band in five of the candidate antibodies; although, 
it was slightly higher (125 kDa) than the approximate size expected of 93 kDa (Figure 
5.4A). Many other non-specific bands were also observed and there was often no 
difference between the Ago-1 knockdown sample and the control sample, with the 
exception of some bands present in antibodies candidates ‘Ago-1/4.3’ and ‘Ago-1/4.4’.  
Of the eight antibodies received targeting Dcr-1 only one candidate was identified that 
produced a pronounced band at a compatible size (Figure 5.4B). However, this band was 
identified to be approximately 180 kDa, much smaller than the expected 250 kDa. As was 
observed following Ago-1 detection, the Dcr-1 blots produced a number of aspecific bands 
and no difference between the Dcr-1 knockdown and the control sample was evident.  
Antibodies specific to Dcr-2 and Ago-2 were tested by infecting BHK-21 cells with SFV1-
Dcr-2-mCherry and SFV1-Ago-2-ZsGreen VRPs (Chapter 5.3.4). BHK-21 cells were 
used as their genome does not present any putative regions corresponding to any of the 
antibody recognition sequences (Table 5.2) and so successful detection should only be 
evident in cells expressing the tagged proteins induced through infection. In addition, 
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expression of fluorescent proteins in both VRPs has also been demonstrated (Figure 5.8). 
BHK-21 cells were seeded at a density of 8 x10
4
cells/well in a 24-well plate and incubated 
for 24 h at 37 °C prior to infection with either SFV1-Dcr-2-mCherry or SFV1-Ago-2-
ZsGreen VRPs at an approximate MOI of 1 as described. Samples were incubated for a 
further 24 h before protein expression was confirmed by fluorescent microscopy. The cells 
were then lysed with 100 µl/well 2 x Laemmli sample buffer, denatured and run on a Bis-
Tris pre-cast gel. Regrettably, Abmart reported difficulties with the production of the Ago-
2 antibody library as many of the antigens selected failed to generate an immune response 
in the mice. As a consequence, only one of the six epitopes selected rendered any 
antibodies. Seven antibodies to this epitope were received and tested by Western blot as 
described (Figure 5.5A). Unfortunately, no evidence of purported recognition was evident 
for any of them.  
Confirmation of this result was investigated with the use of anti-ZsGreen antibodies. BHK-
21 samples infected with SFV1-Ago-2-ZsGreen were compared with those infected with 
SFV4-ZsGreen (virus), SFV1-ZsGreen (VRP) as positive controls. BHK-21 samples which 
had been mock infected were used as a negative control (Figure 5.5B). Detection with 
anti-ZsGreen antibodies is known to be lamentable and as a result is not commonly used 
for Western blot analysis. However, the results demonstrate that the anti-ZsGreen antibody 
produces a strong signal at a size consistent with that of ZsGreen (approximately 26 kDa) 
in the SFV4-ZsGreen and SFV1-ZsGreen samples. Although no band as vivid as those in 
the virus and VRP samples is detected there is a faint signal at that approximate expected 
weight of 140 kDa in the SFV1-Ago-2-ZsGreen, in addition to others at 30, 60, 70 and 190 
kDa, which are not seen in any of the other samples.  
Recognition of Dcr-2 by anti-Dcr-2 antibodies was tested by comparing the results with an 
anti-mCherry antibody (Figure 5.6). Although 10 antibodies were produced only two 
detected a pattern similar to that seen with the anti-mCherry control antibody. The SFV1-
Dcr-2-mCherry infected samples were also different from non-treated BHK samples, 
which is as expected as BHKs do not contain a corresponding sequence.  
From these results it was suggested that there were a total of eight antibodies which 
merited further examination and that there were potential candidates for the detection of 
each protein with the exception of Ago-2 (Table 5.3).   
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Figure 5.4: Detection of endogenously expressed Ae. aegypti Ago-1 and Dcr-1 in Ae. aegypti-
derived Aag2 cells. Ae. aegypti-derived Aag2 cells samples were either transfected with dsRNA 
against A) Ago- 1 (Ago-1 knockdown), B) Dcr-1 (Dcr-1 knockdown) or control eGFP (eGFP). 
Ago-1 protein size was expected to be approximately 93 kDa while Dcr-1 protein size was 
expected to be approximately 250 kDa. Potential target recognition was achieved by antibodies 
designated Ago-1/2.2, Ago-1/3.2, Ago-1/3.4, Ago-1/4.3, Ago-1/4.4 and Dcr-1/5.1. Unsuccessful 
antibody detections are not shown. Protein antibodies were recognised by an anti-mouse secondary 
antibody and detected by chemiluminescence. Arrows indicate potential protein band weights.     
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Figure 5.5: Detection of over-expressed Ae. aegypti Ago-2 in BHK-21 cells. A) BHK-21 cells 
were either transfected with SFV1-Ago-2-ZsGreen RNA or were mock transfected (Mock). The 
protein size was expected to be approximately 140 kDa. No potential target recognition was 
achieved by any of the anti-Ago-2 antibodies tested. B) Detection of ZsGreen in SFV infected 
BHK-21 cells. BHK-21 cells were either infected with SFV4-ZsGreen (virus) or SFV1-ZsGreen 
(VRP). These were compared to cells infected with SFV1-Ago-2-Zsgreen VRPs and a mock 
infected BHK cell sample (Mock) was used as a negative control. Cleaved ZsGreen was expected 
to be 26 kDa and was detected by an anti-ZsGreen antibody. All primary antibodies were 
recognised by an anti-mouse secondary antibody and detected by chemiluminescence. Arrows 
indicate protein band weights.               
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Figure 5.6: Detection of over-expressed Ae. aegypti Dicer 2 in BHK cells by Western blot 
analysis. BHK-21 cells were either transfected with SFV1-Dcr-2-mCherry RNA or were mock 
transfected (Mock). The size expected for Dcr-2-mCherry was approximately 218 kDa. Potential 
target recognition was achieved by antibodies designated Dcr-2/4.2 and Dcr-2/4.3. Unsuccessful 
antibody detections are not shown. A band was detected with both anti-Dcr-2 antibodies at a 
similar weight for that detected using the anti-mCherry antibody. However, this was lower than 
expected at approximately 160 kDa. All primary antibodies were recognised by an anti-mouse 
secondary antibody and detected by chemiluminescence. An arrow indicates the potential protein 
band weight.      
 
  
Chapter 5                                      The development of novel tools to enhance understanding  
   of the RNAi response in mosquitoes 
 
179 
 
Table 5.3: Successful antibody candidates as determined by Western blot analysis. 
Target protein 
Epitope target 
Epitope 
Index 
Antibody 
designation 
Successful 
detection (predicted weight) 
Argonaute-1 
EHDSGEGSHQ 1 
Ago-1/1.1 
 
Ago-1/1.2 
 
KKEQSGKSGN 2 
Ago-1/2.1 
 
Ago-1/2.2 
Ago-1/2.3 
 
PVSTTAGAQN 3 
Ago-1/3.1 
 
Ago-1/3.2 
Ago-1/3.3 
 
Ago-1/3.4 
(93 kDa) 
PPSPTQSQTS 4 
Ago-1/4.1 
 
Ago-1/4.2 
 
Ago-1/4.3 
Ago-1/4.4 
Ago-1/4.5 
 
Ago-1/4.6 
 
SNPRTDAKRT 5 
Ago-1/5.1 
 
Ago-1/5.2 
 
Argonaute-2 
KIHSSALLPV 3 
Ago-2/3.1 

Ago-2/3.2 

Ago-2/3.3 

(114 kDa or  
140 kDa  
fused to ZsGreen) 
Ago-2/3.4 

Ago-2/3.5 

Ago-2/3.6 

Ago-2/3.7 

Dicer-1 
PIKDPKEAEI 1 
Dcr-1/1.1 

Dcr-1/1.2 
 
KESDKSAAIE 4 Dcr-1/4 
 
KPEKLADGRR 5 
Dcr-1/5.1 
(250 kDa) Dcr-1/5.2 
 
Dcr-1/5.3 
 
Dcr-1/5.4 
 
Dcr-1/5.5 
 
Dicer-2 
DDGKSTRSKH 1 Dcr-2/1 
 
GKTINRPDPL 2 
Dcr-2/2.2 
 
Dcr-2/2.1 
 
RAAGSPKREP 4 
Dcr-2/4.1 
 
Dcr-2/4.2 
(190 kDa or  
218 kDa  
fused to mCherry) 
Dcr-2/4.3 
Dcr-2/4.4 
 
Dcr-2/4.5 
 
Dcr-2/4.6 
 
DVEYKERKGK 6 Dcr-2/6 
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5.3.4 Recombinant Dicer-2 and Argonaute-2 for in vitro Visualisation  
As the experiments described previously suggest that the antibodies designed against 
endogenous RNAi proteins were largely unsuccessful, an alternative strategy was devised 
to produce recombinant forms of Dicer-2 (Dcr-2) and Argonaute-2 (Ago-2). These were 
first produced fused to fluorescent tags to allow the spatial and temporal properties of both 
proteins following a viral infection to be investigated. In this way, the stage of acute 
infection that Dcr-2 is able to interact with its substrate within the viral replication 
complexes and the involvement of the silencer protein Ago-2 could be studied. This was 
achieved by using the known Ae. aegypti Dcr-2 (AAW48725) and Ago-2 (ACR56327) 
sequences.  
Dcr-2 was acquired from ShineGene Molecular Biotech Inc. (Shanghai, China) fused to the 
mCherry sequence (AY678264) on the carboxyl (C-) terminus. The mCherry protein is 
known to be monomeric and photostable. It was selected as it had been shown to be 
unobtrusive and did not interfere with protein folding (Graewe et al., 2009; Kümmerer et 
al., 2012). The Dcr-2-mCherry fusion was inserted into the pIB/V5-His vector under the 
control of the OpIE2 promoter. This immediate-early (IE) promoter is derived from the 
baculovirus Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus (OpMNPV) 
which naturally infects the Douglas fir tussock moth and is known to be an efficient 
promoter for gene expression in insect cells, including mosquito cell cultures (Pfeifer et al., 
1997; Massotte et al., 2003; Xu et al., 2008; Paradkar et al., 2014). Early experiments 
performed with this construct did not result in any detectable expression of the mCherry 
tag in either Ae. aegypti-derived Aag2 cells, Ae. albopictus-derived U4.4 cells or the 
mammalian BHK-21 cell line (Donald, 2010). It was suggested that due to the extensive 
size of Dcr-2 a lack of expression could be explained by incomplete 
transcription/translation, erroneous protein folding or reduced stability. Consequently, it 
was decided to use a stronger expression system to establish if this enhanced protein 
expression levels. One suggested to be a suitable alternative was to place the tagged 
protein behind the subgenomic promoter within the SFV genome and use the virus 
infection to express the proteins. For this to be achieved the pIB-Dcr-2-mCherry construct 
was sent to the lab of Prof. Andres Merits (Institute of Technology, University of Tartu, 
Estonia) for cloning into the backbone of SFV replicating particles (VRPs) (Figure 5.7A). 
The Ae. aegypti sequence for Ago-2 was also provided for fusion to the ZsGreen sequence 
(AFD54300), again on the C- terminus. ZsGreen was preferred over eGFP due to its 
superior brightness (Bell et al., 2007; Nakamura et al., 2013). Unlike Dcr-2-mCherry, Ago-
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2-ZsGreen was not cloned into pIB/V5-His but directly inserted into SFV1. It was first 
necessary to modify the original SFV1 plasmid to permit the insertion of both RNAi 
enzymes. This was achieved by inserting two restriction endonuclease recognition sites 
(NruI and SpeI) subsequent to the subgenomic promoter. In addition, as the SpeI cleavage 
sequence was previously used to linearise the plasmid after the poly (A) tail for in vitro 
transcription, this was replaced by the PacI recognition sequence. The constructs fused to 
their respective fluorescent tags were inserted in place of the viral structural proteins, 
although, the non-structural proteins remain in situ. This cloning was gratefully carried out 
by Margit Ool (Institute of Technology, University of Tartu, Estonia) (Figure 5.7B).  
Following the receipt of both SFV1-Dcr-2-mCherry and SFV1-Ago-2-ZsGreen it was first 
necessary to establish if the recombinant RNAi enzymes could be expressed under the SFV 
subgenomic promoter in BHK-21 cells. Cells were seeded at a density of 8 x 10
4
 cells/well 
in a 24-well plate and incubated for 24 h prior to transfection with approximately 4 µg in 
vitro transcribed RNA for either SFV1-Dcr-2-mCherry or SFV1-Ago-2-ZsGreen. Cells 
were incubated for a further 24 h period before they were fixed and fluorescence observed 
with the Zeiss 710 confocal microscope (Figure 5.8). Successful expression was observed 
following transfection with both constructs suggesting that the SFV subgenomic promoter 
was able to express both complete protein sequences in BHK-21 cells. SFV1-Dcr-2-
mCherry and SFV1-Ago-2-ZsGreen could then be used to induce protein expression 
following VRP infection. 
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Figure 5.7: SFV replicons expressing Aedes aegypti RNAi genes, Dicer-2 and Argonaute-2 
after the subgenomic promoter. A) Each protein is further labelled with a fluorophore, mCherry 
or ZsGreen respectively on the C terminus, for protein detection by confocal microscopy. The 
white arrow represents the genomic promoter while the grey arrow represents the subgenomic 
promoter. B) The original SFV plasmid was modified to allow insertion of the recombinant 
proteins. SP6, SP6 promoter; nsP1-4 non-structural proteins 1-4; SGP, subgenomic promoter.     
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Figure 5.8: BHK-21 cells expressing tagged Ae. aegypti RNAi proteins. BHK-21 cells were 
transfected with either in vitro transcribed A) SFV1-Dcr-2-mCherry or B) SFV1-Ago-2-ZsGreen 
capped RNA. Fluorophore expression is detected with a Zeiss 710 confocal microscope. Red, 
SFV1-Dcr-2-mCherry; Green SFV1-Ago-2-ZsGreen. Scale bars indicate 10 μm.  
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Production of the SFV VRPs required the VRP RNA to be combined with RNA encoding 
only the viral structural proteins (as described in Chapter 2.5.2 and Figure 5.9). There 
were two options available for delivery of the structural proteins; either by the helper 
system (using the Helper 1 plasmid providing all of the structural proteins; C-E3-E2-6K-
E1) (Berglund et al., 1993), or the split helper system (were the capsid and envelope 
glycoproteins are separately encoded by different plasmids) (Smerdou and Liljestrom et 
al., 1999). As the replicon RNA is encoded separately from the structural proteins VRPs 
are unable to produce viral progeny which could be released and cause a productive 
infection. Although the split helper system reduces the risk of viral recombination and the 
potential production of infectious viral particles observed when using the Helper 1 system 
(Berglund et al., 1993), this was not deemed to be important for the expression of the 
recombinant proteins and single helper system (the Helper 1 plasmid) was used for SFV1-
Dcr-2-mCherry and SFV1-Ago-2-ZsGreen production. Both plasmids were linearised with 
the appropriate restriction endonuclease, in vitro transcribed and capped prior to combining 
the RNAs for joint electroporation into BHK-21 cells (Figure 5.9).  
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Figure 5.9: Schematic representation of the production of Virus Replicating Particles (VRPs) 
using the Helper 1 plasmid system. The Helper 1 plasmid encodes the capsid and glycoproteins 
(C, E3, E2, 6K and E1) and is first linearised prior to capping and in vitro transcription from the 
SP6 promoter alongside the replicase plasmid which contains the non-structural proteins as well as 
the required foreign gene of interest. The two RNAs are combined and electroporated into BHK-21 
cells and VRPs are produced into the supernatant.  
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SFV1-Dcr-2-mCherry and SFV1-Ago-2-ZsGreen VRPs were produced and used to infect 
both Aag2 and C6/36 mosquito cells. As both protein sequences were taken from the Ae. 
aegypti genome, it was important to confirm that expression was observed in an Ae. 
aegypti-derived cell line. Although there are several Ae. aegypti-derived cell lines, the lab 
has a substantial level of experience in the handling and maintenance of the Aag2 line and 
so this cell line was selected. In addition, as previously discussed the C6/36 cell line 
provides an ideal system for determining the function of the recombinant Dcr-2 construct 
as a result of its Dcr-2/RNAi null phenotype (Brackney et al., 2010; Scott et al., 2010; 
Morazzani et al., 2012). The production of the VRPs consistently resulted in a very low 
titre (approximately 2 x 10
6 
- 1.5 x 10
8 
pfu/ml) (calculated as described in Chapter 2.5.4). 
Moreover, as the TNE buffer used to re-suspend the VRPs was toxic to the cells when 
applied directly, the VRP suspension was required to be diluted in sPBSA to protect cell 
viability. Therefore, the final MOI used for each experiment was approximately 1 although 
a higher MOI would have been preferred to target the greatest number of cells.  
Aag2 and C6/36 cells were seeded at a density of 1.8 x 10
5
 and 1.2 x 10
5
 cells/well 
respectively in a 24-well glass bottom plate 24 h prior to infection with either SFV1-Dcr-2-
mCherry or SFV1-Ago-2-ZsGreen VRPs. Cells were incubated at 28 °C for a further 24 h 
post infection before they were fixed and immunostained with an antibody against SFV-
nsP3. As preliminary results suggested that the titre of the VRPs was lower than 
anticipated, immunostaining with SFV-nsP3 was done to establish if there was a difference 
between the number of cells which had been infected with the SFV VRPs compared to the 
number expressing either of the recombinant proteins. Detection of SFV-nsP3 was done 
using an anti-mouse secondary antibody conjugated to a fluorophore of a different 
wavelength from the fluorophore tag. In this way when Dcr-2-mCherry was observed (594 
nm), nsP3 was identified with a secondary antibody detected at 488 nm and vice versa 
when Ago-2-ZsGreen (488 nm) was visualised. Finally, a coverslip was mounted using 
DAPI mounting media to allow the cell nucleus to be discerned. The results indicate that 
for both Aag2 and C6/36 cell lines (Figure 5.10 and 5.11) expression of both fluorescently 
tagged constructs is evident. However, in both cases the staining for SFV-nsP3 was more 
wide spread than the signal for the recombinant protein for both cell types (Table 5.4).    
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Table 5.4: Percentage of expression of labelled RNAi protein in comparison to SFV nsP3 
staining in Aag2 and C6/36 cell types. 
 SFV1-Dcr-2-mCherry SFV1-Ago-2-ZsGreen 
Cell type Anti-nsP3 Dcr-2-mCherry Anti-nsP3 Ago-2-ZsGreen 
Aag2 80 % 16 % 87 % 5 % 
C6/36 99 % 33 % 96 % 17 % 
 
With the success of Dcr-2-mCherry and Ago-2-ZsGreen expression from SFV1 VRPs, this 
system could be further optimised and used to establish adequate protein function.     
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Figure 5.10: Aag2 and C6/36 cell lines expressing Dicer-2-mCherry. Confocal microscopy 
images of the Ae. aegypti–derived Aag2 and Ae. albopictus-derived C6/36 cell lines infected with 
SFV1-Dcr-2-mCherry VRPs. Mock infected samples (Neg Merge) were included as a negative 
control. Immunostaining was also carried out to detect SFV-nsP3 and nuclear staining was 
recognised by DAPI expression. Blue, DAPI; Green, SFV-nsP3; red, Dcr-2-mCherry. Scale bars 
indicate 10 μm.    
 
 
 
 
Figure 5.11: Aag2 and C6/36 cell lines expressing Argonaute-2-ZsGreen. Confocal microscopy 
images of the Ae. aegypti–derived Aag2 and Ae. albopictus-derived C6/36 cell lines infected with 
SFV1-Ago-2-ZsGreen VRPs. Mock infected samples (Neg Merge) were included as a negative 
control. Immunostaining was also carried out to detect SFV-nsP3 expression and nuclear staining 
was recongised by DAPI expression.  Blue, DAPI; Green, SFV-nsP3; red, Dcr-2-mCherry. Scale 
bars indicate 10 μm.   
  
DAPI Dcr-2-mCherrySFV-nsP3 Merge Neg Merge
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5.3.5 Assessing the Function of Recombinant Dicer-2 in C6/36 Cells  
To establish the functionality of the recombinant Dcr-2-mCherry construct the C6/36 cell 
line was used. Natural function of the recombinant Dcr-2 would be confirmed if the cell 
line’s ability to cleave long dsRNA molecules into shorter 21 nt siRNA molecules could be 
recovered. To establish if expression of the Dcr-2-mCherry fusion in the C6/36 cell line 
was able to restore active Dcr-2 processing an in vitro dicer cleavage assay was performed. 
This assay is well established in the literature (Matranga et al., 2005; Vermeulen et al., 
2005; Iwasaki et al., 2010; Yoda et al., 2010; Nayak and Andino, 2011; Yang et al., 2011; 
van Mierlo et al., 2012; Vodovar et al., 2012) but has not previously been used in the lab. 
To first optimise the assay it was carried out using Drosophila embryo extracts gratefully 
provided by Joël T van Mierlo (Department of Medical Microbiology, Nijmegen Center 
for Molecular Life Sciences, University Medical Center Nijmegen, The Netherlands). The 
results were compared to those of Drosophila-derived S2 cells which are also known to 
efficiently process dsRNA in this assay. Confirmation of dsRNA cleavage was achieved 
using internally [
32
P] UTP-labelled dsRNA molecules. The S2 cellular extracts were 
prepared by seeding the cells in a 6-well plate at a density of 1 x 10
6
/well. Following an 
incubation of 24 h at 28 °C, the cells were lysed with 1 x lysis buffer to disrupt the cell 
membranes. Embryo extracts were prepared as previously described (Haley et al., 2003; 
van Mierlo et al., 2012). The samples received 16.2 pCi of radio-labelled dsRNA and were 
incubated overnight at 28 °C before the RNA was isolated, purified and loaded onto a 
denaturing gel. (Figure 5.12A). The size of the fragments generated was determined by a 
comparison to size markers; input dsRNA (114 nt) and siRNAs (21 nt). The input dsRNA 
was purified alongside the samples in a cell-free reaction. From the images generated it can 
be concluded that the assay was successful as both the cell and embryo extracts showed 
efficient cleavage of dsRNA into shorter RNAs of approximately 21 nt as determined by 
the siRNA size marker.  
Once the assay was successfully established it was subsequently repeated involving 
extracts derived from both C6/36 and U4.4 Ae. albopictus cell lines. U4.4 cells are known 
to be RNAi competent and produce 21 nt siRNAs which can be detected by this assay 
(Vodovar et al., 2012). Extracts from these cells were left untreated and were used as a 
positive control alongside samples from C6/36 cells which were either infected with SFV1-
Dcr-2-mCherry or SFV1-ZsGreen VRP (as a negative control) or were untreated. If the 
Dcr-2-mCherry fusion was functional then a difference would be expected to be observed 
between the C3/36 sample which obtained Dcr-2-mCherry compared to those were only 
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the natural truncated form was present. Both cell lines were seeded at a density of 8 x 
10
5
/well in a 6-well plate and the lysate prepared 24 hpi as described previously. Image J 
analysis was used to quantify the total of dsRNA and siRNAs present (Figure 5.12C). The 
total quantity of nucleic acids in each lane from three experiments was measured and set to 
100 %. The band density of the cleaved dsRNA was then measured as a percentage of this.   
It was observed that as expected no strong band was detected in the C6/36 untreated 
sample (Figure 5.12B). Although there was a discernible band detected for the C6/36 
sample infected with SFV1-Dcr-2-mCherry, this also appeared in the sample infected with 
the control SFV1-ZsGreen VRP. Therefore, these results do not allow us to conclude that 
the recombinant Dcr-2 is functional. The presence of the tag could be disrupting the ability 
of the enzyme to function correctly suggesting further adjustments are required. In 
addition, only a very faint band was detected for the U4.4 sample signifying it was not as 
successful as had been anticipated.        
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Figure 5.12: Processing of long dsRNA molecules into 21 nt siRNAs detected by an in vitro 
dicer cleavage assay. Cellular extracts were prepared from A) Drosophila embryos and 
Drosophila S2 cells or B) Ae. albopictus-derived U4.4 cells, in addition to extracts from C6/36 
cells which were either untreated or infected with SFV1-Dcr-2-mCherry or SFV1-ZsGreen. 
Extracts were incubated with [
32
P] internally radio-labelled 114 nt dsRNA. A size marker of [
32
P] 
radio-labelled 21 nt siRNA was also loaded. This image is a representative of three experiments. C) 
Image J analysis quantifying the percentage of cleaved dsRNAs. Error bars show the standard 
deviation of three independent experiments performed in triplicate.    
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5.3.6 Expression of Dicer-2 Using a Cell-Free System  
In addition to functional protein production through plasmid amplification in bacteria and 
expression in cells in culture, cell-free systems are an alternative opportunity to produce 
and purify proteins for characterisation. The advantages of cell-free systems include; 1) the 
capacity to produce large quantities of functional protein in a short space of time, reduced 
from days to hours; 2) coupled lysate reactions incorporating both transcription and 
translation stages into one reaction greatly simplifying production; 3) proteins can be 
produced directly from linear PCR products reducing the time and challenges associated 
with sub-cloning; and 4) detection can be performed immediately due to direct co-
translational labelling during synthesis (Figure 5.13). This system was not yet established 
in the lab but was chosen to assist with Dcr-2-mCherry expression and for the development 
of a new strategy for protein production in the future. If successful it would allow 
complications with SFV1-Dcr-2-mCherry to be bypassed by removing the difficulty of 
expressing an antiviral protein within a viral backbone. 
 Although several systems are available for protein production (E.coli, Wheat Germ and 
Spodoptera frugiperda), the rabbit reticulocyte method was selected. This native 
mammalian set up is recommended for its ability to efficiently produce full-length protein 
sequences downstream from either T7, T3 or SP6 RNA polymerase promoter sequence 
sites. A study of the literature and company websites showed that there was no difference 
between the three promoters. On that basis the SP6 promoter was selected as it is well used 
in the lab for the in vitro transcription of SFV plasmids. In addition, cloning Dcr-2-
mCherry between the SP6 promoter sequence and a poly(A) tail of the pSP64 Poly(A) 
vector has been reported to improve stability and enhance translation (Jackson and 
Standart, 1990). The cloning strategy used is illustrated in Figure 5.14 and the correct 
plasmid sequence was confirmed by both restriction digestion and sequencing. Protein 
translation was performed by combining the required components into a single tube as 
described in Chapter 2.4.3 and incubating at 30 °C for 90 min. A positive control SP6 
plasmid encoding the Fluc gene was supplied in the Promega kit and was also included to 
confirm the functionality of the assay. Detection of successful gene expression was 
permitted by the incorporation of [
35
S] methionine into the protein products. The lysate 
was diluted to three different concentrations prior to loading onto a 4 - 12 % Bis-Tris gel to 
prevent the large protein aggregations collecting in the wells of the gel and restricting 
movement into the gel. Although strong bands are clearly distinguished in all of the control 
plasmid dilutions, there is no signal at any of the concentrations of the SP6-Dcr-2-mCherry 
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sample (Figure 5.15). Unfortunately, it can be concluded that this assay requires further 
optimisation which was not able to be completed within the timescale of this project.               
As a result of the findings so far it can be concluded that expression of Dcr-2-mCherry, as 
well as Ago-2-ZsGreen, is only achieved when the proteins are present within the 
backbone of SFV VRPs. However, the in vitro dicer cleavage assay has shown that the 
Dcr-2-mCherry appears not to be functional. Therefore, further adaptations are required to 
optimise successful production of functional RNAi enzymes for investigative studies.  
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Figure 5.13: Schematic representation of the TNT rabbit reticulocyte lysate system. The Ae. 
aegypti Dcr-2-mCherry recombinant protein was inserted into the pSP64 Poly (A) vector after the 
SP6 gene promoter and ahead of the Poly(A) tail sequence. All the required components are 
combined in a single tube, including [
35
S] methionine, and incubated for 90 min at 30 °C. The 
samples can then be analysed by gel electrophoresis and exposed to a phosphorimaging screen.     
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Figure 5.14: Schematic illustration of the insertion of Dcr-2-mCherry from the pIB/V5-His 
vector into the pSP64 Poly (A) vector. This was done after the SP6 gene promoter sequence for 
expression in the TNT rabbit reticulocyte lysate protein production system.   
 
 
Figure 5.15: Production of the mCherry tagged Ae. aegypti Dcr-2 protein by TNT rabbit 
reticulocyte lysate expression. The SP64-Dcr-2-mCherry plasmid was mixed with the TNT 
coupled rabbit reticulocyte lysate system, including radio-labelled [
35
S] methionine. A control SP6 
plasmid expressing Fluc was used for comparison. Both samples were tested at decreasing 
concentrations and detected by exposing to a phosphoimaging screen.       
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5.3.6 Further Developments in Dicer-2 Cloning  
To circumvent some of the challenges encountered when designing a fluorescent Dcr-2 
reporter protein, a second approach was investigated. A potential pitfall was identified that 
the fluorescent tags were not sufficiently discrete as to allow for correct protein folding and 
that a smaller tag may bypass this issue. Therefore, the V5 epitope tag was selected (Table 
5.5). This 14 amino acid peptide is derived from an epitope of the paramyxovirus simian 
virus 5 (SV5) located on the P and V proteins and is a widely used tag for immunostaining, 
immunoprecipitation and Western blotting (Cornwell and Kirkpatrick, 2001; Horng and 
Medzhitov, 2001; Kaneko et al., 2006; Lipardi and Paterson, 2009; van Cleef et al., 2014; 
van den Beek et al., 2014; van Mierlo et al., 2014).  
 
Table 5.5: Nucleotide and corresponding amino acid sequence for the V5 tag. See Page 
xix for amino acid codes. 
 V5 epitope tag sequence 
Single Letter 
Code 
N-GKPIPNPLLGLDST-C 
Triple Letter 
Code 
N-Gly-Lys-Pro-Ile-Pro-Asn-Pro-Leu-Leu-Gly-Leu-Asp-Ser-Thr-C 
Nucleotide 
Sequence 
5’GGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACG 3’ 
 
As V5 is approximately 5 kDa, it is substantially smaller than both ZsGreen (26 kDa) and 
mCherry (28 kDa). Primers were designed which allowed the removal of the fluorescent 
tag and its replacment with the V5 tag either on the amino (N-) or C- terminals of Dcr-2 
within the pIB/V5-His vector (Figure 5.16 and Chapter 2.9). Sequencing the cloning 
products confirmed the sequences were correct. Initial experiments were performed using 
Aag2 and C6/36 cell lines seeded at a density of 1.8 x 10
5
 and 1.2 x 10
5
 cells/well 
respectively in 24-well plates 24 h prior to transfection with 500 ng/well of either pIB-Dcr-
2-V5/C or pIB-Dcr-2-V5/N. Cells were incubated at 28 °C for 24 h before they were lysed 
directly in 100 µl/well 2 x Laemmli sample buffer. Samples were denatured by heating to 
100 °C for 10 min prior to loading 30 µl into a self-made 10 % acrylamide gel for Western 
blot analysis. A positive control was also included courtesy of Dr. Ben Hale (CVR, 
University of Glasgow) consisting of a sample of MDCK cells which stably expressed the 
SV5 V protein (Hale et al., 2010). Protein detection was achieved using an anti-V5 
antibody. This interaction was then recognised with an anti-mouse secondary antibody and 
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detected by chemiluminesence. Following anti-V5 antibody detection, a large band is 
present at 25 kDa in the MDCK V5+ sample in agreement with the expected size of the 
complete V5 protein (Figure 5.17). Although the predicted size of Dcr-2-V5 is 195 kDa, 
no band is apparent in any of the samples at this weight and all samples resembled non-
transfected controls. The only band detected was present at the expected size for bovine 
serum albumin (BSA).  
To further confirm the suggestion that this finding is due to the insufficient strength of the 
OpIE2 promoter for expression of the tagged Dcr-2 to a sufficient concentration for 
Western blot analysis, the two Dcr-2-V5 sequences were transfected into Spodoptera 
frugiperda-derived Sf21 cells. These cells are known to be a good expression system for 
baculovirus promoters and would be the best candidate for successful expression of the 
recombinant proteins. Sf21 cells were seeded at a density of 2 x 10
5
 cells/well in a 24-well 
plate and transfected using Fectofly™ (Polyplus Transfection), a DNA specific 
transfection reagent, following the manufacturer’s instructions. Briefly, cells were allowed 
to settle for 2 h at 28 °C prior to preparing 2 µg of DNA with 50 µl 150 mM NaCl and 2 µl 
of Fectofly with 50 µl 150 mM NaCl. Four plasmids were used for this experiment; pIB-
Dcr-2-V5/N, pIB-Dcr-2-V5/C, pIB-eGFP and pIB-Dcr-2-mCherry. Both V5 tagged 
proteins were included for detection by Western blot analysis while the fluorescent 
plasmids were used for visualisation by fluorescent microscopy. The total volume of 
Fectofly/NaCl mix was added to the total volume of the DNA/NaCl mix, vortexed for 10 
sec and incubated for 30 min at room temperature. The total volume of 100 µl/well was 
added dropwise to the cell monolayer and the plates rocked gently to ensure an even 
distribution of the DNA complexes. The plates were then incubated for 4 h ahead of 
replacing the media with 1 ml of fresh growth media. Finally, the cells were incubated for 
a further 48 h and expression of pIB-eGFP and pIB-Dcr-2-mCherry was determined by 
visualising with a Zeiss Axiovert S100 microscope.  
Expression of the pIB-eGFP could be observed; although, pIB-Dcr-2-mCherry could not 
be detected (data not shown). Western blot analysis was carried out by lysing the pIB-Dcr-
2-V5/N and pIB-Dcr-2-V5/C transfected samples in 100 µl/well 6 x loading buffer and 
denaturing them prior to loading onto a home-made acrylamide gel. As before protein 
electrophoresis was carried out until the 25 kDa band marker approached the end of the gel 
before wet transfer was performed. Detection by anti-V5 antibody was carried out as 
described previously. The anticipated size for Dcr-2-V5 is 195 kDa; although, this was not 
observed for either pIB-Dcr-2-V5/C and pIB-Dcr-2-V5/N (Figure 5.18). A faint band was 
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observed for the sample transfected with pIB-Dcr-2-V5/C; however, this appears at 
approximately 90 kDa, much lower than the predicted size of 195 kDa. This strongly 
suggests that the OpIE2 promoter is not adequate to produce the tagged Dcr-2. 
As a result the V5 tagged proteins were further cloned into the modified SFV1 plasmid 
received from Prof. Andres Merits (Institute of Technology, University of Tartu, Estonia), 
described in Chapter 5.3.4. The Ago-2-ZsGreen was modified using the same protocol as 
Dcr-2-mCherry to generate Ago-2-V5/N and Ago-2-V5/C. Insertion of both Ago-2-V5 and 
Dcr-2-V5 proteins was achieved by digesting the modified pSFV1 with NruI and SpeI. Due 
to the presence of one or both of these restriction endonuclease sites within the Ago-2-V5 
and Dcr-2-V5 sequences, they were digested from the pJet1.2/blunt vector, into which they 
had been previously subcloned, with either NruI and XbaI or HindIII and XbaI respectively 
(Figure 5.19 and 5.20). Ligation of Ago-2-V5 could be carried out directly as the XbaI site 
is compatible to the SpeI site. Dcr-2-V5 was first required to be treated with Klenow which 
has 3’→5’ exonuclease activity and removes the overhanging nucleotides from the 3’ end 
and generates a blunt end which is able to pair with the blunt end produced by digestion 
with NruI. Unfortunately, successful cloning of SFV1- Dcr-2-V5/N or SFV1- Dcr-2-V5/C 
was not completed within the timeframe of the project. Conversely, both SFV1-Ago-2-
V5/N and SFV1-Ago-2-V5/C were produced and their sequences confirmed by restriction 
digestion and sequencing before being carried forward for Western blot analysis. The size 
of Ago-2-V5 was predicted to be 119 kDa.  
To establish if the Ago-2-V5 constructs could be detected with anti-V5 antibody, BHK-21 
cells were seeded at a density of 8 x 10
4
 cells/well in a 24-well plate and transfected with 
the in vitro transcribed, capped RNA of either SFV1-Ago-2-V5/N, SFV1-Ago-2-V5/C, 
SFV1-Ago-2-ZsGreen (negative control) or were mock transfected. The cells were 
incubated at 37 °C for 24 h before they were lysed by the addition of 100 µl/well 2 x 
Laemmli sample buffer, denatured and run on a pre-cast Bis-Tris gradient gel. Wet transfer 
was again implemented for transport of the protein molecules to the membrane. As before, 
MDCK control samples were used to confirm successful antibody detection of the V5 
epitope. As predicted the MDCK V5+ sample gave a very strong band at the approximate 
size of the V5 protein which was not present in the V5- control sample (Figure 5.21). 
Samples transfected with SFV1-Ago-2-V5/C showed a very strong signal which was 
slightly higher than the expected size of 119 kDa. However, several other bands were also 
present and these are most likely to be degradation products. In contrast, the sample which 
received SFV1-Ago-2-V5/N produced one specific band which, although fainter than that 
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seen in the SFV1-Ago-2-V5/C sample, was unique to that sample. Samples which had 
received SFV1-Ago-2-ZsGreen or were mock transfected showed no strong bands 
although a faint, non-specific signal can be perceived at approximately 30 kDa in the 
SFV1-Ago-2-ZsGreen sample. These results indicate that expression of the tagged Ago-2 
is achieved when placed behind the subgenomic promoter of SFV. 
Successful completion of both SFV1-Dcr-2-V5 and SFV1-Ago-2-V5 cloning may permit 
correct folding and functional expression to be achieved; however, the issue of expressing 
an antiviral protein within a viral backbone still exists which is required to be addressed.  
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Figure 5.16: Schematic illustration of Dcr-2-V5 cloning into pIB/V5-His. The insertion of A) 
Dcr-2-V5/C or B) Dcr-2-V5/N from the sub-cloning vector pJet1.2/blunt into pIB/V5-His after the 
OPIE2 gene promoter sequence.   
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Figure 5.17: Expression of V5 tagged Ae. aegypti Dcr-2 protein from pIB/V5-His plasmid in 
C6/36 and Aag2 cells. Ae. aegypti-derived Aag2 cells and Ae. albopictus-derived C6/36 cells were 
transfected with either plasmid encoding Dcr-2 with the V5 tag on the C- (V5/C) or the N- 
terminus (V5/N). Mock transfected cells (NTC) were used as a negative control while MDCK cell 
samples constituently expressing the V5 protein were used as a positive control. Protein expression 
was detected with an anti-V5 antibody by Western blot analysis and chemiluminescence. Arrow 
indicates the expected protein weight. 
 
 
Figure 5.18: Expression of V5 tagged Ae. aegypti Dcr-2 protein from pIB/V5-His plasmid in 
Sf21 Spodoptera frugiperda cells. Sf21 cells were transfected with either the pIB/V5-His plasmid 
expressing Dcr-2 with the V5 tag on the C- (V5/C) or the N- terminus (V5/N). Mock transfected 
cells (NTC) were used as a negative control while MDCK cell samples constituently expressing the 
V5 protein were used as a positive control. Protein expression was detected with an anti-V5 
antibody by Western blot analysis and chemiluminescence. Arrow indicates a potential protein 
band.  
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Figure 5.19: Schematic illustration of the cloning of Ago-2-V5 into pSFV1. The insertion of A) 
Ago-2-V5/C or B) Ago-2-V5/N from the sub-cloning vector pJet1.2/blunt into SFV1 replicase 
plasmid after the SP6 gene promoter sequence.    
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Figure 5.20: Schematic illustration of the cloning of Dcr-2-V5 into pSFV1. The insertion of A) 
Dcr-2-V5/C or B) Dcr-2-V5/N from the sub-vector pJet1.2/blunt into SFV1 replicase plasmid after 
the SP6 gene promoter sequence.    
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Figure 5.21: Expression of V5 tagged Ae. aegypti Ago-2 protein in BHK-21 cells. BHK-21 cells 
were transfected with SFV1-Ago-2 in vitro transcribed capped RNA. Ago-2 was labelled with 
either a V5 tag on the C (V5/C) or N (V5/N) terminus or a ZsGreen tag (ZsG) as a negative control 
in addition to mock infected BHK-21 cells (Ctrl). MDCK cell samples either constituently 
expressing (V5+) or negative for (V5-) the V5 epitope were also included as further controls. 
Protein expression was detected with an anti-V5 antibody by Western blot analysis and 
chemiluminescence. An arrow indicates the weight of potential protein bands.     
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5.3.8 Characterisation and Development of a Highly Active in vitro Insect Expression 
System  
One particular challenge encountered when working with mosquito cells in culture is 
transgene expression from plasmid-based systems. Currently the most efficient and 
commonly used plasmid promoter is the OpIE2 promoter (described Chapter 5.3.4 and 
5.3.7). However, a recent publication from Adelman and colleagues described the 
properties of the Ae. aegypti polyubiquitin (PUb) gene promoter for the successful 
expression of gene products in insect in vitro systems (Anderson et al., 2010). This 
promoter has been studied in Drosophila (Davis et al., 1995; Handler and Harrell, 1999) 
and has recently been shown to generate potent gene expression in both C6/36 and Aag2 
mosquito cells. The pGL3-PUb plasmid described in this paper was gratefully received 
from Professor Zach Adelman (Department of Entomology, College of Agriculture and 
Life Sciences, Virginia Tech, Virginia, United States of America). To extend the 
experiments to additional mosquito-derived cell lines, a comparison between the PUb 
promoter (accession number GU179018) driving expressing from pGL3-PUb and the 
OpIE2 promoter in the pIZ-Fluc plasmid was performed. Both plasmids contain the Fluc 
GL3 gene downstream from their promoter which allows relative luciferase activity to be 
determined by luciferase assay.  
Each cell line to be tested was seeded in 24-well plates at the appropriate cell density 
required per well (1.8 x10
5
 Aag2, 1.2 x10
5
 C6/36 and U4.4 and 2 x10
5
 TRA-171) and were 
incubated at 28 °C preceding transfection 24 h later with either: 500 ng/well of pGL3-PUb 
or pIZ-Fluc. Each well was co-transfected with 25 ng/well pRL-CMV (also containing the 
OpIE2 promoter sequence) as an internal control to account for discrepancies in 
transfection efficiency. Following a 24 h incubation period each well was lysed and 
luciferase expression quantified. The level of pIZ-Fluc expression was set to 1 and the 
level of pGL3-PUb expression measured as fold increase relative to pIZ-Fluc expression 
for each cell line (Figure 5.22). The results demonstrated that for all of the cell lines tested 
the level of Fluc expression was consistently greater from the pGL3-PUb plasmid than 
from the currently preferred pIZ-Fluc expression plasmid (Aag2 138- fold, C6/36 206- 
fold, U4.4 45- fold, TRA-171 104- fold increases). This suggests that the PUb promoter is 
more successful in insect cell lines than the OpIE2 promoter, which is in agreement with 
what was shown previously in C6/36 and Aag2 cell lines where pGL3-PUb was 
consistently more actively expressed (Adelman et al., 2010).  
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As a result of this success it was decided to adapt the plasmid for use in future experiments 
to permit required genes of interest to be expressed to high levels. In order for this to be 
implemented, it was first necessary to insert a multiple cloning site (MCS) into the pGL3-
PUb plasmid. This was achieved through the design of oligonucleotides which recognised 
regions of the plasmid backbone but contained restriction endonuclease recognition sites 
unique to the completed plasmid. These primers are described in Chapter 2.9. Due to the 
strategy which was used to create the pGL3-PUb plasmid, the insertion of a new MCS 
required the Fluc luciferase gene to be removed (Figure 5.23A). Following the PCR the 
DNA was treated with DpnI which only cleaves its recognition site when it is methylated 
and thus permits the removal of methylated DNA sequences (i.e. the original plasmid 
grown in E.coli) while the plasmid generated by PCR remained intact. The DNA was then 
treated with T4 ligase which ligates the phosphorylated compatible sites at the end of each 
primer. The resulting DNA, now referred to as pGL3-PUb/MSC, was transformed into 
DH5α E.coli, purified and the correct sequence confirmed by digestion and sequencing 
(Figure 5.23B). All restriction enzymes cut efficiently in the modified plasmid and not in 
the original pGL3-PUb. It is hoped that this can be used as an alternative expression 
strategy for the recombinant Dcr-2 and Ago-2 sequences; however, completion of this was 
not possible within the timescale of the project.  
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Figure 5.22: Expression of pGL3-PUb and pIZ-Fluc plasmids in a number of different 
mosquito-derived cell lines. The efficiency between two mosquito expression systems was 
compared in Ae. aegypti-derived Aag2 cells, Ae. albopictus-derived C6/36, U4.4 and C7-10 cell 
lines and Toxorhynchites amboinensis-derived TRA-171 cells. Cells were transfected with either 
the pGL3-PUb or pIZ-Fluc plasmids and co- transfected with pRL-CMV as an internal control. 
Following a 24 h incubation, the ratio of Fluc:Rluc expression was determined by luciferase assay. 
A) Expression of pIZ-Fluc was set to 1 and pGL3-PUb measured against it. Panel B) shows the 
pIZ-Fluc results in detail. pGL3-PUb expression is shown in (light grey) compared to pIZ-Fluc 
expression which is indicated in (dark grey). Error bars show the standard deviation of three 
independent experiments performed in triplicate. * represents p < 0.05, Student’s t-test. 
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Figure 5.23: Design and creation of pGL3-PUb encoding a MCS. A) Schematic illustration of 
the removal of the luciferase gene from pGL3-PUb and the insertion of the new MCS. The red 
arrows indicate the sites where the PCR primers bound and their direction. B) Agarose gel picture 
demonstrating digestion with each restriction endonuclease included in the new MCS of pGL3-
PUb/MCS. L, 1 Kb ladder; Kb, kilobase pairs.  
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5.4 Discussion  
 
As RNAi is the major antiviral defence mechanism in mosquitoes it is important to grasp 
the intricate details involved in its ability to process a viral assault. Although it has been 
well studied, there are still a large number of unanswered questions regarding the action of 
Dcr-2 and Ago-2 and their faculty for dsRNA and siRNA-mediated silencing. For instance 
what exactly does Dcr-2 bind too and how does it recognise viral replication complexes? 
Although arboviral replication is known to occur in the cytoplasm, the exact location of 
where the virus dsRNA meets the antiviral components has yet to be determined. It is 
known that Dcr-2 does not function independently and is not biologically distinct from co-
factors; although, with the exception of R2D2 (Liu et al., 2003) and Ars-2 (Sabin et al., 
2009), the interactions between it and other proteins which may regulate its activity in both 
Drosophila and mosquitoes are largely unknown. Moreover, as the infection progresses 
from acute to persistence, do these interactions remain or are the replaced with associations 
with different protein(s)/molecule(s) (Flynt et al., 2009; Goic et al., 2013)? Is this also the 
case with protein(s)/molecule(s) interacting with RISC? Do viral proteins interact directly 
with Dcr-2/Ago-2 or both? The biological relevance of many of the interactions made by 
Dcr-2 and RISC/Ago-2 are yet to be fully investigated and this project intended to expand 
the limited number of biological tools available to answer many of these questions within 
the mosquito system.  
The most ideal situation would be to create antibodies against the endogenous mosquito 
RNAi proteins. It is known that the development of antibodies against these proteins in 
mosquitoes has proved to be particularly challenging (personal communication with Dr. 
Ronald van Rij, Nijmegen University). Although there are some against RNAi components 
in Drosophila and humans, these are not effective when used for cross detection of the 
same proteins in mosquitoes and their derived cell lines (personal communication with Dr. 
Esther Schnettler, University of Glasgow). These findings are echoed in the production of 
the antibodies described in this project, as although an experienced company was tasked 
with their production, they also reported some difficulties. This is particularly evident in 
the lack of antibodies against the preferred epitopes of Ago-2. Furthermore, the dot blot 
which was hoped to be utilised for screening the large number of antibodies was 
unsuccessful, implying failings with some of the peptides themselves. However, the 
Western blot experiments described were all performed with the aid of a reducing agent 
and therefore any antibodies recognising the native conformation of the epitope rather than 
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the linear structure would be missed. With more time these Western blot experiments 
should be repeated without the presence of a reducing agent to determine if this improves 
the number of successful endogenous antibody interactions. However, it should be noted 
that the expected running pattern of the proteins on the gel is still unknown. Further work 
with the potential candidate antibodies identified is also required to optimise their use. On 
completion of this, successful antibodies could be used to facilitate immunoprecipitation 
and immunofluorescence assays and allow other associated proteins and molecules to be 
identified, as has previously been shown for other systems (Meister et al., 2005; Peters and 
Meister, 2007). Understanding the relationship that these proteins have with other enzymes 
and molecules is essential to give researchers the complete picture of their roles within the 
cell. In particular, it would be beneficial to understand the distinguishing characteristics 
between siRNAs which are taken up by RISC and incorporated into Ago-2, compared to 
those which are not and as a result are unable to target the virus during infection (Aliyari et 
al., 2008; Myles et al., 2008 and 2009, Brackney et al., 2009; Flynt et al., 2009; Sanchez-
vargas et al., 2009; Mueller et al., 2010; Siu et al., 2011). Are all the siRNAs produced 
functional? Of those viRNAs which are free and not bound to Ago-2, how many are 
stable? Are they stabilised elsewhere? In addition, it is also not yet known exactly what 
determines Dcr-2 binding to dsRNA. Does it bind to the whole genome or recognise 
particular parts? Further studies are required to establish if, like plant RNA viruses, genetic 
conformation plays a role in inducer recognition and interactions (Siu et al., 2011). These 
areas of interest can then be extended beyond the cell to further our understanding of the 
interactions between the cell and the virus and how these associated proteins shape 
virus/RNAi connections.  
Due to the disappointing results obtained for the endogenous antibody trials the alternative 
method was to over-express recombinant forms of Dcr-2 and Ago-2 fused to specific tags. 
The initial preference was to use a fluorescent tag which would allow the temporal and 
spatial kinetics of these proteins to be visualised during the stages of SFV infection of 
mosquito cells. A significant challenge to completing this aim was to obtain sufficient 
levels of protein expression. No expression was obtained after cloning into the insect 
pIB/V5-His vector; although, efficient expression of both Ago-2 and Dcr-2 was achieved 
following their insertion into SFV VRPs. However, there were issues with the titre of 
VRPs which could be produced. To date, there is no evidence that large proteins, such as 
Dcr-2 and Ago-2 are able to be expressed within SFV particles. Indeed, the structural ORF 
of SFV is approximately 1253 amino acids long compared to the size of Dcr-2-mCherry 
Chapter 5                                      The development of novel tools to enhance understanding  
   of the RNAi response in mosquitoes 
 
211 
 
(1894 amino acids) and Ago-2-ZsGreen (1223 amino acids). The findings demonstrated 
here suggest that the presence of large proteins within the virus genome may make it 
unstable and most likely results in the incorrect folding and the failed formation of the 
infectious body. Therefore, there is a high probability that the proteins are ejected. This 
would explain why there is a high degree of SFV-nsP3 detection but very little expression 
of each tagged protein, in particular Dcr-2 which is the larger of the two. Additionally, 
such large proteins may have difficulty folding correctly on their own if the environmental 
conditions are not optimal. It is also likely that the expression of both Dcr-2 and Ago-2 is 
highly regulated by the cell preventing naturally high levels of protein accumulation which 
would contribute to the difficulties encountered. However, although the VRPs are difficult 
to obtain the RNA is sound and further experiments are merited.  
Although there is currently no convenient assay available to test the function of Ago-2, the 
C6/36 cell line provides an invaluable system in which to test the function of the reporter 
Dcr-2-mCherry construct. This is because it exhibits a Dcr-2/RNAi null phenotype within 
the context of RNAi and is unable to produce 21 nt siRNA molecules as a result of the lack 
of dicing activity (Brackney et al., 2010; Scott et al., 2010; Morazzani et al., 2012). The 
Dcr-2-mCherry construct would be shown to be functional if it was capable of restoring the 
ability of the C6/36 cell line to digest long dsRNA molecules into 21 nt siRNAs, the 
hallmark of Dcr-2 activity. Once shown to be functional, it could then be used in a relevant 
Ae. aegypti expression system. This has been previously achieved through the addition of a 
recombinant human Dicer protein to C6/36 cell lysates (Scott et al., 2010). The successful 
function of this exogenously applied enzyme indicated that there was no inhibitory affects 
upon its action. Furthermore, the direct transfection of siRNAs permitted targeted plasmid 
silencing signifying that the other constituent components of the RNAi pathway are both 
present and functional (Scott et al., 2010). Unfortunately, despite clear levels of protein 
expression within the C6/36 cell line, Dcr-2 function could not be confirmed by 
performing either an in vitro dicer cleavage assay or by plasmid silencing in the C6/36 cell 
line (data not shown). This may be due to insufficient levels of protein expression, 
subcellular compartmentalisation away from SFV replication complexes or the resulting 
protein may be incorrectly folded or unstable and unable to recognise or process the 
dsRNA. The band observed for the C3/36 cell samples in the dicer assay could be larger 
siRNAs produced by Dcr-1, although this is difficult to confirm due to the poor band 
produced from the U4.4 sample. It was therefore evident that further work was required to 
optimise its production.  
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Of course it is disadvantageous to test the function of antiviral proteins within the confines 
of a viral infection. Firstly, the cells are not in their natural state but are already fighting an 
infection. Secondly, high levels of viral replication would be expected to vastly over 
express the protein above its normal cellular concentrations. However, expression of Dcr-2 
from a replicating virus could immediately initiate digestion of the viral RNA and decrease 
the number of genomes produced. With this in mind, the SP6 promoter was used under a 
different context in the TNT rabbit reticulocyte lysate system. Unfortunately, this proved 
unsuccessful and it failed to generate expression of Dcr-2 despite the confirmation that the 
cloning and protocol were correct. In addition to the restrictions encountered when testing 
Dcr-2 activity described previously, there may also be inhibitors present in the lysate 
preventing Dcr-2 activity. A suitable alternative would be to use the native insect cell 
system. Although, this is a logical choice as it is a natural system and is known to produce 
highly-active full-length proteins, it requires the use of a baculovirus expression promoter 
which has been shown to be unsuccessful at producing detectable levels of Dcr-2-mCherry.     
A second avenue of interest was explored using an alternative tag inserted onto the end of 
the RNAi enzymes. Although the fluorophore tags are beneficial for localisation studies, 
they are known not to be successful with other procedures which would be beneficial to 
this project and for that reason a second molecular tag was employed. The tag selected was 
the V5 epitope tag which has been commonly used as a target for protein detection due to 
its compact size and recognition by reliable, high-affinity antibodies (Southern et al., 1991; 
Olczak et al., 2005; Mourez et al., 2007; Grimberg et al., 2011). It has been shown to 
produce robust results when used for immunoprecipitation and protein-protein interaction 
experiments; as well as Western blotting, immunohistochemistry and protein microarrays 
which may be useful for future studies. It was decided to place the tag on either the N- 
terminus or the C- terminus of Dcr-2 and Ago-2 to determine which orientation was more 
successful to facilitating correct protein folding. It was unfortunate that the Dcr-2-V5 
cloning could not be completed during the designated time; however, similar cloning has 
been successful in other systems. Cloning a FLAG tag onto the N- terminus of the 
functional Dcr-2 derived from Bombyx mori (silkmoth) has recently been achieved (Liu et 
al., 2012) although the addition of dual polyhistidine tags (one of each terminus) onto 
Drosophila Dcr-2 has been documented as improving expression levels using the 
baculovirus expression system without affecting functionality (Jiang et al., 2005; Ye and 
Liu, 2008). It is hoped that if this cloning is successful in the future, the smaller V5 tag 
may solve some of the potential folding issues encountered with the use of the mCherry 
Chapter 5                                      The development of novel tools to enhance understanding  
   of the RNAi response in mosquitoes 
 
213 
 
tag. As neither the structure nor folding of Ae. aegypti Dcr-2 and Ago-2 are known it was 
determined that the V5 tag would be placed on either the N- or the C- terminal ends. It was 
hoped this would provide information relating to the geography of the terminus which 
would affect ease of folding and accessibility to antibody detection. There were promising 
initial results for both Ago-2-V5 constructs which indicated strong bands at approximately 
the weight expected (119 kDa). Given the apparent stability of Ago-2-V5/N compared to 
Ago-2-V5/C, it is suggested that this would be the more convenient and reliable cloning 
and expression strategy to use in the future.  
Although baculovirus gene promoters has been shown to be functional in a number of 
insect cell lines (Pfeifer et al., 1997; Massotte et al., 2003; Xu et al., 2008; Paradkar et al., 
2014) and are commonly used by groups studying insect biology (Li et al., 2001; Yang et 
al., 2008; Mon et al., 2009), this project has found that there was a substantial increase in 
the level of gene expression obtained following gene regulation from the Ae. aegypti 
polyubiquitin promoter over the currently used OpIE2 baculovirus promoter in each of the 
cell lines tested. This is consistent with results generated previously where there was at 
least a ten-fold increase in both C6/36 and Aag2 cell lines compared to a second 
baculovirus IE promoter (Anderson et al., 2010). The PUb promoter has also been shown 
to maintain enhanced expression levels in transgenic mosquitoes. As a result of these 
findings it can be suggested that the PUb gene promoter is highly efficient and produces 
stable expression in both in vitro and in vivo mosquito systems. Therefore, it will be of 
exceptional use in the future for gene regulation and function studies in this important 
disease vector over traditionally used baculovirus promoters (Khoo et al., 2013). It may 
also be beneficial to combine its use with the insect cell expression system to determine if 
it is also possible to achieve high levels of functional proteins with the PUb gene promoter 
in this cell-free system.      
A notable lack of genetic and biological tools has been a great impediment to studies into 
mosquito immunity and it has been a major aim of this PhD project to improve this. The 
use of the potential endogenous antibodies would negate the need to treat the cells and 
would allow investigations into the natural intracellular environment prior to infection, 
without the disadvantages associated with protein over-expression, to be carried out. 
However, the use of the developed recombinant proteins will greatly facilitate 
investigations into answering some long standing queries. The successful use of V5 tags on 
Ago-2, as well as the powerful expression of the reporter genes via the PUb promoter, 
indicate that there are realistic possibilities available for taking this work forward. 
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Fundamental questions such as how rapidly post infection the RNAi defence is activated 
and at what stage during the replication cycle this occurs are currently not known and so it 
is important to determine the stages of acute infection in which Dcr-2 and RISC play their 
most predominant role. These crucial factors may also be connected to the rate of viral 
replication and so may vary depending on the specific pathogenic infection (Grimm et al., 
2007). The ability to detect, isolate and purify the main RNAi enzymes will strongly aid 
the study into their spatial and temporal activities and will considerably reduce the gaps in 
our awareness of these important processes. Further insights into the mechanism of RNAi 
will ultimately support public health policies for the development of novel strategies for 
the control of arthropod transmitted diseases through understanding the mechanisms of 
transmission regulation.      
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5.5 Future Work 
  
Although the C6/36 cell line has a Dcr-2 null phenotype they are not a Dcr-2 null cell line 
as parts of the Dcr-2 protein are still translated. However, we do not know if the other parts 
of the enzyme which are expressed are important for other responses in addition to the 
siRNA pathway and this requires further investigation. Although the C6/36 were used to 
establish if the Dcr-2-mCherry reporter was functional, this could not be concluded. 
Further to the continued optimisation suggested previously for expression of Dcr-2, an 
additional in vitro dicer cleavage assay would be required. If this was successful the 
isolation of small RNAs derived from C6/36 cells treated with Dcr-2-mCherry should be 
collected and analysed by deep sequencing to determine the production of 21 nt siRNAs 
achieved following this treatment. The identification of an Ago-2 loss-of-function cell line 
would allow validation of the function of the Ago-2 construct. In addition, due to the low 
levels of Dcr-2 and Ago-2 expression following SFV infection of mosquito cell lines it 
would have been beneficial to separate those cells by fluorescence-activated cell sorting 
(FACS) to generate a homogenous population. However, as the cells were infected with 
SFV this was not possible. Following the success of the suggested cloning strategies out 
with the virus background this may be a viable technique available in the future.  
Following the success of gene expression under the PUb promoter it would be 
advantageous to clone the recombinant Dcr-2 and Ago-2 sequences into the pGL3-
PUb/MCS. This may allow sufficient expression of both proteins outwith the virus 
expression system. Alternatively, the insect expression cell system should be tested as a 
further substitute system. This study should be performed with both the PUb and 
baculovirus gene promoters.     
The construction of Ago-2 with a V5 tag should be completed to confirm that it maintains 
the correct conformation and activity. The V5 tag will allow RISC immunoprecipiations 
(RISC-IP) to be performed as well as other protein:protein interactions to be identified and 
analysed by mass spectrometry which should be accomplished in due course. The 
completion of the V5 tag cloning onto Dcr-2 would also facilitate further studies of the 
enzymes kinetics and discovery of associated proteins and molecules involved in the 
instigation of the RNAi pathway. Similarly, following further optimisation of the 
antibodies created against the endogenous RNAi proteins these could be used for future 
applications including Western blotting, cellular localisation and interaction studies as well 
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as deep sequencing of small RNAs following RISC-IP. A combination approach with both 
the PUb promoter plasmid and V5 tag would allow us to advance experiments involving 
immunoprecipitation and immunofluorescence beyond what can be achieved at present.   
Mosquito cells expressing the recombinant Dcr-2 and Ago-2 proteins can be infected with 
a strain of SFV expressing an nsP3-fusion (such as nsP3-ZsGreen) which will highlight 
replication complexes. Cells can be examined through the early stages of infection to 
pinpoint subcellular co-localisation. Furthermore, combining this experimental set up with 
immunostaining with the anti-dsRNA J2 antibody will allow the relationship between the 
three major elements of the RNAi response- Dcr-2, viral dsRNA and viral replication 
complexes- to be monitored, especially now that successful protein tagging is within reach. 
A further objective which could be achieved on completion of the recombinant RNAi 
protein expression would be to analyse the important protein domains involved in their 
activity. To do this, a deletion analysis should be carried out to mutate/delete each known 
region. Following this, a more accurate analysis can be performed through sequence 
specific mutations to determine the exact sequences required for their function. In this way 
the activity and function of the different domains of these proteins could be elucidated as 
well as determining any additional involvement in other pathways.        
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5.6 Principle Findings  
 
1. Ae. aegypti-derived Dcr-2 and Ago-2 were successful cloned into SFV replicons 
and VRPs produced. Expression was detected in Ae. aegypti-derived Aag2 cells, 
Ae. albopictus-derived C6/36 and mammalian BHK-21 cells.    
2. An in vitro dicer cleavage assay protocol was successfully implemented. However, 
it did not allow the efficient function of the recombinant Dcr-2 to be concluded.  
3. Recombinant tagged Dcr-2 and Ago-2 failed to be expressed under the control of 
the OpEI2 promoter suggesting it is too weak.  
4. Ago-2 tagged with the V5 epitope was successfully cloned into the SFV replicon 
and Ago-2 was detected at the expected size by Western blotting with an anti-V5 
antibody.  
5. Expression of genes inserted downstream of the PUb promoter was shown to be 
greater in all cell lines tested compared to currently used OpEI2 gene promoter.  
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6.1 Introduction   
 
The genus Toxorhynchites (Diptera, Culicidae) contains 70 species of morphologically 
similar members. Although predominantly tropical, they are distributed from the far north 
of Russia and Canada to the south of Africa (Steffan, 1968; reviewed Focks, 2007). The 
adults are exceptionally large comparative to other genera (several centimetres long) and  
are brightly coloured with a long, downward curving proboscis. As they are non-biting, 
non-haematophagous insects and do not take a blood meal, they are not natural vectors of 
arboviruses. All instars of Toxorhynchites larvae are predatory against the larvae of other 
mosquito species, in addition to other available aquatic and surface trapped invertebrates. 
This early accumulation of nutrients sustains the adult females through the remainder of 
their life cycle and negates the need to take a blood meal to provide the nourishment 
required for egg development. Instead both sexes consume nectar and other plant derived 
sugars (Focks, 2007). The larvae feed opportunistically and rely on the eggs being 
oviposited in an area with an adequate food source. However, it has been shown in 
laboratory conditions that they will feed on whatever is available, both living and non-
living food sources, provided it is of similar size or smaller. Furthermore, cannibalism has 
been documented as a common behaviour (reviewed Steffan and Evenhuis, 1981; Annis et 
al., 1990a and b; reviewed Focks, 2007). Female Toxorhynchites will lay their eggs in both 
natural and artificial water containers with no apparent bias between an urban or rural 
distribution. As such, there is a substantial degree of overlap between Toxorhynchites and 
its predominant prey of the larvae of major arboviral vectors, such as Aedes spp. 
mosquitoes.  
Research involving Toxorhynchites mosquitoes has concentrated on their potential as an 
alternative to chemical insecticides for biological pest control of vector mosquitoes (Board 
of Sciences and Technology for International Development, 1973; reviewed Steffan and 
Evenhuis, 1981). For instance Tx. amboinensis (miss identified as Tx. splendens) and Tx. 
brevipalpis were introduced to the Hawaiian Islands from the Philippines in 1953 to 
control Ae. albopictus (Steffan, 1975; Nakagawa, 1963) and Tx. amboinensis were released 
onto Java in 1987 for the joint control of Ae. aegypti and Ae. albopictus (Annis et al., 
1990a). Although it is logical to use vector mosquitoes for arbovirus research, few studies 
have investigated the advantages of Toxorhynchites in this area and the number of major 
benefits which make these a convenient and adept system for in vivo studies. Firstly, as 
these mosquitoes do not take a blood meal, there is a reduced health risk associated with 
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the use of females in this field of research since they cannot transmit the virus to their 
handlers. Secondly, their exceptional size and stability compared to Aedes and Culex 
species, which are predominantly used for current in vivo studies, would improve the ease 
of handling, injection accuracy, allow a greater volume of inoculum to be used and provide 
a greater quantity of tissue samples for detection (e.g. by immunofluorescence and head 
squashes). Thirdly, numerous studies have shown that they efficiently propagate all four 
dengue virus serotypes (DENV- 1 - 4), Japanese encephalitis virus (JEV) and St. Louis 
encephalitis virus (SLEV) to high titres when artificially infected by intrathoracic injection 
(Rosen et al., 1978; Tesh, 1979; Kuno, 1981; Rosen, 1981). DENV titres in particular are 
as high as 100 - 1,000 times greater than observed in Ae. albopictus–derived C6/36 and Ae. 
pseudoscutellaris–derived AP-61 cell lines in culture typically used for DENV propagation 
(Tesh, 1979). While the majority of arbovirus studies performed have focused on their 
ability to propagate dengue and other flaviviruses, Tx. amboinensis have also been 
identified as an artificial host for other arboviruses, including alphaviruses (Ross River 
(RRV, Tesh et al., 1981), chikungunya (CHIKV) and Venezuelan encephalitis virus (VEV, 
Scherer and Chin, 1981)), bunyaviruses (La Crosse, San Angelo and Keystone viruses 
(Rosen, 1981)), as well demonstrating a susceptibility to Rhabdoviruses (vesicular 
stomatitis virus (VSV, Rosen, 1980a) and the true insect virus Nodamura virus (NoV, 
Tesh, 1980a). Zeller and Mitchell (1989) also showed the replication of several 
Reoviruses, Rhabdoviruses and other Bunyaviruses isolated from mosquitoes, birds and 
mammals. Therefore, the use of Tx. amboinensis for arbovirus research may uncover as yet 
unknown factors related to the interplay between cellular control and the replication of a 
number of arboviruses from different families.    
Continuous insect cells lines have been a vital research tool to investigate different features 
of insect immunity. They provide a controlled system which is sensitive, reproducible and 
where subtle changes can be detected following the application of various stimuli. Often in 
vitro findings mimic those from in vivo studies in the whole insect organism, validating the 
cell culture results as true to nature (Riedel and Brown, 1979; Condreay and Brown, 1986 
and 1988; Miller and Brown, 1992; Barletta et al., 2012). Following the success of Tx. 
amboinensis as a host for the propagation of dengue viruses, an in vitro system was 
established from them for the recovery and isolation of certain arboviruses from human 
sera, as well as for the study of virus replication in non-haematophagous mosquito cells in 
culture. Several cell lines have since been derived from Tx. amboinensis (Tesh, 1980a; 
Kuno, 1980, 1981b and 1982a; Munderloh et al., 1982). TRA-171 cells were created from 
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live, immotile Tx. amboinensis larvae (Kuno, 1980 and 1981b) and, unlike some of the 
other derived cell lines (TA-42 and TA-9) they exhibit similar levels of sensitivity to 
dengue observed in the adult insects (Tesh, 1980a, Kuno, 1982a). A subline from a further 
Tx. amboinensis-derived cell line, TRA-284, could be grown in serum free media (TRA-
284-SF) and the isolation of DENV serotypes 1, 2 and 4 from human sera was found to be 
similar to the level detected in the Ae. albopictus-derived C6/36 cell line, while exceeding 
isolation of DENV-3 isolates (Kuno, 1982b). In addition, the adaptation of the cells to 
serum-free media did not alter their sensitivity to DENV compared to those where bovine 
sera was included. The aim of cells cultivated in serum-free media was to further reduce 
material costs and the complexity of detecting clinical viral infections in the field. At the 
same time it also minimised contamination by antibodies, other viruses, endotoxins and 
Mycoplasma that the bovine serum may contain and which could potentially interfere with 
arbovirus detection (Kuno, 1983; Nawa et al., 1987). TRA-171 cells have also been shown 
to allow the replication of all four dengue virus serotypes to high titres (Kuno, 1981a) 
comparable to those observed from the C6/36 (Igarashi, 1978) and AP-61 cell lines (Varma 
et al., 1974) which are known to be highly susceptible to DENV infection. Furthermore, 
DENV infection resulted in evident cytopathic effect (CPE) presenting as syncytial 
development. This is also described for Aedes cells in culture following DENV infection 
and is a characteristic unobserved in other non-haematophagous insect cell lines (Singh, 
1967; Kuno, 1980 and 1981a; Legrand and Hotta, 1983). DENV infection also results in 
plaque formation in TRA-171 monolayers and the cells were shown to be as equally 
sensitive as the C6/36 and AP-61 cell lines. This made TRA-171 cells appeal as a 
candidate to replace previous methods involving vertebrate cells and live adult mosquito 
systems for the isolation and identification of dengue viruses from clinical human sera 
samples collected in the field (Tesh, 1979; Kuno, 1981a). Further to dengue, replication of 
other flaviviruses: Yellow Fever virus (YFV) and SLEV, the rhabdovirus VSV, as well as 
NoV, have been reported in this cell line reflecting similar results observed in the adult 
insects (Kuno, 1981a and 1987; Johnson et al., 2004). Legrand and Hotta (1983) also 
observed CHIKV replication at titres similar to those measured for DENV-2 and DENV-4 
serotypes in TRA-171 cells and close to titres expected in infected C6/36 cells (Igarashi, 
1978). This demonstrates that TRA-171 cells may be a useful in vitro system for studying 
the replication of different groups of arboviruses.  
The natural maintenance of some of the major human pathogens known to replicate within 
Toxorhynchites and their derived cell lines has been demonstrated to involve vertical or 
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transovarial transmission of the virus to the progeny of infected female mosquitoes. This 
allows the virus to survive in unfavourable conditions (e.g. absence of susceptible 
vertebrates, adverse climate conditions for mosquito activity). Vertical transmission of 
flaviviruses is believed to occur when the fully developed egg passes through the oviduct 
(Rosen, 1980b, 1987a and b). This has a lower rate of infection compared to true 
transovarial transmission (direct infection of the developing egg) seen with bunyaviruses 
(Tesh, 1980c; Rosen, 1987a and b). In contrast to cases of vertical transmission of 
alphaviruses which are not widely known and can be inconsistent (Kay, 1982; Mourya, 
1987; Lindsay et al., 1993; Dhileepan et al., 1996; Vazeille et al., 2009; Bellini et al., 
2012), descriptions of this route of infection have been well documented for the majority 
of mosquito-borne flaviviruses. These include; dengue viruses in Ae. aegypti (Khin and 
Than, 1983; Chen et al., 1990; Joshi et al., 1996), Ae. albopictus (Rosen et al., 1983), Ae. 
malayensis, Ae. polynesiensis, Ae. pseudoscutellaris (Rosen et al., 1985);  DENV 1, SLEV 
and JEV in Ae. albopictus (Rosen, 1988); JEV in Culex tritaeniorhynchus (Rosen et al., 
1980b); YFV in Ae. aegypti (Aitken et al., 1979; Fontenille et al.,1997), SLEV in Ae. 
atropalpus (Pelz and Freier, 1990), Ae. dorsalis, Cx. peus, Tx. amboinensis (Hardy et al., 
1984) and Cx. pipens (Francy et al., 1981), Kunjin virus in Ae. albopictus (Tesh, 1980) and 
West Nile virus (WNV) in Ae. aegypti and Ae. albopictus (Baqar et al., 1993) as well as 
Ae. triseriatus (Unlu et al., 2010).  
In addition, a new branch of the Flaviviridae family has recently become the focus of 
intensive research. The first member of this new group was identified in 1975 by a ‘chance 
observation’. It was termed cell fusion agent virus (CFAV) and was first detected in the 
medium of endogenously infected Ae. aegypti cells (Stollar and Thomas, 1975); although 
CFAV-related viruses have since been isolated from both male and female mature field-
collected Ae. aegypti, Ae. albopictus and Culex species in Puerto Rico (Cook et al., 2006). 
This suggested that CFAV originated from the adult mosquito and was not a lab strain 
contamination of the isolated cell line. The RNA genome of CFAV had the characteristic 
organisation of a flavivirus as it was found to consist of a single open reading frame (ORF) 
which encoded three structural and seven non-structural proteins (nsPs). Conservation 
homology with other flaviviruses was greatest in the nsPs and lowest with the structural 
proteins. Furthermore, antigenic detection with anti-flavivirus antibodies was unsuccessful. 
CFAV was originally classified as an ungrouped member of the Togaviridae family, along 
with flaviviruses and pestiviruses due to its biophysical and biochemical properties 
(Porterfield et al., 1978). However, its genome was not sequenced until 17 years later 
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(Cammisa-Parks et al., 1992) and it was regrouped as a distant member of the Flaviviridae 
family, flavivirus genus (Heinz et al., 2000; Cook et al., 2006). Despite the shared genome 
motifs and organisation with classical flaviviruses, CFAV was demonstrated to be part of a 
distinct group referred to as insect-specific flaviviruses (ISF) as it failed to replicate in tick 
or vertebrate-derived cell lines, chicken embryo fibroblasts or mice (Stollar and Thomas, 
1975; Cammisa-Parks et al., 1992). 
CFAV is by no means the only ISF to have been discovered. Over the past decade there 
has been a surge in the number of isolated ISF strains from distinct species which have 
been identified in various wild mosquito populations across the globe. Most of these are 
found in Aedes and Culex species. In addition to CFAV, other tentative members which are 
believed to belong in this group include Kamiti River virus (KRV) (Crabtree et al., 2003; 
Sang et al., 2003), Culex flavivirus (CxFV) (Hoshino et al., 2007; Morales-Betoulle et al., 
2008; Farfan-Ale et al., 2009 and 2010; Kim et al., 2009; Blitvich et al., 2009; 
Saiyasombat et al., 2010; Huanyu et al., 2012), Aedes flavivirus (AEFV) (Hoshino et al., 
2009; Calzolari et al., 2012), Quang Binh virus (QBV) (Crabtree et al., 2009), Nounané 
virus (NOUV) (Junglen et al., 2009), Lammi virus (LAMV) (Huhtamo et al., 2009), 
Nakiwogo virus (NAKV) (Cook et al., 2009), Calbertado virus (CLBOV) (Bolling et al., 
2011; Tyler et al., 2011), Culex theileri flavivirus (CTFV) (Parreira et al., 2012), Hanko 
virus (HANKV) (Huhtamo et al., 2012), Palm Creek virus (PCV) (Hobson-Peters et al., 
2013), Nanay virus (NANV) (Evangelista et al., 2013) and Ochlerotatus Caspius flavivirus 
(OCFVPT) (Ferreira et al., 2013). The detection of many of these viruses in both male and 
female adult mosquitoes indicates passage of the virus by vertical transmission (Cook et 
al., 2006; Lutomiah et al., 2007; Farfan-Ale et al., 2009; Saiyasombat et al., 2011; Haddow 
et al., 2013). These findings indicate that this new group of viruses is more highly 
prevalent and geographically more widespread than previously anticipated. This group of 
newly described viruses are classified into the insect flavivirus clade which diverged as a 
basal lineage of the genus and may represent predecessors of true flavi- arboviruses (Cook 
et al., 2012). As not all replicate in insect cells asymptomatically, this cannot be classed as 
a distinguishing characteristic of the group. However, due to their lifecycle lacking 
transmission to vertebrates they are not classed as arboviruses. It is of note, therefore, that 
the flavivirus genus contains members which are conventional arboviruses (mosquito-
borne and tick-borne), vertebrate only pathogens (no known vector) and insect only 
pathogens (Kuno et al., 1998; Cook and Holmes, 2006; Kuno, 2007; Cook et al., 2012).  
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It is therefore interesting to know if non-vector Toxorhynchites mosquitoes have developed 
an antiviral response against infections most likely acquired by ingestion of larvae which 
have become infected through vertical transmission of arboviruses or ISFs. Yet the 
antiviral capacity of these mosquitoes and their derived cell lines has not yet been 
established. With the absence of an annotated genome to allow the identification of 
orthologues of Drosophila and Ae. aegypti RNAi genes, the antiviral defence of TRA-171 
cells has been established here based on reporter- gene based assays.    
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6.2 Objectives  
 
1. To investigate if SFV is capable of establishing an infection in Toxorhynchites 
amboinensis derived TRA-171 cells.  
2. To determine if TRA-171 cells possess a functional antiviral immune response 
capable of mediating SFV infection.  
3. If an antiviral response is present, is it mediated by dsRNA molecules? 
4.  Does this response result in the production of small RNAs of 21 nt length?  
5. To investigate if TRA-171 cells are infected by the endogenous insect-specific 
flavivirus, cell fusion agent virus (CFAV).   
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6.3 Results 
 
6.3.1 SFV Infection of Toxorhynchites amboinensis-derived TRA-171 Cells  
Although TRA-171 cells are known to be susceptible to infection with CHKV it has not 
been demonstrated if they can be infected with the related alphavirus, Semliki Forest virus 
(SFV). To establish this, and for all further experiments, TRA-171 cells were obtained 
from the European Collection of Cell Cultures (ECACC). They were seeded at a density of 
2.2 x 10
5
 cells/ well in a 24 well plate and infected 24 h later with a reporter strain of SFV 
expressing Renilla luciferase (Rluc) after the nsP3 gene as a marker of replication 
(SFV4(3H)-Rluc) (Table 2.4). The infection was performed at either a high (10), mid 
(0.01) or a low (0.001) multiplicity of infection (MOI). Following a 24 h incubation at 28 
°C the cells were lysed and luciferase activity determined by luciferase assay. As 
anticipated, SFV replication was detected following infection at each MOI (Figure 6.1A 
and B) with levels of Rluc expression decreasing proportionally.      
The replication kinetics of SFV in TRA-171 were determined by infecting the cells with a 
second reporter strain of SFV, SFV4(3H)-Fluc. This was due to the availability of virus 
stocks prepared in the lab and, as both strains are structurally identical to each other (with 
the exception of the reporter gene substitution) the two viruses behave in the same fashion 
and there is no difference to the experimental outcome. TRA-171 cells were seeded in 6-
well plates at a density of 9 x 10
5 
cells/well. They were either infected with SFV4(3H)-
Fluc at an MOI of 10 or mock infected 24 h post seeding and returned to the incubator 
until the required time point. The medium from three wells was collected for virus 
production curves which were performed by plaque assay on BHK-21 cells. These wells 
were washed twice gently with sPBS and recovered with fresh media and returned to the 
incubator. Growth media was removed from a further three wells for each condition and 
these cells were scraped and counted to compare the growth rate of SFV infected and 
uninfected cells. Once a count had been determined the cells were then lysed in passive 
lysis buffer and virus replication determined by luciferase assay. SFV infection did not 
appear to have any detrimental effects on cell viability as infected cells grew at the same 
rate as those which had been mock infected and no visible CPE was evident (Figure 6.2). 
Virus production was measured in plaque forming units (PFU/ml) and shown to increase 
up to 48 hours post infection (hpi) followed by a decrease until 96 hpi where the beginning 
of a plateau is evident (Figure 6.3). The rate of virus replication was seen to rapidly 
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increase up to 48 hpi where after there was steady decrease until the final time point at 120 
hpi (Figure 6.4).  
SFV, like other arboviruses, has been shown to be capable of establishing persistent 
infection in insect cells (Brown, 1984) characterised by low virus production. A persistent 
infection is suggested for SFV in TRA-171 cells as observed in Figure 6.3. Dengue virus 
was also previously documented to progress into a latent infection in TRA-171 cells. To 
determine if SFV can establish a long term persistent infection in TRA-171 cells, infected 
cells were passaged up to 50 times post infection and were seeded at intervals in glass 
bottom 24-well plates at a density of 2.2 x 10
5 
cells/well. Cells were immunostained as 
described with anti SFV-nsP3 antibodies and viewed with the Zeiss LSM 710 confocal 
microscope. The results were compared to non-infected TRA-171 cells as well as both 
infected and non-infected U4.4 cells as a control as it is known that SFV can establish a 
persistent infection in that cell line (Davey and Dalgarno, 1974; Fragkoudis et al., 2008). It 
can be seen that SFV-nsP3 can be detected in up to 50 passages post infection (Figure 6.5 
and Table 6.1). This is comparable to persistent SFV infection in U4.4 cells.     
 
Table 6.1: Percentage of TRA-171 and U4.4 cells cultures infected with SFV after set 
passages post infection.  
 
  
Passage Number (post 
infection) 
Percentage of Culture Infected (%) 
U4.4 TRA-171 
20 98 47 
30 81 35 
40 66 28 
50 57 25 
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6.3.2 Processing of dsRNA Generates Antiviral siRNAs in TRA-171 Cells  
A key feature of the RNAi response is the production of siRNAs which are loaded into 
RISC for targeted gene silencing by the Argonaute proteins. In insects, a hallmark of these 
small RNAs is that they are specifically 21 nt in length as a result of processing by Dcr-2 
(Aliyari et al., 2008; Siu et al., 2011; Vodovar et al., 2012). The ability of TRA-171 cells to 
generate siRNA molecules was determined by an in vitro dicer cleavage assay. TRA-171 
cells were seeded in a 6-well plate at a density of 9 x 10
5 
cells/well. U4.4 cells were also 
seeded at 8 x 10
5 
cells/well as these have been shown to be RNAi competent and produce 
21 nt siRNAs which can be detected by this assay (Vodovar et al., 2012). Following a 24 h 
incubation, the cells were lysed with 1 x lysis buffer and the cell membranes disrupted. 
Sample extracts were prepared as described (Chapter 2.4.4) and incubated with 
32
P 
internally radio-labelled dsRNA overnight at 28 °C before the small RNAs were purified, 
denatured and loaded onto an acrylamide gel. Following electrophoresis, the results were 
determined by exposing the dried gel to a phosphoimaging screen and viewing with a 
personal molecular imager (PMI) (Figure 6.6). The size of the fragments generated was 
determined by comparison to size markers; input dsRNA (114 nt) and siRNAs (21 nt) 
(Figure 6.6A). There is a faint band corresponding to small RNAs which can been seen to 
match the marker size of 21 nt in the U4.4 sample lane used as a positive control. 
However, there is a much more intense band of cleaved siRNAs produced in the TRA-171 
sample lane and this can be seen to be the approximate size of the marker siRNA band. 
This implies that a mechanism is active in TRA-171 cells causing the cleavage of dsRNA 
into siRNAs of approximately 21 nt in size. Image J analysis was used to quantify the total 
of dsRNA and siRNAs present (Figure 6.6B). The total quantity of nucleic acids from 
each sample in the three experiments was measured and set to 100 %. The band density of 
the cleaved dsRNA was then measured as a percentage of this.    
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Figure 6.1: Replication of SFV(3H)-Rluc in Tx. amboinensis-derived TRA-171 cells. A) Cells 
were infected with a recombinant strain of SFV expressing Renilla (Rluc) luciferase (SFV(3H)-
Rluc) at high (10), mid (0.01) and low (0.001) MOIs. Rluc expression was detected by luciferase 
assay and measured in relative luciferase light units. Results were compared to those which had 
been mock infected. Error bars represent the standard deviation of three independent experiments 
performed in triplicate. Panel B) shows the MOI 0.001 and mock results from Panel A in more 
detail.   
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Figure 6.2: Growth curve of SFV4(3H)-Fluc infected TRA-171 cells. Growth of TRA-171 cells 
infected with a recombinant strain of SFV expressing Firefly (Fluc) luciferase (SFV4(3H)-Fluc) at 
an MOI of 10 (light grey) or mock infected (dark grey). Error bars represent the standard deviation 
of two independent experiments performed in triplicate.     
 
 
 
Figure 6.3: The production of SFV4(3H)-Fluc in PFU/ml at increasing time points following 
infection of TRA-171 cells. TRA-171 cells were infected with a recombinant strain of SFV 
expressing Firefly (Fluc) luciferase (SFV4(3H)-Fluc) at an MOI of 10, the supernatant was 
collected at given time points post infection (hours post infection, hpi) and viral titres determined in 
plaque forming units (PFU/ml) by plaque assay. Error bars represent the standard deviation of two 
independent experiments performed in triplicate.  
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Figure 6.4: The replication kinetics of SFV4(3H)-Fluc following infection of TRA-171 cells. 
TRA-171 cells were infected with a recombinant strain of SFV expressing Firefly (Fluc) luciferase 
(SFV4(3H)-Fluc) at a MOI of 10 and relative light units detected by luciferase assay as a 
representative of virus replication at specific hours post infection (hpi). Error bars represent the 
standard deviation of two independent experiments performed in triplicate.  
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Figure 6.5: Persistence of SFV4(3H)-Fluc infection in TRA-171 cells. TRA-171 and Ae. 
albopictus derived U4.4 cells were infected with a recombinant strain of SFV expressing Firefly 
(Fluc) luciferase (SFV4(3H)-Fluc) at an MOI of 10 and maintained for 50 passages. At designated 
time points the cells were seeded and immunostained with anti-SFV nsP3 antibody. Detection was 
determined with a Zeiss LSM 710 confocal microscope. Results were compared to those which had 
been mock infected (Neg). Representative images are shown. Blue, DAPI nuclear staining; green, 
anti-SFV-nsP3 staining. Scale bars indicate 50 μM.   
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Figure 6.6: Processing of long dsRNA molecules into 21 nt siRNAs by in vitro Dicer cleavage assay. 
A) Cellular extracts were prepared from Ae. albopictus derived U4.4 and Tx. amboinensis derived TRA-
171 cells infected with a recombinant strain of SFV expressing Firefly (Fluc) luciferase (SFV4(3H)-
Fluc) at an MOI of 10. Extracts were incubated with 
32
P labelled 114 nt dsRNA and the RNAs 
generated detected by loading onto an acrylamide gel and exposing to a photosensitive film. Size 
markers of 
32
P labelled 21 nt siRNA and 114 nt dsRNA were also loaded to permit a size comparison. 
This was repeated three times and a representative image is shown. The arrow indicates the size 
expected for viral-derived small RNAs (21 nt) B) Image J software was used to quantify the percentage 
of cleaved dsRNAs. Error bars show standard deviation of the mean from the three independent 
experiments.  
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6.3.3 dsRNA-mediated Interference in TRA-171 Cells  
Prior to performing experiments to ascertain the existence of an inducible RNAi response 
in TRA-171 cells, they must first be characterised in detail to establish their transfection 
efficiency in addition to their ability to transact RNAi. To determine the capacity of 
nucleic acid (plasmid, dsRNA and siRNA) uptake by liposomal transfection, fluorescently 
labelled plasmid (Fluorescein Label IT®, Mirus), dsRNA (Chapter 2.3.11), and siRNA 
molecules (BLOCK iT™ Fluorescent Oligo, Invitrogen), were transfected into TRA-171 
cells seeded in 24-well glass bottom plates at a density of 2.2 x 10
5 
cells/well. After a 24 h 
incubation each well either received: 500 ng plasmid, 500 ng dsRNA or 50 nM siRNAs or 
were mock transfected with Lipofectamine 2000. Following a further incubation of 24 h 
the cells were fixed and a coverslip mounted using DAPI mounting media. Images of each 
condition were taken using the Zeiss LSM 710 confocal microscope (Figure 6.7). The 
images reveal that all forms of nucleic acids were taken up by the TRA-171 cells with a 
transfection efficiency of 92 % plasmid, 38 % dsRNA and 35 % siRNAs.  
The expression efficiency of plasmid encoding Renilla luciferase (Rluc) was also 
determined by transfecting cells with pRL-CMV (Promega) that expresses Rluc under the 
control of the cytomegalovirus immediate-early promoter. TRA-171 cells were seeded in 
24-well glass bottom plates as previously and 24 h post seeding were transfected with 
either: 300 ng, 30 ng or 3 ng/well. The cells were incubated for a further 24 h before being 
lysed with passive lysis buffer and the expression of Rluc quantified by luciferase assay. 
The results of plasmid expression were compared to cells which had been mock transfected 
(Figure 6.8). The levels of expression were variable and so one representative experiment 
is shown. In each repetition a proportional level of expression was detected for each 
concentration of plasmid treatment the cells received. Expression via an alternative 
plasmid promoter is discussed previously in Chapter 5.    
 
  
Chapter 6  Antiviral capabilities of Toxorhychites  
  amboinensis- derived cells  
 
235 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
Condition 
Plasmid dsRNA siRNA 
Percentage Uptake 
(%) 
92 38 35 
 
Figure 6.7: Uptake of fluorescent plasmid, dsRNA and siRNA in TRA-171 cells. A) Cells were 
transfected with appropriate concentrations of each nucleic acid and expression was viewed with a Zeiss 
LSM 710 confocal microscope. Results were compared to those which had been mock transfected (Neg). 
Representative images are shown. Blue, DAPI nuclear staining; green, fluorescent nucleic acid staining.  
Scale bars indicate 50 μM.  B) Cell positively expressing each nucleic acid were counted and averaged 
for each experiment. 
dsRNA
siRNA
Neg
Plasmid
488 nm MergeDAPI
Chapter 6  Antiviral capabilities of Toxorhychites  
  amboinensis- derived cells  
 
236 
 
 
Figure 6.8: Expression of plasmid encoding Rluc in TRA-171 cells. Cells were transfected with 
serial 10- fold dilutions of pRL-CMV. Rluc expression was detected by luciferase assay and 
measured in relative luciferase light units. Results were compared to those which had been mock 
transfected. A representative of three independent experiments done in triplicate is shown. Error 
bars represent the standard deviation of three representative replicates performed during a single 
experiment.  
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6.3.4 Is There a dsRNA Induced Antiviral Response in TRA-171 Cells? 
The presence of a dsRNA inducible RNAi response in TRA-171 cells was first determined 
using plasmids expressing luciferase reporter genes as this is a more controllable 
experimental set up than with a virus infection. The cells were seeded in 24-well plates at a 
density of 2.2 x 10
5 
cells/well and co-transfected 24 h later with 30 ng pIZ-Fluc plasmid 
(Ongus et al., 2006), 5 ng pRL-CMV plasmid as an internal control and 0.1 ng of either 
Fluc specific dsRNA, control (eGFP) dsRNA or no dsRNA. RNAi has been shown to be 
dependent on the concentration of dsRNA (Fire et al., 1998; Kennerdell and Cathew, 1998; 
Yang et al., 2000). Different concentrations of specific dsRNA were tested to determine 
the optimal concentration for the experiment. Concentrations > 0.1 ng resulted in complete 
100 % targeted silencing which lead to the selection of 0.1 ng/well (results not included). 
Cells were lysed 24 h post transfection and luciferase expression determined. The results 
are presented as a correlation between eGFP control treated cells (100 %) and Fluc 
expression (Figure 6.9). Cells which received Fluc specific dsRNA showed a decrease of 
82.4 % in luciferase light units compared to control cells suggesting that a dsRNA induced 
silencing mechanism is present in TRA-171 cells.       
It has been shown that establishing a virus-specific RNAi response before infection can 
inhibit virus replication (Caplen et al., 2002).  To establish if an antiviral pathway exists in 
TRA-171 cells which is stimulated by the presence of specific, long dsRNA, cells were 
first treated with Rluc specific dsRNA prior to infection with the reporter strain of SFV 
SFV4(3H)-Rluc. The cells were seeded in 24-well plates as described and transfected 24 h 
later with 50 ng of dsRNA which was either specific for Rluc or control dsRNA (eGFP). A 
further mock transfected control was also included. The cells were incubated for 24 h to 
allow for the incorporation of the specific Rluc siRNAs into RISC ahead of infection with 
SFV4(3H)-Rluc at either a high MOI (10) or a low MOI (0.005). Following a further 24 h 
incubation the cells were lysed and luciferase activity determined by luciferase assay. The 
results are presented as a correlation between eGFP control treated cells (100 %) and Rluc 
expression. Luciferase expression for both MOI 10 (Figure 6.10A) and 0.05 (Figure 
6.10B) were reduced in cells treated with Rluc specific dsRNA compared to control treated 
cells (41 and 85 % respectively).  
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Figure 6.9: The effect of dsRNA induced silencing of Fluc encoding plasmid in TRA-171 cells. 
Cells were co-transfected in parallel with both pIZ-Fluc and pRL-CMV (internal control) plasmids 
and either specific Rluc dsRNA, control eGFP dsRNA or no dsRNA. Following this, cells were 
incubated for 24 h where after they were lysed and the ratio of Fluc: Rluc expression was measured 
in relative luciferase light units. Values recorded for control eGFP dsRNA were set to 100 % and 
the specific Rluc dsRNA viewed as a percentage of this. Error bars represent the standard deviation 
of three independent experiments performed in triplicate. * represents p < 0.05, Student’s t-test.  
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Figure 6.10: The effect of dsRNA induced silencing on SFV(3H)-Rluc infection in TRA-171 
cells. Cells were transfected with specific dsRNA against Renilla (Rluc) or control dsRNA (eGFP). 
Following an incubation of 24 h, the cells were infected with SFV4(3H)-Rluc at either a high A) 
(MOI 10) or B) a low MOI (MOI 0.005). Cells were incubated for a further 24 h after which they 
were lysed and Rluc expression measured in relative luciferase light units. Values recorded for 
control eGFP dsRNA treated cells were set to 100 % and the cells treated with specific Rluc 
dsRNA viewed as a percentage of this. Error bars represent the standard deviation of three 
independent experiments performed in triplicate. * represents p < 0.05, Student’s t-test.   
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6.3.5 Detecting Cell Fusion Agent Virus (CFAV) Infection in TRA-171 Cells  
Observations between the monolayers of the Ae. aegypti-derived Aag2 and TRA-171 cell 
line revealed that they share morphological similarities which clearly distinguish them 
from the Ae. albopictus-derived cell lines used as part of this project. Figure 6.11 
illustrates representative images obtained with the Zeiss LSM 510-Meta confocal 
microscope with differential interference contrast (DIC) of the four mosquito cell lines. 
Both the U4.4 (Panel C) and C6/36 (Panel D) appear as individual, round cells with small 
protruding filaments. In contrast, Aag2 cells (Panel A) and TRA-171 cells (Panel B) are 
elongated, fibroblast-like with the cytoplasm stretching away from the nucleus. Often, in 
the case of the Aag2 cells, large aggregations can be observed (indicated with arrows).    
Aag2 cells have been demonstrated to be persistently infected with CFAV (Scott et al., 
2010). As a result of this observation it was interesting to investigate if CFAV was 
detected in our TRA-171 cell line. Primer sets were designed against three regions of 
CFAV using the Genbank accession number M91671 as a reference sequence (Chapter 
2.9). Total RNA was isolated from each of the untreated cell lines by Trizol extraction as 
described (Chapter 2.3.18). First strand cDNA synthesis was performed by reverse 
transcription to generate cDNA for gene detection by PCR. The DNA products from each 
PCR were analysed by agarose gel electrophoresis (Figure 6.12). None of the primer sets 
showed positive detection in either the U4.4 or C6/36-derived cDNA. Conversely, all three 
primer sets strongly recognised sequences of the correct size (Primer set 1:559 nt, Primer 
set 2:701 nt, Primer set 3: 330 nt) in the Aag2 derived cDNA. Similar detection was also 
observed in the TRA-171 cDNA samples, although the intensity was less than observed in 
the Aag2 samples. Sequencing of the PCR products generated from each primer set 
confirmed them to be the expected CFAV sequence for each case. There was no detection 
by any of the primer sets in the RNA (No RT) control samples. Actin was used as an 
internal housekeeping control in the Ae. albopictus samples to demonstrate the presence of 
cDNA. 
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Figure 6.11: Morphology of different mosquito derived cells. DIC confocal images of A) Ae. 
aegypti-derived Aag2 cells, B) Tx. amboinensis-derived TRA-171 cells, C) Ae. albopictus-derived 
U4.4 cells and D) Ae. albopictus-derived C6/36 cells. Aggregates of Aag2 cells are indicated with 
arrows. Scale bars indicate 50 μM.   
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Figure 6.12: Detection of CFAV in different mosquito-derived cell lines. The expression of the 
insect specific cell fusion agent virus (CFAV) was detected using three primer sets recognising 
different regions of the genome. RNA was extracted from the Ae. aegypti derived Aag2 cell line,  
Tx. amboinensis-derived TRA-171 cells and Ae. albopictus-derived U4.4 and C6/36 cell lines. RT-
PCR was carried out using random hexamers and PCR was performed using each primer set. No 
RT indicates samples where the Superscript III enzyme was omitted. Primers recognising Ae. 
albopictus actin were used as a control.  
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6.4 Discussion  
 
Toxorhynchites mosquitoes may potentially offer an alternative system for arbovirus 
research with several advantages over current in vivo models. However, the interaction 
between cellular and arboviral factors during infection has been overlooked indubitably 
due to their non-haematophagous biology. This is despite several studies demonstrating 
that a number of important human pathogens can replicate and can be readily propagated 
within these mosquitoes (Rosen et al., 1978 and 1981; Tesh, 1979; Kuno, 1981a; Scherer 
and Chin, 1981). These findings invoke the need to establish if there is a natural antiviral 
defence(s) involved in the control of these infections.      
It was first established that TRA-171 cells derived from Toxorhynchites amboinensis are 
efficiently infected by the alphavirus SFV at multiple MOIs as expected due to their 
permissibility to infection by the related CHIKV (Legrand and Hotta, 1983). The 
appearance and growth characteristics of SFV infected TRA-171 cells were not dissimilar 
to uninfected cells. This is expected following a natural viral infection as SFV, in addition 
to other arboviruses, does not cause any insect pathology and allows the survival of the 
vector ensuring its own transmission to susceptible vertebrates when its vector takes a 
blood meal. A further characteristic of mosquito-borne alphaviruses is that they have a 
distinctive growth cycle where an initial rapid increase in viral load during the acute stages 
of infection progresses through to a steady decline and eventual plateau at a prolonged low 
level infection which is maintained for the remainder of the insect’s lifespan. This latent or 
persistent stage generates titres of infective virus which are understandably lower than 
during the acute stage of infection. Following SFV infection in TRA-171 cells this 
distinctive growth pattern was evident. However, the peak of both virus production and 
replication was after 48 h rather than after 24 h as observed in U4.4 cells which are known 
to be a good model for representing infection in the whole organism (Davey and Dalgarno, 
1974; Fragkoudis et al., 2008; Attarzadeh-Yazdi et al., 2009). The growth pattern of SFV 
also differs from observations with CHIKV which did not peak until eight days post 
infection (dpi) and only reached 10
9
 PFU/ml (Legrand and Hotta, 1983). TRA-171 cell 
growth was not observed to be affected by SFV infection and population doubling time 
was approximately 40 h for both infected and non-infected cells. It was also observed that 
cells could be maintained without passaging for two months with no apparent detrimental 
affects to the monolayer while actively growing cells were passaged nine times during this 
period. Cell to cell contact was beneficial to the growth rate of TRA-171 cells as a sparse 
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cell layer resulted in a decrease in growth rate and so cells were maintained at a high 
density to encourage growth. The characteristics displayed by SFV in the TRA-171 cell 
line are similar to those observed during infection of the immunocompetent U4.4 cell line. 
TRA-171 cells appear to inhibit infection and allow SFV to enter persistence in a manner 
similar to U4.4 cells impling that TRA-171 cells could be used as a suitable alternative 
model for SFV:vector interactions.   
The major antiviral defence in insects is known to be based on RNA silencing pathways. It 
was unclear if Toxorhynchites mosquitoes utilised this response against acquired infections 
as nothing has been published to date relating to their antiviral defences. In this study 
TRA-171 cells were shown to be immunocompetent by 1) cleaving dsRNA into small 
RNA molecules of approximately 21 nt and 2) data produced by plasmid and viral 
reporter-gene based silencing assays.  
The results observed from the in vitro dicer cleavage assay indicate that TRA-171 cells can 
cleave dsRNA molecules into siRNA molecules of approximately 21 nts. It can therefore 
be proposed that a protein, such as Dicer or similar, with endonuclease activity is acting in 
these cells. It has been shown that Dicer cleavage of viral genomes in insects generates 
siRNAs of specifically 21 nt in length (Aliyari et al., 2008; Myles et al., 2008 and 2009; 
Siu et al., 2011; Vodovar et al., 2012). Due to comparison with the 21 nt size marker also 
loaded on the gel it can be estimated that these small RNAs are approximately what would 
be anticipated in RNAi competent insects; however, definitive quantification of the size of 
these molecules produced by TRA-171 cells would need to be determined by deep 
sequencing analysis. As the TRA-171 natural antiviral response is most likely required for 
handling low level infections, functional siRNA molecules against the disseminating virus 
may be heavily relied upon to spread to neighbouring cells and curtail the incoming 
infection.           
TRA-171 cells efficiently expressed luciferase genes encoded by plasmids under the 
control of the OpIE2 promoter, known to be functional in other insect cells (See also 
Chapter 5.3.8); although further testing of other promoter types would also be interesting 
to assess their function in this cell type. Nucleic acid uptake was shown to be proficient in 
TRA-171 cells, a necessary element for their use as an in vitro system for arbovirus 
research. Natural uptake of dsRNA was also tested by adding the molecules directly to the 
media, without the addition of a transfection reagent (data not shown). Although dsRNA 
molecules can be readily taken up from the media by Drosophila-derived cells (Saleh et 
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al., 2009), this is not known for any mosquito-derived cells lines. The findings of this 
project are consistent with what is already known for mosquitoes cells in culture as dsRNA 
molecules added directly to the media without the use of a transfection reagent proved to 
be unsuccessful and no expression or functional response was detected above background. 
However, siRNAs may play a more important role in non-cell autonomous control of  
impeding virus dissemination in mosquito cells (Attarzadeh-Yazdi et al., 2009) and should 
be further investigated to understand the exact mechanism(s) involved.    
The existence of an endogenous siRNA pathway induced by dsRNA was determined 
through silencing of plasmid and viral reporter-gene expression and was comparable to 
results seen in other insect cell lines such as the U4.4 and Aag2 cell lines which are known 
to be immunocompetent (Schnettler et al., 2012; Vodovar et al., 2012). Viral silencing in 
TRA-171 cells was more successful at a low MOI when only a small proportion of the 
cells are infected and the virus undergoes multiple rounds of replication to disseminate 
throughout the culture. This suggests that as documented in other cell lines, the TRA-171 
cell’s immune system is overwhelmed by the high viral load and is less able to control the 
infection effectively. This is anticipated as the viral titre in vertically infected larvae is less 
than in the adult female and so the natural response would not encounter such high viral 
load. As it is known that alphaviruses cannot inhibit the RNAi response due to the lack of 
an encoded suppressor protein, it can be suggested that TRA-171 cells would be more 
adept at controlling an alphavirus infection compared to a flavivirus infection which have 
been shown to express silencing suppressing molecules (Schnettler et al., 2012; Kakumani 
et al., 2013). However, as both alphaviruses and flaviviruses are capable of establishing a 
persistent infection this indicates that the cellular defences are able to interfere with the 
infection (Davey and Dalgarno, 1974; Kuno, 1982a; Brown, 1984; Randolph and Hardy, 
1988; Chen et al., 1994; Bowers et al., 1995; Bugrysheva et al., 2001; Mlera et al., 2014). 
Future research is required to properly understand the mechanisms involved in regulating 
persistence and understanding when, where and to what extent the immune response is 
engaged in this aspect of infection.         
Taken together these results suggest that TRA-171 cells have a functional RNAi response 
that can be used to successfully target SFV infection. Further work is required to fully 
characterise the antiviral response in these mosquitoes and validate their use as a model. 
This should include small RNA sequencing, viral sensor plasmids assays and knockdown 
of pathway proteins. 
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It has previously been demonstrated that the Aag2 cell line is persistently infected with 
CFAV which is controlled by the RNAi response (Scott et al., 2010). Initial CFAV 
infections of the Ae. albopictus – derived C6/36 cell line resulted in the normally 
individually distributed cells coming together to form multinucleated cells (Stollar and 
Thomas, 1975). However, these clumped cells had low viability and were eventually 
replaced by the few remaining scattered cells. The virus then passed into a persistent stage 
of infection where few virus particles were produced and the cell monolayer resembled an 
uninfected culture. Further infection of endogenously infected cells with CFAV does not 
result in any CPE presenting as syncytia formation and no additional cell fusion is 
exhibited. This is of particular importance for two reasons. Firstly, Aag2 cells are 
historically documented as an adherent monolayer which is not uniform and with many 
clusters of cells (Lan and Fallon, 1990). This suggests that CFAV interacts with Aag2 cells 
in a different fashion to cells which are more spread within the culture and require fewer 
cell-to-cell contacts. A similar mechanism appears to be involved with the interaction in 
TRA-171 cells. Initial tests to investigate viral contamination in the TRA-171 cell line 
proved to be negative for any endogenous infections (Kuno, 1980), therefore any 
contamination has occurred following the original generation of line. Although the TRA-
171 cell line was maintained in the same environment as the Aag2 cell line it is possible 
that cross contamination occurred in my hands. However, due to the different growth 
media of the two cell lines this is unlikely. Certainly no morphological differences were 
observed in the TRA-171 cells during passaging and they appear to be of similar 
appearance to those initially described. Secondly, this information indicates that an 
apparently healthy cell line may be harbouring an unknown agent which presents no 
obvious symptoms other than initial syncytium formation immediately following infection. 
This emphasises the need for accurate detection methods to be developed to identify the 
extent of contamination within cultures and the potential implications this has for their use 
in arbovirus studies and the effect that endogenous viruses have on further viral infections.  
ISFs don’t have any known medical impact but are of interest due to the potential for 
interactions with pathogenic flaviviruses and in advancing the understanding of flavivirus 
evolution. In addition to ISFs, long flavivirus-related sequences have been found to be 
integrated into the Ae. albopictus and Ae. aegypti genomes, although complete putative 
genomic structures have not been described. One such example is the ‘cell silent agent’ 
(CSA, Crochu et al., 2004) which is related to the nsP1- nsP4 genes of CFAV and KRV, as 
well as to other ISF sequences (Roiz et al., 2009). This could represent a novel mechanism 
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of horizontal gene transfer in eukaryotic cells from a non-retroviral RNA virus. This 
unique integration into the genome suggests that insect-only viruses are highly specialised 
to their insect hosts and it may be postulated that ISFs are an early adaptation of true 
arthropod transmitted flaviviruses. These integration events are only known for Aedes so it 
will be of interest to uncover if such events are also described in other vector populations.  
As Aedes and Culex mosquitoes are major flavivirus vectors, further research into these 
viruses may uncover essential information regarding the evolution of arboviruses and 
vector/host interactions. The presence of ISFs in wild populations of mosquitoes also asks 
the question of how endogenous insect viruses interact with contracted arbovirus 
pathogens and if they are capable of ‘super-infection exclusion’. In such an instance, an 
ISF would allow its host to be refractory to a further infection with a related virus thus 
preventing further transmission. This is becoming of increasing importance due to recent 
emerging cases of certain arthropod-borne flavivirus infections across the globe. In 
particular, West Nile virus (WNV) and CxFV have been documented to co-infect. There is 
conflicting evidence regarding the nature of the association between CxFV and WNV and 
it is not yet fully understood if the interaction between the two is beneficial or restrictive to 
WNV transmission (Kent et al., 2010; Newman et al., 2011; Bolling et al., 2012). Certainly 
super-infection exclusion is virus/vector association dependent and has yet to be fully 
investigated in the context of persistent ISFs infection; although, genetic diversity, as well 
as ecological factors, are considered to be critically involved. Tx. amboinensis would be a 
useful model in which to study co-infections due to the low level of risk associated with 
this species. These experiments are of particular importance to establish if endogenous 
viruses such as ISFs are naturally capable of/or could be manipulated to restrict arboviral 
infections in their host.     
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6.5 Future Work  
 
Further work should be performed to completely characterise SFV infection of TRA-171 
cells by determining the viral titres produced during an established persistent infection by 
plaque assay analysis or by qPCR. Additionally, it would be interesting to compare titres of 
SFV produced from TRA-171 with those from C6/36 cells. As C6/36 cells are commonly 
used to produce high titres of mosquito passaged alphaviruses, it would be beneficial to 
determine if TRA-171 cells may be used for similar purposes and produce high titres of 
other arboviruses in addition to dengue and other flaviviruses. The success of siRNA 
production in these cells also suggests that orthologues of key RNAi proteins may be 
present in their genome and transcriptome analysis would help to identify these. Moreover, 
to investigate the antiviral RNAi response in these cells deep sequencing analysis of the 
small RNAs would ascertain if they are 21 nt in length, as documented in RNAi competent 
insects, or if they are longer and include characteristics of piRNAs that are the major viral 
specific small RNA population produced in C6/36 cells, which have a Dcr-2 null 
phenotype (Brackney et al., 2010). Northern blot and deep sequencing analysis of both 
SFV and the endogenous CFAV infections would determine if these small RNAs are viral-
specific and if they are generated from specific regions of the viral genome. If, as is noted 
in the Aag2 cell line, CFAV activates the antiviral pathway in TRA-171 cells, then you 
would expect a proportion of the small RNA population to match the CFAV genome. This 
avenue of analysis would be necessary to determine if the endonuclease active observed in 
the in vitro dicer assay was acting antivirally. In addition, knockdowns of implied RNAi 
proteins in this cell line followed by viral infection or treatment with viral sensor 
constructs would also be required to fully understand their function during a viral infection.  
As discussed in Chapter 4, the spread of silencing molecules is important for effective 
dissemination of the targeted signal. Potential spread of siRNAs observed within TRA-171 
cells should be further investigated to establish if biologically functional siRNAs are able 
to pass to neighbouring cells and restrict impending infection within the culture. 
Furthermore, if the viral specific siRNA population plays an important role in viral 
targeting there would be a substantial effect on viral spread following infection by the SFV 
reporter strain encoding the tombusvirus siRNA binding protein p19 and these experiments 
should be carried out to determine if this is the case. If the greatest risk of acquiring 
arboviral infections is through the consumption of vertically infected larvae then it would 
also be beneficial to investigate the antiviral defence of TRA-171 cells against flaviviruses 
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that are well known to be transmitted in this way and is in contrast to alphaviruses which 
are not. Unfortunately, these experiments could not be performed due to licensing 
constraints.     
 
  
     
 
Chapter 6  Antiviral capabilities of Toxorhychites  
  amboinensis- derived cells  
 
250 
 
6.6 Principle Findings  
 
1. Determined that SFV is capable of establishing an infection which progresses to 
persistence in the Toxorhynchites amboinensis derived TRA-171 cell line.  
2. This infection does not result in any apparent CPE and reaches the peak of infection 
48 hpi. 
3. The TRA-171 cell line successfully expressed plasmid encoded Rluc and Fluc 
genes under the control of promoters known to be expressed in insect cells. 
4. A functional RNA silencing response initiated by dsRNA was demonstrated against 
both plasmid DNA and SFV infection in these cells.  
5. Small RNA molecules that are approximately 21 nt in length are produced 
following SFV infection.  
6. In our hands, the TRA-171 cell line is endogenously infected by the insect specific 
flavivirus CFAV.  
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Chapter 7: Concluding Remarks  
 
Antiviral RNAi in insects is employed by cells to detect long dsRNA molecules generated 
following a viral infection. Through their recognition by Dcr-2 they are digested into 
smaller fragments which are then utilised by Ago-2 to recognise complementary 
homologous coding sequences for degradation. Previously, the most comprehensive 
studies focusing on the involvement of RNAi in insect antiviral activities were carried out 
using Drosophila. However, the importance of understanding the fine workings of these 
important RNAi proteins in mosquitoes has become increasing recognised over the past 
number of years, in particular for the control of mosquito-borne arboviruses. Many of these 
viruses are highly pathogenic to both humans and animals and pose a substantial risk to 
their welfare, as well as to the economic and environmental health of infected areas. 
Conventional mosquito control methods, such as insecticides, breeding site reduction 
programmes and trapping, have proved to be valuble but difficult to implement and 
unsustainable. Certainly many arbovirus vectors are rancorous daytime biters and require 
the implementation of more complex protective apparatus compared to night-time feeders 
which may be efficiently controlled with properly installed bed nets. Therefore, alternative 
approaches are sought to stem the growing burden that arboviral infections place on 
populations across the globe. Understanding the intricacies of the complex interactions 
between arboviruses and the antiviral immune response will allow new insights into the 
mechanisms involved in viral limitation at the infection or replication level before 
transmission is able to occur to be determined. This can, for example lead to the generation 
of genetically modified mosquitoes or those with defined refractory alleles.    
The aim of this project was to extend the scope of our understanding of the RNAi response 
in Aedes mosquitoes through the development of a molecular ‘tool-box’. Although RNAi 
studies in Drosophila benefit from an array of genetic and biological tools, these are 
conspicuously absent from mosquito research. Moreover, given the growing understanding 
that the little data already determined for mosquitoes does not always equate with what is 
known in Drosophila, it has been crucial to establish appropriate assays and biological 
tools in order to authenticate the RNAi response in mosquitoes. Indeed it has recently been 
brought to light that species specificities may exist, further highlighting the vital need for 
these tools (van Mierlo et al., 2014).   
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In Chapter 3 an efficient gene silencing assay was developed for the knockdown of key 
RNAi proteins (Ago-1, Ago-2, Dcr-1 and Dcr-2) within the Ae. aegypti-derived Aag2 cell 
line. The treatment of cells with transcript specific dsRNA successfully reduced expression 
of each of the protein mRNAs after 24 h and revealed that the most significant influence on 
SFV infection was Ago-2. These findings are therefore in line with other literature in live 
mosquitoes which also suggests that Ago-2 knockdown enhances alphavirus and flavivirus 
replication and is a major effector in the antiviral RNAi defences (Keene et al., 2004, Li et 
al., 2004, Franz et al., 2006, Campbell et al., 2008, Sanchez-Vargas et al., 2009, Schnettler 
et al., 2013a, McFarlane et al., 2014). Due to the difficulties in generating stable knockout 
cell lines, establishing effective silencing assays was necessary. These have proved to be 
important for characterising the hierarchy of each protein and uncovering their roles within 
the antiviral response in mosquito-derived cell lines. It is known that the competence of 
different vector populations for disease transmission is influenced by the natural degree of 
variation in the expression of the RNAi genes (Lambrechts et al., 2013). Therefore, 
understanding those which play the most prominent role in immunity can drive the 
development of transgenic mosquitoes to present resistance to arboviral infections through 
engineering enhanced activity of the RNAi pathway (Adelman et al., 2002, Olson et al., 
2002, Franz et al., 2006, Lambrechts et al., 2013). In addition, screening of certain 
variations in RNAi genes has the potential to aid disease monitoring by identifying vector 
populations either at risk of enhanced arbovirus transmission or those which are refractory. 
Certainly, it is important to understand the mechanism(s) involved in vector competency in 
order to develop novel control strategies and altering the competency of arboviral vector 
by genetic manipulation has been proposed as a viable approach (Crampton et al., 1990, 
Travanty et al., 2004).     
Furthermore, the production of viral-derived small RNAs from the Ae. aegypti-derived 
Aag2 and Ae. albopictus-derived U4.4 cell lines was investigated through the use of 
Northern blot analysis and deep sequencing technology. Flaviviruses are the only 
arboviruses known to express inhibitors of RNAi (Pijlman et al., 2008, Schnettler et al., 
2012, Kakumani et al., 2013) while SFV, as with other alphaviruses, is believed to evade 
the RNAi response rather than directly suppress it (Siu et al., 2011). Previously performed 
deep sequencing analysis determined that 21 nt viRNAs are produced following SFV 
infection in both cell lines (Siu et al., 2011); however, these were present in such small 
quantities that Northern blot detection could not be achieved, even against those known to 
be generated in the greatest concentrations. Many unanswered questions still remain 
regarding alphavirus replication within invertebrate cells and the kinetics of RNAi 
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detection and interaction with viral-derived dsRNAs, which is something this thesis aimed 
to go some way towards addressing. Certainly work described in Chapter 3 determined 
that the small RNAs pattern of ‘hot’ and ‘cold’ spots is not limited to viral-derived dsRNA. 
Interestingly, non-target specific external dsRNA also exhibited this pattern of distribution 
across the coding sequence and that 21 nt was the predominant size produced 
implementing Dcr-2 processing. Therefore, it can be suggested that the RNAi response is 
activated by perfect non-viral dsRNA sequences and the ‘hot’ and ‘cold’ patterns are due 
to cellular processing and not as a result of a viral mechanism. Questions as to why some 
sequences appear to be targeted more than others remain to be clarified and it will be 
necessary to investigate these in depth in order to fully understand RNAi processing during 
viral infections. It may be suggested that this is a technical artefact produced due to the 
detection of both double-stranded siRNAs and single-stranded, incorporated siRNA 
molecules during the deep sequencing analysis. The ‘hot’ spot siRNAs may simply be 
those which are incorporated into RISC and used for silencing, therefore generating a 
greater number of reads compared to those which are double-stranded and have not been 
taken up. Alternatively there may be a degradation system in place which rapidly removes 
the passenger strand which is yet to be characterised. Validation of this hypothesis may 
only be achieved through RISC immunopreciptations and a method for establishing these 
in Ae. aegypti-derived cells was attempted in Chapter 5.              
Chapter 4 discusses the interesting hypothesis that an RdRP exists within the genome of 
Ae. aegypti. Although RdRps are crucial for the amplification and spread of the RNAi 
signal in organisms such as plants and worms, only one group suggested they existed 
within the Drosophila genome (Lipardi et al., 2001, Lipardi et al., 2003, Lipardi et al., 
2005, Lipardi and Paterson, 2009). However, since the initiation of this area of my project 
the suggestion was retracted; although, the authors still maintain that there is an association 
between the protein, D-elp1 and the RNAi mechanism through an interaction with Dcr-2 
(Lipardi and Paterson, 2011). Therefore, it was interesting to understand if an orthologue 
of D-elp1 existed within the Ae. aegypti genome and if it did, was it expressed by the Ae. 
aegypti-derived Aag2 cell line and exhibit any discernible antiviral function. The data 
obtained from the investigations carried out during this study determined that although a 
homologue is encoded by Ae. aegypti (Aa-elp1) and is translated, the protein does not 
appear to act antivirally following SFV infection as established by transcript knockdown 
assays. There was also no evidence of increased virus replication detected following Aa-
elp1 silencing. These findings are therefore in agreement with the majority of literature that 
Drosophila and mosquitoes do not express a functional RdRP and so, unlike plants and C. 
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elegans, do not appear to require the amplification of the RNAi signal in order to establish 
the robust antiviral RNAi response exhibited by these insects (Hammond et al., 2000, 
Zamore et al., 2000, Nykanen et al., 2001, Schwarz et al., 2002, Roignant et al., 2003).     
The development and generation of biological tools for the study of Ae. aegypti RNAi 
proteins is presented in Chapter 5. In order to reduce our reliance on Drosophila systems, 
a number of strategies for monitoring the key RNAi proteins were investigated, with 
varying degrees of success. A major void in the field is the absence of efficient antibodies 
against the mosquito Ago-1, Ago-2, Dcr-1 and Dcr-2 proteins. Therefore, a number of 
antibodies were commissioned as part of this project and screened to determine their 
efficiency to recognise their targets. As a result of this work a number of candidate 
antibodies were selected against Ae. aegypti Ago-1, Dcr-1 and Dcr-2 proteins; however, 
unfortunately no successful antibodies were identified for Ago-2, which, as previously 
discussed, has been identified as the most important antiviral protein (Keene et al., 2004, 
Li et al., 2004, Franz et al., 2006, Campbell et al., 2008, Sanchez-Vargas et al., 2009, 
Schnettler et al., 2013a, McFarlane et al., 2014). Further work is required to optimise those 
potential successes for use in future experiments involving detection and tracking of the 
endogenous proteins during the activation of their respective pathways, as well as protein 
immunoprecipitations to determine bound small RNAs and associating proteins.    
The second approach tackled was to produce fluorescently tagged versions of Ago-2 and 
Dcr-2 which could be monitored within the cell using confocal microscopy. Initial 
production of the proteins was problematic due to the lack of expression achieved using 
conventional insect OpEI2 promoters. Although an inconvenient expression system for the 
study of antiviral processes, protein production was achieved using the SFV subgenomic 
promoter. Both Ago-2 and Dcr-2 fused to their respective tags were cloned into the SFV 
VRPs and used to successfully infect Ae. aegypti-derived Aag2 cells and Ae. albopictus-
derived U4.4 cells as well as mammalian BHK-21 cells. Unfortunately, this resulted in 
extensive over-expression of both proteins meaning that detailed co-localisation and 
kinetic studies would not be able to be performed accurately. In addition, performing an in 
vitro Dicer cleavage assay using Dcr-2 null phenotype Ae. albopictus-derived C6/36 cells 
did not allow the successful function of the Dcr-2 construct to be ascertained. Similarly, an 
alternative expression system using a cell-free, rabbit reticulocyte extract failed to generate 
any fluorescently tagged Dcr-2. Taken together these results highlight the difficulties faced 
when developing new means of studying mosquito systems.  
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However, there were two significant advances produced during this part of my project. 
Firstly, the creation of Ago-2 constructs with a V5 tag on either the C- or N- terminals was 
achieved and these were successfully cloned into the SFV replicon. Detection of the 
expressed V5 tag from BHK-21 cell extracts was accomplished by Western blot analysis 
using an anti-V5 tag. In the future these constructs will allow immunoprecipitation studies 
to be performed and permit analysis of the small RNAs incorporated into the active RISCs, 
in addition to protein-protein interaction studies to investigate co-factors associated with 
RISC. Secondly, the development of a plasmid containing the Ae. aegypti polyubiquitin 
(PUb)  promoter for the control of gene expression within insect cells was accomplished. 
This promoter was shown to generate significantly higher levels of expression compared to 
the OpEI2 gene promoter. The adaptation of a promoter which is capable of providing a 
maintained level of gene expression within both mosquitoes in vivo and their derived cell 
lines would greatly augment studies into gene regulation, expression and function, in 
particular for arboviral research into immune genes and those related to virus replication 
and transmission (Anderson et al., 2010). Both of these developments will greatly benefit 
studies of the small RNA pathways in mosquitoes in the future.            
The results discussed in Chapter 6 indicate that, as with other arboviruses determined in 
the literature, SFV is able to replicate within the Tx. amboinensis-derived TRA-171 cell 
line. This was important to learn in order to establish that this cell line is a viable model for 
arbovirus research given the ample number of advantages associated with this large, non-
haematophagous mosquito. Moreover, during the course of this research area two crucial 
findings were also made which further enhances the need to study this mosquito more 
closely. Firstly, the cell line was shown to perform RNAi if induced by dsRNA. Whether 
this is truly an active antiviral RNAi response or the adaptation of another small RNA 
pathway, for example the miRNA pathway, to act antivirally following the detection of 
exogenous dsRNA has yet to be confirmed. As with other mosquito species it will be 
necessary to determine if viral-derived small RNAs are produced to ascertain if there is an 
active exogenous RNAi response defending against a viral infection. It will also be 
necessary to determine if these insects are able to be infected by insect-specific viruses and 
if so does this evoke an antiviral reaction? This project also determined that the TRA-171 
cells contained an endogenous insect-specific flavivirus, CFAV. Although the origin of 
this case of infection is unknown and may have occurred through contamination, it is 
important to understand how these infections affect mosquito immunity. Certainly, the 
interplay between endogenous viruses and arboviruses may have a significant impact on 
arbovirus transmission and/or vector fitness and fecundity in the field. It has been shown 
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that endogenous viruses may decrease the replication of subsequent/co-infecting arboviral 
infections by the ‘super-infection exclusion’ principle which is similar to the impact some 
strains of Wolbachia have on a mosquitoes ability to transmit some infections (Bolling et 
al., 2012, Hobson-Peters et al., 2013, Rainey et al., 2014). The discovery of endogenous 
viruses adds further complexity to vector: virus interactions and we are only just beginning 
to elucidate their involvement in modulating simultaneous arbovirus infections. However, 
it has been suggested that they may be utilised in the future as a potential control method 
of arboviral transmission and further work will be required to understand this preventative 
mechanism.     
Overall the work presented as part of this thesis goes some way towards filling the void of 
tools available for researching RNAi in Ae. aegypti. It has been established that data 
obtained in Drosophila focused immunity experiments does not always translate well to 
mosquito based set-ups and these tools are necessary to perform appropriate experiments 
and achieve accurate results for viral infections in the natural vector system. In the long 
term these applications will be highly valuable in controlling the transmission, spread and 
emergence of highly important arboviruses through the use of transgenic mosquitoes or 
biological control mechanisms.     
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